Congresses/IGCS2010/Documents/Secretariat

Transcription

Saturday, October 23, 2010
08:00-12:00
Hall C
Educational Symposium:
TEACHING SURGERY IN GYNECOLOGICAL ONCOLOGY
Chairpersons:
D. Cibula, Czech Republic
N. Abu-Rustum , USA
08:00
TEACHING PELVIC LYMPHADENECTOMY
N. Abu-Rustum, USA
08:30
TEACHING PARAAORTIC LYMPHADENECTOMY
F. Raspagliesi, Italy
09:00
TEACHING RADICAL HYSTERECTOMY
09:30
DISCUSSION
10:00
Coffee Break, Exhibition and Poster Viewing
10:30
TEACHING PERITONECTOMY (PELVIC, DIAPHRAGM)
J. Sehouli, Germany
11:00
TEACHING BOWEL SURGERY
D. Chi, USA
11:30
TEACHING LAPAROSCOPY
A. Martinez, France
12:00
Lunch Break, Exhibition and Poster Viewing
1
08:00-12:00
Hall D
BIOLOGICAL AGENTS AND TARGETED THERAPIES
Supported by an educational grant from Boehringer Ingelheim International GmbH
Chairpersons:
R.L. Coleman, USA
R. Burger, USA
R.D. Alvarez, USA
08:00
INTRODUCTION
R.L. Coleman, USA
08:05
GOG 218: WHAT'S NEXT
R. Burger, USA
08:30
ICON7: WHAT'S NEXT
A. Oza, Canada
08:55
DISCUSSION
A. Oza, Canada
R. Burger, USA
09:15
NON-VEGF ANTIANGIOGESIS AGENTS
A. Alvarez Secord, USA
09:40
ANGIOGENESIS ESCAPE - WHAT IS IT?
R.D. Alvarez, USA
10:00
10:30
CLINICAL UTILITY OF THE PARP INHIBITORS
S. Kaye, UK
11:00
FOLATE AS A TARGET: FARLETUZUMAB
D.K. Armstrong, USA
11:20
FOLATE AS A TARGET: EC145/EC-20
R.W. Naumann, USA
11:40
DISCUSSION
12:00
2
08:00-12:00
Hall E
GYNECOLOGICAL CANCER NURSING AND INNOVATIONS IN PRACTICE
Chairperson:
K. Weare, Australia
GYNAECOLOGICAL CANCER CARE CO-ORDINATORS
08:00
CARE CO-ORDINATION AND CARE NAVIGATORS IN CANADA
J. Power, Canada
08:25
INNOVATIONS IN NURSE LED CLINICS
K. Nattress, Australia
PALLIATIVE CARE NURSES
08:55
PALLIATIVE CARE NURSING IN AFRICA
K. Defilippi, South Africa
LYMPHOEDEMA NURSING
09:30
THE ROLE OF THE NURSE IN LYMPHOEDEMA CARE AND INNOVATIONS IN
MANAGEMENT
M. Sneddon, UK
10:00
NURSE RESEARCHERS
10:30
OPPORTUNITIES AND OBSTACLES FOR NURSE RESEARCHERS AND
RESULTS OF A STUDY INTO 'SELF-REPORTED FECAL INCONTINENCE AND
QUALITY OF LIFE AMONG LONG-TERM GYNAECOLOGICAL CANCER
SURVIVORS TREATED WITH PELVIC RADIOTHERAPY
G. Dunberger, Sweden
10:50
OPPORTUNITIES AND OBSTACLES FOR NURSE RESEARCHERS AND
RESULTS OF A STUDY INTO 'THE LIVED EXPERIENCE OF WOMEN WITH
CANCER OF THE VULVA'
H. Jefferies, UK
NURSE ABSTRACT PRESENTATIONS
11:10
DEVELOPMENT OF THE ROLE OF CANCER NURSE COORDINATOR: A WEST
AUSTRALIAN APPROACH
P. Tanner, Australia
11:20
THE NURSE’S ROLE IN IMPROVING NUTRITIONAL STATUS FOR WOMEN
WITH GYNAECOLOGICAL CANCER: AN EVIDENCE IMPLEMENTATION STUDY
M. Ryan, K. White, S. Watts, E. Knowland, D. Jennifer, G. Mulvany, Australia
3
08:00-12:00
Hall E
GYNECOLOGICAL CANCER NURSING AND INNOVATIONS IN PRACTICE (contd.)
NURSE ABSTRACT PRESENTATIONS
11:30
DEVELOPMENT AND IMPLEMENTATION OF THE OVARIAN CANCER CENTRE
AT THE EUROPEAN INSTITUTE OF ONCOLOGY
C. Beltrami, M. Cerone, E. Misurelli, M. Biggiogero, E. D'Anna, I. Feroce,
A. Milani, Italy
11:40
LIVING ON THE PEAK- THE LIVED EXPERIENCES OF PATIENTS
UNDERGOING EXTENSIVE CHEMOTHERAPY FOR RECURRING OVARIAN
CANCER
E. Ekwall, B. Sorbe, B.-M. Tenestedt, H. Sunvisson, Sweden
12:00
08:00-12:00
Hall F
PATHOLOGY
Chairperson: E.G. Silva, USA
08:00
LYNCH SYNDROME ASSOCIATED ENDOMETRIAL CANCER
R. Soslow, USA
08:30
HEREDITARY “OVARIAN” CANCER: UPDATE AND ROLE OF THE FALLOPIAN
TUBE
T.A. Longacre, USA
09:00
NEW DEVELOPMENTS FROM GYN PATHOLOGY: WHAT IS IMPORTANT FOR
GYN ONCOLOGISTS?
E.G. Silva, USA
09:30
DISCUSSION
10:00
10:30
CLASSIFICATION OF OVARIAN CARCINOMAS BASED ON PATHOLOGY AND
MOLECULAR GENETICS
J. Prat, Spain
11:00
DIFFERENT MORPHOLOGIC SUBTYPES OF OVARIAN CARCINOMA: WHY IT IS
CLINICALLY IMPORTANT FOR THE PATHOLOGIST TO GET IT RIGHT
W.G. McCluggage, UK
11:30
BORDERLINE OVARIAN TUMORS: WHAT WE HAVE LEARNED IN THE LAST 50
YEARS
R.J. Kurman, USA
4
10:30-12:00
Hall B
EUTROC Symposium:
PERSONALIZING TREATMENT FOR OVARIAN CANCER: HOPE OR HYPE?
Sponsored by PharmaMar, Ipsen and Fujirebo
10:30
PERSONALIZATION AND TRANSLATION: WHAT IS EUTROC AND WHY DO
WE NEED IT NOW
J. Sehouli, Germany
10:40
BIOMOLECULAR INSIGHTS IN OVARIAN CANCER: INFORMATION FOR
PERSONALIZATION
M. Birrer, USA
10:55
PERSONALIZED MEDICINE IN CLINICAL PRACTICE NOW: HISTOLOGICAL
SUBTYPES AND CLINICAL PLATINUM RESISTANCE IN OVARIAN CANCER
J. Green, UK
11:10
PERSONALIZING THE REVERSAL OF TREATMENT FAILURE: STRATEGIES
FOR TARGETING PLATINUM RESISTANCE
H. Gabra, UK
11:25
BUILDING TECHNOLOGY INTO CLINICAL TRIALS – TOOLS TO IMPROVE OUR
CURRENT AND FUTURE PROSPECTS
B. Brown, UK
11:40
EUTROC: ONGOING STUDIES FOR A EUROPEAN DIMENSION
F. Esposito, Italy
R. Zeillinger, Austria
10:30
SUMMARY: ADDRESSING UNMET NEEDS BY COLLABORATIVE PANEUROPEAN TRANSLATIONAL RESEARCH
H. Gabra, UK
12:00
12:30-13:30
Hall A
Industry Satellite Symposium:
A NOVEL BIOMARKER FOR THE MANGEMENT OF OVARIAN CANCER
Sponsored by Fujirebio Diagnostics, Inc.
12:30
INTRODUCTION
R.G. Moore, USA
12:35
OVARIAN CANCER SYMPTOM INDEX AND BIOMARKERS
B. Goff, USA
12:55
PELVIC MASS RISK ASSESSMENT
R.G. Moore, USA
13:15
VALIDATION OF ROMA IN CHINA
H. Cui, China
13:25
QUESTIONS AND ANSWERS
5
14:00-15:30
Hall B
TRABECTEDIN: CHANGING PARADIGMS IN THE TREATMENT OF RELAPSED OVARIAN
CANCER
Sponsored by PharmaMar
Chairperson:
A. Poveda, Spain
14:00
TRABECTEDIN, A NEW OPTION EMERGING FROM THE SEA FOR PATIENTS
A. Poveda, Spain
14:05
AN INCREASING ROLE FOR TRABECTEDIN IN GYNAECOLOGICAL CANCERS
I. Ray-Coquard, France
14:20
SAFETY PROFILE OF TRABECTEDIN: CONSIDERATIONS FOR GOOD
MANAGEMENT
A. Gonzalez-Martin, Spain
14:35
BENEFITS OF ENHANCING THE PLATINUM-FREE INTERVAL IN THE
TREATMENT OF RELAPSED OVARIAN CANCER: MORE THAN JUST A
HYPOTHESIS?
J. Ledermann, UK
14:50
EFFICACY OF TRABECTEDIN IN PLATINUM-SENSITIVE RELAPSED OVARIAN
CANCER: NEW DATA FROM THE RANDOMIZED STUDY OVA 301
N. Colombo, Italy
15:15
DISCUSSION
15:25
CONCLUSIONS
A. Poveda, Spain
15:30
6
16:00-17:30
Hall A
Plenary Session I:
OPENING PLENARY SESSION
Chairpersons:
L. Rob, Czech Republic
C.L. Creutzberg, The Netherlands
16:00
SUMMARY OF CLINICAL TRIAL EFFICACY RESULTS OF GARDASIL®
(QUADRIVALENT HUMAN PAPILLOMAVIRUS [HPV] 6/11/16/18 VACCINE)
W. Huh, for the FUTURE II Study Group, USA
16:11
END-OF-STUDY EFFICACY OF GARDASIL® AGAINST HPV6/11/16/18-RELATED
PERSISTENT INFECTION AND DISEASE IN WOMEN AGED 24 TO 45
X. Castellsague, FUTURE III Investigators, Spain
16:22
PARAMETRIAL INVOLVEMENT IN WOMEN WITH EARLY STAGE CERVICAL
CANCER WITH TUMOR LESS THAN 20MM AND WITH NEGATIVE SENTINEL
LYMPH NODES
J. Klát, L. Ńevţík, P. Gráf, P. Buzrla, Z. Jalůvková, O. Ńimetka,
O. Kraft, Czech Republic
16:33
BRACHYTHERAPY VERSUS RADICAL HYSTERECTOMY AFTER
CHEMORADIATION WITH GEMCITABINE PLUS CISPLATIN. A RANDOMIZED
PHASE III STUDY IN IB2-IIB CERVICAL CANCER
L. Cetina, D. Cantù, C. Lopez-Graniel, J. Coronel, A. Gonzalez E., D. Pèrez,
J. Chanona, J. Hinojosa, L. Rivera, A. Poitevin, R. Jimènez, A. Mota, G. Montalvo,
D. Muñoz, J. De la Garza, A. Mohar, A. Dueñas G., Mexico
16:44
ENDOMETRIAL CANCER IN THE OLDEST OLD: TUMOR CHARACTERISTICS,
PATTERNS OF CARE, AND OUTCOME
J. Wright, S. Lewin, N. Barrena Medel, X. Sun, W. Burke, T. Herzog, USA
16:55
A RANDOMIZED PHASE II TRIAL OF RIDAFOROLIMUS COMPARED WITH
PROGESTIN OR CHEMOTHERAPHY IN FEMALE ADULT PATIENTS WITH
ADVANCED ENDOMETRIAL CARCINOMA
A. Oza, A. Poveda, J.M. Del Campo, A. Richard, D.J. Dorer, F. Haluska, Canada
17:06
SYSTEMATIC COCHRANE REVIEW EXAMINING THE ROLE OF ADJUVANT
CHEMOTHERAPY FOR ENDOMETRIAL CANCER
N. Johnson, A. Bryant, T. Miles, P. Cornes,
Cochrane Gynaecological Cancer Review Group, UK
17:17
7
17:30-19:00
Hall B
Interactive Session:
SENTINEL NODE MAPPING IN GYNECOLOGICAL CANCER
Chairpersons:
N. Abu-Rustum, USA
17:30
SENTINEL LYMPH NODE MAPPING IN CERVICAL CANCER
17:50
SENTINEL LYMPH NODE MAPPING IN VULVAR CANCER
A.G.J. van der Zee, The Netherlands
18:10
SENTINEL LYMPH NODE MAPPING IN ENDOMETRIAL CANCER
N. Abu-Rustum, USA
18:30
CONTROVERSIES AND FUTURE OF SLN IN GYNECOLOGIC ONCOLOGY GROUP DISCUSSION
C. Levenback, USA
17:30-19:00
Hall C
SCREENING FOR OVARIAN CANCER
Chairperson:
I. Jacobs, UK
17:30
INTRODUCTION
I. Jacobs, UK
17:35
OVARIAN SCREENING ARM PLCO STUDY UPDATE
A. Black, USA
17:55
UK COLLABORATIVE STUDY OF OVARIAN CANCER SCREENING (UKCTOCS)
UPDATE
U. Menon, UK
18:15
DISCUSSION
8
17:30-19:00
Hall D
ADVANCES IN ENDOMETRIAL CANCER
Chairperson:
I. Konishi, Japan
17:30
SYSTEMATIC LYMPHADENECTOMY IN ENDOMETRIAL CANCER: WHERE ARE
WE NOW AND WHERE ARE WE GOING?
S.C. Dowdy, USA
17:50
DETECTION OF SENTINEL LYMPH NODES DURING SURGERY FOR
ENDOMETRIAL CANCER: A SOLUTION FOR CONTROVERSY?
N. Yaegashi, Japan
18:10
WHAT IS THE STANDARD, POSTOPERATIVE CHEMOTHERAPY FOR
HIGH-RISK ENDOMETRIAL CANCER?
D. Aoki, Japan
18:30
THE ROLE OF RADIATION THERAPY FOR EARLY STAGE ENDOMETRIAL
CANCER
M. Gultekin, Turkey
18:50
DISCUSSION
9
17:30-19:00
Hall E
ADVANCES IN RADIATION ONCOLOGY
Chairpersons:
C.L. Creutzberg, The Netherlands
G. Thomas, Canada
IMRT FOR CERVICAL CANCER
17:30
TARGET VOLUMES, ORGAN MOTION AND CONTOURING PITFALLS FOR IMRT
K. Lim, Australia
17:42
ROLE OF PET-CT IN TREATMENT PLANNING AND FOLLOW-UP
J.H. Nam, Republic of Korea
17:54
COULD IMRT REPLACE 3-D CONFORMAL BRACHYTHERAPY FOR THE
BOOST
K. Alektiar, USA
18:06
DISCUSSION
OUTCOMES: SURVIVING GYNAECOLOGICAL CANCERS - LATE TOXICITY
AND QUALITY OF LIFE
18:15
ACUTE AND LATE TOXICITY AFTER IMRT VS CONVENTIONAL RT
L. Mell, USA
18:27
IMPACT OF RT ON BLADDER AND BOWEL SYMPTOMS AND SEXUALITY
E. Åvall-Lundqvist, Sweden
18:39
LYMPHEDEMA AND LONG-TERM IMPACT OF CANCER
L. van de Poll-Franse, The Netherlands
18:51
DISCUSSION
17:30-19:00
Hall F
HEREDITARY GYNECOLOGIC CANCER
Chairperson: J. Boyd, USA
17:30
INTRODUCTION
J. Boyd, USA
17:40
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME
N. Kauff, USA
18:10
DISCUSSION
18:20
LYNCH SYNDROME
K. Lu, USA
18:50
DISCUSSION
10
17:30-19:00
Hall G
QUALITY OF LIFE
Chairpersons:
L. Wenzel, USA
D. Chase, USA
17:30
GYNECOLOGIC CANCER - SEXUAL HEALTH AND REPRODUCTIVE ISSUES
J. Carter, USA
17:50
THE IMPORTANCE OF HOPE IN MAINTAINING QUALITY OF LIFE DURING
OVARIAN CANCER TREATMENT
L. Ramondetta, USA
18:10
QUALITY OF LIFE AND SURVIVAL IN ADVANCED CERVICAL CANCER: A
GYNECOLOGIC ONCOLOGY GROUP STUDY
D. Chase, USA
18:30
BIOBEHAVIORAL FACTORS WHICH AFFECT GYNECOLOGIC CANCER
SURVIVORSHIP
L. Wenzel, USA
18:50
CONCLUSIONS
19:00-21:00
Hall A
OPENING CEREMONY & WELCOME RECEPTION
GREETINGS
J. Berek, USA
IGCS President
R. Barakat, USA
IGCS-13 Scientific Program Chair
IGCS-13 Local Organizing Committee Chair
OPENING REMARKS
L. Heger, Czech Republic
Minister of Health
SPECIAL PERFORMANCE
Black Light Theater
Followed by a Welcome Reception
11
12
Sunday, October 24, 2010
07:00-08:00
Hall B
Meet the Expert:
SURGICAL COMPLICATIONS
WHO TO BLAME FOR COMPLICATIONS? THE POWER OF SURGICAL AUDIT
A. Obermair, Australia
COMPLICATIONS: HOW AND WHEN TO DISCUSS
J.P. Curtin, USA
07:00-08:00
Hall C
Meet the Expert:
FUNCTIONAL IMAGING IN GYNECOLOGICAL ONCOLOGY
THE ADDED VALUE OF FUNCTIONAL IMAGING IN THE EVALUATION OF
GYNECOLOGICAL MALIGNANCIES
E. Sala, UK
THE CLINICAL ROLE OF PET /CT IN THE MANAGEMENT OF
GYNAECOLOGICAL MALIGNANCIES
B. Simcock, New Zealand
07:00-08:00
Hall D
Meet the Expert:
UPDATE ON BRCA AND OVARIAN CANCER
PRE-GESTATIONAL COUNSELING OF THE COUPLE WITH A BRCA MUTATION
U. Beller, Israel
THE TUBAL ORIGIN OF BRCA RELATED OVARIAN CANCER
B. Rosen, Canada
07:00-08:00
Hall E
Meet the Expert:
THE FUTURE OF ANTI-CANCER DRUGS: DETERMING VALUE, LOOKING AT SCIENCE,
STRUGGLING WITH COSTS
Speaker:
S. Pecorelli, Italy
13
07:00-08:00
Hall F
Meet the Expert:
ADVANCES IN CHEMOTHERAPY FOR CERVICAL CANCER
Speaker:
B.J. Monk, USA
07:00-08:00
Hall G
Meet the Expert:
CHALLENGES IN THE TREATMENT OF PREMENOPAUSAL BREAST CANCER PATIENTS
07:00
THE YOUNG BREAST CANCER PATIENT: SPECIAL PROBLEMS NEED
SPECIAL SOLUTIONS
C. Marth, Austria
T. Tejada-Berjes, USA
07:15
SURGICAL CONCEPTS IN PREMENOPAUSAL BREAST CANCER
D. Wallwiener, Germany
07:30
TAILORING ADJUVANT THERAPY
S. Campos, USA
07:45
DISCUSSION
14
08:00-12:00
Hall A
Presidential Plenary Session
THE GENETICS AND GENOMICS OF OVARIAN CANCER
Members and Guests are Welcome
Chairperson:
J. Berek, USA
08:00
ROLE OF HIGH PENETRANCE GENES (BRCA1/2 AND OTHER RARE
VARIANTS) IN OVARIAN CANCER SUSCEPTIBILITY AND CHEMOTHERAPY
RESPONSE
K. Offit, USA
08:30
ROLE OF COMMON LOW PENETRANCE GENES (POLYMORPHISMS) IN
OVARIAN CANCER SUSCEPTIBILITY AND CHEMOTHERAPY RESPONSE
A. Berchuck, USA
09:00
THE GENOMIC CHARACTERIZATION OF OVARIAN CANCER THROUGH THE
CANCER GENOME ATLAS (TCGA)
D. Levine, USA
09:30
PANEL DISCUSSION
10:15
10:45
INTRODUCTION OF PRESIDENT
N. Hacker, Australia
11:00
PRESIDENTIAL ADDRESS
J. Berek, USA
11:45
IGCS AWARDS FOR EXCELLENCE IN GYNECOLOGIC ONCOLOGY
Presented by Jonathan S. Berek to:
R. Ozols, USA
R. Young, USA
12:00
15
12:30-14:00
Hall A
CERVICAL CANCER: FROM VACCINE TO VACCINATION
The Role of the Gynecologist
Sponsored by GSK
Chairpersons:
M. Zaiac, Belgium
12:15
WELCOME & INTRODUCTION
12:25
CLINICAL UPDATE ON THE CERVICAL CANCER VACCINE CERVARIX®
A. Szarewski, UK
IMPLEMENTATION OF CERVICAL CANCER VACCINATION:
12:45
HOW FAR CAN PRIMARY PREVENTION TAKE US?
A. Schneider, Germany
13:00
COMMUNICATION STRATEGIES TO OVERCOME BARRIERS TO VACCINATION
A. Szarewski, UK
13:15
APPLYING CERVICAL CANCER VACCINATION IN CLINICAL PRACTICE
T. Paszkowski, Poland
13:15
14:00-15:30
Hall B
Interactive Session
Tumor Board: COVERING OVARY, CERVIX, VULVA AND ENDOMETRIUM
Speakers:
R.W. Naumann, USA
16
14:00-15:30
Hall C
NEO-ADJUVANT CHEMOTHERAPY VS. PRIMARY DEBULKING
Pro/Con Debate
Chairperson: D. Chi, USA
14:00
RESULTS OF THE EORTC RANDOMIZED TRIAL (Pro NACT)
I. Vergote, Belgium
14:20
THOSE WHO IGNORE HISTORY ARE DOOMED TO REPEAT IT (Contra NACT)
D. Chi, USA
14:45
ULTRA RADICAL SURGERY – TOO MUCH OF A GOOD THING (Pro NACT)
P. Hoskins, Canada
15:05
NACT - THE DEAD END STREET OF SURGICAL THERAPY IN OVARIAN
CANCER (Contra NACT)
A. du Bois, Germany
15:30
14:00-15:30
Hall D
ADVANCES IN ROBOTIC SURGERY
Supported by an Educational Grant from Intuitive Surgical
Chairpersons:
W. Gotlieb, Canada
A. Maggioni , Italy
14:00
THE EUROPEAN EXPERIENCE WITH ROBOTIC SURGERY
A. Maggioni, Italy
14:20
THE EVOLVING ROLE OF ROBOTICALLY-ASSISTED SURGERY IN PATIENTS
WITH ENDOMETRIAL CANCER
M. Leitao, USA
14:40
ADVANTAGES OF ROBOTICS IN THE MORBIDLY OBESE AND ELDERLY
POPULATION: EXTENDING THE PATIENT POPULATION BENEFITING FROM
MIS
W. Gotlieb, Canada
15:00
ROBOTIC SURGERY FOR THE TREATMENT OF CERVICAL CANCER
F. Nezhat, USA
15:20
DISCUSSION
17
14:00-15:30
Hall E
CONTROVERSIES IN THE MANAGEMENT OF GYNECOLOGIC CANCERS
Pro/Con Debate
Chairperson:
W. Lichtenegger, Germany
14:00
LYMPHADENECTOMY IN ADVANCED OVARIAN CANCER
Pro: W. Lichtenegger, Germany
Con: T. Herzog, USA
14:30
DOSE-DENSE THERAPY IN PRIMARY OVARIAN CANCER
Pro: K. Fujiwara, Japan
Con: J. Sehouli, Germany
15:00
ROLE OF CA-125 IN THE FOLLOW UP OF OVARIAN CANCER PATIENTS
Pro: C. Marth, Austria
Con: S. Kaye, UK
15:30
14:00-15:30
Hall F
LYMPHADENECTOMY IN ENDOMETRIAL CANCER
Pro/Con Debate
Chairperson:
W.T. Creasman, USA
PRO
W.T. Creasman, USA
K. Podratz, USA
CON
H. Kitchener, UK
P. Benedetti-Panici, Italy
18
14:00-15:30
Hall G
MANAGEMENT OF UTERINE SARCOMAS
Chairperson:
F. Amant, Belgium
14:00
INTRODUCTION/FIGO
J. Prat, Spain
14:07
ESS PATHOLOGY
W.G. McCluggage, UK
14:17
ADENOSARCOMA - PATHOLOGY
W.G. McCluggage, UK
14:27
ESS/ADENOSARCOMA CLINICAL ISSUES
F. Amant, Belgium
14:37
LEIOMYOSARCOMA PATHOLOGY
J. Prat, Spain
14:47
LEIOMYOSARCOMA CLINICAL ISSUES
F. Amant, Belgium
14:57
CARCINOSARCOMA PATHOLOGY
S. Silverberg, Japan
15:07
CARCINOSARCOMA CLINICAL ISSUES
F. Amant, Belgium
15:15
DISCUSSION
15:30
19
16:00-17:30
Hall A
Plenary Session II
Chairpersons:
J. Berek, USA
E. Eisenhauer, Canada
LATE-BREAKING ABSTRACT PRESENTATIONS
16:00
PHASE III TRIAL OF BEVACIZUMAB IN THE PRIMARY TREATMENT OF
ADVANCED OVARIAN, PERITONEAL OR FALLOPIAN TUBE CANCER: A GOG
STUDY
R. Burger, M. Brady, G. Fleming, M. Bookman, J. Walker, R. Mannel, H. Homesley,
J. Fowler, B. Monk, B. Greer, M. Boente, S. Liang, USA
16:11
ICON7: A RANDOMISED CONTROLLED TRIAL OF BEVACIZUMAB IN WOMEN
WITH NEWLY DIAGNOSED EPITHELIAL OVARIAN, PRIMARY PERITONEAL OR
FALLOPIAN TUBE CANCER
J. Pfisterer, T. Perren, A.M. Swart, J. Ledermann, F. Selle, G. Kristensen, M. Carey,
P. Beale, A. Cervantes, A. Oza, on behalf of ICON7 GCIG collaborators, Germany
16:22
ROLE OF CYTOREDUCTIVE SURGERY IN RECURRENT OVARIAN CANCER
(ROC). INTERNATIONAL DESKTOP SERIES OF AGO-KOMMISSION OVAR,
AGO-STUDY GROUP, NOGGO, MITO, AGO-AUSTRIA
J. Sehouli, A. du Bois, D. Lorusso, C. Marth, A. Reuss, M. Pölcher, U. Canzler,
K.U. Petry, A. Obermair, P. Harter, Germany
16:33
EFFICACY OF THE AS04-ADJUVANTED HPV-16/18 VACCINE IN WOMEN AGED
18-25 YEARS: PATRICIA END-OF-STUDY RESULTS
B. Romanowski, J. Paavonen, P. Naud, J. Salmerón, C. Wheeler, S.-N. Chow,
D. Apter, H. Kitchener, X. Castellsagué, J. Teixeira, R. Skinner, J. Hedrick,
U. Jaisamrarn, G. Limson, S. Garland, A. Szarewski, F. Aoki, T. Schwarz,
W. Poppe, K. Hardt, T. Zahaf, D. Descamps, F. Struyf, M. Lehtinen,
G. Dubin, for the PATRICIA Study Group, Canada
PLENARY SESSION CONTINUED
16:44
THE METASTASIS OF DEEP OBTURATOR AND PARA-AORTIC LYMPH NODE
IN 383 PATIENTS WITH CERVICAL CARCINOMA
H. Huang, J. Liu, Y. Li, China
16:55
BILATERAL LYMPHADENECTOMY FOR MIDLINE SQUAMOUS CELL
CARCINOMA OF THE VULVA IS NOT ALWAYS NECESSARY: AN ANCILLARY
ANALYSIS FROM GOG-173
R.L. Coleman, S. Ali, M. Gold, J. Fowler, P. Judson, C.F. Levenback, USA
17:06
ROBOT-ASSISTED SURGERY FOR GYNAECOLOGICAL CANCER
D. Lu, G. Shi, Z. Liu, D. Liu, X. Zhou, China
20
Monday, October 25, 2010
07:00-08:00
Hall B
Meet the Expert:
HOW ON EARTH SHOULD WE MANAGE ENDOMETRIAL CANCER?
THE US PERSPECTIVE
D.S. Miller, USA
THE EUROPEAN PERSPECTIVE
P. Benedetti-Panici, Italy
THE LATIN AMERICAN PERSPECTIVE
R. Puente, Chile
07:00-08:00
Hall C
Meet the Expert:
NERVE SPARING RADICAL HYSTERECTOMY
SURGICAL ANATOMY OF THE INFERIOR HYPOGASTRIC PLEXUS
S. Fujii, Japan
RADICAL PARAMETRIALS DISSECTION AND SYMPHATETIC AND
PARASYMPHATETIC NERVE PRESERVATION
07:00-08:00
Hall D
Meet the Expert:
NEW FIGO STAGING FOR GYNECOLOGICAL CANCER
SARCOMA AND ENDOMETRIUM
D. Mutch, USA
CERVIX AND VULVA
S. Pecorelli, Italy
07:00-08:00
Hall E
Meet the Expert:
OVARIAN CANCER VACCINES
OVARIAN CANCER VACCINES: A CLINICAL UPDATE
P. Sabbatini, USA
21
07:00-08:00
Hall F
Meet the Expert:
POPULATION BASED CANCER SCREENING PROGRAMS ACROSS EUROPE
Speakers:
N. Ozgul, Turkey
M. Gultekin, Turkey
07:00-08:00
Hall G
Meet the Expert:
GESTATIONAL TROPHOBLASTIC NEOPLASIA
INTERESTING CASES OF GESTATIONAL TROPHOBLASTIC NEOPLASIA
J. Schink, USA
J.R. Lurain, USA
08:00-10:00
Hall B
Free Communication:
Ovarian Cancer
Chairpersons:
W. Gotlieb, Canada
N. Colombo, Italy
08:00
CHEMOSENSITIVITY AND OUTCOME OF BRCA1- AND BRCA2-ASSOCIATED
OVARIAN CANCER PATIENTS AFTER FIRST LINE CHEMOTHERAPY
COMPARED WITH SPORADIC OVARIAN CANCER PATIENTS
P.M. Vencken, M. Kriege, D. Hoogwerf, S. Beugelink, M. van der Burg, M. Hooning,
E. Berns, A. Jager, M. Collee, C. Burger, C. Seynaeve, The Netherlands
08:09
CONTRACEPTION METHODS, BEYOND ORAL CONTRACEPTIVES AND TUBAL
LIGATION, AND RISK OF OVARIAN CANCER
R.B. Ness, R.C. Dodge, R.P. Edwards, K.B. Moysich, USA
08:18
MICROARRAY-BASED OVARIAN CLEAR CELL CARCINOMA SIGNATURE
PREDICTS SORAFENIB AS A PROMISING REAGENT TARGETING SPECIFIC
CELL SIGNALING
M. Mandai, K. Yamaguchi, N. Matsumura, T. Okamoto, T. Baba, J. Hamanishi,
S. Fujii, I. Konishi, Japan
08:27
ROLE OF NOTCH SIGNALING IN OVARIAN CANCER
J. Wright, M. Zerlin, M. Shah, T. Herzog, J. Kitajewski, USA
08:36
A PHASE II TRIAL DEMONSTRATING ACTIVITY OF SINGLE AGENT OLAPARIB
IN WOMEN WITH RECURRENT SEROUS OVARIAN CARCINOMA
A. Oza, M. Tischkowitz, H. Mackay, K. Swenerton, H. Hirte, A. Robidoux,
D. Huntsman, E. Macpherson, J. Carmichael, K. Gelmon, Canada
22
08:00-10:00
Hall B
Free Communication:
Ovarian Cancer (contd.)
08:45
THE IMPACT OF ADJUVANT CHEMOTHERAPY FOR STAGE I CLEAR CELL
CARCINOMA OF THE OVARY: JAPAN CLEAR CELL CARCINOMA STUDY
M. Takano, T. Sugiyama, N. Yaegashi, S. Sagae, K. Kuzuya, Y. Udagawa,
H. Tsuda, M. Suzuki, T. Goto, H. Tsuda, T. Moriya,
Y. Kikuchi, Japan Clear Cell Carcinoma Study Group, Japan
08:54
SECOND-LINE TREATMENT OF PARTIALLY-PLATINUM-SENSITIVE
RECURRENT OVARIAN CANCER: A MANGO - PIEMONTE E VALLE D'AOSTA
CANCER NETWORK ITALIAN MULTICENTRIC RETROSPECTIVE STUDY
A. Ferrero, L. Fuso, R. Fossati, B. Sostegni, O. Nicoletto, A. Gadducci,
F. Raspagliesi, A. Testa, N. Colombo, A.A. Lissoni, P. Zola, MaNGO,
Piemonte e Valle d'Aosta Cancer Network, Italy
09:03
A GEICO RANDOMIZED PHASE II STUDY OF PACLITAXEL-CARBOPLATIN
(PC) VERSUS GEMCITABINE-CARBOPLATIN (GC) FOLLOWED BY
PACLITAXEL-CARBOPLATIN IN PLATINUM-SENSITIVE RECURRENT OC
(PSROC)
A. Gonzalez-Martin, A. Casado, J.A. Arranz, M.J. Rubio, E. Calvo, E. Guerra,
M. Beltran, C. Mendiola, A. Sanchez-Muñoz, A. Santaballa, I. Bover, A. Herrero,
B. Pardo, A. Cervantes,
GEICO (Grupo Español de Investigación en Cáncer de Ovario), Spain
09:12
PHASE I STUDY OF A SRC INHIBITOR, DASATINIB, IN COMBINATION WITH
PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN
CANCER
A. Alvarez Secord, D. Teoh, L. Havrilesky, P. Lee, A. Berchuck, J. Lancaster,
R. Wenham, USA
09:21
POTENTIAL FOR TARGETED CHEMOTHERAPY WITH PARP INHIBITORS IN
HOMOLOGOUS RECOMBINATION DEFICIENT EPITHELIAL OVARIAN
CANCERS AND CLINICO PATHOLOGICAL CORRELATION
A. Mukhopadhyay, S. Soohoo, B. Uzir, A. Ellatar, S. Wilkinson, A. Cerbinskaite,
S. Kyle, N. Curtin, R. Edmondson, UK
09:30
TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN
RELAPSED OVARIAN CANCER (ROC): AN ANALYSIS OF THE PARTIALLY
PLATINUM-SENSITIVE(PPS) SUBSET OF PATIENTS
B.J. Monk, S. Kaye, A. Poveda, S. Tjulandin, B. Kong, M. Roy, S. Chan,
E. Filipczyk-Cisarz, H. Hagburg, I. Vergote, C. Lebedinsky, P. Santabarbara,
A. Nieto, A. Tanovic, P. Zintl, T. Parekh, Y.C. Park, N. Colombo, USA
10:00
23
08:00-10:00
Hall C
Free Communication:
Cervical Cancer; Vulvar and Vaginal Cancer
Chairpersons:
S. Fujii, Japan
W.J. Koh, USA
08:00
HUMORAL AND CELLULAR IMMUNITY INDUCES APOPTOSIS(PCD) IN CIN23,HPV16+ CERVICAL CA AFTER DIVALENT GENETIC VACCINATION WITH
CRS TARGETING P53 AND RB
J. Giannios, S. Giannios, J. Peristeris, K. Peristeris, Greece
08:09
ABSENCE OF HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) DETECTION IN
ENDOCERVICAL ADENOCARCINOMA WITH GASTRIC MORPHOLOGY AND
PHENOTYPE
A. Kojima, Y. Mikami, T. Kiyokawa, T. Sudo, S. Yamaguchi, Y. Kusanagi,
R. Nishimura, Indonesia
08:18
A PROSPECTIVE STUDY CORRELATING NATURAL HISTORY OF LOW-GRADE
SQUAMOUS INTREPITHELIAL NEOPLASIA TO SYSTEMIC HPV16-SPECIFIC
T-CELL RESPONSE
Y.L. Woo, M. van den Hende, J. Sterling, R. Crawford, M. Stanley,
S.H. van der Burg, Malaysia
08:27
LONG-TERM FOLLOW-UP OF A PHASE II FEASIBILITY STUDY OF REGIONAL
HYPERTHERMIA ADDED TO CHEMORADIOTHERAPY IN ADVANCED
CERVICAL CANCER
A. Westermann, J. van der Zee, E. van der Steen-Banasik, P. Koper,
A. Uitterhoeve, R. de Wit, H. van Tinteren, J. van der Velden, C. Burger,
C. van der Wilt, The Netherlands
08:36
INCIDENCE OF MICROMETASTASES IN HISTOLOGICALLY NEGATIVE PARAAORTIC LYMPH NODES IN ADVANCED CERVICAL CANCER PATIENTS
A. Martinez, E. Mery, G. Ferron, D. Querleu, France
08:45
PROGNOSTIC MODEL FOR SURVIVAL IN PATIENTS WITH SURGICALLY
TREATED EARLY- STAGE CERVICAL CANCER
P. Biewenga, J. van der Velden, B.W.J. Mol, L.J.A. Stalpers, M.S. Schilthuis,
J.W. van der Steeg, M.P.M. Burger, M.R. Buist, The Netherlands
08:54
MOVING BEYOND PRIMARY SCREENING FOR CERVICAL CANCER IN LOWRESOURCE SETTINGS
N.A. Jumah, B. Rosen, Canada
09:03
IMPACT OF THE NUMBER OF METASTATIC LYMPH-NODES FOR LOCOREGIONAL CONTROL IN VULVAR CANCER
S. Mahner, C. Eulenburg, M. Hager, M. Choschzick, L. Kock, F. Jaenicke,
J. Schwarz, F. Gieseking, L. Woelber, Germany
24
08:00-10:00
Hall C
Free Communication:
Cervical Cancer; Vulvar and Vaginal Cancer (contd.)
09:12
POSTOPERATIVE CHEMOTHERAPY IS SUPEROR TO WHOLE ABDOMINAL
IRRADIATION IN SINGLE NODE-POSITIVE AND/OR CERVICAL STROMAPOSITIVE ENDOMETRIAL CANCER: GYNECOLOGIC ONCOLOGY GROUP
STUDY
K. Tewari, G. Filiaci, N. Spirtos, R. Mannel, J.T. Thigpen, M. Cibull, B. Monk,
M. Randall, USA
09:21
THE INTERACTION BETWEEN EPITHELIAL BIOMARKERS, LOCAL IMMUNE
RESPONSE AND HPV GENOTYPE IN REGRESSION AND PERSISTENCE OF
CIN2-3
I. Øvestad, E. Gudlaugsson, I. Skaland, A. Malpica, A.C. Munk, E.A.M. Janssen,
J.P. Baak, Norway
09:30
GROIN ULTRASOUND (USS) AND FINE NEEDLE ASPIRATION CYTOLOGY
(FNAC) - AN ALTERNATIVE TO LYMPHADENECTOMY IN PRIMARY VULVAL
SQUAMOUS CELL CARCINOMA(VSCC)
J. Butler, E. Moskovic, A. Sohaib, J. Pilchard, S. Ghaem-Maghami, S. Eccles,
D. Barton, UK
09:39
RISK OF NEW INFECTION WITH THE SAME HPV-TYPE IN WOMEN WITH
NATURALLY-ACQUIRED HPV-16/18 ANTIBODIES
X. Castellsagué, on behalf of the HPV PATRICIA Study Group, Spain
09:48
IMPLANT STRATEGIES FOR CATHETER-BASED ULTRASOUND
HYPERTHERMIA ADJUNCT TO HDR BRACHYTHERAPY IN THE UTERINE
CERVIX
J. Wootton, P. Prakash, L.-M. Chen, C. Diederich, I.-C. Hsu, USA
10:00
25
08:00-10:00
Hall D
Free Communication:
Uterine Cancer, including Sarcoma
Chairpersons:
K. Podratz, USA
H. Robova, Czech Republic
08:00
CORRELATION BETWEEN PREOPERATIVE SERUM CA 125 AND
SURGICOPATHOLOGIC PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER
E. Strebel, J.T. Luna, Philippines
08:09
INCREASED EPITHELIAL STEM CELL TRAITS IN ADVANCED ENDOMETRIAL
ENDOMETRIOID CARCINOMA
S.-J. Chang, T.-Y. Wang, C.-Y. Tsai, T.-F. Hu, M.D.-T. Chang, H.-W. Wang,
Taiwan R.O.C.
08:18
HIGHER SENSITIVITY TO PATUPILONE VERSUS PACLITAXEL
CHEMOTHERAPY IN PRIMARY UTERINE SEROUS TUMORS WITH HIGH
VERSUS LOW HER-2/NEU EXPRESSION IN VITRO
A. Santin, D. Paik, E. Cocco, S. Bellone, F. Casagrande, M. Bellone, E. Siegel,
C. Richter, M. Azodi, D.-A. Silasi, S. Pecorelli, P. Schwartz, T. Rutherford, USA
08:27
PEGYLATED LIPOSOMAL DOXORUBICIN AND CARBOPLATIN IN MALIGNANT
MIXED EPITHELIAL MESENCHYMAL GYNECOLOGIC TUMOURS. A PHASE-II
TRIAL OF THE AGO STUDY GROUP
P. Harter, A. Burges, C. Kurzeder, A. Reuss, U. Canzler, H.-J. Lück, W. Meier,
E. Solomayer, A. Stähle, A. du Bois, J. Sehouli, K. Baumann, L.C. Hanker,
P. Wimberger, W. Schröder, M. Gropp, S. Mahner, Germany
08:36
EUROPEAN ORGANISATION FOR THE RESEARCH AND TREATMENT OF
CANCER (EORTC) QUALITY OF LIFE QUESTIONNAIRE FOR ENDOMETRIAL
CANCER: A VALIDATION STUDY
A. Lanceley, A. Nordin, E. Greimal, on behalf of the EORTC Quality of Life
Gynaecological Cancer Group, UK
08:45
ENDOMETRIAL CANCER SIDE-POPULATION CELLS SHOW PROMINENT
MIGRATION AND HAVE A POTENTIAL TO DIFFERENTIATE INTO THE
MESENCHYMAL CELL LINEAGE
K. Kato, A. Kuboyama, S. Kusunoki, M. Kimura, S. Suga, Y. Terao, N. Wake,
S. Takeda, Japan
08:54
ADJUVANT RADIOTHERAPY FOR ENDOMETRIAL CARCINOMA:
A COMPARISON OF TOXICITY WITH CONFORMAL AND INTENSITY
MODULATED TECHNIQUES
V. Harris, A. Challapalli, A. Taylor, UK
09:03
LYMPHADENECTOMY IN APPARENT EARLY-STAGE ENDOMETRIAL CANCER
- CLINICAL UTILITY AND COST EFFECTIVENESS
A. Rodolakis, N. Thomakos, J. Biliatis, D. Haidopoulos, G. Vlachos, K. Sarris,
M. Sotiropoulou, A. Antsaklis, Greece
26
08:00-10:00
Hall D
Free Communication:
Uterine Cancer, including Sarcoma (contd.)
09:12
EVALUATION OF THE ENDOMETRIUM IN POSTMENOPAUSAL WOMEN USING
TRANSVAGINAL ULTRASONOGRAPHY: OUTCOME OF INVESTIGATIONS
WHEN ENDOMETRIUM IS NOT IDENTIFIED USING ULTRASONOGRAPHY
N. Burbos, T. Duncan, S. Crocker, E. Morris, J. Nieto, UK
09:21
STATHMIN OVEREXPRESSION IDENTIFIES HIGH RISK PATIENTS AND LYMPH
NODE METASTASIS IN ENDOMETRIAL CANCER
J. Trovik, E. Wik, I.M. Stefansson, J. Marcickiewicz, S. Tingulstad, A.C. Staff,
F. Amant, L.A. Akslen, H.B. Salvesen, MoMaTEC Study Group, Norway
09:30
HORMONE RECEPTOR STATUS IN ENDOMETRIAL CARCINOMA CURETTAGE
INDEPENDENTLY PREDICTS LYMPH NODE METASTASIS AND PROGNOSIS IN
A MULTICENTRE SETTING
J. Trovik, E. Wik, H. Helland, I. Vandenput, T.S. Njolstad, I.M. Stefansson,
J. Marcickiewicz, S. Tingulstad, A.C. Staff, F. Amant, L.A. Akslen, H.B. Salvesen,
MoMaTEC Study Group, Norway
09:39
CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 115
UTERINE SARCOMAS: BCL-2 AND KI67 IDENTIFY LEIOMYOSARCOMAS WITH
DIFFERENT PROGNOSIS
E. D'Angelo, R. Ali, I. Espinosa, C.B. Gilks, M. van de Rijn, C.-H. Lee, J. Prat, Spain
10:00
27
08:00-10:00
Hall E
Free Communication:
Surgical techniques; Symptom management / palliation, and Misc.
Chairpersons:
E. LeBlanc, France
08:00
A COMPARISON OF STAGING SYSTEMS FOR VULVAR SQUAMOUS CELL
CARCINOMA (VSCC)
J. Sznurkowski, A. Żawrocki, T. Milczek, D. Wydra, D. Mazurkiewicz, J. Emerich,
Poland
08:09
RISK FACTORS FOR SHORT AND LONG TERM COMPLICATIONS AFTER
GROIN SURGERY IN VULVAR CANCER
F. Hinten, L.C.G. van den Einden, J.C.M. Hendriks, A.G.J. van der Zee, H. Bulten,
L.F.A.G. Massuger, H.P. van de Nieuwenhof, J.A. de Hullu, The Netherlands
08:18
SENTINEL LYMPHNODE DETECTION IN CERVICAL CANCERS: “WHERE IS
THE NODE?”
G. Mehra, M. Coutts, A. Papadopoulos, S.P. Adamson, S.A. Montalto, O. Devaja,
UK
08:27
SENTINEL LYMPH NODE BIOPSY IN EARLY CERVICAL CANCER: HOW TO
REDUCE THE FALSE NEGATIVE RATE?
A.-S. Bats, P. Mathevet, D. Querleu, E. Leblanc, P. Morice, E. Daraï, H. Marret,
F. Lécuru, France
08:36
THE LAPAROSCOPIC APPROACH TO CARCINOMA OF THE
ENDOMETRIUM(LACE) RANDOMIZED TRIAL: ADVERSE EVENTS COMPARING
TOTAL LAPAROSCOPIC HYSTERECTOMY VERSUS TOTAL ABDOMINAL
HYSTERECTOMY
A. Obermair, V. Gebski, J. Nicklin, L. Perrin, T. Jobling, T. Manolitsas, R. Land,
A. McCartney, M. Nascimento, G. Otton, S. Salfinger, M. Oehler, D. Neesham,
R. Hogg, A. Brand, A. Garrett, M. Laney, T. Walsh, A. Crandon, K.-F. Tam,
I. Hammond, Y. Leung, P. Sykes, F. Chan, D. Wrede, R. Farrell, T. Ng,
S. Pather, H. Ngan, B. Simcock, S. Kondalsamy-Chennakesavan, M. Janda,
Australia
08:45
LAPARASCOPIC PARA AORTIC LYMPHADENECTOMY AS STAGING IN
ADVANCED CERVICAL CANCER
O. Puga, M.I. Barriga, M. Fernandez, M. Saavedra, F. Nuñez, T. Rodriguez, Chile
08:54
LAPAROSCOPIC EXTRA PERITONEAL PARA-AORTIC LYMPH NODE
DISSECTION (LEPAND) IN WOMEN WITH LOCALLY ADVANCED CERVICAL
CANCER - INDIVIDUALISED TREATMENT
T. Al Rawahi, J. Price, H. McClelland, S. Dobbs, H. Nagar, I. Harley, UK
28
08:00-10:00
Hall E
Free Communication:
Surgical techniques; Symptom management / palliation, and Misc. (contd.)
09:03
ANALYSIS OF LOWER EXTREMITY LYMPHEDEMA AFTER GYNECOLOGIC
CANCER TREATMENT
A. Hongo, Japan
09:12
COMORBIDITY IS A CRITICAL FACTOR IN INFORMING OUTCOMES IN
GYNAECOLOGICAL CANCER
R. Crawford, D. Greenberg, J. Thomas, J. Poole, D. Meechan, D. Riley, UK
09:21
WHOLE PELVIC RADIOTHERAPY AND THE RISK OF SECONDARY
LYMPHOMA
N. Barrena Medel, T. Herzog, W. Burke, X. Sun, S. Lewin, J. Wright, USA
09:30
PIK3CA, RAS AND RAF MUTATIONS IN PATIENTS WITH BREAST, CERVICAL,
ENDOMETRIAL, AND OVARIAN CANCER TREATED WITH PI3K/AKT/MTOR
AXIS INHIBITORS
F. Janku, A. Tsimberidou, I. Garrido-Laguna, D. Hong, A. Naing, S. Fu, G. Falchook,
S. Moulder, J. Wheler, S. Piha-Paul, R. Kurzrock, USA
09:39
CONTINENT CUTANEOUS ILEOCECAL RESERVOIR USING THE
SUBMUCOSALLY EMBEDDED APPENDIX AFTER ANTERIOR EXENTERATION
FOR GYNAECOLOGICAL MALIGNANCIES: TECHNIQUE AND COMPLICATIONS
M. Friedrich, W. Poleska, D. Salehin, M. Friedrich, Germany
10:00
29
08:00-10:00
Hall F
Free Communication:
Video Presentations
Chairpersons:
N. Abu-Rustum, USA
E. Domingo, Philippines
08:00
THE CAIRO BREAST SCREENING TRIAL (CBCST)
S. Michel Boulos, M. Gadallah, S. Naguib, E.A. Ezzat, A. Youssef, E. Cassano,
A.B. Miller, I. Mittra, A. Costa, Egypt
08:09
SINGLE INCISION LAPAROSCOPIC SURGERY HYSTERECTOMY
F. Ciancio, F. Cannone, France
08:18
FERTILITY SPARING THERAPY IN EARLY ENDOMETRIAL CARCINOMA
A.B. Güzel, M.A. Vardar, S. Büyükkurt, I.F. Ürünsak, D. Gümürdülü, Turkey
08:27
RADICAL HYSTERECTOMY WITH RELIABLE NERVE SPARING PROCEDURE
IN PATIENTS WITH CERVICAL CANCER OF WHICH TUMOR SIZE IS LESS
THAN 2CM
K. Utsugi, Y. Sugiyama, H. Iwase, K. Umayahara, Y. Kawamata, N. Takeshima,
K. Takizawa, Japan
08:36
V-Y ADVANCEMENT SKIN FLAPS BASED ON THE PUDENDAL ARTERY
PERFORATORS: PRELIMINARY RESULTS OF A SERIE OF 24 FLAPS
V. Conri, R. Gauzere, France
08:45
ROBOTIC EXTRAPERITONEAL PARA-AORTIC STAGING (REPPS) IN
CERVICAL CANCER
A. Burnett, P. Stone, K. Reynolds, J. Roman, USA
08:54
LAPAROSCOPIC VERSUS LAPAROTOMIC APPROACHES IN WOMEN WITH
EARLY STAGE ENDOMETRIAL CANCER
M.A. Vardar, A.B. Güzel, S. Büyükkurt, I.F. Ürünsak, Ü. Güleç, Turkey
09:03
VAGINOSCOPIC HYSTEROSCOPY IN THE EVALUATION OF UTERINE CANCER
OF UNCERTAIN CERVICAL OR ENDOMETRIAL ORIGIN
A. El-Shalakany, K.K. Ali, S.T. Fayed, Egypt
09:12
RECONSTRUCTIVE PLASTIC OPERATIONS IN VULVA CANCER
S. Mavrichev, H. Maisei, D. Rovski, I. Bakinovskaya, Belarus
09:21
LAPAROSCOPIC RETROPERITONEAL SALVAGE LYMPHADENECTOMY FOR
RECURRENCE OF CERVIX CANCER WITH PREVIOUS RADIATION IN A
PATIENT WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA (IPT)
A.T. Tsunoda, R.W. Bordinhao, J.H.T.G. Fregnani, C.E.M.C. Andrade, Brazil
09:30
TIPS AND TRICKS ON LAPAROSCOPIC MANAGEMENT OF LARGE OVARIAN
CYST
M. Alazzam, A. Gillespie, UK
09:39
RADICALITY OF LAPAROSCOPIC SURGERY COMPARED TO TRADITIONAL
ABDOMINAL SURGERY IN THE MANAGEMENT OF CERVICAL CANCER
T. Simsek, Z. Saruhan, B. Sever, E. Pesterli, Turkey
30
08:00-10:00
Hall G
Free Communication:
Young Investigator Oral Presentations
Chairpersons:
R.L. Coleman, USA
H.Y.S. Ngan, Hong Kong S.A.R.
08:00
PRO-CADHERIN 10 - A NOVEL METHYLATION BIOMARKER FOR CERVICAL
CANCER SCREENING
D. Pandey, P.J. Snijders, C. Meijer, R. Steenbergen, India
08:09
ELEVATED EXPRESSION OF P53 GAIN-OF-FUNCTION MUTATION R175H IN
ENDOMETRIAL CANCER CELLS CAN INCREASE INVASION BY ACTIVATION
OF EGFR/PI3K/AKT PATHWAY
P. Dong, China
08:18
PHARMACOKINETICS OF CHEMOTHERAPEUTIC AGENTS IN PREGNANT
WOMEN
K. Van Calsteren, R. Verbesselt, P.B. Ottevanger, M.J. Halaska, L. Heyns,
R. Van Bree, E. de Bruijn, M. Delforge, L. Noens, V. Renard, P. Witteveen, L. Rob,
J. de Hoon, F. Amant, Belgium
08:27
ANTI- INVASIVE AND ANTI- METASTATIC ACTIONS OF METFORMIN IN
HUMAN ENDOMETRIAL CARCINOMA CELLS: ROLE OF NUCLEAR FACTORKAPPA-B, MMP-2/9, AKT, ERK1/2
B.K. Tan, R. Adya, J. Chen, H. Lehnert, L.J. Sant Cassia, H.S. Randeva, UK
08:36
PARENTAL ACCEPTANCE OF HUMAN PAPILLOMAVIRUS (HPV)
VACCINATION IN INDONESIA
L. Jaspers, S. Budiningsih, R. Wolterbeek, F.C. Henderson, A.A.W. Peters,
The Netherlands
08:45
SMOKERS WITH CERVICAL CANCER HAVE MORE UTERINE CORPUS
INVASIVE DISEASE AND AN INCREASED RISK OF RECURRENCE
FOLLOWING TREATMENT WITH CHEMO-RADIATION
L. Mileshkin, D. Bernshaw, A. Paramanathan, K. Narayan, Australia
08:54
NOVEL INFLAMMATORY SIGNATURE PREDICTS OUTCOME IN EPITHELIAL
OVARIAN CANCER
D. Brennan, D. DeNardo, E. Rexhepaj, M. Foley, C. O'Herlihy, W. Gallagher,
L. Coussens, Ireland
09:03
DYNAMIC SPECTRAL IMAGING COLPOSCOPY: HIGHER SENSITIVITY FOR
DETECTION OF PREMALIGNANT CERVICAL LESIONS
J. Louwers, A. Zaal, M. Kocken, W. ter Harmsel, G. Graziosi, J. Spruijt,
J. Berkhof, C. Balas, E. Papagiannakis, P. Snijders, C. Meijer, F. van Kemenade,
R. Verheijen, The Netherlands
31
08:00-10:00
Hall G
Free Communication:
Young Investigator Oral Presentations (contd.)
09:12
PROGNOSTIC VALUE OF SERUM CA125 IN OVARIAN TUMORS OF LOW
MALIGNANT POTENTIAL: A MULTICENTER COLLABORATIVE STUDY
A. Tang, S. Kondalsamy-Chennakesavan, H. Ngan, P. Zusterzeel, M. Quinn,
J. Carter, A. Obermair, Australia
09:21
EFFECTS OF DIHYDROARTIMINISIN ON THE PROLIFERATION, ADHESION,
MIGRATION, AND INVASION OF EPITHELIAL OVARIAN CANCER CELLS IN
VITRO
X.J. Tan, J. Plouet, J.H. Lang, K. Shen, M. Wu, China
09:30
HELPING WOMEN MAKE INFORMED TREATMENT CHOICES: DECISION AIDS
FOR TWO STAGES OF OVARIAN CANCER
I. Juraskova, C. Bonner, G. Heruc, C. Anderson, K. Nattress, J. Carter, Australia
09:39
OVARIAN TUMOR MULTITARGETING WITH MABS AGAINST GP38,MUC1,AND
TAG72 ON PEGYLATED NANODELIVERY PLATFORM OF CYLD AND RIP-1
LEADS TO NECROPTOSIS/ APOPTOSIS
J. Giannios, S. Giannios, J. Peristeris, K. Peristeris, N. Alexandropoulos, Greece
10:00
32
10:30-12:00
Hall A
Plenary Session III
Chairpersons:
R. Angioli, Italy
M. Bookman, USA
10:30
UPFRONT SURGERY VS NEOADJUVANT CHEMOTHERAPY IN ADVANCED
EPITHELIAL OVARIAN CARCINOMA (EOC): A RANDOMIZED STUDY
L. Kumar, R. Hariprasad, S. Kumar, N. Bhatla, S. Thulkar, S. Deo, N. Shukla, India
10:41
SECONDARY CYTOREDUCTIVE SURGERY BASED ON AN INTERNATIONAL
COHORT：REDEFINING A NEW STANDARD OF CARE FOR PATIENTS WITH
PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER
R. Zang, P. Harter, D.S. Chi, J. Sehouli, C.G. Tropé, A. Ayhan, G. Cormio, R. Jiang,
Y. Xing, J. Berek, A. du Bois, Western & Eastern Gynecology Oncologists, WEGO,
China
10:52
IMPACT OF LYMPH NODE STATUS AND LYMPHADENECTOMY IN ADVANCED
OVARIAN CANCER CORRELATED TO RESIDUAL DISEASE: AN AGO-OVAR
META-ANALYSIS
W. Schroeder, J. Pfisterer, E. Pujade-Lauraine, A. Reuss, I. Ray-Coquard,
A. duBois, Germany
11:03
PACLITAXEL/CARBOPLATINUM +/- LONAFARNIB IN FIRST-LINE TREATMENT
OF OVARIAN CANCER: A RANDOMIZED PHASE II STUDY BY THE AGO-OVAR
STUDY GROUP
W. Meier, J. Rau, J. Huober, K. Wollschläger, C. Kurzeder, U. Canzler, J. Sehouli,
M. Gropp, B. Schmalfeldt, P. Wimberger, B. Richter, W. Schröder, A. Belau,
A. Stähle, Germany
11:14
PROGNOSTIC IMPACT OF THE INTERVAL BETWEEN SURGERY AND
CHEMOTHERAPY IN ADVANCED OVARIAN CANCER - ANALYSIS OF
PROSPECTIVE-RANDOMIZED PHASE-3 TRIALS
S. Mahner, A. Staehle, C. Eulenburg, K. Wegscheider, A. Reuss,
E. Pujade-Lauraine, P. Harter, I. Ray-Coquard, J. Pfisterer, A. du Bois,
AGO-OVAR, GINECO, Germany
11:25
STANDARDISED STUDY OF HUMAN PAPILLOMAVIRUS TYPE DISTRIBUTION
IN WOMEN WITH HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA
AND INVASIVE CERVICAL CANCER IN EUROPE
A. Fiander, on behalf of the HERACLES/SCALE Study Group, UK
11:36
THE NEED TO LOWER THE LOWER AGE LIMIT OF THE CERVICAL CANCER
SCREENING PROGRAM IN ENGLAND
A. Anantharachagan, D. Kolomainen, J. Shepherd, UK
12:00
33
12:30-14:00
Hall A
A CALL FOR ACTION: OPTIMIZING PROTECTION FOR WOMEN FROM HPV RELATED
DISEASES
Sponsored by MSD
Chairperson:
M. Stanley, UK
12:30
WELCOME
M. Stanley, UK
12:35
HPV INFECTION & IMMUNOLOGICAL FINDINGS FOR QUADRIVALENT HPV
VACCINE
M. Stanley, UK
12:55
HPV DISEASE BURDEN IN ADULT WOMEN
X. Castellsague, Spain
13:15
HPV VACCINATION OF SEXUALLY ACTIVE WOMEN: BENEFITS AND
BARRIERS
W. Huh, USA
13:45
13:55
CLOSING REMARKS
M. Stanley, UK
14:00-15:30
Hall B
Interactive Session
Tumor Board: COVERING OVARY, CERVIX, VULVA AND ENDOMETRIUM
Speakers:
R.W. Naumann, USA
34
14:00-15:30
Hall C
IP CHEMOTHERAPY FOR OVARIAN CANCER
Pro/Con Debate
Chairpersons:
M. Gore, UK
C. Marth, Austria
14:00
PRO - IP THERAPY
F. Muggia, USA
14:20
ANTI - IP THERAPY
A. du Bois, Germany
14:40
QUALITY OF LIFE AND SIDE EFFECTS
L. Wenzel, USA
15:00
DISCUSSION
15:30
14:00-15:30
Hall D
DIFFERENT APPROACHES FOR FERTILITY PRESERVATION IN CERVICAL CANCER
Chairperson:
D. Denschlag, Germany
14:00
FERTILITY PRESERVATION IN CERVICAL CANCER - THE DIFFICULTY OF
TEACHING TECHNICAL SKILLS IN RARE EVENTS
D. Denschlag, Germany
14:10
RADICAL TRACHELECTOMY VIA AN ABDOMINAL APPROACH - THE US
EXPERIENCE
N. Abu-Rustum, USA
14:25
RADICAL TRACHELECTOMY VIA A LAPAROSCOPY - THE GERMAN
EXPERIENCE
A. Schneider, Germany
14:40
RADICAL TRACHELECTOMY VIA A VAGINAL APPROACH - THE EUROPEAN
EXPERIENCE
E. Leblanc, France
14:55
MODERN CONCEPTS -"IS SIMPLE TRACHELECTOMY OR LARGE CONE
REALLY SAFE?"
15:10
DISCUSSION / CLOSING REMARKS
35
14:00-15:30
Hall E
PERSONALIZED TREATMENT STRATEGIES IN ENDOMETRIAL CARCINOMA
Chairpersons:
D. Levine, USA
H. Salvesen, Norway
14:00
INTRODUCTION AND OVERVIEW OF TARGETED THERAPY IN ENDOMETRIAL
CANCER
D. Levine, USA
14:10
MOLECULAR FEATURES OF PRIMARY VERSUS METASTATIC LESIONS
F. Amant, Belgium
14:30
MOLECULAR DIAGNOSTICS FOR PREDICTING ENDOMETRIAL CANCER
RECURRENCE AND STAGE
R. Broaddus, USA
14:50
PROMISING MOLECULAR TARGETS FOR DEVELOPMENT OF NEW THERAPY
IN ENDOMETRIAL CANCER
H. Salvesen, Norway
15:10
THE CANCER GENOME ATLAS PROJECT - STATUS REPORT FOR
ENDOMETRIAL CANCER
D. Levine, USA
15:20
HOW TO INCORPORATE MOLECULAR MEDICINE INTO CLINICAL TRIALS AND
ENGAGE INDUSTRY IN A TRANSPARENT FASHION?
Panel Discussion
15:30
36
14:00-15:30
Hall F
CERVIAL CANCER PREVENTION AND CONTROL IN THE THIRD WORLD
Chairpersons:
K.U. Devi, India
V. Kesic, Serbia
14:00
DEVELOPING EFFECTIVE SCREENING STRATEGIES FOR CERVICAL CANCER
IN THE THIRD WORLD COUNTRIES
K.U. Devi, India
14:20
CHANGING TRENDS IN THE PATTERN OF CARE FOR WOMEN WITH
CERVICAL CANCER AT LOW RESOURCE SETTINGS
V. Kesic, Serbia
14:40
THERAPEUTIC DILEMMAS IN THE MANAGEMENT OF CERVICAL CANCER IN
THIRD WORLD COUNTRIES
A. Bermudez, Argentina
15:00
THE FEASIBILITY AND PITFALLS OF CLINICAL TRIALS & JOINT
COLLABORATION FOR CERVICAL CANCER BETWEEN THE THIRD WORLD &
WEST THROUGH NATIONAL ORAGNIZATIONS
E. Trimble, USA
14:00-15:30
Hall G
NACT VS. CHEMO/RT IN CERVICAL CANCER
Pro/Con Debate
Chairpersons:
W.J. Koh, USA
B.J. Monk, USA
14:00
NEO-ADJUVANT THERAPY PRIOR TO SURGERY FOR CERVICAL CANCER
R. Angioli, Italy
14:35
CONCURRENT RT/CHEMOTHERAPY: THE OPTIMAL TREATMENT FOR
G. Thomas, Canada
15:10
DISCUSSION
37
14:00-15:30
Hall G
NACT VS. CHEMO/RT IN CERVICAL CANCER
Pro/Con Debate
Chairpersons:
W.J. Koh, USA
B.J. Monk, USA
14:00
NEO-ADJUVANT THERAPY PRIOR TO SURGERY FOR CERVICAL CANCER
R. Angioli, Italy
14:35
CONCURRENT RT/CHEMOTHERAPY: THE OPTIMAL TREATMENT FOR
G. Thomas, Canada
15:10
DISCUSSION
16:00-17:30
Hall A
INHIBITING ANGIOGENESIS: A NEW FRONTIER IN OVARIAN CANCER THERAPY
Sponsored by F. Hoffmann-La Roche Ltd.
16:00
INTRODUCTION
A. du Bois, Germany
16:15
VEGF INHIBITION IN OVARIAN CANCER
E. Pujade-Lauraine, France
16:30
CLINICAL DATA FOR BEVACIZUMAB IN FRONT-LINE OVARIAN CANCER
B.J. Monk, USA
A. du Bois, Germany
17:00
CASE STUDY: CLINICAL CONSIDERATIONS FOR THE USE OF BEVACIZUMAB
IN FRONT-LINE OVARIAN CANCER
E. Pujade-Lauraine, France
B.J. Monk, USA
17:15
CHALLENGE THE FACULTY AND Q&A
17:25
CLOSE
38
17:30-19:00
Hall B
HOW TO INDIVIDUALIZE TREATMENT FOR SPECIFIC PATIENT POPULATIONS IN OVARIAN
CANCER?
Sponsored by Johnson & Johnson / Janssen
16:00
WELCOME AND INTRODUCTION
T. Herzog, USA
16:00
GENERAL CONSIDERATIONS IN TREATING ELDERLY CANCER PATIENTS
E. Brain, France
16:00
OPTIMIZING TREATMENT OF OVARIAN CANCER WITH INDIVIDUALIZED
APPROACHES BASED ON AGE AND CO-MORBIDITIES
T. Herzog, USA
16:00
PANEL DISCUSSION
T. Herzog, USA
E. Brain, France
G. Freyer, France
16:00
EXPANDING OPTIONS FOR PATIENTS WITH BREAST CANCER THROUGH
TAILORING TREATMENT APPROACHES
G. Freyer, France
16:00
PANEL DISCUSSION AND SUMMARY/CLOSE
T. Herzog, USA
E. Brain, France
G. Freyer, France
18:30-19:30
Hall G
IGCS BUSINESS MEETING (Members only)
39
40
Tuesday, October 26, 2010
07:00-08:00
Hall B
Meet the Expert:
UPDATES IN IP THERAPY FOR OVARIAN CANCER
07:00
OUTLINE OF SESSION
F. Muggia, USA
07:05
GYNECOLOGIC ONCOLOGY GROUP STUDIES
J. Walker, USA
07:25
JAPANESE STUDIES
K. Fujiwara, Japan
07:45
OPEN DISCUSSION ON FUTURE DIRECTIONS
F. Muggia, USA
07:00-08:00
Hall C
Meet the Expert:
VACCINES AND CERVICAL CANCER
IMMUNE THERAPIES FOR HPV DISEASE
C. Trimble, USA
PROPHYLACTIC VACCINATION FOR PRIMARY PREVENTION
M. Anil Onan, Turkey
07:00-08:00
Hall D
Meet the Expert:
GYNECOLOGIC CANCER IN PREGNANCY
CANCER DURING PREGNANCY: EPIDEMIOLOGY, DIAGNOSTICS,
TREATMENT AND OUTCOME
K. Van Calsteren, Belgium
GYNAECOLOGICAL CANCERS AND BREAST CANCER IN PREGNANCY
M. Halaska, Czech Republic
07:00-08:00
Hall E
Meet the Expert:
THE RELATION BETWEEN IVF AND THE RISK OF CANCER IN WOMEN AND THEIR
OFFSPRING
CANCER RISK IN WOMEN WHO UNDERWENT IVF
C. Burger, The Netherlands
THE RISK OF THE USE OF IVF AND INFERTILITY TREATMENTS IN PATIENTS
PREVIOUSLY TREATED FOR GYNE CANCER (PARTICULARLY FOR OVARIAN
TUMORS)
P. Morice, France
41
07:00-08:00
Hall F
Gynaecological Cancer Intergroup Update (GCIG)
Chairperson: M. Quinn, Australia
UPDATE ON GCIG ACTIVITIES SINCE BANGKOK
M. Quinn, Australia
CURRENT AND PLANNED INTERNATIONAL TRIALS IN CANCER OF THE
CERVIX
W. Small, USA
THE CERVIX CANCER NETWORK
H. Kitchener, UK
07:00-08:00
Hall G
Meet the Expert:
CANCER GENOME AND SYSTEMS BIOLOGY APPROACHES-BASED PERSONALIZED
TREATMENT OF BREAST CANCER
CANCER GENOME AND SYSTEMS BIOLOGY APPROACHES-BASED
PERSONALIZED TREATMENT OF BREAST CANCER
D. Roukos, Greece
SINGLE-GENES MOLECULAR RESEARCH: ADVANCES WITH BRCA1/2 AND
LIMITATIONS
D. Ziogas, Greece
42
08:00-10:00
Hall B
Oral Poster Session:
Ovarian Cancer
Chairpersons:
I. Vergote, Belgium
M. Zikan, Czech Republic
08:00
PROGNOSTIC IMPACT OF CONCOMITANT P53 AND PTEN ON OUTCOME IN
EARLY STAGE (FIGO I-II) EPITHELIAL OVARIAN CANCER (EOC)
I. Skirnisdottir, B. Sorbe, K. Lindborg, T. Seidal, Sweden
08:08
WOMEN WITHOUT OVARIAN CANCER WHO REPORT DISEASE-SPECIFIC
SYMPTOMS
E. Pavlik, J. Ubellacker, I. Norris, I. Podzielinski, R. Ware, S. Goodrich,
C. Desimone, F. Ueland, L. Seamon, J. van Nagell, USA
08:16
POSSIBLE PROTECTIVE EFFECT OF STATINS IN GYNECOLOGICAL
CANCERS
O. Lavie, M. Pinchev, Y. Segev, O. Gemer, S. Sagie, H. Rennert, G. Rennert, Israel
08:24
CONSERVATIVE TREATMENT OF EARLY STAGE MALIGNANT EPITHELIAL
OVARIAN CANCER: ONCOLOGICAL AND FERTILITY OUTCOME IN A SERIES
OF 189 PATIENTS
S. Corso, R. Fruscio, L. Ceppi, A. Garbi, D. Garavaglia, F.P. Sina, I. Floriani,
M.C. Bonazzi, C. Mangioni, R. Milani, Italy
08:32
TRIAGE WITH RMI RESULTS IN BETTER TREATMENT OF EARLY AND
ADVANCED OVARIAN CANCER: A PROSPECTIVE POPULATION STUDY
J. van der Velden, R. Verheijen, M. van Beurden, M. Buist, W. Wegdam, I. Mulder,
O. Visser, The Netherlands
08:40
MORPHOLOGIC, IMMUNOHISTOCHEMICAL AND MOLECULAR
CORRELATIONS OF OVARIAN AND TUBAL DYSPLASIA IN PROPHYLACTIC
OOPHORECTOMIES FOR GENETIC RISK
G. Chene, F. Penault-Llorca, I. Raoelfils, E. Pierre, P. Vago, Y.-J. Bignon,
I. Ray-Coquard, C. Pomel, J. Dauplat, France
08:48
U.S. GOG 218 VS. EURO ICON7 - A COST ANALYSIS OF BEVACIZUMAB IN
THE PRIMARY TREATMENT OF OVARIAN CANCER
J. Chan, B. Monk, K. Fuh, R. Urban, L. Hu, D. Kapp, A. Caughey, X. Yu, USA
08:56
HIGH THROUGHPUT DRUG SCREENING USING OVARIAN CANCER STEM
CELLS IDENTIFIES NOVEL COMPOUNDS FOR OVARIAN CANCER THERAPY
H.C. Lai, H.Y. Lee, Y.C. Wang, Y.T. Yo, M.H. Yu, Taiwan R.O.C.
09:04
MICROARRAY ANALYSIS OF ONCOGENIC PATHWAYS IN ADVANCED
SEROUS PAPILLARY OVARIAN CARCINOMA
X.B. Trinh, W. Tjalma, L. Dirix, P. Vermeulen, D. Peeters, L. Sas, I. Van der Auwera,
F. Tjin Asjoe, S. Van Laere, P. van Dam, Belgium
43
08:00-10:00
Hall B
09:12
A PHASE 2 STUDY OF PEMETREXED IN COMBINATION WITH CARBOPLATIN
IN PATIENTS WITH PLATIN-SENSITIVE RECURRENT OVARIAN OR
PERITONEAL CANCER
J. Sehouli, A. Alvarez, S. Manouchehrpour, P. Ghatage, C. Szczylik,
A. Zimmermann, T. Bauknecht, K. Look, G. Oskay-Özcelik, Germany
09:20
A NOVEL TREATMENT STRATEGY FOR OVARIAN GRANULOSA CELL
TUMORS BASED ON IMMUNIZATION AGAINST ZP3
H.J.T. Coelingh Bennink, N.A. Rahman, M. Chrusciel, V. Sharp, Y. Zimmerman,
A. Ellonen, A. Rivero-Müller, X. Li, S. Dilworth, O. Vainio, I. Huhtaniemi,
The Netherlands
09:28
FACTORS INFLUENCING UPTAKE OF RISK REDUCING SALPINGOOOPHORECTOMY (RRSO) IN WOMEN AT HIGH RISK OF FAMILIAL OVARIAN
CANCER
R. Manchanda, A. Abdelraheim, M. Johnson, A. Rosenthal, E. Benjamin,
C. Brunell, M. Brunell, L. Side, S. Gessler, E. Saridogan, D. Oram, I. Jacobs,
U. Menon, UK
10:00
44
08:00-10:00
Hall C
Cervical Cancer; Vulvar and Vaginal Cancer
Chairpersons:
V. Kesic, Serbia
K.U. Devi, India
08:00
REVISING THE ROLE OF PARAMETRIAL BOOST IN LOCALLY ADVANCED
CERVIX CANCER PATIENTS STAGED WITH POSITRON EMISSION
TOMOGRAPHY
C. Rajasooriyar, S. van Dyk, M. Lindawati, D. Bernshaw,
S. Kondalsamy- Chennakesavan, K. Narayan, Sri Lanka
08:08
P16INK4A IMMUNOSTAINING AS AN ALTERNATIVE TO HISTOLOGY REVIEW
FOR RELIABLE GRADING OF CERVICAL INTRAEPITHELIAL LESIONS
M.G. Dijkstra, D.A.M. Heideman, S.C. de Roy, L. Rozendaal, J. Berkhof, K. van
Krimpen, K. van Groningen, P.J.F. Snijders, C.J.L.M. Meijer, F.J. van Kemenade,
The Netherlands
08:16
TO TREAT OR NOT TO TREAT, THE CLINICAL DILEMMA OF ASC-US
R.P. de Bie, L.F.A.G. Massuger, R.A.J.M. van Dongen, M.P.M.L. Snijders, J. Bulten,
W.J.G. Melchers, R.L.M. Bekkers, The Netherlands
08:24
EFFICACY OF GARDASIL® AGAINST PERSISTENT INFECTION OR DISEASE IN
WOMEN WITH PRIOR VACCINE HPV TYPE INFECTION
08:32
PROGNOSTIC FACTORS FOR IMPROVED SURVIVAL IN FIGO STAGE IVB
CERVICAL CANCER
J.Y. Kim, M.-K. Kim, H.S. Kim, Y.B. Kim, H.H. Chung, H.J. Kim, T.S. Lee, J.W. Kim,
N.H. Park, Y.S. Song, S.-B. Kang, H.P. Lee, Republic of Korea
08:40
HIGH DOSE - DENSITY NEOADJUVANT CHEMOTHERAPY FOLLOWED BY
SIMPLE TRACHELECTOMY. ONCOLOGICAL AND PREGNANCY RESULTS
H. Robova, M. Pluta, M. Halaska, O. Sebestova, P. Skapa, L. Rob, Czech Republic
08:48
CERVICAL CANCER CURE FRACTIONS IN RELATION TO SCREENING.
FURTHER EVIDENCE FROM THE SWEDISH NATIONWIDE AUDIT
B. Andrae, T. Andersson, P. Lambert, L. Kemetli, L. Silfverdal, B. Strander, W. Ryd,
J. Dillner, S. Törnberg, P. Sparén, Sweden
08:56
PHOTODYNAMIC THERAPY FOR PRECANCER AND EARLY STAGE CANCER
OF THE UTERINE CERVIX WITH FERTILITY PRESERVATION
M. Sakamoto, S. Okamoto, K. Miyake, Y. Koyamatsu, T. Akiya, M. Nakano,
T. Muroya, Y. Tenjin, K. Ochiai, T. Tanaka, Japan
45
08:00-10:00
Hall C
Cervical Cancer; Vulvar and Vaginal Cancer (contd.)
09:04
HUMAN PAPILLOMAVIRUS PREVALENCE AND TYPE DISTRIBUTION IN
CERVICAL ADENOCARCINOMA: RESULTS FROM A MULTINATIONAL
EPIDEMIOLOGICAL STUDY IN EUROPE
W. Tjalma, on behalf of the SCALE Study Group, Belgium
09:12
EFFICACY OF THE HPV-16/18 AS04-ADJUVANTED VACCINE IN WOMEN
ACCORDING TO THEIR INITIAL DNA AND SEROSTATUS: PATRICIA END-OFSTUDY RESULTS
W. Huh, J. Paavonen, P. Naud, J. Salmeron, C. Wheeler, S.-N. Chow, D. Apter,
H. Kitchener, X. Castellsagué, J. Teixeira, R. Skinner, J. Hedrick, U. Jaisamrarn,
G. Limson, S. Garland, A. Szarewski, B. Romanowski, F. Aoki, T. Schwarz,
W. Poppe, K. Hardt, T. Zahaf, D. Descamps, F. Struyf, M. Lehtinen, G. Dubin, for the
PATRICIA Study Group, USA
09:20
HIGHLY EFFECTIVE RISK STRATIFICATION BY HUMAN PAPILLOMAVIRUS
TESTING IN WOMEN WITH ABNORMAL CERVICAL CYTOLOGY; 17.5 YEARS
PROSPECTIVE COHORT STORY
M. Kocken, J.A. Louwers, A. Zaal, J. Berkhof, M.A.E. Nobbenhuis, P.J.F. Snijders,
C.J.L.M. Meijer, T.J.M. Helmerhorst, The Netherlands
09:28
EFFICACY OF GARDASIL® IN WOMEN AGED 16 TO 26 WHO HAVE
UNDERGONE DEFINITIVE CERVICAL THERAPY
W. Huh, E. Joura, S. Garland, J. Paavonen, D. Ferris, G. Perez, K. Ault, H. Sings,
M. James, R. Haupt, for the FUTURE I and II Study Group, USA
09:36
CONFORMAL TECHNIQUES LEAD TO A HIGH COMPLETION RATE OF
EXTERNAL BEAM RADIATION FOR CERVIX CARCINOMA IN A DEVELOPING
WORLD SETTTING
H. Simonds, N. Du Toit, South Africa
09:44
DUTCH ALGORITHM FOR FOLLOW-UP AFTER TREATMENT FOR CERVICAL
INTRAEPITHELIAL NEOPLASIA; EFFECTIVE TO PREDICT RECURRENCES UP
TO 7.5 YEARS AFTER TREATMENT
M. Kocken, J.A. Louwers, W.A. ter Harmsel, J. Berkhof, P.J.F. Snijders,
R.H.M. Verheijen, T.J.M. Helmerhorst, C.J.L.M. Meijer, The Netherlands
10:00
46
08:00-10:00
Hall D
Uterine Cancer, including Sarcoma
Chairpersons:
E. Åvall-Lundqvist, Sweden
A. Aldini, Argentina
08:00
LIPOSOMAL DOXORUBICIN (LD) AND CARBOPLATIN (CP) IN PRIMARY
ADVANCED OR RECURRENT ENDOMETRIAL CANCER - A PHASE-II-TRIAL OF
AGO AUSTRIA
B. Volgger, A. Reinthaller, C. Schauer, U. Sevelda-Schwarzgruber, M. Klein,
M. Mörtl, A. Zeimet, M. Deibl, C. Marth, AGO Austria - Arbeitsgemeinschaft für
Gynäkologische Onkologie Austria, Austria
08:08
MULTIMODALITY TREATMENT WITH CARBOPLATIN AND TAXOL IMPROVES
SURVIVAL IN ADVANCED STAGE UTERINE SEROUS CARCINOMA
S. Ueda, A. Nickles-Fader, T. Diaz-Montes, R. Giuntoli, R. Bristow, USA
08:16
MICROARRAY ANALYSIS OF THE GENES INVOLVED IN ENDOMETRIAL
CARCINOGENESIS: UP-REGULATION OF LIPOCALIN2 IN NEOPLASTIC
ENDOMETRIA, AND ITS FUNCTIONAL RELEVANCE
T. Miyamoto, H. Kashima, A. Suzuki, N. Kikuchi, A. Takatsu, I. Konishi, N. Seki,
T. Shiozawa, Japan
08:24
MULTICELLULAR SPHEROIDS OF EPITHELIAL ENDOMETRIAL CANCER:
CHARACTERISATION AND APPLICATION FOR ANTI-CANCER DRUG
SCREENING
K. Chitcholtan, A.P.J. Evans, P.H. Sykes, New Zealand
08:32
PROGNOSTIC INDICATORS IN ENDOMETRIAL STROMAL SARCOMAS AND
UNDIFFERENTIATED ENDOMETRIAL SARCOMAS
W. Feng, K. Hua, E. Gudlaugsson, Y. Yu, S.-T. Nilsen, X. Zhou, J. Baak, China
08:40
EARLY-ONSET ENDOMETRIAL CANCER IN METROPOLITAN DETROIT,
MICHIGAN: A 20 YEAR REVIEW
R. Ali-Fehmi, A. Munkarah, J.J. Ruterbusch, S. Bandyopadhyay, M.L. Cote, USA
08:48
INTRAOPERATIVE ASSESSMENT OF MYOMETRIAL INVASION AND
HISTOLOGICAL GRADE IN ENDOMETRIAL CANCER USING REVISED FIGO
STAGING SYSTEM
H. Ugaki, T. Enomoto, T. Miyatake, T. Kimura, Y. Ueda, K. Yoshino, M. Fujita,
M. Takemura, T. Kimura, Japan
08:56
MORBIDITY AND MORTALITY OF THE SURGICAL TREATMENT OF THE
OLDEST OLD WOMEN WITH ENDOMETRIAL CANCER
09:04
EVALUATION OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED
CERVICAL CANCER AND ANALYSIS OF RISK FACTORS
L. Gong, Z. Peng, China
47
08:00-10:00
Hall D
Uterine Cancer, including Sarcoma (contd.)
09:12
THE ROLE OF D2-40 (PODOPLANIN) AS A MARKER FOR LYMPH VESSEL
INVASION IN PRIMARY ENDOMETRIAL CANCER
S. Weber, A. Sauerwald, M. Poelcher, M. Braun, M. Debald, N. Serce, W. Kuhn,
C. Rudlowski, Germany
09:20
THE EVOLUTION OF TREATMENT FOR GESTATIONAL TROPHOBLASTIC
NEOPLASIA(GTN): THE FIRST FIVE DECADES AT THE JOHN I BREWER
TROPHOBLASTIC DISEASE CENTER
J. Schink, J. Lurain, USA
09:28
THERAPEUTIC IMPACT OF PARA-AORTIC LYMPHADENECTOMY IN PATIENTS
WITH HIGH-RISK, EARLY STAGE AND ADVANCED STAGE ENDOMETRIAL
CARCINOMA
Y. Suzuki, Y. Todo, K. Okamoto, S. Minobe, H. Kato, Japan
10:00
48
08:00-10:00
Hall E
Surgical techniques; Symptom management / palliation, and Misc.
Chairpersons:
M. Pluta, Czech Republic
A.G.J. van der Zee, The Netherlands
08:00
NEOADJUVANT CHEMOTHERAPY PRIOR TO PELVIC EXENTERATION IN
PATIENTS WITH RECURRENT OR ADVANCED CERVICAL CANCER
A. Maggioni, F. Landoni, F. Sanguineti, A. Lopes, V. Zanagnolo, G. Aletti,
M. Peiretti, L. Bocciolone, E. Preti, N. Colombo, G. Roviglione, Italy
08:08
TEACHING CERVICAL CANCER SURGERY IN LOW OR MIDDLE RESOURCE
COUNTRIES
L. Elit, B. Rosen, W. Jimenez, C. Giede, Cybulka, S. Sinesat, J. Dodge,
M. Bernardini, S. Finlayson, J. McAlpine, D. Miller, Canada
08:16
DOES PRE-OPERATIVE PET-CT REDUCE THE RATE OF POST -OPERATIVE
RADIOTHERAPY IN PATIENTS WITH EARLY CERVICAL CANCER TREATED BY
PRIMARY SURGERY?
O. Gemer, B. Piura, A. Mamanov, A. Rabinovich, B. Ryss, R. Halperin, R. Eitan,
H. Levavi, S. Finci, U. Beller, A. Ben Arie, I. Ben Shachar, A. Meirovitz,
M. Gdalevich, O. Lavie, Israel
08:24
THE NERVE SPARING RADICAL HYSTERECTOMY (NSRH) FOR CERVICAL
CANCER (CC): UPDATE OVER 246 PATIENS EVALUATED
A. Soderini, N. Cuneo, A. Greco, C. Reyes, J. Sardi, G. Garrido, A. Aragona,
I. Perez Tomasone, Argentina
08:32
TREATMENT-TRENDS IN LOCALLY ADVANCED CERVICAL CANCER CARE
BETWEEN 2000 AND 2007 IN THE SOUTH OF THE NETHERLANDS
E. Dovern, L.C.H.W. Lutgens, R.F.P.M. Kruitwagen, B.F.M. Slangen, T. Van Gorp,
A.C. Voogd, M. Engelen, K. Flobbe, K. Van de Vijver, R.I. Lalisang, The Netherlands
08:40
CYTOREDUCTIVE SURGERY FOR RECURRENT OVARIAN CANCER. SINGLE
CENTER EXPERIENCES WITH THE APPLICATION OF THE AGO SCORE TO
PREDICT COMPLETE RESECTION
M.Z. Muallem, P. Harter, C. Buhrmann, R. Hils, F. Heitz, S. Kommoss,
N. Ewald-Riegler, A. Traut, A. du Bois, Germany
08:48
QUALITY OF SURGERY IN ADVANCED OVARIAN CANCER: VALIDATION OF
THE EORTC-GCG QUALITY INDICATORS
L. Verleye, P.B. Ottevanger, F. Amant, G.B. Kristensen, M.E.L. van der Burg,
R. Verheijen, N. Johnson, K. Gaarenstroom, N.S. Reed, J.M. Seoane, B. Mosgaard,
T. Ehlen, J. van der Velden, R. Lotocki, G. Rustin, R. Sandvei, E. Eisenhauer,
C. Coens, I. Vergote, EORTC-GCG and NCIC-CTG, Belgium
49
08:00-10:00
Hall E
Surgical techniques; Symptom management / palliation, and Misc. (contd.)
08:56
PSYCHO-ONCOLOGY: STRUCTURE AND PROFILES OF EUROPEAN CENTERS
TREATING PATIENTS WITH GYNECOLOGICAL CANCER
A. Hasenburg, F. Amant, P. Achimas-Cadariu, V. Kesic, Germany
09:04
POPULATION BASED CASE CONTROL STUDY OF A VEGF GENE
DIMORPHISM AND OVARIAN CANCER RISK AMONG PAKISTANI WOMEN
G. Siddiqui, F. Hanif, K. Elmasry, D. Salaheen, A.B. Maclean, P.M. Frossard,
Pakistan
09:12
CA125 RESPONSE COMPARED TO RADIOLOGIC RESPONSE IN PATIENTS
WITH RECURRENT OVARIAN CANCER UNDERGOING CLINICAL TRIALS OF
MOLECULARLY TARGETED AGENTS
S. Welch, L. Wang, R. Gunawan, H. Mackay, K. Macalpine, H. Hirte,
S. Sivaloganathan, A. Oza, Canada
09:20
D.OV.E.- DETECTING OVARIAN CANCER EARLIER - A PILOT PROJECT
L. Gilbert, S. Piedmonte, C. Martins, N. Albaracin, J. Dubuc, M. Cinquino,
S. Krishnamurthy, Canada
09:28
OVARIAN CRYOPRESERVATION WITH SLOW-FREEZING FOLLOWED BY REIMPLANTATION RESTORES OESTROGEN PRODUCTION AFTER
GONADOTOXIC RADIOTHERAPY TO THE PELVIS
M.H. Botha, T.F. Kruger, South Africa
10:00
50
08:00-10:00
Hall F
Miscellaneous
Chairpersons:
P. Bartos, Czech Republic
L. Kumar, India
08:00
EARLY PREDICTION OF POSTMOLAR GESTATIONAL TROPHOBLASTIC
NEOPLASM BY USING REGRESSION RATE OF HCG FROM WEEKLY
MEASUREMENT
B. Kim, D. Chay, S. Kim, E. Nam, Y. Kim, J.-H. Kim, Republic of Korea
08:08
ESTROGEN REPLACEMENT INDUCES A UNIQUE GENE EXPRESSION
PROFILE IN OVARIAN CANCER THAT DIFFERS FROM BREAST CANCER
M. Spillman, N. Manning, W. Dye, B. Jacobsen, K. Horwitz, USA
08:16
CURCUMIN ENHANCED THE ANTITUMOR EFFECT OF HERPES SIMPLEX
VIRUS THYMIDINE KINASE IN HUMAN BREAST CANCER THROUGH
MODULATION OF ANTI-APOPTOTIC PATHWAY
Y.-F. Chang, C.-H. Hsu, H.-Y. Chuang, J.-J. Hwang, Taiwan R.O.C.
08:24
COST EFFECTIVENESS OF LAPAROSCOPIC VERSUS ABDOMINAL
HYSTERECTOMY IN EARLY STAGE ENDOMETRIAL CANCER
C.B.m. Bijen, K.M. Vermeulen, M.J.E. Mourits, H.J.G. Arts, H.G. ter Brugge,
R. van der Sijde, L. Paulsen, J. Wijma, M.Y. Bongers, A.G.J. van der Zee,
G.H. de Bock, The Netherlands
08:32
PROGNOSTIC SIGNIFICANCE OF LYMPHO-VASCULAR SPACE INVASION AND
NODAL INVOLVEMENT IN INTERMEDIATE AND HIGH RISK ENDOMETRIAL
CANCER PATIENTS
K. Narayan, S. Kondalsamy-Chennakesavan, Australia
08:40
DIAGNOSTIC PERFORMANCE OF CONTRAST ENHANCED CT AND FDGPET/CT IN THE ASSESSMENT OF LYMPH NODE METASTASIS IN OPERABLE
CERVICAL CANCER
A. Maheshwari, H.B. Tongaonkar, N.C. Purandare, India
08:48
FACTORS ASSOCIATED WITH ENROLMENT IN OVARIAN CANCER CLINICAL
TRIALS AND THE IMPACT ON OUTCOME
S. Ananda, P. Gibbs, O. McNally, M. Quinn, Australia
08:56
SYSTEMATIC PELVIC AND PARAAORTIC LYMPHADENECTOMY IN
ENDOMETRIAL CANCER: LYMPH NODE METASTASIS PATTERN AND
IDENTIFICATION OF PREDICTIVE FACTORS FOR LYMPH-NODE STATUS
A. El-Balat, C. Fotopoulou, J. Sehouli, F. Heitz, M.Z. Muallem, P. Harter,
R. Krätschell, A. du Bois, Germany
09:04
HEPATIC RESECTION IS A POTENTIAL TREATMENT FOR RECURRENT
METASTATIC OVARIAN CARCINOMA OR PERITONEAL CARCINOMA
X. Yan, Y. Gao, Q. Bao, N. An, G. Jiang, M. Gao, H. Zheng, W. Wang, China
51
08:00-10:00
Hall F
Miscellaneous (contd.)
09:12
FORTY YEARS REVIEW FOR THE TREATMENT OF VAGINA CARCINOMA: AN
INSTITUTIONAL EXPERIENCE
T. Wan, J. Liu, Q. Huang, China
09:20
CHEMORADIOSENSITIZATION OF BRACHYTHERAPY IN CARCINOMA OF
UTERINE CERVIX: THE FRINGE EFFECTS IN ADVANCE DISEASE
M. Sharma, A. Sharma, N. Somaiah, India
09:28
DISPARITIES IN TREATMENT FOR EPITHELIAL OVARIAN CANCER IN A
LARGE UNITED STATES POPULATION
S.L. Stewart, A.R. Kahn, M.J. Schymura, J.S. Townsend, J.M. Wike, R.D. Cress,
K. Bauer, C.D. O'Malley, USA
10:00
52
08:00-10:00
Hall G
Basic / translational science; and Misc.
Chairpersons:
M. Seoud, Lebanon
E. Trimble, USA
08:00
ANTI-GLYCAN ANTIBODIES AS NEW OVARIAN CANCER TUMORMARKERS
IDENTIFIED USING PRINTED GLYCAN ARRAY
V. Heinzelmann-Schwarz, F. Jacob, D. Goldstein, N. Bovin, D. Fink, M. Huflejt,
Australia
08:08
OVARIAN CANCER IN HEREDITARY NONPOLYPOSIS COLORECTAL CANCER;
CLINICAL CHARACTERISTICS, MORPHOLOGY AND MISMATCH-REPAIR
MUTATIONS
K. Domanska, M. Nilbert, Sweden
08:16
TOPOTECAN/CARBOPLATIN VS. PACLITAXEL/CARBOPLATIN OR
GEMCITABIN/CARBOPLATIN OR CARBOPLATIN/PEGYLATED DOXORUBICIN:
A PLANNED 200 PTS INTERIM SAFETY ANALYSIS OF THE HECTOR-STUDY
(NOGGO/AGO-OVAR/GEICO/AGO-AUSTRIA)
A.K. Belau, G. Heinrich, A. Reinthaller, M.J. Rubio, A. Stähle, H. Sommer, E. Petru,
M. Beltran, F. Hilpert, U. Canzler, G. Oskay-Özcelik, S. Mahner, J. Sehouli,
NOGGO,AGO-Ovar,GEICO, AGO-Austria, Germany
08:24
NUTRITIONAL STATUS AND SURVIVAL AMONG PATIENTS WITH SUSPECTED
OR PROVEN GYNECOLOGICAL MALIGNANCIES
S. Kondalsamy-Chennakesavan, B. Laky, M. Janda, G. Cleghorn, J. Nicklin,
R. Land, L. Perrin, A. Crandon, A. Obermair, Australia
08:32
DIFFERENT AMPLIFICATION PATTERNS OF THE HUMAN TELOMERASE RNA
GENE IN INVASIVE CERVICAL CARCINOMAS AND CERVICAL
INTRAEPITHELIAL NEOPLASIA GRADE III
L. Xiang, H. Yang, J. Li, X. Wu, X. Zhou, China
08:40
DUAL METRONOMIC CHEMOTHERAPY RESULTS IN POTENT ANTIANGIOGENIC EFFECTS IN OVARIAN CARCINOMA
R.L. Coleman, Y.G. Lin, R.L. Stone, W.M. Merritt, A.M. Nick, A.R. Carroll,
R.R. Langley, A.K. Sood, USA
08:48
PHASE II STUDY OF PELVIC INTENSITY MODULATED RADIOTHERAPY +/CHEMOTHERAPY FOR POST- OPERATIVE PATIENTS WITH ENDOMETRIAL
OR CERVICAL CARCINOMA (RTOG 0418)
L. Portelance, K. Winter, A. Jhingran, B.E. Miller, M.R. Salehpour, D. D'Souza,
L. Souhami, W. Small, D. Gaffney, Radiation Therapy Oncology Group (RTOG),
Canada
08:56
TARGETING THE IGF-I RECEPTOR IN ENDOMETRIAL CANCER WITH
MONOCLONAL ANTIBODY MK-0646
I. Bruchim, C. Bitelman, R. Sarfstein, Z. Attias, H. Werner, A. Fishman, Israel
53
08:00-10:00
Hall G
Basic / translational science; and Misc. (contd.)
09:04
HE-4 A NOVEL TUMOR MARKER FOR OVARIAN CANCER: COMPARISON
WITH CA 125 IN PATIENTS WITH GYNECOLOGICAL DISEASES
R. Molina, J.M. Escudero, J.M. Auge, X. Filella, L. Foj, A. Torne, J. Lejarcegui,
J. Pahisa, Spain
09:12
FERTILITY-SPARING SURGERY IN YOUNG WOMEN WITH BILATERAL GERM
CELL TUMOR
A. Garbi, R. Fruscio, M. Cantù, C.M. Bonazzi, S. Corso, V. Chiappa, L. Ceppi,
F.P. Sina, R. Milani, Italy
09:20
PATIENTS' PREFERENCES FOR INTRAPERITONEAL CHEMOTHERAPY FOR
ADVANCED OVARIAN AND RELATED CANCERS: WHAT MAKES IT
WORTHWHILE?
P. Blinman, C. Gainford, V. Duric, M. Friedlander, M. Stockler, Australia New
Zealand Gynaecological Oncology Group, Australia
09:28
PREDICTING GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN): IS URINE
HCG (UHCG) THE ANSWER?
M. Alazzam, T. Young, R. Coleman, B. Hancock, J. Tidy, UK
10:00
54
10:30-12:00
Hall B
Plenary Session IV:
Chairpersons:
G. Gitsch, Germany
E. Trimnle, USA
10:30
GENE EXPRESSION SIGNATURE CHARACTERIZED BY PI3KINASE
ACTIVATION VALIDATES TO IDENTIFY AGGRESSIVE DISEASE AND A
POTENTIAL FOR PI3KINASE-INHIBITORS IN ENDOMETRIAL CARCINOMAS
E. Wik, J. Trovik, M.B. Raeder, M. Mannelqvist, A.M. Oyan, K.H. Kalland,
L.A. Akslen, H.B. Salvesen, Norway
10:41
PROTECTIVE EFFECT OF AMIFOSTINE DURING PELVIC IRRADIATION: LONG
TERM EFFECTS AND RESULTS
M. Mehta, P. Nandwani Patel, R. Vyas, India
10:52
SYMPTOM BURDEN AMONG PATIENTS WITH PLATINUM
RESISTANT/REFRACTORY RECURRENT OVARIAN CANCER (PRR ROC):
STAGE 1 OF THE GCIG SYMPTOM BENEFIT STUDY
M. Friedlander, M. Voysey, M. King, M. Stockler, A. Oza, K. Gillies, B. Miller,
H. Donovan, J. Martyn, P. Butow, Australia
11:03
IDENTIFICATION OF POINT MUTATIONS AND LARGE REARRANGEMENTS IN
THE BRCA1 GENE IN 667 TURKISH UNSELECTED OVARIAN CANCER
PATIENTS
D. Aktas, M. Gultekin, S. Kabacam, M. Alikasifoglu, A.T. Turan, G. Tulunay,
M.F. Kose, F. Ortac, K. Yuce, E. Tuncbilek, A. Ayhan, Turkey
11:14
AGO-OVAR-2.11: A RANDOMIZED PHASE II TRIAL TO EVALUATE TWO
DIFFERENT DOSAGES OF THE KINASE-INHIBITOR SU11248 IN PLATINUMREFRACTORY OVARIAN CANCER
C. Kurzeder, A. du Bois, W. Meier, J. Rau, P. Wimberger, J. Sehouli, R. Kreienberg,
F. Hilpert, A. Hasenburg, T. Dewitz, K. Wollschlaeger, U. Canzler, K. Baumann,
L. Hanker, P. Hillemanns, B. Richter, D. Bauerschlag, U. Wagner, Germany
11:25
MICRORNA AS PROGNOSTIC FACTOR FOR RECURRENCE AND SURVIVAL
OF OVARIAN CANCER - ANALYSIS OF THE CANCER GENOME ATLAS
PROJECT
A. Sherman, K. Fuh, D. Kapp, J. Chan, USA
11:36
A PHASE 2 STUDY OF CEDIRANIB IN RECURRENT OVARIAN CANCER: FINAL
RESULTS OF A PMH, CHICAGO AND CALIFORNIA CONSORTIA TRIAL
H. Hirte, G. Fleming, A. Sugimoto, R. Morgan, J. Biagi, F. Moens, L. Wang, K. Allen,
S.P. Ivy, A.M. Oza, PMH, Chicago, California Phase 2 Consortia, Canada
55
12:00-13:00
Hall A
Closing & Awards Ceremony
INTRODUCTION
J. Berek, USA
AWARDS
R. Barakat, USA
ANNOUNCEMENT OF IGCS 2012 VANCOUVER
D. Miller, Canada
CONCLUSIONS
J. Berek, USA
56
Saturday - Sunday, October 23-24, 2010
Poster Area and Exhibition
Poster Session I
Basic/translational science
Poster No
1
ANTI-GLYCAN ANTIBODIES AS NEW OVARIAN CANCER TUMORMARKERS
IDENTIFIED USING PRINTED GLYCAN ARRAY
V. Heinzelmann-Schwarz, F. Jacob, D. Goldstein, N. Bovin, D. Fink, M. Huflejt,
Australia, Switzerland
2
FREQUENT INACTIVATION OF HSRBC IN OVARIAN CANCERS BY PROMOTER
CPG ISLAND HYPERMETHYLATION
S.-K. Lee, S.-Y. Tong, K.-D. Ki, J.-M. Lee, S.-G. Chi, Republic of Korea
3
CYTOTOXIC EFFECT AND INDUCTION OF APOPTOSIS IN HUMAN OVARIAN
CANCER CELLS BY ANTRODIA CAMPHORATA
F.-S. Liu, D.-N. Hu, P.-Y. Yang, M.-R. Chen, Y.-W. Huang, Y.-Z. Ye, Taiwan R.O.C.
4
TARGETED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
FOR PATIENTS WITH PRIMARY AND RECURRENT EPITHELIAL OVARIAN
CANCER
S. Farghaly, USA
5
HUMAN TRA2-BETA1 AND ACIDOSIS REGULATE CYR61 (CCN1)
ALTERNATIVE SPLICING
M. Hirschfeld, M. Jaeger, G. Gitsch, E. Stickeler, Germany
6
POSSIBLE INVOLVEMENT OF BMP SIGNALING IN REGULATING T CELL
DIFFERENTIATION AND IL-2 PRODUCTION
Y. Yoshioka, M. Ono, M. Osaki, H. Yaguchi, J. Hamanishi, T. Baba, N. Matsumura,
M. Masaki, S. Sakaguchi, I. Konishi, Japan
7
A POSSIBLE CLINICAL ADAPTATION OF CRM197, A SPECIFIC INHIBITOR
FOR HB-EGF, WITH CONVENTIONAL CHEMOTHERAPEUTIC AGENTS ON
OVARIAN CANCER
H. Tsujioka, T. Fukami, F. Yotsumoto, S. Hikita, T. Ueda, S. Horiuchi, K. Shirota,
T. Yoshizato, S. Miyamoto, Japan
8
INDOLEAMINE -DIOXYGENASE (IDO) AND FOXP3 EXPRESSION IN VULVAR
SQUAMOUS CELL CARCINOMA - NEW TARGETS TO PROMOTE EN
EFFECTIVE IMMUNE RESPONSE
J. Sznurkowski, A. Żawrocki, J. Emerich, W. Biernat, Poland
9
PROGNOSTIC SIGNIFICANCE OF CD4+ AND CD8+ T CELLS INFILTRATION
WITHIN CANCER CELL NESTS IN VULVAR SQUAMOUS CELL CARCINOMA
(VSCC)
J. Sznurkowski, A. Żawrocki, J. Emerich, W. Biernat, Poland
10
A BTB/POZ GENE, NAC-1, A TUMOR RECURRENCE-ASSOCIATED GENE, AS A
POTENTIAL TARGET FOR TAXOL RESISTANCE IN OVARIAN CANCER
M. Ishikawa, K. Nakayama, A. Katagiri, K. Miyazaki, Japan
57
Poster Session I
Basic/translational science (contd.)
Poster No
11
NUTRITIONAL STATUS AND SURVIVAL AMONG PATIENTS WITH SUSPECTED
OR PROVEN GYNECOLOGICAL MALIGNANCIES
S. Kondalsamy-Chennakesavan, B. Laky, M. Janda, G. Cleghorn, J. Nicklin,
R. Land, L. Perrin, A. Crandon, A. Obermair, Australia
12
THE CONTRIBUTING ROLE OF ICC (INTERSTITIAL CAJAL CELLS) IN
ADENOMYOSIS SYMPTOMS
C. Vrabie, D.C. Terzea, M. Cojocaru, C.M. Ardeleanu, Romania
13
PACLITAXOL INDUCE OXIDIZED LIPID CHANGE IN HUMAN CERVICAL
CANCER CELL DETECTED BY MALDI-SPECTROMETRY
C.-B. Liu, L.-H. Chen, H.-Y. Wang, W.-S. Liou, Taiwan R.O.C.
14
THE COST OF COMPLICATIONS: HOSPITAL COSTS ASSOCIATED WITH
SURGICAL ADVERSE EVENTS IN GYNECOLOGICAL ONCOLOGY
S. Kondalsamy-Chennakesavan, L. Gordon, K. Sanday, C. Bouman, S. deJong,
J. Nicklin,, R. Land, A. Obermair, Australia
15
ERYTHROPOIETIN AND ANGIOPOIETIN EXPRESSION IN UTERINE TUMORS:
HOW DO UTERINE TUMORS MAINTAIN CELL VIABILITY TO BECOME VERY
LARGE?
M. Asai-Sato, E. Miyagi, M. Inada, T. Mogami, S. Yamanaka, Y. Nagashima,
T. Nagata, H. Sakakibara, Y. Inayama, F. Hirahara, Japan
16
HNRNP G AND HTRA2-BETA1: OPPOSITE REGULATION OF ESTROGEN
RECEPTORΑ Γ7 WITH DIVERGENT IMPACT ON TYPE I ENDOMETRIAL
CANCEROUTCOME
Y.Q. Ouyang, A. zur Hausen, M. Jäger, M. Hirschfeld, X.W. Tong, G. Gitsch,
E. Stickeler, Germany
17
P14ARF EXPRESSION PATTERN IN PRIMARY AND METASTATIC
ENDOMETRIAL CARCINOMAS
A. Semczuk, P. Olcha, M. Cybulski, D. Skomra, B. Obrzut, M. Gogacz, A. Ignatov,
M. Jozwik, R. Schneider-Stock, Poland
18
SYNCHRONOUS PRIMARY NEOPLASMS OF THE FEMALE REPRODUCTIVE
TRACT
S. Eser, I. Gulhan, R. Ozdemir, N. Dicle, M. Hanhan, A. Baloglu, A. Ozsaran,
U. Saygili, Turkey
19
DEVELOPMENT OF A UTERINE TRANSPLANTATION MODEL IN ANIMALS
USING THE SUPERMICROSURGERY TECHNIQUE
T. Iida, I. Kisu, M. Mihara, J. Araki, I. Koshima, Japan
20
RAPID AND SENSITIVE HUMAN PAPILLOMAVIRUS GENOTYPING BY HIGH
RESOLUTION MELTING ANALYSIS
J.-T. Qiu, H.-H. Chou, T.-C. Chang, C.-H. Lai, Taiwan R.O.C.
58
Poster Session I
Poster No
21
A GENE EXPRESSION SIGNATURE THAT PREDICTS THE PROGNOSIS OF
CERVICAL CARCINOMA PATIENTS
L. Huang, H.-Y. Wang, Y. Zhang, W.-H. Jia, M. Zheng, China
22
HYPERTHERMIA ABROGATES THE Y-BOX BINDING PROTEIN-1 (YB-1)
EXPRESSION
S. Iborra, M. Jager, M. Hirschfeld, G. Gitsch, E. Stickeler, Germany
23
MICROSATELLITE INSTABILITY AND PROGNOSIS IN ENDOMETRIAL CANCER
IN PATIENTS AT THE BRAZILIAN NATIONAL CANCER INSTITUTE
C.B.P. Chaves, V.P. Leite, B.P. Silva, F.C.B. Moreira, D.M.P. Ramalho,
J.C. Casali-da-Rocha, Brazil
24
DIFFERENT AMPLIFICATION PATTERNS OF THE HUMAN TELOMERASE RNA
GENE IN INVASIVE CERVICAL CARCINOMAS AND CERVICAL
INTRAEPITHELIAL NEOPLASIA GRADE III
L. Xiang, H. Yang, J. Li, X. Wu, X. Zhou, China
25
HYPOXIA INDUCIBLE FACTOR-1Α (HIF-1Α) POLYMORPHISMS AND EARLY
CERVICAL CANCER
Y.H. Kim, H.H. Chung, J.W. Kim, N.-H. Park, Y.-S. Song, S.-B. Kang,
Republic of Korea
26
INCIDENCE OF BRCA FOUNDER MUTATIONS IN JEWISH PATIENTS WITH
UTERINE SEROUS CARCINOMA
S. Wethington, F. Bogomolniy, N. Olvera, F. Dao, N. Kauff, D. Levine, USA
27
ENDOCERVICOSIS: CAUSE OF AN EXTRAOVARIAN MUCINOUS
CYSTADENOCARCINOMA
A.-J. Kruse, K. Van de Vijver, G. Dunselman, T. Pirens, F. Bakers, B. Slangen,
The Netherlands
28
A12 MONOCLONAL ANTIBODY AGAINST IGF-IR IS A POTENTIAL
THERAPEUTIC STRATEGY IN ENDOMETRIAL CANCER
I. Bruchim, Z. Attias, D. Ludwig, A. Fishman, H. Werner, Israel
29
ASSOCIATION OF THE HSRBC GENE POLYMORPHISM WITH ENDOMETRIAL
CANCER
S.-Y. Tong, J.-M. Lee, S.K. Lee, K.-D. Ki, S.G. Chi, Republic of Korea
30
LEPTIN INCREASES INVASIVENESS AND ANGIOGENESIS IN HUMAN
EPITHELIAL OVARIAN CANCER CELLS BY ACTIVATING MULTIPLE SIGNALTRANSDUCTION PATHWAYS
D. Diaz, S. Kato, J. Brañes, D. Mayerson, M. Barriga, G. Owen, M. Cuello, Chile
59
Poster Session I
Poster No
31
DUAL METRONOMIC CHEMOTHERAPY RESULTS IN POTENT ANTIANGIOGENIC EFFECTS IN OVARIAN CARCINOMA
R.L. Coleman, Y.G. Lin, R.L. Stone, W.M. Merritt, A.M. Nick, A.R. Carroll,
R.R. Langley, A.K. Sood, USA
32
EFFECT OF GONADOTROPIN AND GNRH ANTAGONIST ON MORPHOLOGY,
APOPTOSIS AND EXPRESSION OF P53 IN OVARIAN TISSUE OF RATS
T. Guvenal, A. Goker Tamay, S. Cilaker Micili, Y. Yildirim, S. Oruc Koltan,
C. Ozogul, F.M. Koyuncu, Turkey
33
ENHANCEMENT OF PRE-EXISTING HUMORAL IMMUNE RESPONSE TO
GYNECOLOGIC MALIGNANCY BY PERSONALIZED PEPTIDE VACCINE
K. Kawano, N. Tsuda, K. Ushijima, T. Sasada, A. Yamada, K. Itoh, T. Kamura,
Japan
34
HYPOXIA REGULATES YT521 EXPRESSION THROUGH COUPLING OF
ALTERNATIVE SPLICING WITH NONSENSE-MEDIATED DECAY (NMD)
B. Zhang, M. Hirschfeld, M. Jaeger, G. Gitsch, E. Stickeler, Germany
35
INCREASED EXPRESSION OF PLACENTAL GROWTH FACTOR, A HOMOLOG
OF VASCULAR ENDOTHELIAL GROWTH FACTOR, IN HIGH GRADE
ENDOMETRIAL CARCINOMAS
L. Coenegrachts, H. Soenen, J. Billen, R. van Bree, E. Despierre, J.-M. Stassen,
P. Carmeliet, I. Vergote, F. Amant, Belgium
36
TARGETING THE IGF-I RECEPTOR IN ENDOMETRIAL CANCER WITH
MONOCLONAL ANTIBODY MK-0646
I. Bruchim, C. Bitelman, R. Sarfstein, Z. Attias, H. Werner, A. Fishman, Israel
37
ANGIOGENESIS AND ITS ASSOCIATION WITH EXTRACELLULAR MATRIX
PROTEINS IN ADVANCED CERVICAL CANCER
A. Sharma, R. Khan, M. Sharma, India
38
TARGETING Α-LINKED SIALYLATION BY SOYASAPONIN I MIGHT BE USEFUL
IN THE OVARIAN CANCER TREATMENT
M.-C. Ko, W.-L. Lee, K.-C. Chao, Y.-C. Tsai, L.-W. Yang, P.-H. Wang,
Taiwan R.O.C.
39
THE METHYLATION LEVEL OF HERV-K PROVIRUS IN OVARIAN CLEAR CELL
CARCINOMA
K. Iramaneerat, P. Rattanatunyong, N. Khemapech, S. Triratanachat,
A. Mutirangura, Thailand
40
METHYLATION PROFILING OF SEROUS CARCINOMA OF THE FEMALE
GENITAL TRACT
L. Seeber, G. Bol, K. Suijkerbuijk, R. Zweemer, R. Verheijen, P. van Diest,
The Netherlands
60
Poster Session I
Poster No
41
IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES USING
ANNEALING CONTROL PRIMER SYSTEM IN STAGE III SEROUS OVARIAN
CARCINOMA
Y.-S. Kim, J.H. Do, D.-H. Bae, S.J. Han, T.-G. Ahn, W.S. Ahn, Republic of Korea
42
FEASIBILITY OF DEVELOPING A FUNCTIONAL ASSAY FOR HOMOLOGOUS
RECOMBINATION IN PRIMARY CULTURES OF EPITHELIAL OVARIAN
CANCER FROM ASCITIC FLUID
A. Mukhopadhyay, S. Soohoo, B. Uzir, A. Ellatar, E. Mulligan, N. Curtin,
R. Edmondson, UK
43
ANALYSIS OF B7H4 AND HLA-G IMMUNOREACTIVITY WITHIN OVARIAN
CANCER RELAPSE AND ITS MICROENVIRONMENT ACCORDING TO APPLIED
PRECEDING CHEMOTHERAPY
P. Basta, P. Mach, L. Wicherek, Poland
44
INFECTIVITY-ENHANCED ADENOVIRAL-BASED GENE THERAPEUTICS FOR
GYNECOLOGIC CANCER: FROM BENCH TO BEDSIDE
K.H. Kim, K.J. Kimball, M.A. Preuss, M. Wang, M.N. Barnes, G.P. Siegal,
D.T. Curiel, R.D. Alvarez, USA
45
THE WOMEN´S CANCER CELL GENOTYPE ATLAS (WCCGA): DNA
AUTHENTICATION OF ENDOMETRIAL CANCER, OVARIAN CANCER, AND
BREAST CANCER CELL LINES
M. Spillman, B. Jacobsen, A. Bradford, S. Murphy, T. Jackson, B. Helfrich,
B. Lessey, C. Korch, USA
46
AVALIATION OF CYTOKINE LEVELS, NAG AND MPO ACTIVITY IN WOMEN
WITH PRE-INVASIVE CERVIX LESIONS AND INVASIVE CERVICAL CANCER
E.L. Lages, A.V. Belo, S.P. Andrade, M.A. Rocha, P. Traiman, G.F. Freitas,
L.M. Silva, A.L. Silva-Filho, Brazil
47
THE ESTROGEN RECEPTOR Α-DEPENDENT SERINE PROTEASE PRSS23
MEDIATES PROLIFERATION OF ENDOMETRIAL CANCER CELLS
S.-J. Chang, H.-J. Ko, H.-S. Chan, Y.-J. Chuang, Taiwan R.O.C.
48
WHOLE SLIDE AUTOMATED COMPUTER-ASSISTED QUANTIFICATION OF
LYMPHANGIOGENESIS THROUGHOUT THE CERVICAL CANCER PROCESS:
AN ORIGINAL METHOD
N. Signolle, C. Balsat, F. Kridelka, F. Goffin, S. Blacher, P. Delvenne, K. Delbecque,
A. Béliard, C. Munaut, J.-M. Foidart, A. Noël, Belgium
49
P16 GENE PROMOTER REGION METHYLATION STATUS IN OVARIAN
CANCER - CORRELATION BETWEEN BLOOD AND TUMOUR TISSUE
L.S. Bammidi, G.N. Neerukonda, N.B. Parvataneni, S.R. Tammineedi,
R.D. Kanapuram, India
61
Poster Session I
Poster No
50
STUDY OF ADAPTATIVE IMMUNE RESPONSE IN WOMEN WITH OVARIAN
CANCER
G.F. Freitas, E.L. Lages, S.O.C. Paula, T.M.R.F. Franco, A.T. Carvalho,
O.A. Martins-Filho, P. Traiman, A. Silva-Filho, Brazil
51
HUMAN PAPILLOMAVIRUS TYPE 16 AND 18 ARE IMPORTANT ETIOLOGIC
AGENTS IN PREDISPOSING WOMEN FOR OVARIAN CANCER DEVELOPMENT
O. Bilyk, L.G. Buchynska, N. Pande, T. Pejovic, Ukraine
52
EXPRESSION PROFILING OF THE OVARIAN SURFACE KINOME REVEALS
CANDIDATE GENES FOR EARLY NEOPLASTIC CHANGES
T. Pejovic, N. Pande, K. Odunsi, USA
53
ARRAY CGH CHARACTERIZATION OF UTERINE CERVICAL CANCER
A. Ohno, T. Fujii, Y. Murayama, A. Takayanagi, S. Asakawa, J. Kudoh, D. Aoki,
N. Shimizu, Japan
54
IDENTIFICATION ISOLATION AND GENE EXPRESSION OF CD8 ALPHA/ALPHA
T LYMPHOCYTES IN SEROUS OVARIAN ADENOCARCINOMA
S. Attard Montalto, O. Devaja, A. Papadopoulos, S.K. Raju, J. Spencer, UK
55
RAPID AND SIMULTANEOUS DETECTION OF PROLIFERATION, APOPTOSIS,
INVASIVE ABILITY, AND CYTOSKELETAL REORGANIZATION IN
GYNECOLOGICAL CANCER CELLS BY NANODEVICE
Y.-C. Hung, L.-C. Huang, Y.-Y. Chang, W.-C. Wu, S.-A. Pan, S.-M. Tai, G.S. Huang,
Taiwan R.O.C.
56
SIZE-DEPENDENT IMMUNE PROPERTIES OF GOLD NANOPARTICLES AS
DRUG (VACCINE) TARGETING CARRIER IN NANOMEDICINE- ELICITED BY
SYNTHETIC FOOT-AND-MOUTH DISEASE VIRUS PEPTIDE
Y.-C. Hung, L.-M. Chen, L.-C. Huang, Y.-S. Chen, W.-H. Lin, G.S. Huang,
Taiwan R.O.C.
57
GAIN-OF-FUNCTION WNT-INDEPENDENT ACTIVITY OF THE PYGOPUS2
TRANSCRIPTION FACTOR IN GYNECOLOGIC CANCER
P. Andrews, C. Popadiuk, K. Kao, Canada
Imaging/Staging
58
18F-FDG PET/CT AS A SELECTION TOOL FOR SALVAGE SURGERY OR
IMAGE-GUIDED RADIOTHERAPY IN PATIENTS WITH RECURRENT OVARIAN
CANCER
N.M. Blumstein, A. Geretschlaeger, S. Gebhard, S. Perner, S.N. Reske,
C. Kurzeder, Switzerland
59
WHAT IS THE ADDITIONAL ROLE OF 18F FDG-PET/CT ON THERAPY
MANAGEMENT DURING FOLLOW UP IN BREAST CANCER?
N.M. Blumstein, G. Jäger, C. Blumstein,, S. Perner, A. Geretschlaeger, S.N. Reske,
C. Kurzeder, Switzerland
62
Poster Session I
Imaging/Staging (contd.)
Poster No
60
WHOLE-BODY DIFFUSION-WEIGHTED IMAGING USED IN PREOPERATIVE
EVALUATION OF CERVICAL CANCER AND LYMPH NODE METASTASIS ANALYSIS OF 31 CASES
M. Yu, J.-X. Yang, K. Shen, H.-D. Xue, Z.-Y. Jin, China
61
EVALUATION OF ROLE OF FDG-PET/CT IN STAGING AND MANAGEMENT OF
OVARIAN MALIGNANCIES
N. Bhatla, P. Lal, R. Kumar, A. Kriplani, L. Kumar, R. Malhotra, India
62
ROLE OF TRANSVAGINAL ULTRASOUND IN THE FOLLOW UP OF PATIENTS
TREATED WITH CONSERVATIVE SURGERY FOR OVARIAN BORDERLINE
TUMORS
G. Perniola, C. Exacoustos, A. Di Giovanni, M.E. Romanini, V. Lanzillotta,
D. Savone, P. Benedetti Panici, D. Arduini, Italy
63
THREE DIMENSIONAL ULTRASOUND TO ASSESS THE NEO-ADJUVANT
CHEMOTHERAPY RESPONSE OF LOCALLY ADVANCED CERVICAL CANCER
G. Perniola, C. Exacoustos, M. Graziano, F. Bellati, I. Palaia, C. Achilli, D. Arduini,
P. Benedetti Panici, Italy
64
THE ROLE OF ULTRASOUND IN PELVIC RELAPSE OF PATIENTS TREATED
FOR EPITHELIAL OVARIAN CANCER
G. Perniola, C. Exacoustos, M. Graziano, F. Rossi, V. Di Donato, L. Riganelli,
A. Cassorelli, D. Arduini, P. Benedetti Panici, Italy
65
RISK OF MALIGNANCY INDEX: HOW FEASIBLE IS IT TO CALCULATE THE
SCORE?
H. Chiu, J. Dodge, Canada
66
ULTRASOUND IN DIAGNOSIS OF NEW AND RECURRENT BORDERLINE
OVARIAN TUMORS
D. Fischerova, D. Franchi, A.C. Testa, L. Valentin, L. Savelli, A.A. Lissoni,
R. Fruscio, C. Van Holsbeke, E. De Jonge, S. Van Huffel, T. Bourne, B. Van Calster,
F. Amant, D. Timmerman, Czech Republic
67
ANALGESIC EFFICACY OF FORCED COUGHING VERSUS LOCAL
ANESTHESIA DURING CERVICAL PUNCH BIOPSY
O. Unal, M. Naki, O. Api, H. Acioglu, M. Uzun, B. Kars, Turkey
68
THE ADDED VALUE OF A SENIOR ADULT ONCOLOGY PROGRAM FOR
ELDERLY WOMEN WITH GYNECOLOGIC CANCERS
M.-C. Van Nes, I. Demande, C. Mottet, M. Philippe, A. Schoumackers, J.-M. Foidart,
F. Goffin, Belgium
69
18F-FDG PET CAN IDENTIFY TUMOR RELAPSE IN OVARIAN CANCER
PATIENTS (PTS)WITH NEGATIVE SERUM MARKERS LEVELS?
A. Villa, L. Florimonte, S. Noli, E. Grossi, M. Gasparini, R. Benti, P. Gerundini, Italy
63
Poster Session I
Poster No
70
IMAGING APPEARANCES OF RECURRENT CERVIX CANCER FOLLOWING
UTERUS CONSERVING SURGERY (TRACHELECTOMY)
S. Liyanage, A. Sahdev, P. Narayan, A. Sohaib, A. Rockall, R. Reznek, UK
71
UTERINE GIANT TUMOR-DIFFERENTIAL DIAGNOSIS DILEMMA AND
MANAGEMENT: A CASE REPORT SERIES
G. Malenkovic, A. Mandic, D. Nincic, P. Novakovic, N. Prvulovic, T. Ivkovic-Kapicl,
Serbia
72
FDG-PET/CT FINDINGS IN CORRELATION WITH LAPAROSCOPY IN
ADVANCED OVARIAN CANCER STAGING: USEFULNESS AND LIMITS
A. Musto, P. De Iaco, I. Strada, L. Ricci Maccarini, L. Orazi, M.J. Tsivian, F. Pozzati,
S. Fanti, S. Venturoli, Italy
73
DEPENDENCE OF LYMPH NODE COUNT BY LAPAROSCOPIC
LYMPHADENECTOMY FROM THE EXAMINING PATHOLOGIST
J. Vasiljeva, M. Lanowska, K. Hasenbein, V. Chiantera, G. Favero, S. Marnitz,
A. Schneider, C. Köhler, Germany
74
IS PET-CT A SUPERIOR INVESTIGATION FOR DETECTING DISTANT
METASTASIS IN CERVICAL CANCER?
S. Chachan, T. Madhuri, S. Butler-Manuel, A. Tailor, UK
75
ULTRASONOGRAPHIC COMPARISON BETWEEN TYPES I AND II
ENDOMETRIAL ADENOCARCINOMAS
M.A. Vieira, M.C. Silva, R.A. Perdomo, A.T. Tsunoda, C.E.M.C. Andrade,
J.H.T.G. Fregnani, Brazil
76
IS ULTRASOUND A GOOD EXAM TO EVALUATE PATIENTS WITH OVARIAN
MASSES BEFORE SURGERY?
F. Martra, P. Modaffari, E. Piovano, C. Baima Poma, E. Tripodi, V. Zanfagnin,
E. Volpi, P. Zola, Italy
77
PREOPERATIVE ASSESSMENT OF ENDOMETRIAL CARCINOMA BY 3D
POWER DOPPLER ULTRASOUND: MATURE RESULTS OF A PROSPECTIVE
STUDY
S.K. Saarelainen, M. Vuento, P. Kirkinen, J.U. Mäenpää, Finland
78
PET/CT IN MANAGEMENT OF RECURRENT GYNECOLOGICAL CANCER
C.-L. Chen, W.-T. Wang, L.-Q. Li, Y.-G. Zhang, C.-F. Zou, Z.-Y. Cao, China
79
BORDERLINE OVARIAN TUMORS - STILL A CHALLENGE FOR AN ACCURATE
PREOPERATIVE DIAGNOSIS
Y. Goldberg, O. Lavie, Y. Segev, R. Auslender, Israel
80
LARGE METASTASIS PELVIC LYMPH NODE IN LAPAROSCOPIC UTERINE
CANCER STAGING SURGERY
C.-L. Lee, H. Su, K.-G. Huang, C.-F. Yen, Taiwan R.O.C.
64
Poster Session I
Poster No
81
UTERINE ARTERY DOPPLER IN PERIMENOPAUSAL UTERINE BLEEDING
F. Tanase, A. Comanescu, L. Dijmarescu, C. Marinas, F. Cornitescu, N. Cernea,
Romania
82
ADEQUACY, ACCURACY AND SAFETY OF ULTRASOUND GUIDED TRU-CUT
BIOPSY IN THE MANAGEMENT OF ABDOMINAL AND PELVIC TUMORS
M. Zikan, D. Fischerova, I. Pinkavova, D. Cibula, Czech Republic
83
LEARNING CURVE OF THE LAPAROSCOPIC STAGING PROCEDURE FOR
EARLY STAGE OVARIAN CANCER
H. Schreuder, R. Zweemer, T. Pattij, M. van Baal, R. Verheijen, The Netherlands
84
PRE-TREATMENT STAGING AND PROGNOSTIC VALUE OF 18-FDG PET/CT
AND MRI IN CERVICAL CANCER IB1-IIA
P. Zubor, K. Kajo, D. Zuborova, H. Polacek, P. Grac, S. Krivus, J. Danko,
Slovak Republic
85
ARE PRE-OPERATIVE COMPUTED TOMOGRAPHY (CT) SCANS A RELIABLE
INDICATOR OF OPTIMAL SURGICAL CYTOREDUCTION? FOR STAGE 34OVARIAN CANCER
T.K. Madhuri, C. Kumari, S. Butler-Manuel, F. Hussain, A. Irvine, A. Tailor, UK
86
THE EVALUATION OF OVARIAN TUMORS - THE ROLE OF 3D ULTRASOUND
A. Comanescu, F. Tanase, L. Dijmarescu, D. Iliescu, R. Capitanescu, N. Cernea,
L. Novac, Romania
87
CLINICAL MANAGEMENT OF ADNEXIAL MASSES: A RETROSPECTIVE
COHORT
G. Mancebo, S. Agramunt, M. Sastre, N. Baños, G. Misson, F. Larrazábal,
S. Dexeus, R. Carreras, Spain
88
ROLE OF SENTINEL NODE DETECTION IN HIGH RISK ENDOMETRIAL
CANCER
P. Paredes, S. Vidal-Sicart, I. Navales, S. Martínez-Roman, T. Aureli, A. Perissinotti,
S. Albela, J. Pahisa, F. Pons, Spain
89
PREOPERATIVE ASSESSMENT OF MYOMETRIAL AND CERVICAL INVASION
BY ENDOMETRIAL CARCINOMA WITH TRANSVAGINAL SONOGRAPHY AND
MR IMAGING
M. Zivaljevic, D. Nincic, J. Rajovic, B. Draskovic, A. Mandic, K. Mastilovic, D. Zikic,
M. Popovic, Serbia
90
QUANTITATIVE, MULTI-PARAMETRIC IMAGING AT 3 TESLA TO MONITOR
TREATMENT RESPONSE IN OVARIAN CANCER
J. Carter, J. Kuehn-Hajder, N. Lakkadi, I. Iltis, D. Rattigan, L. Downs, P. Bolan, USA
65
Poster Session I
Vulvar and Vaginal Cancer
Poster No
91
SHOULD WE CONSIDER CANCER/TESTIS ANTIGENS NY-ESO-1, MAGE-A4
AND MAGE-A1 AS POTENTIAL TARGETS FOR IMMUNOTHERAPY IN VULVAR
SQUAMOUS CELL CARCINOMA?
J.J. Sznurkowski, A. Żawrocki, W. Biernat, J. Emerich, Poland
92
HPV-NEGATIVE, UNIFOCAL AND SUBCLITORAL CARCINOMA OF THE VULVA
IN YOUNG WOMEN
D. Salehin, W. Poleska, S. Riethdorf, R. Gehrmann, M. Friedrich, Germany
93
V-Y FASCIOCUTANEOUS ADVANCEMENT FLAPS FOR VULVAR
RECONSTRUCTION
M.A. Clark, USA
94
PATHOLOGY SLIDE REVIEW IN VULVAR CANCER DOES NOT CHANGE
PATIENT OUTCOME
M. Beugeling, P. Ewing, Z. Mzallassi, L. van Doorn, The Netherlands
95
VAGINAL BENIGN LESIONS: A CLINICOPATHOLOGICAL STUDY OF 105
CASES
C. Iavazzo, K. Bakalianou, E. Vouza, N. Salakos, A. Liapis, A. Kondi-Pafiti, Greece
96
INVASIVE AND PREINVASIVE VULVAR LESIONS: A CLINICOPATHOLOGICAL
STUDY OF 63 CASES
C. Iavazzo, K. Bakalianou, E. Vouza, N. Salakos, A. Liapis, A. Kondi-Pafiti, Greece
97
BENIGN LESIONS OF THE VULVA: A CLINICOPATHOLOGICAL STUDY OF 93
CASES
C. Iavazzo, K. Bakalianou, E. Vouza, D. Hassiakos, A. Liapis, A. Kondi-Pafiti,
Greece
98
DIFFERENTIATED VIN IS OFTEN FOUND IN LESIONS, PREVIOUSLY
DIAGNOSED AS LICHEN SCLEROSUS, THAT HAVE PROGRESSED TO
VULVAR SQUAMOUS CELL CARCINOMA
H.P. van de Nieuwenhof, J. Bulten, H. Hollema, R.G. Dommerholt, L.F. Massuger,
A.G. van der Zee, J.A. de Hullu, L.C. van Kempen, The Netherlands
99
LOCALLY ADVANCED VULVAR CANCER IN ELDERLY WOMEN: IS
CHEMORADIATION BENEFICIAL?
A. Stuckey, M. Schutzer, D. Dizon, USA
100
V-Y FASCIOCUTANEOUS FLAP IN THE TREATMENT OF INVASIVE VULVAR
CANCER
S. Djurdjevic, Z. Janjic, A. Mandic, Serbia
101
PAGET DISEASE OF THE VULVA IN A 44-YEAR-OLD WOMAN: CASE REPORT,
SURGICAL APPROACH AND EIGHT-MONTHS FOLLOW UP
I. Kotsopoulos, P. Xirou, P. Skafida, G. Tampakoudis, E. Michalopoulou, C. Ble,
V. Kartsiounis, D. Evaggelinos, Greece
66
Poster Session I
Vulvar and Vaginal Cancer (contd.)
Poster No
102
EPIDEMIOLOGICAL CHARACTERISTICS OF VULVAR CANCER IN VOJVODINA
FROM 1988 TO 2007
T. Dugandzija, M. Miladinov Mikov, G. Malenkovic, T. Ivkovic Kapicl, J. Djekic,
S. Rajcevic, Serbia
103
DETECTION OF SENTINEL NODE IN SQUAMOUS CELL CANCER OF THE
VULVA. SAFETY AND CLINICAL APPLICATIONS
N. Akrivos, A. Rodolakis, D. Haidopoulos, N. Thomakos, G. Vlachos,
M. Sotiropoulou, I. Biliatis, M. Simou, A. Antsaklis, Greece
104
SOME NEW TENDENCIES IN DIAGNOSIS AND COMPLEX TREATMENT OF
VULVAR CANCER- OUR AND FOREIGN EXPERIENCE
S. Ivanov, A. Tsonev, A. Abbud, S. Koko, Bulgaria
105
PRIMARY MALIGNANT MELANOMA VAGINA: A LARGE, SINGLE INSTITUTION
EXPERIENCE
M. Frumovitz, M. Etchepareborda, C. Sun, P. Eifel, C. Levenback, P. Ramirez, USA
106
THE GREAT MIMIC MIGHT BE A HARBINGER OF A MORE PROFOUND
DISEASE. PAGET'S DISEASE OF THE VULVA: A CASE REPORT
D.J. Tablante-Reyes, C. Damaso-Rayel, Philippines
107
FATAL CUTANEOUS METASTASIS FROM VULVAR CANCER
F. Abbasi, M. Modarres, M. Bandarian, Iran
108
RADIOCHEMOTHERAPY IN ADVANCED VULVAR CANCER
R. Krynicki, J. Jonska-Gmyrek, L. Boguslaw, J. Staniaszek, E. Bobek-Pstrucha,
J. Borowiak, M. Miedzinska, M. Bidzinski, Poland
109
“I NEVER UNDERSTOOD WHAT IT WAS…” EXPERIENCES OF WOMEN WITH
VULVAR INTRAEPITHELIAL NEOPLASIA
J. Taylor, E. Lobb, I. Juraskova, Australia
110
PATIENT OUTCOMES FOLLOWING RADICAL VULVAL EXCISIONS AND
PLASTIC FLAP RECONSTRUCTION
M. McComiskey, C. Hoo, A. Robinson, K. Khan, J. Price, UK
111
VULVAR LEIOMYOSARCOMA , WHICH MIMICKS BARTHOLIN GLAND
ABSCESS CLINICALLY
A.B. Güzel, M.A. Vardar, I.F. Ürünsak, L. Toksöz, D. Gümürdülü, Turkey
112
MANAGEMENT OF PRIMARY VAGINAL ADENOCARCINOMA OF INTESTINAL
TYPE
A.B. Güzel, S. Büyükkurt, I.F. Ürünsak, M.A. Vardar, D. Gümürdülü, Ü. Güleç,
Turkey
67
Poster Session I
Poster No
113
EXPLORING THE PROTEOME CHARACTERISTICS OF HPV-POSITIVE VS HPVNEGATIVE VULVAR CARCINOMA USING MASS SPECTROMETRY
G. Lindell, A. Sandberg, R. Mamede Branca, K. Gemzell Danielsson, J. Lehtiö,
J. Forshed, B. Larson, B. Nordström Källström, Sweden
114
GRANULAR CELL TUMOR OF VULVA -A RARE TUMOR OF FEMALE GENITAL
TRACT: CASE REPORT AND REVIEW OF THE LITERATURE
N. Ramapadma, Y. Kwai Lam Philip, C. Yin Nin, L. Yong Kuei, Singapore
115
NUCLEAR DNA- CONTENT, PROLIFERATIVE ACTIVITY AND LAMININ-5Γ2CHAIN EXPRESSION AS PREDICTORS OF PROGNOSIS IN VULVAR
CANCER (VSCC) AND CORRELATION TO HPV
G. Lindell, J. Castro, K. Gemzell Danielsson, B. Larson, B. Nordström Källström,
Sweden
116
A CASE REPORT: AUTOLOGUS SKIN GRAFT IN DEHISCENCE OF RADICAL
VULVECTOMY
T. Fakheri, H. Saeidi Borojeni, A. Nankali, F. Keshavarzi, M. Yari, E. Sadeghi, Iran
117
VAGINAL CANCER: CLINICAL EXPERIENCE OF A 10-YEARS PERIOD
K. Papathanasiou, K. Lathouras, A. Pantelis, M. Tzafettas, P.D. Loufopoulos,
I. Stergioudas, I. Mitsakis, Greece
118
HPV IN VULVAR CANCER - DOES ITS PRESENCE DEMAND AN EXTENDED
ADJUVANT TREATMENT?
S. Johann, B. McKinnon, H. Burger, N. Bersinger, M.D. Mueller, Switzerland
119
WOMEN'S EXPERIENCES FOLLOWING TREATMENT FOR EARLY STAGE
VULVAR CANCER: A QUALITATIVE INSIGHT
E. Barlow, G. Parmenter, N. Hacker,, R. Hussain, Australia
120
RAPID SPONTANEOUS REGRESSION OF ACUTE ONSET VIN 3/VULVAR
CARCINOMA IN SITU IN YOUNG WOMEN: A CASE SERIES
R. Stephenson, T. Denehy, USA
121
VULVAR INTRAEPITHELIAL NEOPLASIA: CLINICAL EXPERIENCE OF A 10YEARS PERIOD
K. Papathanasiou, K. Lathouras, A. Pantelis, M. Tzafettas, P.D. Loufopoulos,
I. Stergioudas, A. Kainantidis, Greece
122
GASTROINTESTINAL STROMAL TUMOR IN THE RECTOVAGINAL SEPTUM: A
MOLECULAR ANALYSIS OF A RARE DIAGNOSIS
J.H. Fregnani, A. Oliveira, V. Vazquez, C. Viana, A. Filho, R. Reis, Brazil, Portugal
123
QUALITY OF LIFE AND URINARY FUNCTION AFTER RADICAL VULVECTOMY
WITH OR WITHOUT FLAP REPAIR
L. Ricci Maccarini, I. Strada, L. Orazi, M.J. Tsivian, F. Pozzati, A. Ferrero, P. Zola,
P. Balocco, P. Modaffari, P. De Laco, S. Venturoli, Italy
68
Poster Session I
Poster No
124
CYTOLOGY OF THE VULVA: FEASIBILITY OF A NEW BRUSH
L.C.G. van den Einden, J.M.M. Grefte, L.F.A.G. Massuger, I.A.M. van der Avoort,
J.A. de Hullu, The Netherlands
125
TUMOUR GRADE AND PROGNOSTIC FEATURES IN VULVAL CANCER - THE
GLASGOW EXPERIENCE
S. Bell, D. Millan, N. Siddiqui, J. Tolhurst, UK
126
RECURRENT VULVAR SARCOMA
E. Halkia, C. Mylona, E. Pateraki, D. Spaliaras, I. Lekka, E. Trihia, G. Vorgias,
N. Kalinoglou, Greece
127
PRIMARY INTESTINAL CANCER OF NEOVAGINA WITH UTERINE
INVOLVEMENT : A CASE REPORT
S. Bogliolo, A. Peroglio Carus, A. Piccardo, A. Noceti, E. Ratto, S. Garzarelli, Italy
128
THE POSTERIOR EXENTERATION WITH RADICAL VULVECTOMY AFTER
NEOADIUVANT CHEMORADIATION IN STAGE IVA PATIENTS WITH VULVAR
CANCER. A PRELIMINARY REPORT
M. Jedryka, M. Rząca, B. Rossochacka, J. Kornafel, Poland
129
SIGNIFICANCE OF POSITIVE MARGINS IN VIN III
J. Currie, A. Shafer, A. Brown, J. Sorosky, USA
130
MANAGEMENT OF VAGINAL CANCER
C.-L. Chen, Y.-G. Zhang, W.-T. Wang, L.-Q. Li, C.-F. Zou, Z.-Y. Cao, China
131
THERAPEUTIC EFFECT OF TOPICAL 5-FLUOROURACIL FOR VAGINAL
INTRAEPITHELIAL NEOPLASIA DIAGNOSED AFTER CERVICAL CANCER
TREATMENT: A SERIES OF 12 CASES
C.B. Batista, A.T. Tsunoda, C.E.M.C. Andrade, J.H.T.G. Fregnani, Brazil
132
ASSESSMENT OF REVISED FIGO STAGING FOR CARCINOMA OF THE VULVA
M.-K. Kim, H.H. Chung, J.W. Kim, N.-H. Park, Y.-S. Song, S.-B. Kang,
Republic of Korea
133
RISK FACTORS FOR VAGINAL INTRAEPITHELIAL NEOPLASIA IN CHINA
H. Li, L. Geng, H. Guo, J. Zhang, Y. Guo, K. You, China
134
FREQUENCY ASSESSMENT OF HPV-INDUCED PRECANCEROUS LESIONS IN
PATIENTS WITH BORDERLINE CYTOLOGY IN THE EMILIA-ROMAGNA
REGION: THE PATER STUDY
S. Costa, S. Venturoli, F.S. Mennini, M. Pesaresi, E. Leo, A. Marcellusi, A. Falasca,
E. Marra, M. Cricca, D. Santini, M. Zerbini, G. Pelusi, Italy
135
SPINDLE CELL CARCINOMA IS PREDICTIVE FOR CLINICAL OUTCOME IN
VULVAR SQUAMOUS CELL CARCINOMA
M.D. Trietsch, K.N. Garenstroom, A.A.W. Peters, G.J. Fleuren, The Netherlands
69
Poster Session I
Poster No
136
IMPACT OF THE PATHOLOGICAL RESECTION MARGIN DISTANCE FOR
DISEASE RECURRENCE IN VULVAR CANCER
L. Woelber, C. Eulenburg, M. Hager, M. Choschzick, J. Schwarz, F. Jaenicke,
F. Gieseking, S. Mahner, Germany
137
PRIMARY YOLK SAC TUMOR OF THE VULVA: CASE REPORT AND REVIEW
OF THE LITERATURE
H. Wen, China
138
VULVAR AND VAGINAL CANCER IN THE “DR. SALVATORVUIA” CLINICAL
OBSTETRICS AND GYNECOLOGY HOSPITAL ARAD DURING THE 2000-2009
PERIOD
V. Daşcău, G. Furău, L. Păiuşan, C. Furău, Romania
139
A CASE OF MICROINVASIVE PAGET` DISEASE OF THE VULVA: TREATMENT
OF POSITIVE RESECTION MARGIN WITH TOPICAL 5-FU CREAM
APPLICATION
C. Park, H. Kang, S. Kim, Republic of Korea
140
PROXIMAL TYPE EPITEHELOID SARCOMA OF THE VULVA - CASE REPORT
AND REVIEW OF THE LITERATURE
I. Aluloski, J. Babusku, N. Bashesha, D. Ivanova, FYR Macedonia
141
PLASTIC SURGERY IN THE THERAPY OF THE VULVAR DEFECT AFTER
ONCOGYNECOLOGICAL TREATMENT
L. Moukova, P. Hyza, R. Feranec, E. Krejci, Czech Republic
142
LIPOMATOUS VARIANT OF ANGIOMYOFIBROBLASTOMA ON THE VULVA
S. Namkoong, J. Yoon, S. Lee, Republic of Korea
143
QUALITY OF LIFE AT THE PATIENTS TREATED FOR MALIGNANT DISEASE OF
VULVA AND UTERUS
S. Vukajlovic, I. Likic Ladjevic, N. Ladjevic, J. Opalic, S. Kadija, R. Argirovic, Serbia
144
SENTINEL LYMPH NODE DETECTION IN VULVAR CANCER - OUR
EXPERIENCE
R. Feranec, L. Moukova, K. Standlova, Czech Republic
145
AN AUDIT OF THE SURGICAL TREATMENT MODALITIES AND OUTCOME IN 17
CASES OF EXTRAMAMMARY PAGET'S DISEASE OF THE VULVA
W. Chu, J. Tolhurst, N. Siddiqui, D. Millan, UK
146
HUMAN EPYDIDIMIS PROTEIN 4 (HE4): IT COULD BE USEFUL IN VULVAR
CANCER?
S. Giudici, M. Montagnana, A. Festi, E. Danese, O. Ruzzenente, V. Bresciani,
G. Salvagno, G. Lippi, G. Guidi, M. Franchi, Italy
70
Poster Session I
Poster No
147
LOWER LIMB LYMPHEDEMA IMPACTS QUALITY OF LIFE IN WOMEN WITH
VULVAR CANCER SUBMITTED TO SURGICAL TREATMENT
A.P.M. Ferreira, E.M. Figueiredo, A.M.R.M. Fonseca, M.V.C. Monteiro,
T.M.R.F. Franco, P. Traiman, A. Silva-Filho, Brazil
148
REPERCUSSIONS FROM VULVECTOMY AND INGUINAL LYMPHADENECTOMY
ON URINARY FUNCTION AND QUALITY OF LIFE IN WOMEN WITH VULVA
CANCER
A.P.M. Ferreira, E.M. Figueiredo, A.M.R.M. Fonseca, M.V.C. Monteiro,
T.M.R.F. Franco, P. Traiman, A. Silva-Filho, Brazil
149
COLLOID CARCINOMA OF THE VULVA
R. Makwela, A. Mouton, South Africa
150
SQUAMOUS CELL CARCINOMA OF THE VULVA IN A MOTHER AND
DAUGHTER: A CASE REPORT INDICATING POSSIBLY NON-CLASSICAL
TUMORIGENIC PATHWAYS
R. Moretti, A.M.S. Teixeira, J.B. de Pádua, X. Mazzini, S.M. Nicolau, Brazil
151
SKINNING VULVECTOMY FOR TREATMENT OF VIN II-III
B. Bildaci, B.K. Karakaya, E. Cabuk, O. Ozen, P. Dursun, A. Ayhan, Turkey
152
TRANSURETHRAL BLADDER PROLAPSE, A RARE CONDITION:
CHALLANGES IN DIAGNOSIS AND MANAGEMENT
A. Kalok, M. Alazzam, M. Patterson, S. Radley, D. Rosario, UK
153
LOTUS PETAL FLAP REPAIR FOR PERINEAL RECONSTRUCTION AFTER
RADICAL VULVECTOMY FOR VULVAL CANCER
S. Tuteja, V. Corkhill, C. Choy, UK
154
PROLIFERATING TRICHILEMMAL TUMOURS AND EPIDERMOID CARCINOMA
OF THE VULVA
Y. Suárez Hernández, E. Sosa Comino, R. Rodríguez Reyes, S. García Hernández,
H. Argüelles Cabrera, J. de la Torre Fernández de Vega, Spain
156
THE EFFICACY OF 4 WEEK NEOADJUVANT PHENOXODIOL MONOTHERAPY
IN PRIMARY OR RECURRENT SQUAMOUS CELL CARCINOMA OF THE
CERVIX AND VULVA
D.-A. Silasi, G. Mor, M. Kelly, A. Husband, L. West, P. Schwartz, T. Rutherford,
S. Mccarthy, F. Tavassoli, M. Azodi, USA
Breast Cancer
157
A CASE OF BREAST CANCER WITH NEUROENDOCRINE DIFFERENTIATION
AND NEW ONSET DIABETES MELLITUS
N. Valizadeh, F. Abbasi, Iran
71
Poster Session I
Breast Cancer (contd.)
Poster No
158
DOCETAXEL-CAPECITABINE IN PATIENTS WITH ANTHRACYCLINES
METASTATIC BREAST CANCER
A. Bensalem, K. Bouzid, Algeria
159
GEMCITABINE - PACLITAXEL VS GEMCITABINE - VINORELBINE IN
METASTATIC BREAST CANCER; AN INTERIM ANALYSIS
A. Bensalem, K. Bouzid, Algeria
160
THE USE OF TRASTUZUMAB IN ADJUVANT OR METASTATIC BREAST
CANCER. AN ALGERIAN EXPERIENCE
A. Bensalem, A. Ammari, H. Djedi, I. Boulouh, F. Grifi, A. Moussei, S. Sami,
K. Bouzid, Algeria
161
CLINICAL FEATURES AND PROGNOSIS OF ASSOCIATION OF TRIPLENEGATIVE BREAST CANCER WITH EXTRACAPSULAR EXTENSION OF
AXILLARY LYMPH NODE METASTASIS
S. Maksimovic, Bosnia-Herzegovina
162
ELEVATED MRE11 EXPRESSION IN BREAST CANCER TISSUES IS
ASSOCIATED WITH POOR PATIENT SURVIVAL
S.-S. Yuan, M.-F. Hou, Taiwan R.O.C.
163
PREDICTORS OF ADHERENCE TO CLINICAL BREAST EXAMINATION AND
MAMMOGRAPHY SCREENING AMONG MALAYSIAN WOMEN
P. Parsa, M. Kandiah, Iran
164
BREAST CANCER SURVIVORSHIP - OPTIMIZING FOLLOW-UP CARE
S. Singh-Carlson, USA
165
GYNECOLOGIC AND BREAST CANCER PEER MENTORS: INTERPRETING
PROGRAM IMPACT
166
NUTRITIONAL AND HEMATOLOGICAL EFFECTS OF A DIETARY
SUPPLEMENTATION WITH AGARICUS SYLVATICUS IN BREAST CANCER
PATIENTS UNDERGOING CHEMOTHERAPY
F. Valadares, M.R. Novaes, Brazil
167
SURVIVORSHIP CARE PLANNING FOR BREAST CANCER SURVIVORS
168
LIPOSOMAL TAXOTERE WITH LINKED-PYMT-MABS INHIBITED VEGFMEDIATED-HUMAN-TELOMERASE-REVERSE- TRANSCRIPTASE (HTTTERT),
C-SRC, PI3K, VEGF-A, MMP-2, AND INTEGRINS- A1- 2-6 INDUCING
APOPTOSIS IN HRBC
J. Giannios, E. Michailakis, Greece
72
Poster Session I
Poster No
169
ANTISENSE TREATMENT WITH PEGYLATED-LIPOSOMAL-MULTITARGETEDSIRNA AGAINST UBCH5,C-SRC,AND HSP90 COMBINED WITH BEVACIZUMAB
ERADICATED HORMONE REFRACTORY BREAST CA(HRBC) BY INDUCTION
OF APOPTOSIS/PCD TYPEI
170
COMPERETIVE KNOWLEDGE AND PRACTICE BREAST SELF EXAMINATION
IN MIDWIFERY AND NURSING STUDENT ISLAMIC AZAD UNIVERSITY KARAJ
BRANCH PARIDOKHT ASHKEVARI
P. Ashkvary, M. Mirfaizi, Iran
171
FURANODIENONE INHIBITS ESTROGEN RECEPTOR-ALPHA EXPRESSION
AND ACTIVITY IN HUMAN BREAST CANCER MCF-7 CELLS
Y. Li, G. Zhu, X. Shen, W.-F. Fong, Hong Kong S.A.R.
172
EPIDEMIOLOGICAL ANALYSIS OF BREAST CANCER IN VOJVODINA IN
THREE PERIODS FROM 1978 TO 2007
T. Dugandzija, M. Miladinov Mikov, G. Malenkovic, T. Ivkovic Kapicl, N. Prvulovic,
M. Ristic, Serbia
173
CORRELATION BETWEEN HORMONE RECEPTOR STATUS (ER,PR),HER-2,P53
IN SOUTH INDIAN BREAST CANCER PATIENTS
R. Patnayak, A. Jena, M.K. Reddy, India
174
COPING STRATEGIES IN IRANIAN BREAST CANCER PATIENT
A. Sajadian, L. Heydari, M. Ansari, M. Habibi, F. Haji-Mollahosseini, Iran
175
EVALUATION THE OF OVARIAN SUPPRESSION AS ADJUVANT THERAPY IN
BREAST CANCER PATIENTS
Z. Yousefi, M. Dehghani Dashtabi, F. Homae, Iran
176
EXPERIENCE WITH SENTINEL LYMPH NODE BIOPSY (SLNB) USING
METHYLENE BLUE DYE IN EARLY STAGE CARCINOMA BREAST
S. Jain, V. Jain, N. Single, S. Jain, India
177
ESTROGEN RECEPTOR-A GENE POLYMORPHISM IN IRANIAN WOMEN WITH
BREAST CANCER
S. Abbasi, Iran
178
PATIENT-REPORTED OUTCOMES IN BREAST CANCER PATIENTS
UNDERGOING ENDOCRINE THERAPY (PRO-BETH): ADHERENCE RATES TO
TAMOXIFEN REGARDING CYP2D6 GENOTYPE AND SIDE-EFFECTS
R. Achleitner, A. Oberguggenberger, V. Meraner, B. Beer, J. Giesinger,
G. Kemmler, H. Oberacher, B. Sperner-Unterweger, B. Holzner, C. Marth,
M. Hubalek, Austria
179
KIDNEY PYRROLIDONE CARBOXYPEPTIDASE ACTIVITY IS MODIFIED IN
RATS WITH MAMMARY TUMOURS
M.D.P. Carrera González, M.J. Ramírez-Expósito, M.J. García-Lopez, M.D. Mayas,
J.M. Martínez-Martos, Spain
73
Poster Session I
Poster No
180
EFFECTS OF TAMOXIFEN ON THE CERVIX AND UTERUS IN WOMEN WITH
BREAST CANCER
N. Sadeghie, M. Karimi Zarchi, Iran
181
HIGH VISFATIN EXPRESSION IN BREAST CANCER TISSUE IS ASSOCIATED
WITH A POOR OVERALL SURVIVAL
S.-S. Yuan, Y.-C. Lee, M.-F. Hou, Taiwan R.O.C.
182
TREATMENT OF PERITONEAL CARCINOMATOSIS FROM BREAST CANCER
BY MAXIMAL CYTOREDUCTION AND HYPERTHERMIC INTRAPERITONEAL
CHEMOTHERAPY: A PRELIMINARY REPORT OF 4 CASES
M. Cardi, S. Sibio, P. Sammartino, F. Accarpio, D. Biacchi, A. Baccheschi,
T. Cornali, A. di Giorgio, Italy
183
HAPTOGLOBIN GENE EXPRESSION AND ITS CORELATION WITH OTHER
CLINICAL PARAMETERS AND PROGNOSIS IN BREAST CANCER AMONG
INDIAN WOMEN
U. Tabassum, S.H. Mir Mazloumi, D.G. Mukherjee, K. Somasundaram, India
184
PREVALENCE OF BRCA1 GERMLINE MUTATIONS AMONG PAKISTANI
WOMEN WITH TRIPLE-NEGATIVE BREAST CANCER
M.U. Rashid, D. Torres, S. Bajwa, M. Tahseen, A. Amin, A. Loya, U. Hamann,
Pakistan
185
SATB1-EXPRESSION AND ITS PROGNOSTIC IMPACT IN BREAST CANCER IS
CORRELATED WITH ESTROGEN RECEPTOR STATUS
L.C. Hanker, T. Karn, L. Mavrova, E. Ruckhäberle, U. Holtrich, A. Rody,
M. Kaufmann, Germany
186
ATYPICAL DUCTAL HYPERPLASIA - CRITERIA OF UNDER-ESTIMATION
AFTER DIAGNOSTIC BY STEREOTAXIC VACUUM-ASSISTED BIOPSY
M. Poilblanc, E. Fondrinier, J.-M. Classe, L. Catala, E. Anglade, V. Verriele,
P. Descamps, Canada
187
DRUGS SCREENING IDENTIFIES A NOVEL COMPOUND AS AN INHIBITOR OF
BREAST CANCER STEM-LIKE CELLS
Y.-C. Wang, H.-Y. Lee, C.-K. Chen, Y.-T. Yo, H.-C. Lai, Taiwan R.O.C.
188
WEEKLY EPIRUBICIN IN GESTATIONAL BREAST CANCER (GBC) PATIENTS
(PTS): A COOPERATIVE STUDY GROUP
G. Scarfone, F. Peccatori, G. Polverino, S. Noli, A. Gadducci, V. Galimberti,
E. Grossi, C. Bonazzi, S. Cinieri, Italy
189
QUALITY PERFORMANCE INDICATORS FOR BREAST CANCER STAGE AND
DIAGNOSIS IN A BRAZILIAN INSTITUTIONAL MAMMOGRAPHIC SCREENING
PROGRAM
A.T. Tsunoda, J.H.T.G. Fregnani, J.S. Nunes, R.A.C. Vieira, E.C. Mauad,
R.R. Brentani, Brazil
74
Poster Session I
Poster No
190
PRESERVATION OF FERTILITY IN YOUNG PATIENTS WITH CERVICAL AND
BREAST CANCER
M. Kiseleva, M. Karpeykina, M. Denisov, Russia
191
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP
ANALYSIS AND ADME PREDICTIONS OF GUANYLHYDRAZONE
COACTIVATOR BINDING INHIBITORS OF ESTROGEN RECEPTORS
S. Shityakov, T. Dandekar, Germany
192
POPULATION BASED MAMMOGRAPHIC SCREENING PROGRAMME IN
LATVIA- THE FIRST RESULTS
A. Hegmane, J. Eglitis, S. Plate, Latvia
193
BREAST CANCER AND MULTIPLE PRIMARY TUMORS IN THE BELORUSSIAN
CANCER REGISTRY
N. Novikava, I. Veyalkin, Y. Averkin, Belarus
194
SENTINEL LYMPH NODE BIOSPY IN BREAST CANCER PATIENTS TREATED
WITH NEOADJUVANT CHEMOTHERAPY
D. Kolarik, V. Pecha, M. Skovajsova, R. Kozevnikova, J. Sykorova, O. Sottner,
M. Halaska, Czech Republic
195
COMPARISON OF TRAM-FLAP AND DIEP-FLAP IN RECONSTRUCTIVE
SURGERY OF BREAST CANCER
P. Kern, S. Krämer, M. Darsow, M. Rezai, Germany
196
IMPACT INDICATORS OF BREAST CANCER
L.E. Medina Fernández, B. Rodriguez Zea, Peru
197
IN VITRO AND IN VIVO CHARACTERIZATION OF NOVEL ENO1-TARGETING
MONOCLONAL ANTIBODY FOR DETECTION OF BREAST CANCER
H.-Y. Chuang, Y.-F. Chang, N.-Y. Shih, J.-J. Hwang, Taiwan R.O.C.
198
SIGNIFICANCE OF HER-2/NEU POSITIVITY IN BREAST CANCER CASES IN
PROGNOSTICATION IN FIVE YEAR FOLLOW-UP
C. Basu, India
199
TRIPLE-NEGATIVE BREAST CANCER AND THE EXPRESSION OF SELECTED
TUMOR MARKERS IN AFRICAN AMERICAN AND CAUCASIAN BREAST
CANCER PATIENTS
R. Ali-Fehmi, Y. Hussein, M.L. Cote, Z. Nahleh, S. Bandyopadhyay, USA
200
THE STUDY OF THERMODYNAMIC PARAMETERS OF THE BLOOD PLASMA IN
THE WOMEN WITH BREAST TUMOURS
N. Kotrikadze, T. Tevdoradze, M. Alibegashvili, L. Ramishvili, I. Bochorishvili,
M. Zibzibadze, N. Veshapidze, G. Nemsadze, Georgia
201
TRIPLE NEGATIVE BREAST CANCER: AN INSTITUTIONAL REVIEW
L. Heras, A. García-Arias, M. Pujol, C. Buqueras, R. Villanueva, O. Serra, F. Losa,
Spain
75
Poster Session I
Poster No
202
THE ROLE OF TRANSVAGINAL ULTRASONOGRAPHY AND SYMPTOM-BASED
TRIAGE FOR DETECTION OF PATHOLOGICAL ENDOMETRIAL CHANGES IN
BREAST CANCER PATIENTS USING TAMOXİFEN
K. Kahraman, E. Pabuccu, S. Taskin, F. Ortac, Turkey
203
BRCA-ASSOCIATED BREAST AND OVARIAN CANCER SYNDROMES - A
RETROSPECTIVE ANALYSIS
A. Rodrigues, J. Oliveira, M.R. Couto, A. Peixoto, P. Rocha, C. Santos, F. Castro,
D. Pereira, H. Rodrigues, M. Teixeira, Portugal
204
BREAST CANCER AND ITS RELATIONSHIP WITH MITOCHONDRIAL
UNCOUPLING PROTEIN 4 (UCP4), APOPTOTIC MARKERS, AND OTHER
PROGNOSTIC FACTORS: AN IMMUNOCYTOCHEMICAL STUDY
M. Gonidi, A.M. Athanassiadou, A. Tsipis, A. Georgiou, V. Kyriakidou,
P. Athanassiadou, Greece
205
PHYLLODES TUMOR. REVIEW OF CASES IN OUR ENVIRONMENT
O. Orribo Morales, M. Hernández Suárez, L. Melgar, C.F. Fernández Robayna,
F.J. De la Torre Fernández Vega., Spain
206
FIRST CASE OF DOSE-DENSE SEQUENTIAL CHEMOTHERAPY WITH
EPIRUBICIN, PACLITAXEL AND CYCLOPHOSPHAMIDE IN A PREGNANCYASSOCIATED BREAST CANCER PATIENT
M.J. Battista, M. Schmidt, A. Puhl, A. Lebrecht, C. Lindner, C. Martin, J. Faber,
E. Mildenberger, H. Koelbl, Germany
207
CORRELATION OF CEA, CA 15-3 LEVELS WITH MAMMMOGRAPHY IN
POSTMENAPOUSALE WOMEN
E. Öztürk, E. Lapsekili, M.F. Can, R. Yıldız, S. Görgülü, G. Yağcı, M. Dede, Turkey
208
PATTERNS OF GRP78 EXPRESSION IN BREAST CANCER PATIENTS
TREATED WITH ADJUVANT DOXORUBICIN-BASED CHEMOTHERAPY
M.Z. Baptista, L.O. Sarian, J. Vassallo, G.A. Pinto, F.A. Soares, G.A. Souza, Brazil
209
UPTAKE OF CANCER SURVEILLANCE AND RISK REDUCTION SURGERY BY
FEMALE BRCA CARRIERS IN MALAYSIA
Y.L. Woo, S.Y. Yoon, C.H. Yip, N.A. Taib, M. Thong, S.H. Teo, Malaysia
210
LAPAROSCOPIC OOPHORECTOMY FOR BREAST CANCER PATIENTS:
EXPERIENCES FROM A CANCER CENTRE AND COMPARISON WITH GNRH
ANALOGUES
K. Haldar, P. Giamougiannis, C. Wilson, R. Crawford, UK
211
TREATMENT AND FOLLOW-UP OF IN SITU BREAST CARCINOMA.
NATIONWIDE CROSS SECTION STUDY OF SPANISH SOCIETY OF
OBSTETRICS AND GYNAECOLOGY (SEGO)
I. Zapardiel, J. Schneider, J. Ponce, J. Xercavins, Spain
76
Poster Session I
Breast Cancer
Poster No
212
ADVANCED STAGES OF BREAST CANCER ARE ASSOCIATED TO LOW
SCHOLARITY LEVEL IN PATIENTS TREATED IN A BRAZILIAN CANCER
CENTER
J.S. Nunes, T.B. Silva, A.T. Tsunoda, J.H. Fregnani, Brazil
213
IMPROVING INFORMED CONSENT: EVALUATING THE FIRST DECISION AIDS
IN A CLINICAL TRIAL SETTING (IBIS-II)
I. Juraskova, P. Butow, B. Smith, M. Seccombe, A. Coates, F. Boyle, N. Mccarthy,
L. Reaby, J.F. Forbes, Australia
214
GERMLINE MUTATIONS OF BRCA2 GENE: A MOLECULAR GENETIC
PROGNOSTICATOR OF BREAST AND OVARIAN CANCER
V. Syamala, H. Sreedharan, R. Ankathil, India
215
IMPACT OF LOW INCOME AND OLDER AGE IN ADJUVANT CHEMOTHERAPY
INDICATION FOR BREAST CANCER (BC) IN BRAZIL
D.A.P. Andrade, J.S. Nunes, J.P.S.N. Lima, E.C. Mauad, Brazil
216
ORAL CONTRACEPTIVES AND BREAST CANCER RISK IN YOUNG WOMEN
C. Delimpalta, A. Zampogiannis, Greece
217
WOMEN'S BREAST CANCER RISK PERCEPTION AND ATTITUDES TOWARD
SCREENING TESTS
T. Yavan, A. Akyüz, N. Tosun, E. Iyigün, Turkey
218
RISK FACTORS FOR BREAST CANCER IN ELDERLY WOMEN-OWN
EXPERIENCES OF 300 PATIENTS
R. Chrzan, T. Kulpa, Poland
219
IS HIGH BONE MASS DENSITY A MARKER FOR BREAST CANCER IN
POSTMENOPAUSAL WOMEN?
C. Costa, F. Costa, D. Arteiro, A. Melo, A. Correia, A.R. Costa, T. Rodrigues,
Portugal
Surgical Techniques
221
CONTINENT CUTANEOUS ILEOCECAL RESERVOIR USING THE
SUBMUCOSALLY EMBEDDED APPENDIX AFTER ANTERIOR EXENTERATION
FOR GYNAECOLOGICAL MALIGNANCIES: TECHNIQUE AND COMPLICATIONS
M. Friedrich, W. Poleska, D. Salehin, M. Friedrich, Germany
222
PRELIMINARY PROSPECTIVE RESULTS OF TREATMENT APPROACH OF
CERVIVAL INTRAEPITHELIAL NEOPLASIA III (CINIII) WITH THE USE OF
ULTASOUND KNIFE
I. Kotsopoulos, D. Evaggelinos, G. Tampakoudis, P. Skafida, V. Papadopoulos,
P. Tanimanidis, V. Kartsiounis, C. Kartsiounis, Greece
77
Poster Session I
Surgical Techniques (contd.)
Poster No
223
COMPLETE CYTOREDUCTION OF ADVANCED OVARIAN MALIGNANCY USING
NEUTRAL ARGON PLASMA
T.K. Madhuri, A. Tailor, S. Butler-Manuel, UK
224
ENDOMETRIAL CANCER AND SENTINEL NODE PROCEDURE
B.J. Mosgaard, V.R. Skovlund, H.W. Hendel, Denmark
225
LAPAROSCOPIC OOPHERECTOMY OF HUGE OVARIAN CYSTS
A. Alobaid, A. Momen, S. Alobaid, L. Aldakhil, Saudi Arabia
226
SINGLE PORT ROBOTIC ASSISTED LAPAROSCOPIC POSTERIOR PELVIC
EXENTERATION IN PATIENTS WITH STAGES IIIC AND IV EPITHELIAL
OVARIAN CANCER: FARGHALY´S TECHNIQUE
S. Farghaly, USA
227
DOES LAPAROSCOPY PROVIDE ADEQUATE STAGING IN ENDOMETRIAL
CARCINOMA COMPARED WITH LAPAROTOMY
M. Güngör, S. Taskin, F. Ortaç, D. Öztuna, Turkey
228
EVALUATION OF ARGON BEAM COAGULATION FOR THE TREATMENT OF
VULVAR INTRAEPITHELIAL NEOPLASIA III
C. Kushnir, M. Hill, A. Fleury, D. Silver, N. Spirtos, N/A, USA
229
MONOPARESIS OF LEG AFTER RADICAL HYSTERECTOMY TYPE II
R. Macuks, I. Baidekalna, M. Zvaigznite, S. Donina, Latvia
230
EXPERIENCE WITH AN ENHANCED SURGICAL RECOVERY PROGRAM
J. Carter, V. Arora, S. Philp, S. Smirnova, P. Patel, K. Nattress, C. Dalrymple,
S. Pather, S. Cotterell, Australia
231
RADICAL SURGICAL TREATMENT WITH NERVE-SPARING TECHNIQUE IN
EARLY CERVICAL CANCER- STAGE 1A-2A. OUR AND FOREIGN EXPERIENCE
232
A COMPARISON OF ROBOT-ASSISTED AND TRADITIONAL RADICAL
HYSTERECTOMY (RH) FOR EARLY-STAGE CERVICAL AND ENDOMETRIAL
CANCER
H.-B. Kim, S.-H. Park, Republic of Korea
233
PERIOPERATIVE MORBIDITY AND MORTALITY OF GYNAECOLOGICAL
ONCOLOGIC SURGERY
P. Uharcek, M. Mlyncek, E. Lajtman, M. Matejka, Slovak Republic
234
EFFICACY OF PROPHYLACTIC APPLICATION OF FIBRIN GLUE (TISSEEL®) IN
REDUCING POSTOPERATIVE DELAYED BLEEDING AFTER LOOP
ELECTROSURGICAL EXCISION PROCEDURE
K. Kim, Y.S. Yu, S.-I. Park, B.-J. Kim, M.-H. Kim, S.-C. Choi, S.-Y. Ryu, E.-D. Lee,
Republic of Korea
78
Poster Session I
Poster No
235
TREATMENT OF HIGH GRADE LESION AND MICROINVASIVE CANCER OF
THE VAGINA WITH LASER SKINNING COLPECTOMY
A. Luyten, C. Liebrich, K.U. Petry, Germany
236
INTERIM RESULTS FROM RCT TO EVALUATE PLASMAJET FOR PREVENTION
OF LYMPHOCYST FORMATION FOLLOWING BILATERAL GROIN NODE
DISSECTION(BGND) FOR VULVAL CANCER
T. Madhuri, G. Beynon, S. Butler-Manuel, A. Tailor, UK
237
CASE CONTROLLED STUDY OF OPEN, LAPAROSCOPIC AND ROBOTIC
ASSISTED HYSTERECTOMY, BILATERAL SALPINGO-OOPHORECTOMY AND
PELVIC LYMPHADENECTOMY IN PATIENTS WITH ENDOMETRIAL CANCER
S. Kankipati Raju, A. Papadopoulos, O. Devaja, UK
238
INITIAL EXPERIENCE WITH ROBOTIC ASSISTED LAPAROSCOPY IN THE
STAGING OF ENDOMETRIAL CANCER - COMPARISON WITH LAPAROSCOPY
R. Pilka, P. Dzvinţuk, M. Kudela, P. Hejtmánek, L. Michnová, Czech Republic
239
PROSPECTIVE STUDY OF ANALGESIA REQUIREMENT AFTER ROBOTIC
HYSTERECTOMY: PRELIMINARY RESULTS
A. Usmani, K. El-Boghdadly, S. Raju, I. Ahmad, UK
240
SENTINEL NODE DETECTION IN ENDOMETRIAL CANCER: DIAGNOSTIC
ACCURACY EVALUATION
E. Solima, F. Martinelli, F. Hanozet, B. Grijuela, A. Ditto, B. Valeri, M. Maccauro,
241
EFFECT OF POSITION CHANGES ON VENTILATION DURING ROBOTIC
HYSTERECTOMY
K. El-Boghdadly, A. Usmani, S. Raju, I. Ahmad, UK
242
PELVIC PERITONIZATION AFTER ABDOMINAL RADICAL TRACHELECTOMY
M.E. Capilna, B. Szabo, A. Toma, C. Rugina, J. Becsi, C.I. Puiac, Romania
243
LAPAROSCOPIC NERVE-SPARING RADICAL HYSTERECTOMY; DESCRIPTION
OF THE TECHNIQUE AND PATIENTS' OUTCOME
A. Kavallaris, Germany
244
MORBIDITY AND MORTALITY STUDY REPORT IN GYNAECOLOGY
ONCOLOGY (MAY - OCT 2009)
M. Kodampur, N. Sumar, A. Bonsu, S. Raju, UK
245
TOTAL LAPAROSCOPIC HYSTERECTOMY WITHOUT UTERINE MANIPULATOR
(TLHWM): DESCRIPTION OF A NEW TECHNIQUE AND ITS OUTCOME
246
PATIENTS ON THE MOVE: A PROSPECTIVE STUDY OF FAST TRACK
SURGERY IN GYNAECOLOGICAL ONCOLOGY PATIENTS
A. Brand, V. Sidhu, L. Lancaster, Australia
79
Poster Session I
Poster No
247
REVIEW OF LYMPHOABSCESS FOLLOWING RETROPERITONEAL
LYMPHADENECTOMY IN THE GYNECOLOGICAL CANCER
S. Suga, Japan
248
ROBOTIC RADICAL HYSTERECTOMY VERSUS TOTAL LAPAROSCOPIC
RADICAL HYSTERECTOMY: USING NERVE SPARING TECHNIQUE
PERFORMED BY A SINGLE SURGEON
Y.S. Lee, G.O. Chong, N.Y. Park, D.G. Hong, Y.L. Cho, I.S. Park, Republic of Korea
249
TWO CASES OF ABDOMINAL TRACHELECTOMY : DETECTION OF TUMOR
MARGINS BY TRANSRECTAL ULTRASONOGRAPHY
F. Demirkiran, C. Onculoglu, E. Meseci, Turkey
250
HAND-ASSISTED LAPAROSCOPY FOR THE REMOVAL OF PELVIC MASSES
R.W. Naumann, M. Elliot, N.D. DiMaria, R. Akers, USA
251
ROBOTIC SURGERY IN GYNECOLOGIC ONCOLOGY: TAIWAN EXPERIENCE
C. Lee, K. Huang, C. Han, Taiwan R.O.C.
252
LAPAROSCOPIC RADICAL HYSTERECTOMY AND PELVIC
LYMPHADENECTOMY FOR EARLY CERVICAL CANCER - THE FIRST
EXPERIENCE IN MACEDONIA
N. Badzakov, B. Sardzovski, N. Panchevski, A. Bojadziev, N. Shikov, D. Jashar,
K. Kubelka, FYR Macedonia
253
NERVE SPARING RADICAL HYSTERECTOMY. EARLY POSTOPERATIVE
URODYNAMIC STUDY
F. Maneschi, P. Ianiri, A. Perugini, I. Ceccacci, C. Pane, F. Gagliardi, M. Parisella,
Italy
254
ULTRASONIC ENERGY IN OPEN SURGERY IN GYNAEONCOLOGY
T.K. Madhuri, S. Chachan, A. Tailor, S. Butler-Manuel, UK
255
CLASS III NERVE-SPARING RADICAL HYSTERECTOMY VERSUS STANDARD
CLASS III RADICAL HYSTERECTOMY: A CASE-CONTROL STUDY
A. Ditto, F. Martinelli, F. Hanozet, F. Matana, C. Reato, E. Solima, F. Zanaboni,
B. Grijuela, M. Carcangiu, F. Raspagliesi, Italy
256
IS TOTAL LAPAROSCOPIC HYSTERECTONY FOR ENDOMETRIAL CANCER A
REALISTIC GOAL WITH CURRENT SKILL LEVELS IN UK PRACTICE?
R. O'Donnell, N. Berugoda, K. Skorupskaite, C. Martin, G. Walker, UK
257
BOWEL SURGERY IN GYNAECOLOGICAL ONCOLOGY TRAINING
PROGRAMME
M. Abu Freij, N. Burbos, S. Kapur, T. Duncan, S. Crocker, J. Nieto, UK
258
ROBOTIC RADICAL HYSTERECTOMY IN CERVICAL CARCINOMA: THE
BELGIAN EXPERIENCE IN 49 CASES
I. Vergote, P. van Dam, K. Traen, A. Segaert, L. Voorhoof, W. Decleer, F. Goffin,
Belgium
80
Poster Session I
Poster No
259
FACTORS AND COSTS ASSOCIATED WITH ROBOTIC VS. LAPAROSCOPIC
VS. OPEN SURGERY FOR ENDOMETRIAL CANCER - ANALYSIS OF 540
PATIENTS
D. Lum, J. Chan, A. Sherman, R. Urban, X. Yu, USA
260
NERVE SPARING SURGICAL TECHNIQUE (NS) IN CERVICAL CANCER. ITS
ROLE ON BLADDER FUNCTION, PRELIMINARY RESULTS OF A RANDOMIZED
STUDY
S. Alessandria, G. Garrido, S. Provenzano, A. Bermudez, Argentina
261
TOTAL LAPAROSCOPIC HYSTERECTOMY FOR EARLY-STAGE
ENDOMETRIAL CANCER USING AN INTRA-UTERINE MANIPULATOR: IS IT A
BIAS FOR FROZEN SECTION ANALYSIS? A CASE-CONTROL STUDY
M.L. Gagliardi, A. Fagotti, G.F. Zannoni, G. Vizzielli, B. Costantini, V. Gallotta,
G. Scambia, F. Fanfani, Italy
262
ADMINISTRATION OF AMINO ACIDS AGENTS FOLLOWED BY
INTRAPERITONEAL IRRIGATION WITH SODIUM BICARBONATE IS EFFECTIVE
THERAPY IN PATIENTS OF PSEUDOMYXOMA PERITONEI
S. Kusunoki, K. Kato, S. Suga, M. Kimura, Y. Terao, S. Takeda, Japan
263
ROBOTIC RADICAL HYSTERECTOMY: COMPARISON OF OUTCOMES AND
COST
W. Gotlieb, D. Haliday, S. Lau, Canada
264
OUTCOME AND QUALITY OF LIFE IN ELDERLY PATIENTS UNDERGOING
ROBOTIC SURGERY FOR ENDOMETRIAL CANCER
W. Gotlieb, Z. Vaknin, T. Perri, C. Deland, N. Drummond, Z. Rosberger, S. Lau,
I. Gourdji, Canada
265
IMPACT OF OBESITY ON ROBOTIC SURGERY FOR ENDOMETRIAL CANCER
W. Gotlieb, K. Buzaglo, Z. Vaknin, S. Brin, R. Kaufer, S. Aubin, S. Lau, Canada
266
ROBOT ASSISTED LAPAROSCOPIC TRANSPERITONEAL PARA - AORTIC
LYMPHADENECTOMY IN THE MANAGEMENT OF GYNAECOLOGICAL
CANCERS
M. Fastrez, J. Vandromme, S. Rozenberg, M. Degueldre, Belgium
267
VAGINA RECONSTRUCTIVE SURGERY IN PRIMARY VAGINAL MELANOMA
AFTER EXTENSIVE SURGERY
C.-L. Chen, Y.-G. Zhang, W.-T. Wang, L.-Q. Li, C.-F. Zou, Z.-Y. Cao, China
268
ROBOTIC ENDOMETRIAL CANCER STAGING IN THE MORBIDLY OBESE
A. Burnett, P. Stone, A. Stevens, J. Roman, USA
269
LAPAROSCOPIC RETROPERITONEAL LYMPHADENECTOMY IN
M. Cusido, S. Baulies, F. Fargas, I. Rodriguez, J. Browne, R. Fabregas, Spain
81
Poster Session I
Poster No
270
ROBOTIC ASSISTED RADICAL HYSTERECTOMY FOR CERVICAL CANCER
S.K. Raju, G. Mehra, M.A. Kodampur, I. Ahmed, O. Devaja, UK
271
CHOOSING THE RIGHT PATIENT: PREDICTING THE CONVERSION OF
LAPAROSCOPY TO LAPAROTOMY DURING THE SURGICAL MANAGEMENT
OF ENDOMETRIAL CANCER
K. Kieser, A. Ball, C. O'Connell, J. Bentley, Canada
272
LASER ABLATION VERSUS LLETZ FOR THE TREATMENT OF CERVICAL
INTRAEPITHELIAL NEOPLASIA: SHORT AND LONG TERM OUTCOMES
K. Chin, F. Khan, J. Roger, UK
273
ROBOT-ASSISTED SURGICAL STAGING FOR ENDOMETRIAL CANCER
COMPARED TO LAPAROSCOPY AND LAPAROTOMY
D.-A. Silasi, K. Elsahwi, P.E. Schwartz, T.J. Rutherford, A.D. Santin, M. Azodi, USA
274
THE USE OF LAPAROSTOMY IN GYNAECOLOGICAL ONCOLOGY PATIENTS
S. Kaushik, K. Akhter, B. Rufford, D. Kolomainen, L. Balasubramani,
M. Nobbenhuis, T. Ind, J. Bridges, J. Shepherd, D. Barton, UK
275
INTRAVENOUS LEIOMYOMATOSIS EXTENDING TO THE RIGHT VENTRICLESUCCESSFUL ONE-STAGE OPERATION WITHOUT CARDIOTOMY AND
CARDIOPULMONARY BYPASS THROUGH MANUAL EXTRACTING METHOD
H.-J. Roh, H.-J. Yoo, S.-J. Lee, H.-J. Jo, W.-D. Joo, Republic of Korea
276
LAPAROSCOPIC ASSISTED VAGINAL HYSTERECTOMY VERSUS
LAPAROSCOPIC TOTAL HYSTERECTOMY
H.Y.S. Ngan, K.F. Tam, Hong Kong S.A.R.
277
UTILITY OF PERITONEAL LAVAGE CYTOLOGY DURING LAPAROSCOPIC
SALPINGO-OOPHORECTOMY
K. Haldar, P. Giamougiannis, R. Crawford, UK
278
SIMULTANEOUS COMBINE OPERATIONS ON PATIENTS WITH
CARDIOVASCULAR AND FEMALE GENITAL DISEASES
S. Mavrichev, V. Andruschuk, H. Maisei, I. Bakinovskaya, D. Rovski, A. Lusenko,
E. Dolomanova, Belarus
279
BUDDY OPERATING AS A TOOL TO ACCELERATE SKILL ACQUISITION FOR
LAPAROSCOPIC RADICAL HYSTERECTOMIES
C. Reade, M.L. Schmuck, F. Moens, J. Hauspy, Canada, Belgium
280
LAPAROSCOPIC MANAGEMENT OF LYMPHOCYST AND SEVERE ADHESION
POST CONVENTIONAL RADICAL HYSTERECTOMY
P. Jarruwale, C.-L. Lee, K.-G. Huang, Y. Tanapat, Thailand
281
INTRA-OPERATIVE COMPLICATIONS IN GYNAECOLOGICAL ONCOLOGY:
THE NEED FOR CLINICAL GOVERNANCE
A. Patel, A. Kucukmetin, K. Galaal, R. Naik, UK
82
Poster Session I
Poster No
282
NOVEL ROBOTIC VAGINAL SUTURING TECHNIQUE
I. Zapardiel, V. Zanagnolo, M. Peiretti, A. Maggioni, L. Bocciolone, Spain
283
PET PROBE ASSISTED SURGICAL DEBULKING IN WOMEN WITH ISOLATED
RECURRENT GYNECOLOGICAL TUMORS
S. Ghamande, F. Weber, S. Bush, H. Williams, M. Macfee, USA
284
NEOADJUVANT CHEMORADIATION FOLLOWED BY LAPAROSCOPIC
RADICAL HYSTERECTOMY IN FIGO STAGE IIB - IIIB CERVICAL CANCER
E. Vizza, C. Vincenzoni, E. Baiocco, E. Mancini, L. Patrizi, F. Tomao, M. Cimino,
G. Corrado, Italy
285
THE EVALUATION OF ANXIETY LEVEL IN WOMEN TREATED BY
LAPAROSCOPY AND LAPAROTOMY IN GYNECOLOGIC ONCOLOGY SETTING
P. Sobiczewski, H. Tchórzewska, T. Wysocka-Bobryk, W. Michalski, M. Bidzinski,
Poland
286
RECTOSIGMOID RESECTION WITH VS. WITHOUT PROTECTIVE OSTOMY AS
PART OF CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN CANCER
M. Arvas, B. Aslan, O. Guralp, F. Demirkıran, C. Sanioglu, T. Bese, Turkey
287
RETROPERITONEAL DEBULKING IN RECURRENT GYNECOLOGICAL
CANCER - THE CHALLENGE OF MULTISPECIALTY COOPERATION
J. Špaček, M. Broďák, Z. Bělobrádek, P. Dvořák, P. Navrátil, E. Křepinská,
A. Řezáţ, Czech Republic
Cervical Cancer
288
LONG-TERM SURVIVAL OUTCOMES OF LAPAROSCOPIC ASSISTED RADICAL
HYSTERECTOMY IN TREATING EARLY STAGE CERVICAL CANCER
C.-L. Lee, K.-Y. Wu, K.-G. Huang, Taiwan R.O.C.
289
MAGNESIUM AND POTASSIUM DEPLETION IN CERVICAL CANCER PATIENTS
RECEIVING WEEKLY CISPLATIN CHEMOTHERAPY CONCURRENT WITH
RADIOTHERAPY: A RETROSPECTIVE COHORT STUDY
C. Zalameda-Castro, G. Benitez, Philippines
290
ANALYSIS OF 89 PATIENTS WITH POSITIVE MARGINS AFTER CONIZATION
C. Wu, Q. Liao, China
291
COMPARISON OF OUTCOMES FOR BONE METASTATIC CERVICAL CANCER
PATIENTS PRIMARY TREATED WITH CONCURRENT CHEMORADIATION VS.
RADIATION THERAPY ALONE
D. Thanapprapasr, A. Nartthanarung, Thailand
292
A SURVEY OF THE KNOWLEDGE AND ATTITUDE OF JORDANIAN
OBSTETRICIANS AND GYNAECOLOGISTS TO CERVICAL CANCER
SCREENING
I. Lataifeh, Jordan
83
Poster Session I
Cervical Cancer (contd.)
Poster No
293
REDUCING CERVICAL CANCER INCIDENCE IN NIGERIA
O. Agboola, Nigeria
294
EFFECTS OF QUERCETIN-INDUCED APOPTOSIS ON HELA CELLS THROUGH
THE MITOCHONDRIAL PATHWAY
W. Zhang, J. Chen, L. Ao, L. Huang, China
295
CERVICAL CANCER SCREENING METHODS - PILOT STUDY IN URBAN AREA
FROM ROMANIA
C. Rada, S. Manolescu, M. Tarcea, C. Zugravu, Romania
296
EXPRESSION AND CLINICAL SIGNIFICANCE OF TGF-Β AND SMAD7 IN
CERVICAL CARCINOMA
T. Yao, Z. Lin, China
297
EARLY DIAGNOSTIC OF CERVICAL CANCER CELLS IN REFLECTED LIGHT
A. Paiziev, V. Krakhmalev, M. Abdullakhodjaeva, Uzbekistan
298
SEXUALL RESPONSIBLE BEHAVIOR AMONG ADOLESCENTS-PROJECTKNOWLEDGE IS PLEASURE
D. Lepusic, Croatia
299
REVISING THE ROLE OF PARAMETRIAL BOOST IN LOCALLY ADVANCED
CERVIX CANCER PATIENTS STAGED WITH POSITRON EMISSION
TOMOGRAPHY
C. Rajasooriyar, S. van Dyk, M. Lindawati, D. Bernshaw, S. KondalsamyChennakesavan, K. Narayan, Sri Lanka
300
ASSESSMENT OF DIFFERENT TYPES OF CYTOLOGICAL FINDINGS IN
PAPANICOLAOU TEST (A 3 YEAR STUDY) IN AN IRANIAN HOSPITAL
KERMANSHAH /IRAN
A. Nankali, T. Fakheri, F. Keshavarzi, M. Yari, N. Jalilian, Iran
301
CLINICAL ANALYSIS OF 37 CASES WITH URINARY RETENTION AFTER
RADICAL TOTAL HYSTERECTOMY
H. Li, R. Wu, Y. Guo, Z. Ma, Y. Ru, B. Lou, L. Zeng, China
302
RADIOTHERAPY WITH OR WITHOUT CHEMOTHERAPY IN THE MANAGMENT
OF CERVIX CANCER: A RETROSPECTIVE REVIEW
S. Sridharan, S. Vinod, A. Lau, Australia
303
PHYSICAL AND PSYCHOLOGICAL ANALYSIS OF FEMALES TREATED FOR
CERVICAL CANCER WITH RADIATION THERAPY. WHAT IS STILL NEEDED?
U. Majeed, N. Hayat, I. Haider, A. Jamshed, M. Shah, A. Ali Syed, S. Hameed,
Pakistan
304
PROGNOSTIC VALUE OF HISTOLOGY IN CERVICAL CANCER PATIENTS
J. Jonska-Gmyrek, L. Gmyrek, B. Lindner, J. Staniaszek, A. Zolciak-Siwińska,
R. Krynicki, M. Bidzinski, B. Kotowicz, Poland
84
Poster Session I
Poster No
305
THE CORRELATION BETWEEN THE CYTOLOGICAL AND COLPOSCOPIC
FINDINGS AND PATHOHISTOLOGICAL FINDINGS OF CERVICAL
INTRAEPITHELIAL NEOPLASIA (CIN)
D. Vuleta, S. Mihaldņiš-Tubiš, R. Maletin, T. Kozarcic, M. Mocko-Kacanski, M. Djolai,
Serbia
306
CORRELATION BETWEEN HOMEODOMAIN-INTERACTING PROTEIN KINASE
2, HUMAN PAPILLOMAVIRUS AND APOPTOSIS IN CERVICAL CANCER
M. Al-Beiti, J. Wang, W. Guang, X. Lu, X. Liu, China, USA
307
COLD COAGULATION: EVALUATION OF A TREATMENT MODALITY FOR HIGH
GRADE CIN
S. Phadnis, K. Sieunarine, R. Dixon, M. Padwick, F.A. Sanusi, UK
308
PREVALENCE OF HIGH-GRADE CIN IN THE PRESENCE OF A TYPE 3
TRANSFORMATION ZONE AND A SMEAR SUGGESTIVE OF LOW-GRADE
DYSKARYOSIS
S. Phadnis, K. Sieunarine, M. Menezes, M. Padwick, F.A. Sanusi, UK
309
THE USE OF INTEGRATED HUMAN PAPILLOMAVIRUS TYPE16 AS A
SURROGATE MARKER IN PREDICTING DISEASE FOR PATIENTS WITH
CERVICAL INTRAEPITHELIAL NEOPLASIA
R. Karaca, I. Alanbay, E. Akturk, A. Kubar, M. Dede, M.C. Yenen, I. Baser, Turkey
310
CLINICAL IMPACT OF RE-STAGING RECURRENT CERVICAL CANCER WITH
FDG-PET
M. Bjurberg, E. Kjellén, E. Brun, Sweden
311
RESULTS OF A RANDOMIZED TRIAL FROM THE FNCLCC COMPARING
HYSTERECTOMY VERSUS NO HYSTERECTOMY AFTER
CHEMORADIOTHERAPY FOR STAGE IB2/II CERVICAL CANCER
P. Morice, P. Rouanet, P. Romestaing, G. Houvenaeghel, J.C. Boulanger,
J. Leveque, D. Cowen, A. Rey, F. Gouttenoire, C. Haie-Meder, France
312
PROGNOSTIC FACTORS AND MORBIDITIES AFTER COMPLETION SURGERY
IN PATIENTS UNDERGOING INITIAL CHEMORADIATION THERAPY FOR
LOCALLY ADVANCED CERVICAL CANCER
C. Touboul, C. Uzan, S. Gouy, A. Rey, C. Lhomme, P. Pautier, P. Duvillard,
C. Haie-Meder, P. Morice, France
313
A RANDOMIZED TRIAL OF LOCAL ANESTHESIA VERSUS FORCED
COUGHING FOR PAIN RELIEF DURING CERVICAL BIOPSY
B. Schmid, S. Pils, G. Heinze, L. Hefler, A. Reinthaller, P. Speiser, Austria
314
RISK FACTORS FOR TUMOR RECURRENCE IN PATIENTS WITH STAGE III-IVA
SQUAMOUS CELL CARCINOMA OF THE CERVIX TREATED WITH
CONCURRENT CHEMORADIOTHERAPY
K. Asato, Y. Nagai, M. Oyakawa, H. Nitta, E. Okubo, M. Hirakawa, W. Kudaka,
M. Inamine, T. Toita, Y. Aoki, Japan
85
Poster Session I
Poster No
315
ABDOMINAL RADICAL TRACHELECTOMY IN PATIENTS WITH EARLY
INVASIVE CERVICAL CARCINOMA
A. Mandic, P. Novakovic, D. Zikic, T. Ivkovic-Kapicl, J. Rajovic, O. Mihajlovic, Serbia
316
EVALUATION OF VISUAL INSPECTION WITH ACETIC ACID AND LUGOL´S
IODINE AS CERVICAL CANCER SCREENING METHODS IN RURAL AREAS OF
CHINA
Y. Zhao, C. Zhao, J. Jiang, L. Qiu, L. Cui, J. Li, L. Wei, China
317
PREVALENCE AND TYPES OF HPV IN CERVICAL CANCER: COMPARISON
BETWEEN LOCAL AND INTERNATIONAL DATA: LESSONS TO LEARN
M. Seoud, L. Alemany, G. Zaatary, A. Khalil, S. de Sanjosé, N. Muñoz, F.X. Bosch,
Lebanon, Spain
318
DETECTION OF HUMAN TELOMERASE GENE AMPLIFICATION COMBINED
WITH HUMAN PAPILLOMAVIRUS TEST: A CLINICAL DIAGNOSTIC VALUATION
FOR UTERINE CERVICAL PRECANCEROSIS
H. Liu, S. Liu, H. Wang, China
319
ANTIBIOTIC USE AND RISK OF GYNECOLOGICAL CANCER
H. Tamim, H. Al Kadri, K. Musallam, J.-F. Boivin, J.-P. Collet, Saudi Arabia,
Lebanon, Canada
320
IRINOTECAN AND CISPLATIN FOR NEUROENDOCRINE CARCINOMA OF THE
UTERINE CERVIX
K. Fujiwara, A. Miyoshi, M. Okazawa, T. Miyatake, Y. Ota, K. Yoshino, T. Enomoto,
S. Kamiura, Japan
321
RADICAL HYSTERECTOMY FOR FIGO STAGE IB-IIB ADENOCARCINOMA OF
THE UTERINE CERVIX
T. Kasamatsu, T. Onda, M. Sawada, T. Kato, S. Ikeda, M. Ishikawa, Y. Sasajima,
H. Tsuda, Japan
322
ROLE OF HIGH-RISK HUMAN PAPILLOMAVIRUS TESTING IN THE SCREENING
AND MANAGEMENT OF CERVICAL CANCER PRECURSORS
S. Lee, S. Lee, G.H. Lee, Y. Lee, D.C. Park, Republic of Korea
323
HPV INFECTION AMONG PATIENTS WITH HIGH GRADE CERVICAL
INTRAEPITHELIAL NEOPLASIA AND SQUAMOUS CELL CARCINOMA OF
CERVIX IN IRAN
F. Yarandi, Z. Eftekhar, N. Izadi-Mood, Iran
324
HPV TYPE DISTRIBUTION IN INVASIVE CERVICAL CANCER AND HIGHGRADE CERVICAL LESIONS IN KOREA
Y.-T. Kim, K.-R. Kim, S.-W. Lee, J.-H. Bae, A. Lee, Y.-J. Choi, S.-H. Lee,
P. Shrestha, J. Chen, J.-S. Park, Republic of Korea
86
Poster Session I
Poster No
325
MANAGEMENT OF ´NORMAL´ COLPOSCOPY IN THE PRESENCE OF HIGHGRADE CYTOLOGICAL ABNORMALITY
S. Phadnis, R. Joseph, K. Sieunarine, S. Disu, M. Padwick, F.A. Sanusi, UK
326
HIGH RISK HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS RELATION
WITH ABNORMAL PAP TEST: A TURKISH UNIVERSITY HOSPITAL
EXPERIENCE
E.S. Özcan, S. Taskin, F. Ortaç, Turkey
327
ABDOMINAL RADICAL TRACHELECTOMY IS AN OPTION FOR FERTILITYSPARING SURGERY IN WOMEN OF REPRODUCTIVE AGE WITH EARLY
STAGE CERVICAL CARCINOMA
M. Muraji, Japan
328
BOTRYOID RHABDOMYOSARCOMA OF THE UTERINE CERVIX: A CASE
REPORT
A. Melo, C. Costa, M. Cruz-Pires, D. Fernandes, M. Soares, T. Amaro, A. Petiz,
Portugal
329
OUTCOME OF PATIENTS WITH ATYPICAL GLANDULAR CELLS DIAGNOSED
DURING PREGNANCY
J. Sláma, D. Cibula, P. Freitag, I. Pinkavová, M. Zikán, D. Fischerová, P. Dundr,
J. Dusková, Czech Republic
330
HIGH-RISK HUMAN PAPILLOMAVIRUS DNA IN PARAAORTIC LYMPH NODES
IN ADVANCED STAGES OF CERVICAL CARCINOMA
J. Sláma, D. Cibula, P. Dundr, I. Pinkavová, M. Zikán, D. Fischerová, P. Freitag,
M. Fanta, D. Kuzel, M. Drazdaková, T. Zima, Czech Republic
331
NERVE-SPARING OKABAYASHI RADICAL TRANSABDOMINAL
HYSTERECTOMY (NORTH) AND ITS LAPAROSCOPIC APPLICATION
W.-D. Joo, H.-J. Yoo, S.-J. Lee, H.-J. Noh, Republic of Korea
332
A 'SEE AND TREAT' POLICY FOR REFERRAL SMEARS SUGGESTIVE OF
MODERATE DYSKARYOSIS: IS ITJUSTIFIED?
S. Phadnis, R. Joseph, K. Sieunarine, M. Menezes, M. Padwick, F.A. Sanusi, UK
333
EXPRESSION OF CYCLIN G1 IN CERVICAL CANCER AND ITS RELATIONSHIP
WITH THE SUB-GENOTYPES OF HPV
P. Sun, Y. Wen, X. Mao, F. Lin, Y. Song, China, Germany
334
THE CLINICAL SIGNIFICANCE OF DETECTION HPV GENOTYPES BY USING
FLOW THROUGH HYBRIDIZATION AND GENE CHIP
P. Sun, X. Chen, C. Lin, X. Mao, F. Lin, L. Cai, Y. Song, China
87
Poster Session I
Poster No
335
THE ANALYSIS OF THE IMMUNE RESPONSE WITH REFERENCE TO THE
PEPTIDE FROM HUMAN PAPILLOMAVIRUS TYPE 16-L1 IN THE CERVICAL
CANCER
A. Fukui, K. Kawano, S. Matsueda, N. Komatsu, T. Sasada, S. Shitijyou,
K. Ushijima, K. Itho, T. Kamura, Japan
336
MODERN TENDENCIES IN EARLY FINDING AND SCREENING OF CERVICAL
PRECANCER AND CANCER
337
COMPARISON OF CERVICAL SMEAR RESULTS RECEIVED BY DOCTORS AND
RECEIVED BY SERVIKS ® SELF-SMEAR TEST KIT
H. Guner, C. Cakici, A. Onan, C. Taskiran, E. Turkyilmaz, B.A. Buyrukcu, H. Ustun,
Turkey
338
LOW DYNAMIN 2 EXPRESSION IS ASSOCIATED WITH TUMOR INVASION AND
METASTASIS IN INVASIVE SQUAMOUS CELL CARCINOMA OF CERVIX
Y.-Y. Lee, B.-G. Kim, J.-W. Lee, T.-J. Kim, C.H. Choi, H.S. Park, T.J. Song,
M.K. Kim, H.J. Kim, W. Lee, J.-H. Lee, D.-S. Bae, Republic of Korea
339
THE EVALUATION OF PROGNOSTIC FACTORS AND EFFECTS OF ADJUVANT
THERAPY ON OUTCOMES OF EARLY STAGE CERVICAL CANCER
M. Karimi Zarchi, N. Behtash, Iran
340
COLPOSCOPY: CYTOLOGY: HISTOLOGY CORRELATION AT THE CERVICAL
PATHOLOGY UNIT IN FUNDACIÓN LÓPEZ PEREZ (SANTIAGO CHILE).
DIFFERENCES BETWEEN RESIDENTS
Y. Mc Conell, R. Urrejola, H. León, P. Torres, L. Urrejola, M. Pierotic, Chile
341
A STUDY OF CHRONIC PELVIC PAIN AFTER RADIOTHERAPY IN SURVIVORS
OF LOCALLY ADVANCED CERVICAL CANCER
I. Vistad, M. Cvancarova, G. Kristensen, Norway
342
CERVICAL CANCER IN CROATIA: THE IMPORTANCE OF PUBLIC EDUCATION
CAMPAIGN FOR CERVICAL CANCER PREVENTION
D. Eljuga, V. Końec, S. Sabolovic-Rudman, A. Znaor, D. Eljuga, G. Grubińiš, Croatia
343
CARCINOSARCOMA OF THE UTERINE CERVIX WITH CLEAR CELL
ADENOCARCINOMA COMPONENT
N. Takahashi-Shiga, M. Toyoshima, J.-I. Akahira, H. Niikura, N. Yaegashi, Japan
344
INDIVIDUALIZED FOLLOW-UP FOR EARLY DETECTION OF CERVICAL
CANCER BY HUMAN PAPILLOMAVIRUS (HPV) TESTING IN CASES OF ASCUS,
LSIL AND HSIL
M. Hosaka, H. Fujita, H. Watari, N. Sakuragi, Japan
88
Poster Session I
Poster No
345
SYSTEMIC CHEMOTHERAPY FOLLOWING CONCURRENT
CHEMORADIOTHERAPY IMPROVED THE SURVIVAL IN PATIENTS WITH
LOCALLY ADVANCED UTERINE CERVICAL CANCER
A. Abe, H. Furumoto, K. Yoshida, T. Kato, M. Irahara, Japan
346
OUTCOME AND EVENTS AFTER CERVICAL CANCER TREATMENT: A
MONOCENTRIC STUDY FOLLOW UP
N. Yarandi, F. Yarandi, N. Izadi-Mood, Iran
347
ADENOID BASAL CARCINOMA OF THE CERVIX
C. Urzal, C. Nunes, M. Rocha, P. Aldinhas, D. Pereira da Silva, Portugal
348
LEIOMYOSARCOMA OF THE CERVIX
C. Urzal, C. Nunes, M. Rocha, P. Aldinhas, D. Pereira da Silva, Portugal
349
SMALL CELL CARCINOMA OF THE UTERINE CERVIX: A CLINICAL
CHARACTERISTICS AND PROGNOSTIC FACTORS OF THE 5 CASES
Y. Oh, Republic of Korea
350
INTRATUMORAL LYMPHATIC MICRO VESSEL DENSITY (MLVD) AND
CLINICOPATHOLOGIC FEATURES OF PATIENTS WITH EARLY STAGE
CERVICAL CANCER FOLLOWING RADICAL HYSTERECTOMY
F. Zaganelli, F. Carvalho, B. Almeida, C. Bacchi, J.C. Goes, M. Calil, E. Baracat,
J. Carvalho, Brazil
351
TREND IN DISTRIBUTION OF HUMAN PAPILLOMAVIRUS TYPE 58 VARIANTS
IN PROGRESSION OF CERVICAL DYSPLASIA IN KOREAN WOMEN
M.J. Song, S.T. Park, S.Y. Hur, J.S. Park, Republic of Korea
352
COMPARISON OF PNA BASED ARRAY WITH DNA-BASED ARRAY FOR
DETECTING AND GENOTYPING HUMAN PAPILLOMAVIRUS
S.T. Park, M.J. Song, S.Y. Hur, J.S. Park, Republic of Korea
353
DETECTION OF HUMAN PAPILLOMAVIRUS TYPE 16 E7-SPECIFIC T CELLS BY
ELISPOT ASSAY
S.Y. Hur, M.J. Song, S.T. Park, J.S. Park, Republic of Korea
354
THE PROGNOSTIC VALUE OF HAEMOGLOBIN SERUM CONCENTRATION AND
WHO STATUS IN CERVICAL CANCER PATIENTS
J. Jonska-Gmyrek, R. Krynicki, L. Gmyrek, B. Lindner, A. Zolciak-Siwinska,
J. Staniaszek, B. Kotowicz, M. Bidzinski, K. Bujko, Poland
355
ANALYSIS OF RESULTS OF INTERSTITIAL BRACHYTHERAPY USING MUPIT
IN LOCALLY ADVANCED GYNECOLOGICAL MALIGNANCIES
R. Vyas, P. Nandwani Patel, U. Suryanarayan, India
356
EVALUATION OF CHEMORADIOTHERAPY EFFICACY AND SIDE EFFECTS IN
LOCALLY ADVANCED CERVICAL CANCER- A STUDY FROM NORTH EAST OF
IRAN
S. Kadkhodayan, F. Homaei Shandiz, F. Farshidy, M. Afsal Aghaee, A. Babaei, Iran
89
Poster Session I
Poster No
357
A SURVEY OF IRANIAN WOMEN KNOWLEDGE AND ATTITUDE TO HPV AND
VACCINE UPTAKE
F. Farzaneh, A. Esmailnia, S. Salehpour, E. Barouti, Iran
358
MRI-BASED PREPLANNING WITH CT/MRI DATA FUSION IN PATIENTS WITH
CERVICAL CANCER TREATED WITH 3D BRACHYTHERAPY
M. Doležel, J. Vanasek, K. Odrazka, T. Kroulik, M. Tichy, M. Kostal, D. Spitzer,
M. Mrklovsky, Czech Republic
359
ANALYSIS OF RISK FACTORS FOR RECURRENCE IN PATIENTS TREATED
FOR CERVICAL CANCER
C. Zhao, L. Wei, China
360
ISOLATION AND IDENTIFICATION OF HUMAN CERVICAL CARCINOMA STEM
CELLS
T. Yao, Z. Lin, China
361
EARLY REMOVAL OF URINARY CATHETER AFTER RADICAL
HYSTERECTOMY
M. Abu Freij, N. Burbos, S. Crocker, T. Duncan, J. Nieto, UK
362
WEEKLY VERSUS TRI-WEEKLY CISPLATIN: WHICH ONE SHOULD BE THE
STANDARD REGIMEN IN CISPLATIN-BASED CHEMORADIATION IN CERVICAL
CANCER TREATMENT?
S.-Y. Ryu, W.-M. Lee, K. Kim, S.-I. Park, B.-J. Kim, M.-H. Kim, C.-K. Cho,
B.-H. Nam, Korea Cancer Center Hospital, Republic of Korea
363
CLINICOPATHOLOGICAL SIGNIFICANCE OF CERVICAL ADENOCARCINOMA
ASSOCIATED WITH LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA
S. Nishio, H. Tsuda, K. Ushijima, Y. Sasajima, T. Kasamatsu, T. Kamura, Japan
364
FIBROBLAST GROWTH FACTOR RECEPTOR2 IIIC IN HUMAN UTERINE
CERVICAL INTRAEPITHELIAL NEOPLASIA(CIN) AND CERVICAL CANCER
R. Kawase, T. Ishiwata, Z. Naito, T. Takeshita, Japan
365
MEDIUM DOSE RATE BRACHYTHERAPY FOR PATIENTS WITH CERVICAL
CARCINOMA ; EARLY RESULT OF A PROSPECTIVE STUDY
F. Amouzegar-Hashemi, F. Zahedi, F. Farhan, M. Aghili, B. Kalaghchi, P. Haddad,
Iran
366
MALIGNANT PERICARDIAL EFFUSION IN CARCINOMA OF THE UTERINE
CERVIX
K. Wongyu, Republic of Korea
367
A COMPARISON BETWEEN SIMPLE FRACTIONATION AND
HYPERFRACTIONATION IN ADVANCED CERVICAL CANCER: TUMOR
CONTROL AND RADIATION COMPLICATIONS
L. Taehwa, Republic of Korea
90
Poster Session I
Poster No
368
HYDRONEPHROSIS AS A PROGNOSTIC INDICATOR OF SURVIVAL IN
ADVANCED CERVICAL CARCINOMA
T. Shah-Pradhan, G. Salame, H. Duan, O. Abulafia, Y.-C. Lee, W. Jeremy,
E. Katsoulakis, USA
369
IMMUNOHISTOCHEMISTRY BASED PROFILE OF CIN MIGHT HELP FOR
TRYAGING OF WOMEN GENUINELY REQUIRING TREATMENT
X. Carcopino, S. Giusiano-Courcambeck, A. Djmeli-Bensmaine, V. Secq, L. Boubli,
D. Olive, C. Taranger-Charpin, France
370
EVALUATION OF HPV DNA TYPING IN SENTINEL LYMPH NODE AND
PRIMARY LESION OF CERVIX IN PATIENTS WITH CERVICAL CANCER
C.-C. Rhim, Republic of Korea
371
SOLITARY RECURRENT METASTASIS OF SQUAMOUS CELL CARCINOMA OF
THE UTERINE CERVIX IN INGUINAL LYMPH NODE
P.-R. Jang, Republic of Korea
372
PHASE II TRIAL OF NEOADJUVANT CHEMOTHERAPY IN CERVICAL CANCER
IN INDIAN WOMEN
M. Biswas, S.P.S. Kochar, B.K. Goyal, R. Rao, S. Bhatnagar, India
373
THE CORRELATION OF KI-67 EXPRESSION WITH TUMOR RECURRENCE AND
SURVIVAL RATES IN EARLY STAGE CARCINOMA OF THE CERVIX
C.M. Pacioles-Flavier, J.T.P. Luna, Philippines
374
PERSISTENCE AND RECURRENCE OF CERVICAL INTRAEPITHELIAL
NEOPLASIA FOLLOWING LOOP ELECTROSURGICAL EXCISION(LEEP) OF
HIGH GRADE LESIONS - 10 YEAR FOLLOW UP
A. Ranganathan, C. Clelland, S. Kehoe, UK
375
INFLUENCE OF POST OPERATIVE ADJUVANT CONCURRENT
CHEMORADIATION ON SURVIVAL FOR HIGH- RISK EARLY STAGE CERVICAL
CANCER - KK HOSPITAL EXPERIENCE
C. Yin Nin, N. Ramapadma, Y. Kwai Lam Philip, L. Yong Kuei, S. Lay Tin,
Y. Swee Peng, Y. Richard, Singapore
376
SEQUENCE-DEPENDENT HEMATOLOGIC SIDE EFFECTS OF TOPOTECAN
AND CISPLATIN IN PERSISTENT OR RECURRENT CERVICAL CANCER
Y.-Y. Lee, J.-W. Lee, H.J. Kim, W. Lee, H.S. Park, T.J. Song, M.K. Kim, C.H. Choi,
T.-J. Kim, J.-H. Lee, D.-S. Bae, B.-G. Kim, Republic of Korea
377
LOCALLY ADVANCED ADENOCARCINOMA OF THE CERVIX TREATED WITH
CONCURRENT CHEMORADIOTHERAPY USING PACLITAXEL AND CISPLATIN
Y. Nagai, K. Asato, M. Hirakawa, M. Inamine, W. Kudaka, T. Toita, Y. Aoki, Japan
378
A PROSPECTIVE STUDY ON COLPOSCOPIC EVALUATION OF POST COITAL
BLEEDING
V. Jain, S. Jain, S. Bansal, India
91
Poster Session I
Poster No
379
PROGNOSTIC IMPLICATIONS OF LEVELS OF INSULIN LIKE GROWTH
FACTOR-I & INSULIN LIKE GROWTH FACTOR-II IN PATIENTS WITH CERVICAL
CANCER
P. Nandwani Patel, R. Vyas, D. Bhavsar, M. Mehta, India
380
RADICAL HYSTERECTOMY IN PREGNANT AND NON-PREGNANT WOMEN: A
COMPARISON OF OPERATIVE RISKS
K.S. Bevis, C. Leath III, T.M. Numnum, P. Ramsey,, W. Huh, J.M. Straughn Jr., USA
381
RISK STRATIFICATION IN PATIENTS WITH STAGE IB-IIA CERVICAL CANCER
WITHOUT PARAMETRIAL INVASION OR PELVIC LYMPH NODE METASTASES
AFTER RADICAL HYSTERECTOMY
S.-I. Ikeda, T. Kasamatsu, T. Kato, T. Onda, M. Ishikawa, Y. Sasajima, H. Tsuda,
Japan
382
P16INK4A IMMUNOSTAINING AS AN ALTERNATIVE TO HISTOLOGY REVIEW
FOR RELIABLE GRADING OF CERVICAL INTRAEPITHELIAL LESIONS
M.G. Dijkstra, D.A.M. Heideman, S.C. de Roy, L. Rozendaal, J. Berkhof, K. van
Krimpen, K. van Groningen, P.J.F. Snijders, C.J.L.M. Meijer, F.J. van Kemenade,
The Netherlands
383
ADJUVANT RADIOTHERAPY AND CHEMORADIATION AFTER SURGERY FOR
CERVICAL CANCER
L. Rogers, S.S.N. Siu, D. Luesley, A. Bryant, H. Dickinson, South Africa
384
TO TREAT OR NOT TO TREAT, THE CLINICAL DILEMMA OF ASC-US
R.P. de Bie, L.F.A.G. Massuger, R.A.J.M. van Dongen, M.P.M.L. Snijders, J. Bulten,
W.J.G. Melchers, R.L.M. Bekkers, The Netherlands
385
THE FTA CARTRIDGE SELF SAMPLE: A PROMISING TOOL TO IMPROVE
CERVICAL CANCER SCREENING
R.P. de Bie, C.E. Schmeink, J.M.J.E. Bakkers, L.F.A.G. Massuger, R.L.M. Bekkers,
W.J.G. Melchers, The Netherlands
386
NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL HYSTERECTOMY
FOR STAGE 1 B2-2B CERVICAL CANCER-PRELIMINARY RESULTS
M. Popovic, N. Prvuloviš, A. Mandic, J. Rajovic, Serbia
387
ROLE OF PET/CT IN PREOPERATIVE LYMPH NODE STAGING IN PATIENTS
WITH EARLY STAGE CERVICAL CANCER UNDERGOING RADICAL SURGERY
L. Ševčík, M. Mysliveţek, J. Klát, P. Gráf, Z. Jalůvková, M. Ţegan, O. Kraft,
R. Formánek, Czech Republic
388
RELATIONSHIPS BETWEEN SENSE OF COHERENCE AND SYMPTOM
OCCURRENCE, INTENSITY, DISTRESS, AND SELF CARE EFFECTIVENESS IN
THAI WOMEN WITH CERVICAL CANCER
B. Sumdaengrit, S. Hanucharurnkul, M. Dodd, S. Wilailak, T. Vorapongsathorn,
K. Pongthavornkamol, Thailand
92
Poster Session I
Poster No
389
THE REAL SIGNIFICANCE OF ASCUS AND ASC-H IN DETECTING HIGH GRADE CERVICAL LESIONS - OUR RESULTS IN TWO YEARS
S. Vukajlovic, L. Vukmirovic, J. Opalic, J. Atanackovic, R. Cerovic, Serbia
390
PROGNOSTIC VALUE OF HEDGEHOG SIGNALLING IN CERVICAL
CARCINOMA
N. Chaudary, R.P. Hill, M. Pintilie, D. Hedley, A.W. Fyles, M. Milosevic, H. Mackay,
Canada
391
EVALUATION OF OUTCOMES IN PATIENTS WITH CARCINOMA OF THE
CERVIX TREATED WITH RADIATION WITH OR WITHOUT CONCURRENT
CHEMOTHERAPY
E. Donnelly, J. Lurain, J. Schink, D. Singh, J. Boyle, M. Gentile, B.B. Weitner,
J. Strauss, A. Rademaker, W. Small, Jr., USA
392
PARTICIPATION OF HEALTH WORKERS IN VIA , VILLI SCREENING IN ILE-IFE,
SOUTHWESTERN NIGERIA, HOW FAR?
B. Adebami, K. Ajenifuja, Gynaeoncology Group, Nigeria
393
PHASE II TRIAL OF PACLITAXEL AND NEDAPLATIN IN PATIENTS WITH
ADVANCED/RECURRENT UTERINE CERVICAL CANCER: A KANSAI CLINICAL
ONCOLOGY GROUP STUDY
M. Takekuma, Y. Hirashima, H. Tsubamoto, T. Tabata, A. Arakawa, Y. Itani,
N. Furukawa, H. Murakoshi, S. Takeuchi, K. Ito, Kansai Clinical Oncology Group,
Japan
394
PROGNOSTIC VALUE OF TUMOR MARKER SCCA IN THE MONITORING OF
CERVICAL CANCER PATIENTS
V. Sukhin, V. Hertman, E. Sukhina, I. Krugovaja, Ukraine
395
PERSISTENCE OF HPV AFTER CONIZATION FOR CERVICAL
INTRAEPITHELIAL NEOPLASIA (CIN)
N. Kiriakopoulos, E. Gavalas, I. Kotsidas, C. Nanini, N. Koutlaki, V. Lymberis,
Greece
396
P16/KI-67 DUAL-STAINED CYTOLOGY TESTING MAY PREDICT POST PARTUM
OUTCOME IN PATIENTS WITH ABNORMAL PAP CYTOLOGY DURING
PREGNANCY
O. Reich, F. Durchschein, A. Schroedel, E. Bankuti, R. Ridder, Austria
397
THE COLUMNAR EPITHELIUM HYPOTHESIS OF CERVICAL CARCINOGENESIS
O. Reich, Austria
398
COST-EFFECTIVENESS ANALYSIS OF WEEKLY VS THREE-WEEKLY
CISPLATIN CHEMORADIATION IN CERVICAL CANCER
S. Wilailak, S. Pongpanich, S.C. Luengsukcharoern, C. Seetatanee,
A. Lertkhachonsuk, C. Charakorn, Thailand
93
Poster Session I
Poster No
399
THE ASSOCIATION BETWEEN MCP-1 AND CCR2 SINGLE NUCLEOTIDE
POLYMORPHISMS AND CERVICAL CANCER IN KOREAN WOMEN
H.-S. Moon, N. Kim, H.W. Chung, Republic of Korea
400
THE ROLE OF HUMAN PAPILLOMAVIRUS TESTING IN PREDICTING THE
RECURRENCE AFTER TREATMENT FOR HIGH-GRADE CERVICAL
INTRAEPITHELIAL NEOPLASIA
G. Dimitrov, E. Dzikova, I. Andonova, E. Trajkovska, FYR Macedonia
401
STUDY OF CHANGES IN LIPID PEROXIDATION AND ANTI-OXIDANTS LEVELS
IN DIFFERENT STAGES OF CARCINOMA CERVIX
U. Singh, A.N. Srivastava, H.P. Gupta, S. Mehrotra, S. Srivastava, India
402
STUDY OF FREE RADICAL INJURY STATUS IN PRE MALIGNANT AND
MALIGNANT CERVICAL LESIONS
H.P. Gupta, A.N. Srivastava, U. Singh, S. Mehrotra, India
403
ADENOCARCINOMA OF THE UTERINE CERVIX. THE RADIUMHEMMETS
SERIES 1914-2004. CHANGES IN STAGE AND AGE DISTRBUTION AND
SURVIVAL TRENDS
A.-C. Hellström, K. Hellman, B.F. Pettersson, Sweden
404
IDENTIFICATION OF A GENE-EXPRESSION SIGNATURE FOR PREDICTING
LYMPH NODE METASTASIS IN EARLY STAGE PATIENTS WITH CERVICAL
CARCINOMA
L. Huang, M. Zheng, H. Ding, Q.-M. Zhou, W.-H. Jia, H.-Y. Wang, China
405
MESONEPHRIC ADENOCARCINOMA OF THE CERVIX WITH SPINDLE CELL
DIFFERENTIATION: A CASE REPORT
M. Arvas, B. Aydogan, O. Guralp, C. Sanioglu, T. Bese, F. Demirkiran, Turkey
406
THE COLPOSCOPIC MANAGEMENT OF CERVICAL INTRAEPITHELIAL
NEOPLASIA DURING PREGNANCY IN R.MACEDONIA
E. Dzikova, G. Dimitrov, I. Andonova, E. Trajkovska, FYR Macedonia
407
SHORT-TERM RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOLLOWED
BY RADICAL SURGERY IN PATIENTS WITH LOCALLY ADVANCED UTERINE
CERVIX CANCER. CASE SERIES
O. Matylevich, I. Kosenko, T. Litvinova, Belarus
408
CHORIOCARCINOMATOSIS DEDIFFERENTIATION FROM ADENOCARCINOMA
OF THE UTERINE CERVIX: A CASE REPORT
K.-C. Chun, D.-Y. Chang, Y.-A. Kim, M.-K. Jeon, E.-S. Lee, Republic of Korea
409
THE EFFECT OF CISPLATIN WITH GREEN TEA POLYPHENOL IN THE HUMAN
UTERINE CERVICAL CANCER CELL LINES
S. Han, T. Ahn, Republic of Korea
94
Poster Session I
Poster No
410
SIGNIFICANCE OF PRETREATMENT SERUM CYFRA 21-1 LEVELS AS AN
INDEPENDENT PROGNOSTIC FACTOR IN CARCINOMA OF THE UTERINE
CERVIX
S.-J. Chang, H.-S. Ryu, K.-H. Chang, Republic of Korea
411
ROBOT-ASSISTED LAPAROSCOPIC RADICAL TRACHELECTOMY AND
BILATERAL PELVIC LYMPHADENECTOMY IN EARLY STAGE CERVICAL
CANCER: THE FIRST CASE REPORT IN KOREA
S.H. Lee, J.W. Kim, S.L. Kim, S.W. Kim, Y.T. Kim, E.J. Nam, Republic of Korea
412
HUMAN PAPILLOMAVIRUS GENOTYPE DISTRIBUTION IN CERVICAL
INTRAEPITHELIAL NEOPLASIA AND INVASIVE CANCERS IN HONG KONG
P. Chan, T. Cheung, M. Yu, W. Li, M. Chan, K. Ho, China
413
PRE-OPERATIVE DIAGNOSIS AND THE MANAGEMENT OF MINIMAL
DEVIATION ADENOCARCINOMA(MDA) AND LOBULAR ENDOCERVICAL
GLANDULAR HYPERPLASIA(LEGH) : A MULTI-CENTER, RETROSPECTIVE
STUDY
A. Takatsu, C. Fuseya, T. Miyamoto, A. Horiuchi, T. Shiozawa, Japan
414
DOES THE SIZE-SUBDIVISION OF STAGE IIA CERVICAL CANCER PREDICT
THE PROGNOSIS? A MULTICENTER RETROSPECTIVE STUDY
S. Okada, T. Kasamatsu, T. Yasugi, K. Mizutani, K. Kawana, S. Nakagawa,
H. Michikami, H. Ochi, M. Onuki, T. Minaguchi, K. Matsumoto, T. Satoh, A. Oki,
H. Yoshikawa, Japan
415
HPV TYPE DISTRIBUTION IN INVASIVE CERVICAL CANCER AND HIGHGRADE CERVICAL LESIONS IN MALAYSIA
R. Soon, B.-K. Lim, J. Chen, C.-M. Yong, S. Subramaniam, M.J. Makanjang,
N.A.M. Adenan, S.Z. Omar, P. Shrestha, Y.-L. Teoh, Malaysia
416
RADICAL ABDOMINAL TRACHELECTOMY IN A FOUR AND HALF YEAR OLD
GIRL FOR CLEAR CELLADENOCARCINOMA OF CERVIX - ACCEPTABLE
SURGICAL APPROACH
Y. Kulkarni, A. Vaidya, India
417
HIGH-RISK GROUP FOR LOCOREGIONAL RECURRENCE IN PATIENTS WITH
STAGE IB-IIB SQUAMOUS CELL CARCINOMA OF THE CERVIX TREATED
WITH CONCURRENT CHEMORADIOTHERAPY
W. Kudaka, M. Hirakawa, Y. Nagai, T. Toita, M. Inamine, K. Ogawa, Y. Aoki, Japan
418
THE STUDY ON EFFICACY OF CHEMOTHERAPY IN PATIENTS WITH
ADVANCED CERVICAL CANCER AFTER TREATMENT FAILURE - PILOT
STUDY
S. Jedrus, K. Raczek-Zwierzycka, H. Grzbiela, Poland
419
CISPLATIN AND ETOPOSIDE AS NEOADJUVANT CHEMOTHERAPY IN
PATIENTS WITH STAGES IIB-IIIB CERVICAL CANCER: A PHASE II STUDY
C. Lee, Republic of Korea
95
Poster Session I
Poster No
420
APPLICATION OF THE RNA-BASED HPV TEST FOR DETERMINATION OF
Е6/Е7 ONCOGENE EXPRESSION IN THE DIAGNOSTICS OF CERVICAL
EPITHELIAL CHANGES
V. Zlatkov, P. Kostova, A. Doganov, M. Boyanova, D. Velcheva, V. Tsoncheva,
K. Mainhard, Bulgaria
421
CLEAR CELL ADENOCARCINOMA OF THE CERVIX ASSOCIATED WITH
RUDIMENTARY UTERUS IN AN 11 YEARS OLD GIRL WITHOUT PRE-NATAL
DES EXPOSURE
A.A. Andi, B.K. Lim, R. Zaharuddin, W.L. Haw, A. Rohani, Malaysia
422
EVALUATION OF TYPE II RADICAL HYSTERECTOMY IN THE TREATMENT OF
960 PATIENTS WITH STAGE IB-IIB CERVICAL CARCINOMA
M. Zheng, L. Huang, L. He, H. Ding, H.-Y. Wang, L.-M. Zheng, China
423
PROGNOSTIC FACTORS IN NODE-POSITIVE STAGE IB-IIB CERVICAL
CANCER PATIENTS TREATED BY TYPE II SURGERY
M. Zheng, L. Huang, L. He, H. Ding, Y.-F. Ren, H.-Y. Wang, China
424
SMALL CELL CARCINOMA OF THE CERVIX (SCCC)
F. Raja, R. Harrand, M. McCormack, J. Ledermann, N. Reed, UK
425
REDUCTION OF CIN, EGL, ABNORMAL PAP TESTS AND CERVICAL
PROCEDURES WITH GARDASIL® VACCINATION
W. Huh, for the FUTURE II Study Group, USA
426
RECENTLY URODYNAMICS CHANGES IN THE PATIENTS WITH CERVICAL
CANCER BETWEEN THE PRE-AND POST RADICAL HYSTERECTOMY
P. Sun, Y. Su, X. Chen, C. Lin, Y. Song, China
427
THE PLACE OF RADICAL SURGERY IN ADVANCED STAGES CERVICAL
CANCER
M.E. Capilna, B. Szabo, A. Toma, S.C. Rusu, S. Birciu, C.I. Puiac, Romania
428
UTILIZATION OF IMMUNOHISTOCHEMICAL STUDIES IN DIFFERENTIATING
SUPERFICIALLY INVASIVE OR MICROINVASIVE SQUAMOUS CELL
CARCINOMA OF UTERINE CERVIX FROM CARCINOMA IN-SITU (CIS)
G. Rasty, D. Smith, F. Siadat, M. Rouzbahman, Canada
429
EFFICACY OF GARDASIL® AGAINST PERSISTENT INFECTION OR DISEASE IN
WOMEN WITH PRIOR VACCINE HPV TYPE INFECTION
430
RADICAL HYSTERECTOMY FOR IRRADIATED CERVICAL CANCER - HOW
RADICAL THE PROCEDURE SHOULD BE IN THESE PATIENTS?
S. Nastasia, Romania
431
CASE REPORT. FANCONI'S ANAEMIA AND CERVICAL CANCER
Y. Ashton, T. Freeman-Wang, N. Pisal, S. Ramachandra, UK
96
Poster Session I
Poster No
432
LONG-TERM OVERALL SURVIVAL OF PATIENTS WITH CERVICAL
CARCINOMA IB2 - IIB TREATED BY SURGERY ALONE OR WITH ADJUVANT
RADIO-/CHEMOTHERAPY
J. Dowaji, Germany
433
OVARIAN TRANSPOSITION FOR THE PRESERVATION OF OVARIAN
FUNCTION IN YOUNG PATIENTS WITH CERVICAL CARCINOMA
S. Carvalho, A. Melo, A. Petiz, C. Lopes, P. Ribas, D. Silva, B. Alves, Portugal
434
COMPARISON WEEKLY CISPLATIN THERAPY WITH TRIWEEKLY
COMBINATION CHEMOTHERAPY AS ADJUVANT CONCURRENT
CHEMORADIATION AFTER RADICAL HYSTERECTOMY IN CERVICAL CANCER
H.N. Lee, K.H. Lee, D.W. Lee, Y.S. Lee, E.K. Park, J.S. Park, Republic of Korea
435
RISK FACTORS FOR DELAYED DIAGNOSIS OF CERVICAL CANCER
ACCORDING TO A MULTIVARIATE HIERARCHICAL MODEL
A.V. Lourenço, C.M.S. Fregnani, P.C.S. Silva, G.B. Neto, J.H. Fregnani, Brazil
436
DELAYED DIAGNOSIS OF CERVICAL CANCER: IS IT POSSIBLE TO DEFINE
RISK GROUPS?
437
REASONS FOR NOT PERFORMING PAP SMEAR: A COMPARISON STUDY
BETWEEN WOMEN WITH CERVICAL INTRAEPITHELIAL NEOPLASIA AND
CERVICAL CANCER
438
IDENTIFICATION OF HEAT SHOCK PROTEIN 27 EXPRESSION IN SQUAMOUS
NEOPLASIA OF THE UTERINE CERVIX
A. Tozawa, N. Suzuki, A. Yoshida, H. Koizumi, Y. Kobayashi, K. Kiguchi,
B. Ishizuka, Japan
439
KNOWLEDGE ABOUT PAP SMEAR AND HUMAN PAPILLOMAVIRUS AMONG
WOMEN WITH CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICAL
CANCER
A. Lourenço, C.M.S. Fregnani, P.C.S. Silva, G.B. Neto, J.H. Fregnani, Brazil
440
ATYPICAL GLANDULAR CELLS DIAGNOSED DURING PREGNANCY AND
POSTPARTUM PERIOD - A RETROSPECTIVE REVIEW
K.F. Tam, A.N.Y. Cheung, E. Szeto, H.Y.S. Ngan, Hong Kong S.A.R.
441
ANEMIA IN PATIENTS WITH EARLY CERVICAL CANCER: ASSOCIATION WITH
PELVIC LYMPH NODE METASTASIS AND POOR OVERALL SURVIVAL
Z. Yuqi, W. XiaoHua, L. Jin, China
442
THE VALUE OF CONIZATION FOR POSTMENOPAUSAL WOMEN WITH HIGH
GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA
X. Cheng, Y. Feng, X. Wang, W. Lv, X. Xie, China
97
Poster Session I
Poster No
443
UNCLEAR RESECTION MARGIN IN CONIZATION AS RECURRENCE MARKER
IN CERVICAL CARCINOMA IN SITU IN SOUTH KOREA
N.H. Kim, H.-S. Moon, Republic of Korea
444
DETECTION OF TERC AMPLIFICATION IN CERVICAL EPITHELIAL CELLS FOR
THE DIAGNOSIS OF HIGH-GRADE CERVICAL LESIONS AND INVASIVE
CANCER
J. Jiang, L.-H. Wei, Y.-L. Li, R.-F. Wu, X. Xie, Y.-J. Feng, G. Zhang, C. Zhao,
Y. Zhao, Z. Chen, China
445
COMPARISON OF THE EXPRESSION OF THE P16 AND KI-67 BETWEEN
CERVICAL SQUAMOUS CELL CARCINOMA AND ADENOCARCINOMA
S.-H. Lee, C.-Y. Park, Republic of Korea
446
OUTCOME OF EXTENDED FIELD RADIOTHERAPY FOR CERVICAL CANCER
PATIENTS WITH PARA-AORTIC LYMPH NODES AT DIAGNOSIS - NCCS
EXPERIENCE
L.M.K. Chua, M.C.R. Yeo, K.T. Hoon Seng, Singapore
447
DIGITAL CERVICOGRAPHY AS AN ADJUNCT TO COLPOSCOPY
R. Dwivedi, P. Eedarapalli, UK
448
THE 10-YEARS FOLLOW-UP RESULTS OF LOOP CONIZATION WITH RIGHTANGLED TRIANGULAR SHAPED EXCISOR IN PATIENTS WITH CIN 3
M.S. Cha, I.J. Choi, Republic of Korea
449
CHEMORADIOSENSITIZATION OF BRACHYTHERAPY IN CARCINOMA OF
UTERINE CERVIX: THE FRINGE EFFECTS IN ADVANCE DISEASE
M. Sharma, A. Sharma, N. Somaiah, India
450
PHASE II STUDY ON TOPOTECAN(T)/CISPLATIN (C) COMBINATION REGIMEN
FOR TREATMENT OF PERSISTENT, RECURRENT OR ADVANCED CERVICAL
CARCINOMA IN CHINESE POPULATION
X. Wu, J. Liu, L. Wu, L. Pan, H. Huang, China
451
THE EFFICACY OF CONCURRENT CISPLATIN AND 5-FLUROURACIL
CHEMOTHERAPY AND RADIATION THERAPY FOR LOCALLY ADVANCED
CANCER OF THE UTERINE CERVIX
M.S. Cha, I.J. Choi, M.S. Han, H.S. Ann, J.C. Byun, Republic of Korea
452
ANALYSIS OF PROGNOSIS IN CERVICAL CANCER PATIENTS WITH
INTERMEDIATE RISK FACTORS
D.-H. Jeong, J.-M. Byun, E.-J. Jeong, I.-H. Jo, Y.-N. Kim, C.-H. Jeong, K.-B. Lee,
M.-S. Sung, K.-T. Kim, Republic of Korea
453
PREVALENCE OF HPV IN WOMEN WITH NORMAL CERVICAL CYTOLOGY AND
CERVICAL NEOPLASIA AND COFACTORS PLAYING ROLE IN CERVICAL
CARCINOGENESIS
H. Yetimalar, B. Kasap, A. Yıldız, K. Çukurova, A. Keklik, Turkey
98
Poster Session I
Poster No
454
DUTCH ALGORITHM FOR FOLLOW-UP AFTER TREATMENT FOR CERVICAL
INTRAEPITHELIAL NEOPLASIA; EFFECTIVE TO PREDICT RECURRENCES UP
TO 7.5 YEARS AFTER TREATMENT
M. Kocken, J.A. Louwers, W.A. ter Harmsel, J. Berkhof, P.J.F. Snijders,
R.H.M. Verheijen, T.J.M. Helmerhorst, C.J.L.M. Meijer, The Netherlands
455
SIGNIFICANCE OF HUMAN PAPILLOMAVIRUS DNA TYPE IN CERVICAL
ADENOCARCINOMA BY HPV DNA CHIP
C.-H. Cho, S.-J. Shin, S.-Y. Lim, S.-H. Kwon, S.-D. Cha, Republic of Korea
456
THE FIRST 18 MONTHS OF INTRACAVITARY HDR BRACHYTHERAPY FOR
GYNAECOLOGICAL MALIGNANCIES AT THE BEATSON WEST OF SCOTLAND
CANCER CENTRE
R. Harrand, R. McCahill, L. Turnbull, S. Kakumanu, N. Reed, UK
457
A CASE REPORT OF EMBRYONAL RHABDOMYOSARCOMA OF THE UTERINE
CERVIX IN A PREGNANT WOMEN
F. Demirkiran, E. Meseci, C. Onculoglu, U. Ince, Turkey
458
HRHPV-TESTING IN A UNIVERSITY OUTPATIENT CLINIC: SHORTCOMINGS
AND RECOMMENDATIONS
J. Louwers, J. Berkhof, A. Zaal, M. Kocken, L. Rozendaal, D. Heideman,
M. van Baal, P. Snijders, R. Verheijen, C. Meijer, The Netherlands
459
PREVALENCE OF ONCOGENIC HPV 16, 18 IN WOMEN ATTENDING A
COLPOSCOPY CLINIC
D.M. Christe, M.P. Kanchana, R.B. Prabhu T, P. Devan, D Karunakaran, Anjalakshi,
Chandrasekhar, India
460
DISTRIBUTION OF HUMAN PAPILLOMA VIRUS TYPES IN TURKISH WOMEN
Z.S. Tuncer, G. Boyraz, I. Adanir, Turkey
461
CAPACITY OF HEALTH PROFESSIONALS IN CERVICAL CANCER SCREENING
IN GOMA/DRC
M. Kambale Sahani, D.M.M. Mutumwa, P.K. Mukama,
The Democratic Republic of the Congo
462
CONFORMAL TECHNIQUES LEAD TO A HIGH COMPLETION RATE OF
EXTERNAL BEAM RADIATION FOR CERVIX CARCINOMA IN A DEVELOPING
WORLD SETTTING
463
PROGNOSTIC FACTORS FOR IMPROVED SURVIVAL IN FIGO STAGE IVB
CERVICAL CANCER
J.Y. Kim, M.-K. Kim, H.S. Kim, Y.B. Kim, H.H. Chung, H.J. Kim, T.S. Lee, J.W. Kim,
N.H. Park, Y.S. Song, S.-B. Kang, H.P. Lee, Republic of Korea
99
Poster Session I
Poster No
464
QUICK COURSES OF NEOADJUVANT CHEMOTHERAPY IN FIGO STAGE IB2
AND IIA2 CERVICAL CANCER PATIENTS WITH CISPLATIN AND IRINOTECAN
M. Kairbayev, E. Kukubassov, Z. Chingisova, R. Shalbayeva, K. Smagulova,
Kazakhstan
465
HIGH DOSE - DENSITY NEOADJUVANT CHEMOTHERAPY FOLLOWED BY
SIMPLE TRACHELECTOMY. ONCOLOGICAL AND PREGNANCY RESULTS
H. Robova, M. Pluta, M. Halaska, O. Sebestova, P. Skapa, L. Rob, Czech Republic
466
QUALITY OF LIFE OF CERVICAL CANCER SURVIVORS: A POPULATIONBASED CROSS-SECTIONAL STUDY IN THE SOUTH OF THE NETHERLANDS
E. Dovern, M. Hoehn, L.C.H.W. Lutgens, R.F.P.M. Kruitwagen, B.F.M. Slangen,
T. Van Gorp, A.C. Voogd, M. Engelen, K. Flobbe, K. Van de Vijver, R.I. Lalisang,
The Netherlands
467
TELECERVICOGRAPHY FOR CERVICAL CANCER SCREENING
S.N. Kim, J.M. Bae, H.P. Lee, K.H. Nam, S.K. Lee, Republic of Korea
468
MINIMAL DEVIATION ADENOCARCINOMA OF THE UTERINE CERVIX
EVOLVED FROM LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA
AFTER FIVE YARES FROM INITIAL DIAGNOSIS
D. Ogishima, Japan
469
A PHASE I STUDY OF CONCURRENT CISPLATIN CHEMOTHERAPY IN
PATIENTS WITH CARCINOMA OF THE CERVIX RECEIVING PELVIC
RADIOTHERAPY
C. Nyongesa, P. Ruff, B. Donde, J. Kotzen, South Africa
470
CERVICAL CANCER CURE FRACTIONS IN RELATION TO SCREENING.
FURTHER EVIDENCE FROM THE SWEDISH NATIONWIDE AUDIT
B. Andrae, T. Andersson, P. Lambert, L. Kemetli, L. Silfverdal, B. Strander, W. Ryd,
J. Dillner, S. Törnberg, P. Sparén, Sweden
471
NEO-ADJUVANT CHEMOTHERAPY (NACT) IN LOCALLY ADVANCED
CERVICAL CANCER: WEST OF SCOTLAND EXPERIENCE
G. Shaikh, R. Harrand, S. Kakumanu, N. Reed, UK
472
CHROMOSOME 3Q 26 REGION GAIN CAN SAFELY IDENTIFY WOMEN LESS
LIKELY TO PROGRESS FROM LGSIL TO HGSIL
A. Rodolakis, J. Biliatis, I. Symiakaki, D. Haidopoulos, N. Thomakos,
M. Papaefthimiou, P. Tsipouras, P. Taffas, A. Antsaklis, Greece
473
90-YEARS EXPERIENCE OF CARCINOMA OF THE UTERINE CERVIX AT
RADIUMHEMMET. DISTRIBUTION BY AGE, STAGE AND HISTOPATHOLOGY
K. Hellman, A.-C. Hellstrom, B.F. Pettersson, Sweden
474
NEO-ADJUVANT CHEMOTHERAPY FOLLOWED BY CONISATION IN PATIENTS
WITH STAGE IB1 CERVICAL CANCER AND CHILD WISH
J. Berger, P. Berteloot, K. Leunen, P. Neven, F. Amant, I. Vergote, Belgium
100
Poster Session I
Poster No
475
EPIDEMIOLOGICAL FACTORS ASSOCIATED WITH CERVICAL CANCER: A 15YEAR REVIEW OF CASES
E. Moss, S. Askew, P. Pearmain, K. Singh, UK
476
PHOTODYNAMIC THERAPY FOR PRECANCER AND EARLY STAGE CANCER
OF THE UTERINE CERVIX WITH FERTILITY PRESERVATION
M. Sakamoto, S. Okamoto, K. Miyake, Y. Koyamatsu, T. Akiya, M. Nakano,
T. Muroya, Y. Tenjin, K. Ochiai, T. Tanaka, Japan
477
A PROSPECTIVE EVALUATION OF SEE AND TREAT IN WOMEN WITH
ABNORMAL VAGINAL CYTOLOGY: IS THIS AN APPROPRIATE MANAGEMENT
PROTOCOL
F. Demirkiran, C. Onculoglu, E. Meseci, H. Erenel, Turkey
478
SQUAMOUS CELL CARCINOMA IN SITU WITH INTRAEPITHELIAL SPREAD TO
THE UPPER GENITAL TRACT AND INVASION OF OVARIES - CASE REPORT
J. Bouda, O. Hes, T. Vanecek, F. Havlicek, V. Kalis, Z. Rokyta, L. Boudova,
Czech Republic
479
DELAYED TYPE HYPERSENSITIVITY SKIN TEST TO HUMAN
PAPILLOMAVIRUS 16 SPECIFIC ANTIGENS IN HEALTHY SUBJECTS AND
CERVICAL CANCER PATIENTS IN INDONESIA
J.N.I. Vet, M.J. Molegraaf, E. Dijkgraaf, A. Vloon, A.R. Wafelman, J. Oostendorp,
M.J.P. Welters, G. Purwoto, S. Cornain, G.J. Fleuren, A.A.W. Peters,
S.H. van der Burg, G.G. Kenter, The Netherlands
480
ANALYSIS OF ROUTINE FOLLOW-UP AFTER PRIMARY TREATMENT FOR
CERVICAL CANCER IN STAGES IA, IB AND IIA
E. Lajtman, M. Mlynţek, P. Uharţek, M. Matejka, Slovak Republic
481
SHOULD WOMEN WITH POSTCOITAL BLEEDING BE REFERRED FOR
COLPOSCOPY?
S. Agarwal, B. Yasmaras, R. Haughney, D. Wilkin, UK
482
RECREATION BLOOD SUPPLY OF UTERI AFTER RADICAL TRACHELECTOMY
N. Wanke, Russia
483
DISCRIMINATION OF CERVICAL NEOPLASIAS USING AUTOMATED IMAGE
ANALYSIS
W. Li, U. Gustafsson, R. Wolters, J. Oyama, D. Ferris, R. Lieberman, C. Santos,
O. Galdos, USA, Peru
484
EXPRESSION OF LYMPHANGIOGENESIS PATHWAY GENES IN CERVICAL
NEOPLASIA
B. Michalski, A. Kachel-Flis, U. Mazurek, M. Michalski, J. Orchel,
B. Rembielak-Stawecka, M. Wętka, V. Skrzypulec-Plinta, J. Wilczok, E. Kapuśniak,
W. Mleczko, Poland
101
Poster Session I
Poster No
485
KNOWLEDGE OF AND ATTITUDES TO CERVICAL CANCER SCREENING
AMONG CAMEROONIAN HEALTHCARE PROFESSIONALS
C. McCarey, D. Pirek, P.-M. Tebeu, M. Boulvain, A.S. Doh, P. Petignat, Switzerland
486
FOLLOW - UP CYTOLOGY IN WOMEN THAT UNDERWENT LOOP EXCISION OF
THE CERVIX: MANAGEMENT OF DYSKARYOTIC SMEARS AFTER
TREATMENT
N. Burbos, M. Abu-Freij, M. ElSawy, T. Duncan, S. Crocker, J. Nieto, UK
487
EXPRESSION OF METASTATIC PATHWAY GENES IN CERVICAL NEOPLASIA
B. Michalski, A. Kachel-Flis, U. Mazurek, M. Michalski, J. Orchel, B. RembielakStawecka, M. Wętka, V. Skrzypulec-Plinta, J. Wilczok, E. Kapuśniak, W. Mleczko,
Poland
488
NEOADJUVANT CHEMOTHERAPY FOR INVASIVE CERVICAL CANCER
DURING PREGNANCY: REPORT OF NINE CASES
R. Fruscio, A. Villa, A. Maneo, I. Cameroni, F.P. Sina, L. Ceppi, M. Sicuri, S. Corso,
M.C. Bonazzi, A. Locatelli, R. Milani, Italy
489
SYSTEMATIC LITERATURE REVIEW, A RANDOMISED TRIAL AND A
PREFERENCE TRIAL CHALLENGING THE PRACTICE OF VAGINAL DILATION
DURING RADIOTHERAPY
T. Miles, N. Johnson, UK
490
EXPRESSION OF ANGIOGENESIS AND LYMPHANGIOGENESIS PATHWAY
GENES IN CERVICAL NEOPLASIA
B. Michalski, A. Kachel-Flis, U. Mazurek, M. Michalski, J. Orchel,
B. Rembielak-Stawecka, M. Wętka, V. Skrzypulec-Plinta, J. Wilczok, E. Kapuśniak,
W. Mleczko, Poland
491
EXPRESSION OF HPV L1 CAPSID PROTEIN AND HPV GENOTYPES IN LIQUIDBASED CYTOLOGY SAMPLES
H.-S. Choi, W. Kang, S. Kim, J. Nam, C. Park, Republic of Korea
492
NEOADJUVANT CHEMOTHERAPY (NCH) FOLLOWED BY ABDOMINAL
RADICAL TRACHELECTOMY (ART) SPARING THE UTERINE ARTERIES (SUA)
FOR INVASIVE CERVICAL CARCINOMA (CC)
A. Soderini, N. Cuneo, A. Aragona, E. Bonavia, C. Reyes, D. Martinez, Argentina
493
LASER ABLATION VERSUS DIATHERMY LOOP EXCISION (LLETZ) FOR THE
TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA: SHORT AND
LONG TERM OUTCOMES
F. Khan, K. Chin, UK
494
TREATMENT OF METASTATIC CERVICAL CANCER WITH PACLITAXEL AND
CISPLATIN - A SINGLE CENTRE EXPERIENCE
J. Oliveira, A. Rodrigues, M.R. Couto, S. Sousa, N. Afonso, D. Pereira, Portugal
102
Poster Session I
Poster No
495
CONCURRENT CHEMORADIATION WITH GEMCITABINE AS SINGLE AGENT
FOR LOCALLY ADVANCED CERVICAL CANCER IN PATIENTS 60 YEARS OR
OLDER
L. Cetina, A. Serrano, D. Cantù, D. Pèrez, J. Chanona, J. De la Garza, L. Rodriguez,
J. Coronel, C. Carlos Zuloaga, L. Rivera, A. Dueñas, Mexico
496
SIGNIFICANCE OF NUMBERS OF METASTATIC AND RESECTED LYMPH
NODES IN IB1 TO IIA CERVICAL CANCER: PRIMARY SURGERY VS.
NEOADJUVANT CHEMOTHERAPY
H.S. Lim, J.H. Kim, H.S. Kim, H.H. Chung, H.-J. Kim, T.S. Lee, J.W. Kim,,
N.H. Park,, Y.S. Song1,, S.-B. Kang, H.P. Lee, Republic of Korea
497
THE IMPACT OF CERVICAL CANCER TREATMENT ON SEXUAL FUNCTION
AND INTIMATE RELATIONSHIPS: A CRYING SHAME
J. Hunter, USA
498
LOCALLY ADVANCED RECURRENT CERVICAL CANCERS - THE WAY OUT
G.N. Neerukonda, H. Vuduyaraju, N.B. Parvataneni, R. Maturi, U.R. Poli,
S.R. Tammineedi, India
499
HPV GENOTYPES PREDICT SURVIVAL BENEFIT FROM CONCURRENT
CHEMOTHERAPY AND RADIOTHERAPY IN ADVANCED SQUAMOUS CELL
CARCINOMA OF CERVIX
C.-C. Wang, C.-H. Lai, J.-H. Hong, Taiwan R.O.C.
500
CORRELATION BETWEEN IMMUNOCYTOCHEMISTRY OF HPV L1 CAPSID
PROTEIN AND BEHAVIOR OF LOW GRADE CERVICAL CYTOLOGY IN
KOREAN WOMEN
S. Lee, J. Kim, J. Park, Republic of Korea
501
AGE-SPECIFIC HPV PREVALENCE AND GENOTYPE DISTRIBUTION IN
WOMEN WITH NORMAL CERVICAL CYTOLOGY: AN ANALYSIS OF TWO
PERIOD COHORTS
C. Lai, A. Chao, C. Chang, J. Qiu, C. Lin, M. Chen, T. Wu, H. Huang, M. Jao,
K. Huang, H. Chou, T. Chang, Taiwan R.O.C.
502
COMBINATION OF IRINOTECAN AND NEDAPLATIN FOR RECURRENT
CERVICAL CANCER
N. Yahagi, Y. Kobayashi, T. Ohara, H. Kondo, A. Tozawa, N. Suzuki, K. Kiguchi,
B. Ishizuka, Japan
503
HUMAN PAPILLOMAVIRUS GENOTYPE IN CERVICAL INTRAEPITHELIAL
NEOPLASIA GRADE 2 AND 3 OF TAIWANESE WOMEN
A. Chao, C.-C. Huang, H.-J. Huang, C.-T. Lin, C.-H. Lai, Taiwan R.O.C.
504
CONCURRENT PARAMETRIAL BOOST DURING PELVIC RADIATION FOR
LOCALLY ADVANCED CARCINOMA CERVIX: LATE EFFECTS AND SURVIVAL
M. Ali, U.N. Majeed, I. Ahmed, W. Ali, A. Masood, A. Ilyas, Pakistan
103
Poster Session I
Poster No
505
POSTOPERATIVE BLADDER FUNCTION OF NERVE-SPARING RADICAL
HYSTERECTOMY NAVIGATED BY INTRAOPERATIVE ELECTRO NERVE
STIMULATION
T. Kato, M. Hosaka, T. Mitamura, T. Odagiri, Y. Konno, N. Kobayashi, S. Sudo,
M. Takeda, H. Watari, M. Kaneuchi, M. Kudo, N. Sakuragi, Japan
506
INCREASED AWARENESS OF THE HUMAN PAPILLOMAVIRUS DOES NOT
INCREASE VACCINE ACCEPTANCE IN YOUNG ADULTS
C.E. Schmeink, K.C.M. Gosens, W.J.G. Melchers, L.F.A.G. Massuger,
R.L.M. Bekkers, The Netherlands
507
A CASE - SUCCESSFUL TREATMENT OF ADENOCARCINOMA (IB2) IN THE
UTERINE CERVIX WITH CONCURRENT CHEMO-PHOTODYNAMIC THERAPY
(CCPDT)
S.J. Han, T.G. Ahn, Republic of Korea
508
CERVICAL INTRAEPITHELIAL NEOPLASIA AND NORMAL EPITHELIUM:
CORRELATIONS BETWEEN EXPRESSION OF TUMOR MARKERS, AND
HORMONAL CONTRACEPTIVES, SEX HORMONE LEVELS AND SMOKING
D. Hellberg, Sweden
509
BURDEN OF FEMALE GYNAECOLOGICAL CANCERS IN CENTRAL ITALY
M. Chiavarini, L. Minelli, F. Stracci, F. La Rosa, Italy
510
EVALUATION OF PATHOLOGICAL RESPONSE (PR) AS A NEW PROGNOSTIC
PARAMETER AFTER NEOADJUVANT CHEMORADIATION PLUS RADICAL
SURGERY FOR ADVANCED CERVICAL CANCER
V. Masciullo, V. Vellone, G. Amadio, G. Scambia, G.F. Zannoni, Italy
511
THE IMPACT OF LYMPH NODE DENSITY ON SURVIVAL OF CERVICAL
CANCER PATIENTS
C. Grimm, V. Seebacher, J. Rahhal, C. Tempfer, A. Reinthaller, L. Hefler,
S. Polterauer, Austria
512
THE CURRENT APPROACHES TO THE TREATMENT OF LOCALLY ADVANCED
CERVICAL CANCER
E. Novikova, L. Demidova, O. Chulkova, E. Ronina, I. Korneeva, E. Kadieva, Russia
513
EARLY EVALUATION OF RESPONSE TO CHEMORADIATION FOR ADVANCED
CERVICAL CANCER BY DIFFUSION AND PERFUSION MRI: A PILOT STUDY
J.-F. Monville, C. Balsat, P. Coucke, K. Delbecque, J.-M. Foidart, C. Gennigens,
F. Goffin, J. Hermesse, F. Kridelka, P. Meunier, A. Thille, Belgium
514
SMALL CELL NEUROENDOCRINE CARCINOMA OF THE CERVIX: RESULT
AND TYPES OF RECURRENCE
H.-S. Park, J.-W. Lee, T.-J. Kim, C.H. Choi, Y.-Y. Lee, M.-K. Kim, T.-J. Song,
B.-G. Kim, D.-S. Bae, Republic of Korea
104
Poster Session I
Poster No
515
IMPLEMENTATION OF RADICAL HYSTERECTOMY (RH) IN WESTERN KENYA
(WK) : AN EDUCATIONAL PILOT PROJECT
B. Rosen, J. Dodge, C. Giede, W. Jimenez Fiedler, P. Cibulska, S. Sinesat,
M. Bernardini, J. McAlpine, S. Finlayson, M. Plante, D. Miller, L. Elit, Canada
516
PELVIC EXENTERATION AFTER CENTRAL POST RADIATION RECURRENT
FOR CERVICAL CANCER
S.A. Almeida Reis, Brazil
517
BONE METASTASIS FROM CERVICAL CANCER : 20-YEAR EXPERIENCES
Y.-M. Kim, Y.-T. Kim, S.-M. Park, K.-C. Chun, D.-Y. Kim, J.-H. Kim, J.-H. Nam,
Republic of Korea
518
RADICAL HYSTERECTOMY FOLLOWING INTENSITY-MODULATED ARC
THERAPY (IMAT) ± CISPLATIN IN THE MULTIMODALITY TREATMENT OF
LOCALLY ADVANCED CERVICAL CANCER
A. Makar, G. De Meerleer, H. Denys, L. Delrue, W. De Neve, R. Van den Broecke,
K. Lambein, B. Lambert, K. Vandecasteele, Belgium
519
CASE-CONTROL ANALYSIS OF DIETARY FOLATE AND RISK OF
PRECANCEROUS CERVIX LESION: A PILOT STUDY
M. Dede, T. Ozgurtas, M. Agıllı, I. Alanbay, R. Karaca, Y. Kurt, E. Akturk,
M.C. Yenen, Turkey
520
RECURRENT CERVICAL CARCINOMA AFTER PRIMARY LAPAROSCOPIC
RADICAL SURGERY
K.-G. Huang, H. Su, C.-L. Lee, Taiwan R.O.C.
521
POSTOPERATIVE MORBIDITY AFTER NERVE-SPARING RADICAL
HYSTERECTOMY
P. Radlovic, A. Cetkovic, Serbia
522
CERVICAL INTRAEPITHELIAL NEOPLASIA IN THE “DR. SALVATOR VUIA”
CLINICAL OBSTETRICS AND GYNECOLOGY HOSPITAL ARAD DURING THE
2000-2009 PERIOD
G. Furău, L. Păiuşan, V. Daşcău, C. Furău, Romania
523
NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL
CARCINOMA AT IIB-IIIB STAGES
L. Ashrafyan, I. Antonova, O. Aleshikova, L. Khunova, S. Ivashina, A. Slonov,
Russia
524
CERVICAL CANCER IN THE “DR. SALVATOR VUIA” CLINICAL OBSTETRICS
AND GYNECOLOGY HOSPITAL ARAD DURING THE 2000-2009 PERIOD
G. Furău, L. Păiuşan, C. Furău, V. Daşcău, Romania
525
EVALUATION OF COLD KNIFE CONIZATION IN DIAGNOSIS AND TREATMENT
OF CERVICAL INTRAEPITHELIAL NEOPLASIA III, A 301 CASES REVIEW
L.-H. Wei, China
105
Poster Session I
Poster No
526
PRIMARY SCREENING FOR CERVICAL CANCER IN CAMEROON:
PRELIMINARY RESULTS COMPARING SELF- VS CLINICIAN-COLLECTED
SPECIMENS FOR HPV DETECTION
I. Navarria, P.-M. Tebeu, P. Vassilakos, A. Gauthier, P.-A. Menoud, Z. Sando,
I. Sandjong, P. Petignat, Switzerland
527
VARIATIONS IN RECURRENCE PATTERN OF STAGE IB CERVICAL CANCER
ACCORDING TO LYMPH NODE INVOLVEMENT
M.F. Kose, T. Turan, B. Dundar, S. Ozer, N. Boran, S. Koc, G. Tulunay, D. Bulbul,
Turkey
528
UTILIZING VARIAN ECLIPSE CONTOUR FUNCTION TO GENERATE A
COMPOSITE PLAN FROM EXTERNAL BEAM AND BRACHYTHERAPY PLANS
FOR CERVICAL CARCINOMA
C. Yashar, R. de los Reyes, D. Scanderbeg, USA
529
FEASIBILITY OF DYNAMIC ADAPTIVE RADIOTHERAPY FOR CERVICAL
CARCINOMA
C. Yashar, M. Cornell, L. Mell, A. Mundt, D. Scanderbeg, USA
530
THE PARTICIPATION OF METALLOTHIONEIN-POSITIVE STROMAL
FIBROBLASTS IN THE DEVELOPMENT AND PROGRESSION CARCINOMAS OF
SQUAMOUS ORIGIN
J. Skret-Magierlo, P. Basta, M. Dutsch-Wicherek, P. Mach, L. Wicherek, Poland
531
OVARIAN TRANSPOSITION IN CERVICAL CANCER
A. Melo, S. Carvalho, C. Lopes, P. Ribas, B. Alves, A. Petiz, Portugal
532
KNOWLEDGE OF HPV AND CERVICAL CANCER AMONG HIV POSITIVE
WOMEN IN LAGOS-NIGERIA
R.I. Anorlu, M.A. Adegbesan, T. Adaramewa, Nigeria
533
PRIMARY MALIGNANT MELANOMA OF THE UTERINE CERVIX - A CASE
REPORT
M. Martinho Simoes, V. Cunha, I. Riscado, H. Nabais, Portugal
534
IB1 INVASIVE CERVICAL CANCER MANAGEMENT IN PREGNANCY
M. Pluta, H. Robova, M. Halaska, M. Hrehorcak, I. Buresova, P. Skapa, L. Rob,
Czech Republic
535
IMPACT INDICATORS OF CERVICAL CANCER
L.E. Medina Fernández, B. Rodriguez Zea, Peru
536
IN VITRO ANTITUMOR EFFECTS OF HIV-PROTEASE INHIBITORS IN CERVICAL
CANCER CELLS
E. Bandiera, C. Romani, R. Tassi, L. Zanotti, E. Bignotti, G. Tognon, F. Odicino,
A.D. Santin, S. Pecorelli, A. Ravaggi, Italy
106
Poster Session I
Poster No
537
ESTROGEN METABOLITES IN PATIENTS WITH VIRUS-ASSOCIATED
CERVICAL CANCER
O. Churuksaeva, O.N. Asadchikova, I.G.Vidyaeva, L.A. Kolomiets, S.L. Stukanov,
Russia
538
PROGNOSTIC VALUE OF PRETREATMENT SCCAG AND CYTOKINE SERUM
CONCENTRATION IN CERVICAL SQUAMOUS CELL CANCER PATIENTS
B. Kotowicz, M. Fuksiewicz, M. Kowalska, J. Jonska-Gmyrek, M. Bidzinski,
J. Kaminska, Poland
539
HUMAN PAPILLOMAVIRUS PREVALENCE AND TYPE DISTRIBUTION IN
CERVICAL ADENOCARCINOMA: RESULTS FROM A MULTINATIONAL
EPIDEMIOLOGICAL STUDY IN EUROPE
W. Tjalma, on behalf of the SCALE Study Group, Belgium
540
THE GENE AMPLIFICATION OF HUMAN TELOMERASE (HTERC) IN
CARCINOMA OF THE UTERINE CERVIX
L. Moukova, V. Vranova, I. Slamova, D. Zezulkova, N. Strossova, P. Kuglik,
Czech Republic
541
DETECTION OF ONCOGENIC TYPES OF HUMAN PAPILLOMAVIRUS (HPV) IN
CASES OF LOW GRADE INTRAEPITHELIAL LESION (LSIL) WITH THE
MICROARRAYS METHOD
M.E. Nikolaidou, S. Papaspyridakos, E. Klapsinou, E. Argyri, T. Vasilikou,
I. Tsiaousi, E. Terzakis, P. Liodantonaki, D. Daskalopoulou, E. Panotopoulou,
Greece
542
E6 AND E7 MRNA EXPRESSION AND HPV DNA TESTING IN CERVICAL
SMEARS. COMPARISON AND CORRELATION WITH THE CERVICAL
CYTOLOGY
E. Argyri, N. Anastasopoulos, M.-E. Nikolaidou, I. Tsiaousi, G. Magiakos, S. Aggeli,
E. Panotopoulou, Greece
543
HPV INFECTION IN MENOPAUSE: AN EPIDEMIOLOGICAL STUDY
I. Tsiaousi, T. Vasilikou, M.E. Nikolaidou, S. Papaspiridakos, N. Anastasopoulos,
P. Liodantonaki, A. Tserkezoglou, E. Panotopoulou, Greece
544
NERVE-SPARING RADICAL HYSTERECTOMY FOR UTERINECERVICAL
CANCER
Y. Miyahara, S. Yoshida, R. Hazama, M. Amano, N. Ohara, H. Yamada, Japan
545
PROGNOSTIC VALUE OF PODOPLANIN EXPRESSION IN THE
INTRATUMORAL STROMA OF UTERINE CERVICAL CARCINOMAS
F. Carvalho, F. Zaganelli, B. Almeida, C. Bacchi, J.C. Goes, M. Calil, E. Baracat,
J. Carvalho, Brazil
546
KNOWLEDGE OF HUMAN PAPILLOMA VIRUS INFECTION AND ACCEPTANCE
OF HUMAN PAPILLOMA VIRUS VACCINE AMONG WOMEN SEEN IN A
COLPOSCOPIC CLINIC
C. Charakorn, Thailand
107
Poster Session I
Poster No
547
HYBRID IMAGING BY SPECT/CT FOR SENTINEL LYMPH NODE DETECTION IN
PATIENTS WITH CANCER OF THE UTERINE CERVIX
A. Martinez, S. Zerdoud, G. Ferron, E. Mery, D. Querleu, France
548
MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 3 AND
MICRO-INVASIVE CARCINOMA OF CERVIX: ANALYSIS OF 83 CASES
X.J. Tan, M. Wu, S.Q. Ma, K. Shen, J.H. Lang, China
549
KNOWLEGE OF TAIWANESE WOMEN SEEKING HPV VACCINATION
Y.-M. Cheng, Gynecology Oncology Group in National Cheng Kung University
Hospital, Taiwan R.O.C.
550
A PHASE I/II STUDY OF CISPLATIN AND RADIATION IN COMBINATION WITH
SORAFENIB IN CERVICAL CANCER
C. Townsley, M. Milosevic, H. Mackay, L. Wang, L. Tinker, J. Quintos, S. Bindra,
K. Macalpine, T. Fyles, A. Oza, Canada
551
THE EFFECT OF HPV 16/18 E6 ON TERT PROMOTER METHYLATION IN
CERVICAL CANCER CELLS
J. Jiang, C. Zhao, G. Zhang, Y. Zhao, J.-R. Li, X.-P. Li, L.-H. Wei, China
552
QUALITY OF LIFE AND COST OF TREATMENT IN CERVICAL CANCER AND
HPV RELATED DISEASE IN THAILAND
W. Termrungruanglert, P. Havanond, N. Khemapech, C. Khorprasert,
S. Taneepanichskul, Thailand
553
A CASE OF CERVICAL CANCER METASTATIC TO THE SMALL INTESTINE 4
MONTHS AFTER INITIAL SURGERY
H. Ryoichi, Y. Miyahara, N. Makihara, S. Yoshida, N. Takemura, N. Ohara,
H. Yamada, Japan
554
MULTI-INSTITUTIONAL PHASE II CLINICAL STUDY OF CONCURRENT
CHEMORADIOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER IN
EAST AND SOUTHEAST ASIA
R. de los Reyes, Y. Chansilpa, S. Kato, T. Ohno, H. Tsujii, M.J. Calaguas,
Philippines
555
CERVICAL ADENOID BASAL CARCINOMA ASSOCIATED WITH INVASIVE
SQUAMOUS CELL CARCINOMA: A REPORT OF RARE CO-EXISTENCE AND
REVIEW OF LITERATURE
B. Viriyapak, A.W. Lee, J.S. Park, S.Y. Hur, Thailand, Republic of Korea
556
EFFECT OF PERI-OPERATIVE BLOOD TRANSFUSION ON THE PROGNOSIS
OF EARLY-STAGE CERVICAL CANCER
G. Bogani, G. Formenti, S. Carollo, T. Rossi, A. Cromi, F. Ghezzi, Italy
557
EMBRYONAL RHABDOMYOSARCOMA OF THE UTERINE CERVIX: A CASE
REPORT AND REVIEW OF THE LITERATURE
E. Ileana, E. Barel, J.L. Deville, A. Nicoara, F. Duffaud, France
108
Poster Session I
Poster No
558
NEOADJUVANT CHEMOTHERAPY FOR BULKY CERVICAL CANCER:
ÇUKUROVA EXPERIENCE
M.A. Vardar, A.B. Güzel, A. Altıntaş, D. Gümürdülü, S. Büyükkurt, Ü. Güleç, Turkey
559
COMPUTER-ASSISTED ASSESSMENT OF LYMPHANGIOGENESIS IN THE
TRANSFORMATION ZONE OF NORMAL CERVIX THROUGH TO EARLY
CERVICAL CANCER
C. Balsat, N. Signolle, F. Goffin, C. Munaut, A. Béliard, S. Blacher, P. Delvenne,
K. Delbecque, A. Noël, J.-M. Foidart, F. Kridelka, Belgium
560
MICROINVASIVE ADENOCARCINOMA OF THE UTERINE CERVIX SHOULD BE
TREATED CONSERVATIVELY
A. Baalbergen, T.J.M. Helmerhorst, The Netherlands
561
CLINICAL-MORPHOLOGICAL PROGNOSTIC FACTORS OF CERVICAL
CANCER IN PATIENTS ІВ STAGES, TREATED BY SURGERY OR COMBINE
THERAPY
I. Yezhova, Ukraine
562
MANAGEMENT OF LOW GRADE SMEAR WITH PROVEN NORMAL
COLPOSCOPY
M. Pann, L. Melson, UK
563
THE ROLE OF CIRCULATING ANTIOXIDANTS ON HIGH RISK HUMAN
PAPILLOMAVIRUSES INFECTION AND CERVICAL CARCINOGENESIS
J.H. Hwang, M.K. Kim, K.A. So, J.K. Lee, N.W. Lee, K.W. Lee, Republic of Korea
564
THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY
RADIOTHERAPY AND CONCURRENT HYPERTHERMIA IN PATIENTS WITH
ADVANCED-STAGE CERVICAL CANCER
S.T. Heijkoop, M. Franckena, M.G.J. Thomeer, C.W. Burger, H.C. van Doorn,
The Netherlands
565
SEXUAL DYSFUNCTION: A CLINIC FOR INFORMATION, INTERVENTION AND
REHABILITATION
L. Lundin, Sweden
566
PATHWAYS INVOLVED IN CERVICAL CLEAR CELL ADENOCARCINOMA
M. Kocken, A. Baalbergen, P. Snijders, J. Bulten, W. Quint, F. Smedts, C. Meijer,
T. Helmerhorst, The Netherlands
567
DETECTION OF NODAL METASTASES IN CERVICAL CANCER - COMPARISON
OF PET AND SENTINEL NODE BIOPSY
R. Feranec, J. Stanicek, L. Moukova, Czech Republic
568
CHRONIC MYELOGENOUS LEUKEMIA IN A PATIENT WITH ADVANCED
STAGE ADENOSQUAMOUS CARCINOMA OF THE CERVIX: A RARE
COMBINATION OF CONCURRENT MALIGNANCIES
J.A. Toral, Philippines
109
Poster Session I
Poster No
569
DETECTION OF HPV TYPE 16 AND 18 BY REAL TIME PCR IN WOMEN WITH
GENITAL WARTS IN SOUTH OF IRAN
M. Momtahan, M. Jaberipour, Z. Sarraf, M. Robati, F.A. Najib, Iran
570
IS RADICAL TREATMENT INDICATED FOR EARLY INVASIVE CERVICAL
ADENOCARCINOMA?
J. Hauspy, P. Rubabaza, A. Rajagopalan, K. Ceballos, K. Onuma, D. Daya, Belgium
571
THE VALUE OF COLPOSCOPY IN SCREENING CERVICAL INTRAEPITHELIAL
NEOPLASIA
J.M. Bae, S.N. Kim, S.J. Han, Republic of Korea
572
CONSERVATIVE SURGERY OF CARCINOMA OF THE CERVIX
E.M.A. Figueiredo, J.A. Figueiredo, Brazil
573
PRIMARY CERVICAL MALIGNANT MELANOMA: A CASE REPORT
E.M.A. Figueiredo, C.M.S. Dayube, J.A. Figueiredo, Brazil
574
DETECTION OF BIOMARKERS FOR HPV INFECTION AND CERVICAL
DYSPLASIA WITH GMR SENSOR- AND HIGH MAGNETIC MOMENT
NANOPARTICLE DEVICE
J. Carter, C. Xing, J.-P. Wang, R. Ghebre, M. Peterson, L. Downs, USA
575
INSUFFICIENT ACCURACY OF LEEP SPECIMENS FOR PREDICTION OF
LYMPH-VASCULAR SPACE INVASION FOUND AT HYSTERECTOMY IN EARLYSTAGE CERVICAL CANCER
M.-K. Kim, H.S. Kim, J.W. Kim, N.-H. Park, Y.-S. Song, S.-B. Kang,
Republic of Korea
576
PREVALENCE OF CHLAMYDIA TRACHOMATIS IN WOMEN WITH NORMAL
AND ABNORMAL PAP SMEARS IN LAGOS-NIGERIA
M.A. Adegbesan, R.I. Anorlu, S.A. Omilabu, C.C. Makwe, Nigeria
577
CERVICAL CARCINOMA AFTER KIDNEY TRANSPLANTATION
J. Rajovic, S. Vitorovic, M. Erak, P. Novakovic, Serbia
578
CLINICAL IMPACT OF BRACHYTHERAPY DOSE RATE AND PLANIMETRY IN
THE TREATMENT OF ADVANCED CERVICAL CANCER (ACC)
C. Cheruy, J. Hermesse, N. Janssen, C. Gennigens, L. De Landsheere,
K. Delbecque, A. Thille, J.-F. Monville, C. Maillard, J.-M. Foidart, F. Goffin,
F. Kridelka, Belgium
579
OVARIAN CRYOPRESERVATION WITH SLOW-FREEZING FOLLOWED BY REIMPLANTATION RESTORES OESTROGEN PRODUCTION AFTER
GONADOTOXIC RADIOTHERAPY TO THE PELVIS
M.H. Botha, T.F. Kruger, South Africa
110
Poster Session I
Poster No
580
CONCURRENT CHEMORADIOTHERAPY IN THE TREATMENT OF LOCALLY
ADVANCED CARCINOMA OF UTERINE CERVIX AND SUPPORT WEEKLY LOW
DOSE ERYTHROPOIETIN ALFA
J. Stejskal, M. Kubecová, D. Dvořáková, V. Ulrych, I. Kolářová, M. Kheck,
A. Roztoţil, J. Vaňásek, Czech Republic
581
TOPOTECAN IN RECURRENT CERVICAL CANCER: A REPORT OF 10 CASES
G. Cormio, V. Loizzi, A. Cazzolla, P. De Mitri, F. Magazzino, L. Leone, D. Scardigno,
A. Camporeale, C. Nardelli, L. Selvaggi, Italy
582
SQUAMOUS CELL CARCINOMA OF UTERINE CERVIX WITH INVASIVE DEPTH
LESS THAN 3MM AFTER CONIZATION: IS CONSECUTIVE SIMPLE
EXTRAFASCIAL HYSTERECTOMY ENOUGH?
J.-R. Chen, M.-L. Chiu, T.-Y. Wang, Y.-H. Huang, C.-C. Shih, S.-J. Chang,
T.-C. Chen, C.-L. Chang, K.-L. Wang,, Y.-C. Yang, Taiwan R.O.C.
583
CLEAR CELL ADENOCARCINOMA OF THE CERVIX WITHOUT ASSOCIATION
IN UTERO DIETHYLSTILBESTROL EXPOSURE: TWO CASES REPORT
S. Akhavan, F. Ayatollahi, Iran
584
AORTIC METASTASIS OF CERVICAL CARCINOMA - A RARE CASE
C. Amalinei, C. Hurduc, R. Balan, L. Liliac, S. Giusca, I.-D. Caruntu, Romania
585
A FIVE-CYCLE TREATMENT REGIMEN FOR ADVANCED NEUROENDOCRINE
CERVICAL CARCINOMA USING PACLITAXEL, CISPLATIN, ETOPOSIDE AND
CARBOPLATIN WITH RADIATION IS REVIEWED
J.S. Saldivar, A. Gupta, USA
586
VALUE OF HPV DNA TESTING IN PREDICTION OF HIGH-GRADE CERVICAL
LESION IN WOMEN WITH ASCUS: REVIEW OF THE LITERATURE
A. Ćetković, P. Radlovic, M. Djakovic, B. Rulic, Serbia
587
INTER-OBSERVER VARIABILITY OF FIGO STAGING IN CERVICAL CANCER
P. Tummers, E. Birnie, J.W. Mens, C. Burger, H. van Doorn, The Netherlands
588
IMMUNOHISTOCHEMICAL DETECTION OF P16 INK4A IN PRECANCEROUS
LESIONS AND CERVICAL CARCINOMAS
K. Kajo, P. Zubor, V. Janusicova, J. Danko, L. Plank, Slovak Republic
589
CLINICAL IMPLICATIONS OF HUMAN PAPILLOMAVIRUS GENOTYPE IN
CERVICAL ADENO-ADENOSQUAMOUS CARCINOMA
H.-J. Huang, C.-C. Wang, A. Chao, C.-J. Chang, S. Hsueh, Y.-T. Huang,
Y.-R. Chen, C.-T. Lin, J.-T. Qiu, T.-I. Wu, K.-G. Huang, H.-H. Chou, T.-C. Chang,
T.-C. Chen, H.-P. Chang, C.-H. Lai, Taiwan R.O.C.
111
Poster Session I
Poster No
590
PREVALENCE OF RESIDUAL TUMOR IN SQUAMOUS CELL CARCINOMA
(SCC) OF THE UTERINE CERVIX POST RADIATION UNDERGOING ADJUVANT
CERVICECTOMY (PRELIMINARY REPORT)
P. Inthasorn, C. Thirapakawong, C. Leelaphatanadit, S. Therasakvichaya,
M. Benjapibal, A. Jaishuen, B. Viriyapak, P. Pattaranutaporn, Thailand
591
PELVIC EXENTERATION IN THE MANAGEMENT OF LOCALLY ADVANCED
UTERINE CERVIX CANCER. CASE SERIES
O. Matylevich, I. Kosenko, S. Krasny, O. Sukonko, S. Polyakov, A. Rolevich,
A. Volkov, I. Fomina, T. Osipova, T. Kurchina, E. Moroz, Belarus
592
FACTORS INFLUENCING HPV VACCINATION UPTAKE AMONGST YOUNG
WOMEN FOLLOWING A NATIONAL VACCINATION PROGRAM
R. Powell, K. Mccaffery, I. Juraskova, Australia
593
ARE HR-HPV TYPING AND VIRAL LOAD QUANTIFICATION PREDICTIVE FOR
INFECTION PERSISTENCE IN WOMEN UNDER 30 WITH NORMAL SMEAR?
X. Carcopino, N. Bolger, M. Henry, J. Mancini, L. Boubli, D. Olive, S. Cleary,
W. Prendiville, C. Tamalet, France
594
EFFICACY OF THE HPV-16/18 AS04-ADJUVANTED VACCINE IN WOMEN
ACCORDING TO THEIR INITIAL DNA AND SEROSTATUS: PATRICIA END-OFSTUDY RESULTS
W. Huh, J. Paavonen, P. Naud, J. Salmeron, C. Wheeler, S.-N. Chow, D. Apter,
H. Kitchener, X. Castellsagué, J. Teixeira, R. Skinner, J. Hedrick, U. Jaisamrarn,
G. Limson, S. Garland, A. Szarewski, B. Romanowski, F. Aoki, T. Schwarz,
W. Poppe, K. Hardt, T. Zahaf, D. Descamps, F. Struyf, M. Lehtinen, G. Dubin, for the
PATRICIA Study Group, USA
595
CONFORMAL RADIOTHERAPY IN CERVICAL CANCER: THE EFFECT OF HIV
INFECTION ON COMPLETION RATE AND RESPONSE
596
CERVICAL INTRAEPITHELIAL NEOPLASIA IN WOMEN WITH SYSTEMIC
LUPUS ERYTHEMATOSUS
T. Nikolova, G. Dimitrov, V. Jovanovska, I. Aluloski, T. Gurzanova, I. Aleksioska,
S. Nikolovski, B. Taleska, N. Nikolova, FYR Macedonia
597
A RARE CASE OF RENAL CELL CARCINOMA METASTAZING TO THE
UTERINE CERVIX
A. Mouton, South Africa
598
RADICAL ABDOMINAL TRACHELECTOMY FOR CERVICAL MALIGNANCIES:
SURGICAL, ONCOLOGICAL AND FERTILITY OUTCOMES IN 60 PATIENTS
X. Wu, J. Li, Z. Li, H. Wang, R. Zang, Y. Zhou, X. Ju, G. Ke, China
112
Poster Session I
Poster No
599
FACTORS AFFECTING THE FORMATION AND PROGRESSION OF CERVICAL
DYSPLASIAS AND CARCINOMAS
J. Cseh, Z. Orsós, E. Pázsit, Z. Ozsváth, I. Ember, I. Kiss, Hungary
600
HPV SUBTYPES IN PATIENTS WITH CYTOLOGICAL ABNORMALITIES IN GAZI
UNIVERSITY OUTPATIENT CLINIC
M. Onan, S. Yaman-Tunc, Z.E. Korun, C. Taskiran, M.S. Ozisik, I. Fidan, S. Rota,
H. Guner, Turkey
601
USEFULNESS OF FDG-PET SCAN IN CERVICAL SMALL CELL CARCINOMA
M.-Y. Chen, T.-C. Chang, C.-H. Lai, H.-H. Chou, Taiwan R.O.C.
602
RAMAN SPECTROSCOPY - A NOVEL TOOL FOR CERVICAL CANCER
SCREENING
K.M. Ostrowska, A. Malkin, H.J. Byrne, C. Martin, J.J. O'Leary, F.M. Lyng, Ireland
603
THE PREVALANCE OF HPV INFECTION IN GAZI UNIVERSITY OUTPATIENT
CLINIC
M. Onan, S. Yaman-Tunc, M.S. Ozisik, C. Taskiran, Z.E. Korun, I. Fidan, S. Rota,
H. Guner, Turkey
604
TAMPON SAMPLING DETECTS CERVICAL CANCER:
M. Theletsane, H. Pienaar, M. De La Rey, E. Van Rensburg, South Africa
605
VILLOGLANDULAR ADENOCARCINOMA OF THE UTERINE CERVIX
S. García Rodríguez, M. Hernández Suárez, R. Rodríguez, J.L. Trujillo,
J. de la Torre, Spain
606
PARA-AORTIC LYMPH NODE (PAN) INVOLVEMENT IN STAGE IB-IIA
CERVICAL CARCINOMA: THE FREQUENCY AND THE ASSOCIATED RISK
FACTORS
X. Wu, J. Li, Y. Zhou, China
607
DIAGNOSTIC CERVICAL BIOPSY AND SUBSEQUENT HPV ACQUISITION
G. Dimitrov, V. Antovska, V. Jovanovska, T. Gurzanova, I. Aluloski, T. Nikolova,
FYR Macedonia
608
P16INK4A IMMUNOPROFILING OF SQUAMOUS LESIONS OF THE UTERINE
CERVIX WITH LIMITED DIAGNOSTIC REPRODUCIBILITY
P. Skapa, H. Robova, L. Rob, J. Zamecnik, Czech Republic
609
LOCALLY ADVANCED CERVICAL CANCER TREATMENT WITH CONCURRENT
RADIATION AND CISPLATIN IN OUT -OF-PROTOCOL MANAGEMENT:
FEASIBILITY AND SURVIVAL
G. Mancebo, F. Larrazábal, C. Colomé, A. Arbós, A. Gil-Moreno, J. Xercavins,
R. Carreras, Spain
113
Poster Session I
Poster No
610
EQUIVALENT SURVIVAL AND RECURRENCE OUTCOME IN EARLY STAGE
INVASIVE ADENOCARCINOMA COMPARED WITH SQUAMOUS CELL
CARCINOMA OF THE UTERINE CERVIX
M. Yanaranop, S. Tuipae, S. Nakrangsee, Thailand
611
CERVICAL CARCINOMA IN A HOMOSEXUAL WOMAN: CLINICAL EVIDENCE
OF HPV TRANSMISSION AMONG WOMEN
D. Roble, R. Sulay, Philippines
612
LYMPH NODE HPV-DNA POSITIVITY IN UTERINE CERVICAL CANCERS AND
ITS RELATIONSHIP WITH PROGNOSTIC FACTORS
E. Baser, F. Can, M. Unlukaptan, P. Dursun, A. Ayhan, Turkey
613
SURGICAL MANAGEMENT OF BULKY (> 4CM) CERVICAL CARCINOMA
A. Ayhan, P. Dursun, L. Atasoy, B.K. Karakaya, S. Gok, E. Kuscu, Turkey
614
DETECTION OF HPV E6 AND E7 ONCOPROTEINS IN CERVICAL
INTRAEPITHELIAL NEOPLASIA (CIN) 2/3 AND INVASIVE CANCERS
T.-C. Chang, S.-L. Cheng, S.-M. Jung, C.-H. Lai, Taiwan R.O.C.
615
P16 INK4A EXPRESSION IN PREINVASIVE CERVICAL LESIONS AND INVASIVE
SQUMAOUS CELL CARCINOMA, AND ITS CLINICIAL VALUE
G. Coban, O. Ozen, P. Dursun, A. Ayhan, Turkey
616
PREDICTORS OF SURGICAL MARGIN POSITIVITY AFTER LEEP
B.K. Karakaya, P. Dursun, E. Cabuk, B. Bildaci, A. Ayhan, E. Kuscu, Turkey
617
HPV PREVALANCE IN TURKEY : A MULTICENTER TURKISH GYNECOLOGIC
ONCOLOGY GROUP STUDY
A. Ayhan, P. Dursun, G. Coban, S. Aykul, H. Arslan, E. Kuscu, A. Onan,
C. Taskiran, H. Guner, K. Yuce, M.C. Salman, B. Sayal, S. Dogan, H. Yetimalar,
B. Kasap, S. Sehirali, E. Gultekin, S. Kose, M. Sanci, Y. Yildirim, L. Keskin,
I. Ustuner, F. Avsar, H. Aydogmus, Y. Ergin, J. Metindir, M. Yenen, M. Dede,
I. Alanbay, R. Karaca, H. Yuksel, S. Kırdar, Turkey
618
WELL DIFFERENTIATED VILLOGLANDULAR ADENOCARCINOMA OF THE
CERVICAL CANCER - SHOULD WE DO CONIZATION WITH HYSTEROSCOPY
TO DIAGNOSE IT?
R. Zaharuddin, B.K. Lim, M.A. Noor Azmi, P.A. Chandran, S.Z. Omar, Malaysia
619
RADIATION SENSITIVITY OF CANCER CERVICIS CELLS (C4-I) AND
EXTRACELLULAR CYCLIC GMP AS A BIOMARKER OF RADIATION EFFECT
G. Sager, M. Livik, T. Hellevik, O. Spanne, B.G. Moe, Norway
620
ADVANCED LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE CERVIX - IS
CURE POSSIBLE?
E.M.A. Figueiredo, T.C. Bonates, B.M. Kolowski, J.A. Figueiredo, Brazil
114
Poster Session I
Poster No
621
ON IMPROVING THE EFFICACY OF UTERINE CERVIX CANCER DIAGNOSTICS
IN PREGNANT WOMEN IN BELARUS
I. Kosenko, T. Litvinova, O. Matylevich, G. Kostevich, Belarus
622
AUDIT OF OUTCOME OF LLETZ (LARGE LOOP EXCISION OF
TRANSFORMATION ZONE) IN A DGH OVER A 7 YEAR PERIOD
M.V. Smitha Raghavan, M. George, UK
623
SENTINEL LYMPH NODE MAPPED BY LYMPHOSCINTIGRAPHY AND BLUE
DYE FOR CERVICAL CANCER - PRELIMINARY ANALYSIS OF THE FIRST SIX
CASES
E.M.A. Figueiredo, J.A. Figueiredo, J.C. Damian Junior, C.M.S. Dayube, R.S. Peter,
J.A. Belloti, T.C. Bonates, Brazil
624
IS IT NECESSARY TO MAKE CT-PLANNING FOR EACH BRACHYTHERAPY
APPLICATION DURING THE TREATMENT OF CERVICAL CANCER?
C. Onal, E. Oymak, G. Arslan, O. Yuksel, A. Sonmez, Turkey
625
CARCINOGENIC SEXUAL PRACTICES OF THE GERIATRIC PERSONS IN
NIGERIA AND PERCEIVED HUMAN PAPPILOMA VIRUS INFECTIONS
K. Odor, N. Igwe, Nigeria
626
CERVICAL CARCINOMA ONTO A COMPLETELY PROLAPSED UTERUS
P. Chatzis, K. Lathouras, A. Daniilidis, I. Stergioudas, E. Karagiannidou,
T. Tantanasis, K. Papathanasiou, Greece
627
POST OPERATIVE COMPLICATIONS IN HIV INFECTED PATIENTS
UNDERGOING RADICAL HYSTERECTOMIES FOR CERVICAL CANCER AND
THE VARIABLES TO PREDICT THEM
U. Herbst, South Africa
628
DOES HIV INFECTION RESTRAIN TREATMENT OPTIONS FOR PATIENTS WITH
ADVANCED CERVICAL CANCER?
G. Lindeque, M. Mangena, G. Dreyer, South Africa
629
CYTOLOGIC AND HISTOPATHOLOGIC DIAGNOSTIC MANAGEMENT IN
EMBRYONAL RHABDOMYOSARCOMA OF THE UTERINE CERVIX
R. Balan, I.D. Caruntu, M. Pavaleanu, L. Liliac, C. Amalinei, Romania
630
INTERLABORATORY VARIABLITY IN THE ASSESSMENT OF CYTOLOGICAL
SAMPLES IN ORGANIZED CERVICAL SCREENING PROGRAMME IN LUBLIN
PROVINCE, POLAND
A. Nowakowski, A. Smoleń, J. Kotarski, Poland
631
SURGICAL TREATMENT,WERTHEIM-MEIGS OF CERVICAL CANCER
N. Lucic, Bosnia-Herzegovina
115
Poster Session I
Poster No
632
RECURRENT CERVICAL CARCINOMA AFTER ROBOT- ASSISTED
LAPAROSCOPIC RADICAL HYSTERECTOMY AND BILATERAL PELVIC LYMPH
NODE DISSECTION
B. Sert, V. Abeler, Norway
633
BORDERLINE SMEARS: IS THE CURRENT FOLLOW UP STRATEGY
ADEQUATE?
M. Datta, A. Mukhopadhyay, M. Alloub, S. Basu, B. Crossley, UK
634
CERVICAL CANCER IN PREGNANCY- IS IT SAFE TO DELAY TREATMENT?
EXPERIENCE FROM ST THOMAS´ HOSPITAL
S. Nimalasena, A. Winship, UK
635
THE RISK OF PELVIC FRACTURE AFTER RADIOTHERAPY IN PATIENTS WITH
CERVICAL CANCER
C. Onal, S. Topuk, E. Efe, A. Kotek, S. Sonmez, Turkey
636
THE IMPORTANCE OF RECTUM DOSES FOR PREDICTING LATE RECTAL
TOXICITIES IN PATIENTS TREATED WITH CERVICAL CANCER
BRACHYTHERAPY
C. Onal, O. Yuksel, E. Efe, E. Oymak, Y. Dolek, S. Topuk, G. Arslan, Turkey
637
PROGNOSTIC ANALYSIS FOR CERVICAL CANCER PATIENTS WITH PELVIC
LYMPH NODE METASTASIS
Z. Yuqi, W. XiaoHua, X. Zhou, China
638
FULL-DOSE CHEMORADIATION IN ADVANCED CERVICAL CANCER PRIMARY
TREATMENT
J. Kreynina, V. Titova, Russia
639
MOLECULAR TESTING OF SELF-COLLECTED TAMPONS: A FEASIBLE WAY
TO TRIAGE YOUNGER WOMEN AND SCREEN OLDER WOMEN IN THE
DEVELOPING WORLD
E. Mnisi, K. Richter, A. Horton, G. Dreyer, South Africa
640
NEOADJUVANT REGIONAL INTRAARTERIAL CHEMOTHERAPY WITH THE
USE OF IRINOTECAN IN PLATINUM-CONTAINED COMPLEXES IN TREATMENT
OF CERVICAL CARCINOMA PATIENTS
G. Ushakova, Russia
641
BLADDER, ANORECTAL AND SEXUAL FUNCTION AFTER NERVE-SPARING
RADICAL HYSTERECTOMY FOR THE TREATMENT OF CERVICAL CANCER; A
LONGITUDINAL PROSPECTIVE COHORT STUDY
Q. Pieterse, M. ter Kuile, K. Maas, B. Trimbos, G. Kenter, The Netherlands
642
CERVICAL CANCER IN A TERTIARY HOSPITAL OF BANGLADESH
A. Nessa, S. Akter, N.E. Ferdous, M.H.U. Rashid, Bangladesh
116
Poster Session I
Symptom management/palliation
Poster No
643
MY BODY MYSELF: BODY IMAGE IN WOMEN WITH CANCER
A. Katz, Canada
644
DISTRIBUTION AND SUFFICIENCY OF PAIN CENTERS ACROSS TURKEY
N. Ozgul, M. Gultekin, E. Olcayto, M. Tuncer, Turkey
645
EVALUATION OF PROPHYLAXIS EFFECTS OF GLYCIRRHIZA GLABRA AND
ACHILLEA MILLEFOLIUM ON RADIOTHERAPY SKIN-INDUCED REACTION IN
BREAST CANCER CASES
F. Homaei Shandiz, M. Malekzadeh, S. Honarei, M. Khajedaluee, S. Saeedneia,
Iran
646
FACTORS ASSOCIATED WITH HOSPICE USE IN OVARIAN CANCER
C. Casey, H. Deshmukh, A. Sherman, L.-M. Chen, J. Chan, USA
647
PAIN MANAGEMENT IN INDIAN WOMEN SUFFERING FROM CANCER CERVIX
U. Singh, S. Goel, A. Mallik, N. Singh, P. Sankhwar, India
648
A SURVEY OF PREVALENCE, INCIDENCE OF ANEMIA IN PATIENTS WITH
GYNECOLOGICAL CANCER
M. Benjapibal, V. Achariyapota, P. Chaopotong, Thailand
649
CLINICAL AND NUTRITIONAL ASPECTS OF ORAL SUPPLEMENTATION WITH
AGARICUS SYLVATICUS FUNGI IN BREAST CANCER PATIENTS
UNDERGOING CHEMOTHERAPY
M.R. Novaes, F. Valadares, L.C. Novaes, Brazil
650
EVALUATION OF THE NEED FOR RED BLOOD CELL TRANSFUSIONS IN
ANEMIC PATIENTS WITH GYNECOLOGIC CANCER RECEIVING
CHEMOTHERAPY - A JGOG STUDY
M. Hiura, Y. Udagawa, T. Sugiyama, M. Hatae, K. Ochiai, JGOG - Japanese
Gynecologic Oncology Group, Japan
651
PSYCHOLOGICAL CHARACTERISTICS OF JAPANESE GYNECOLOGIC
CANCER PATIENTS AFTER LEARNING THE DIAGNOSIS ACCORDING TO THE
HOSPITAL ANXIETY AND DEPRESSION SCALE
N. Suzuki, S. Hosonuma, N. Yoshioka, N. Yahagi, T. Ohara, A. Tozawa, H. Kondo,
Y. Kobayashi, K. Kiguchi, B. Ishizuka, Japan
652
EFFICIENCY AND SATISFACTION OF PAIN MANAGEMENT IN WOMEN WITH
GYNECOLOGIC ONCOLOGY RECEIVING SURGERY IN RAMATHIBODI
HOSPITAL THAILAND
N. Sriintravanit, W. Ittichaikulthol, Thailand
653
FACTORS THAT INFLUENCE TREATMENT DECISIONS IN TERMINALLY-ILL
CANCER PATIENTS - A SURVEY OF PRE-CLINICAL MEDICAL STUDENTS
J. Chan, A. Sherman, T. Miner, J. Chan, USA
117
Poster Session I
Symptom management/palliation (contd.)
Poster No
654
A REVIEW OF ANXIETY AND DEPRESSIVE SYMPTOMS IN GYNAECOLOGICAL
CANCER PATIENTS
C.E.E. Lim, C.Y.I. Chee, V. Keleher, S. Sammugam, A. Ilancheran, J.S. Ng,
K.M. Lee, S.E. Lim, J.J.H. Low, Singapore
655
QUALITY OF LIFE AND DISTRESS IN WOMEN WITH GYNECOLOGIC CANCER
G. Chakalova, B. Chakalov, Bulgaria
656
INCIDENCE AND MANAGEMENT OF SYMPTOMATIC PELVIC LYMPHOCYST
AFTER RADICAL PELVIC OR PELVIC AND PARAAORTIC
LYMPHADENECTOMY FOR CERVICAL AND ENDOMETRIAL CANCER
657
UTILIZATION OF A CANCER CENTER SYMPTOM MANAGEMENT PROGRAM
BY GYNECOLOGIC ONCOLOGY PATIENTS
C. Casey, M. Rabow, A. Sherman, J. Chan, C.B. Powell, L.-M. Chen, USA
658
THE CHALLENGES OF PALLIATIVE CARE AFTER THE 2010 HAITIAN
EARTHQUAKE
A. Goodman, L. Black, USA
659
QUALITY OF VENOUS THROMBOEMBOLISM PROPHYLAXIS IN PATIENTS
UNDERGOING GYNECOLOGIC CANCER SURGERY
J. Wright, M. Shah, W. Burke, X. Sun, S. Lewin, T. Herzog, USA
660
THE VALUE OF TRANSVAGINAL SONOGRAPHY AND
SONOHYSTEROGRAPHY IN THE DETERMINATION OF THE CAUSE OF
ABNORMAL UTTERING BLEEDING
C.-C. Rhim, Republic of Korea
661
COMPRESSION STOCKINGS PLUS LOW MOLECULAR WEIGHT HEPARIN
VERSUS COMPRESSION STOCKINGS ALONE AFTER GYNECOLOGIC
ONCOLOGY SURGERY
H. Zheng, Y. Gao, W. Gao, China
662
STEREOTACTIC RADIOSURGERY IN THE MANAGEMENT OF RECURRENT
GYNECOLOGIC MALIGNANCIES
C.R. Kersh, E. Crandley, W. Irvin, K.M. Richardson, K. Spencer, USA
663
CHYLOUS ASCITE FORMATION FOLLOWING RETROPERITONEAL LYMPH
NODE DISSECTION FOR ENDOMETRIAL CARCINOMA
S. Taskin, E. Pabucçu, F. Ortaç, Turkey
664
FACTORS RELATIONSHIP AND PREDICT PAIN INTENSITY AMONG POST
OPERATIVE PATIENTS
S. Luengsukcharoen, J. Soonthornkul Na Chonburi, C. Chaengchenvate,
W. Ittichaikulthon, Thailand
118
Poster Session I
Symptom management/palliation (contd.)
Poster No
665
MANIFESTATION OF SOMATIC DISTURBENCES IN EARLY POST MENOPAUSE
IN WOMEN AFTER PHYSIOLOGICAL AND SURGICAL MENOPAUSE
A. Daneva Markova, S. Jovcevski, A. Vojnika, I. Aleksievska, N. Aleksievska,
FYR Macedonia
666
ARE WE REMEMBERING TO MONITOR VITAMIN B12 LEVELS AFTER PELVIC
RADIOTHERAPY OR TERMINAL ILEAL RESECTION IN PATIENTS WITH
GYNAECOLOGICAL MALIGNANCIES?
A. Anantharachagan, H.J.N. Andreyev, D.P.J. Barton, UK
667
PALLIATIVE RADIOTHERAPY FOR CERVICAL CANCER: A SYSTEMATIC
REVIEW
L. van Lonkhuijzen, G. Thomas, Canada
668
CHANGES IN SHORT-TERM HEALTH-RELATED QUALITY OF LIFE IN WOMEN
UNDERGOING GYNECOLOGIC ONCOLOGIC LAPAROTOMY: AN ASSOCIATED
FACTOR ANALYSIS
L. Minig, J.I. Vélez, E. Trimble, R. Biffi, A. Maggioni, D. Jeffery, Spain
669
INCIDENCE OF PULMONARY EMBOLISM AFTER LAPAROSCOPIC SURGERY
IN GYNECOLOGIC ONCOLOGY
K. Mitsube, Japan
670
SIGNIFICANT DECREASES IN BONE MINERAL DENSITY ASSOCIATED WITH
PELVIC RADIOTHERAPY: A PROSPECTIVE LONGITUDINAL STUDY OF
WOMEN WITH GYNECOLOGIC MALIGNANCIES
K. Schmeler, A. Jhingran, R. Iyer, M. Munsell, E. Kim, C. Jimenez, C. Sun,
C. Moore, S. Kitaka, P. Eifel, A. Klopp, A. Sood, USA
671
PERMANENT PERITONEAL CATHETER INTRODUCED UNDER ULTRASOUND
GUIDANCE AS A PALLIATIVE TREATMENT OF RESISTANT ASCITES
M. Zikan, I. Pinkavova, D. Fischerova, J. Slama, D. Cibula, Czech Republic
672
CANCER PAIN MANAGEMENT IN ABUTEACHING HOSPITAL ZARIA: THE
HEALTH CARE PROVIDERS PERSPECTIVE
A. Oguntayo, S. Adewuyi, M.S. Zayyan, E.S. Garba, Nigeria
673
RECOVERING AFTER PELVIC RADIATION THERAPY: A PILOT STUDY OF AN
INFORMATION BOOKLET TO HELP WOMEN WITH GYNAECOLOGICAL
CANCER
F. Lubotzky, P. Butow, K. Nattress, J. Carter, C. Milross, S. Carroll, C. Kwong,
S. Philp, I. Juraskova, Australia
674
“METRONOMIC” CYCLOPHOSPHAMIDE CHEMOTHERAPY FOR THE
PALLIATIVE TREATMENT OF PATIENTS WITH GYNAECOLOGICAL CANCER
G. Corrado, V. Salutari, A. Di Stefano, F. De Padova, M. Malaggese, G. Fuoco,
L. Alessandro, G. Ferrandina, Italy
119
Poster Session I
Other
Poster No
675
PREDICTING GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN): IS URINE
HCG (UHCG) THE ANSWER?
M. Alazzam, T. Young, R. Coleman, B. Hancock, J. Tidy, UK
676
OVARIAN CANCER IN HEREDITARY NONPOLYPOSIS COLORECTAL CANCER;
CLINICAL CHARACTERISTICS, MORPHOLOGY AND MISMATCH-REPAIR
MUTATIONS
K. Domanska, M. Nilbert, Sweden
677
TOPOTECAN/CARBOPLATIN VS. PACLITAXEL/CARBOPLATIN OR
GEMCITABIN/CARBOPLATIN OR CARBOPLATIN/PEGYLATED DOXORUBICIN:
A PLANNED 200 PTS INTERIM SAFETY ANALYSIS OF THE HECTOR-STUDY
(NOGGO/AGO-OVAR/GEICO/AGO-AUSTRIA)
A.K. Belau, G. Heinrich, A. Reinthaller, M.J. Rubio, A. Stähle, H. Sommer, E. Petru,
M. Beltran, F. Hilpert, U. Canzler, G. Oskay-Özcelik, S. Mahner, J. Sehouli,
NOGGO,AGO-Ovar,GEICO, AGO-Austria, Germany
678
HE-4 A NOVEL TUMOR MARKER FOR OVARIAN CANCER: COMPARISON
WITH CA 125 IN PATIENTS WITH GYNECOLOGICAL DISEASES
R. Molina, J.M. Escudero, J.M. Auge, X. Filella, L. Foj, A. Torne, J. Lejarcegui,
J. Pahisa, Spain
679
FERTILITY-SPARING SURGERY IN YOUNG WOMEN WITH BILATERAL GERM
CELL TUMOR
A. Garbi, R. Fruscio, M. Cantù, C.M. Bonazzi, S. Corso, V. Chiappa, L. Ceppi,
F.P. Sina, R. Milani, Italy
680
PATIENTS' PREFERENCES FOR INTRAPERITONEAL CHEMOTHERAPY FOR
ADVANCED OVARIAN AND RELATED CANCERS: WHAT MAKES IT
WORTHWHILE?
P. Blinman, C. Gainford, V. Duric, M. Friedlander, M. Stockler, Australia New
Zealand Gynaecological Oncology Group, Australia
681
PHASE II STUDY OF PELVIC INTENSITY MODULATED RADIOTHERAPY +/CHEMOTHERAPY FOR POST-OPERATIVE PATIENTS WITH ENDOMETRIAL OR
CERVICAL CARCINOMA (RTOG 0418)
L. Portelance, K. Winter, A. Jhingran, B.E. Miller, M.R. Salehpour, D. D'Souza,
L. Souhami, W. Small, D. Gaffney, Radiation Therapy Oncology Group (RTOG),
Canada
Nursing & Health Care
682
CURRENT LEVEL OF AWARENESS AGAINST CANCER IN TURKISH CITIZENS
N. Ozgul, M. Gultekin, E. Olcayto, M. Tuncer, Turkey
120
Poster Session I
Nursing & Health Care (contd.)
Poster No
683
PREVENTION OF VAGINAL STENOSIS; A COLLABORATIVE APPROACH TO
MAKE CHANGES IN PRACTICE THAT ARE BOTH EVIDENCE BASED AND
SUSTAINABLE
P. Tanner, G. Lindsay, Australia
684
INTENT OF REGULAR PAP TEST AND ITS RELATING FACTORS IN KOREAN
WOMEN
H.W. Kim, Republic of Korea
685
SUPRA REGIONAL CENTRES IN GYNAECOLOGICAL ONCOLOGY
L. Balasubramani, D. Kolomainen, M. Nobbenhuis, J. Bridges, T. Ind, J. Shepherd,
D. Barton, UK
686
CAN AN EDUCATIONAL INTERVENTION IMPROVE VAGINAL DILATOR USE? A
PROSPECTIVE STUDY
A. Brand, V. Do, A. Stenlake, Australia
687
STRESS IN WOMEN WITH ABNORMAL PAPANICOLAOU SMEAR
J. Changwatchai, S. Wongvatunyu, Y. Siarapo-Ngam, Thailand
688
CHANGES OF SYMPTOM CLUSTER OCCURRENCE IN THAI WOMEN WITH
CERVICAL CANCER FROM PRE TO POST TREATMENT
B. Sumdaengrit, S. Hanucharurnkul, M. Dodd, Thailand
689
KNOWLEDGE, BEHAVIORS, AND BELIEFS RELATED TO CERVICAL CANCER
AND THE PAP SMEAR TEST AMONG TURKISH WOMEN
N. Reis, H. Bebis, S. Kose, A. Sis, R. Engin, T. Yavan, Turkey
690
REHABILITATION TREATMENT OF REPRODUCTIVE-AGED PATIENTS WITH
STAGES IB-IIB CERVICAL AND UTERINE CANCER
S. Molchanov, L.A. Kolomiets, T.D. Gridneva, Russia
691
SEXUAL FUNCTION IN PATIENTS WITH GYNECOLOGIC CANCER AFTER
TREATMENT
J.H. Nho, Y.N. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, J.H. Nam, Republic of Korea
692
THE EFFECT OF HEALTH EDUCATION ABOUT SERVICAL CANCER AND THE
PAP SMEAR TEST
H. Bebis, T. Yavan, N. Reis, D. Bayrak, A.S. Unal, S. Bodur, Turkey
693
SURGICAL MANAGEMENT OF GYNAECOLOGICAL MALIGNANCIES IN
WOMEN OLDER THAN 70 YEARS:THE ROYAL MARSDEN HOSPITAL
D. Kolomainen, J. Butler, M. Nobbenhuis, T. Ind, J. Bridges, D. Barton, J. Shepherd,
UK
694
INCIDENCE OF HEPATITIS B INFECTION IN A NYC PUBLIC HOSPITAL WITH
GYNECOLOGIC MALIGNANCIES
N. Desoyza, T. Pua, A. Novetsky, J. Curtin, USA
121
Poster Session I
Poster No
695
KNOWLEDGE OF HUMAN PAPILLOMA VIRUS INFECTION IN CORRELATION
WITH CERVICAL CANCER AMONG MEDICAL STUDENTS AND MIDWIFERY
STUDENTS
H.M.A.R. Putri, M. Caesarini, A. Kusumanto, Indonesia
696
THE IMPACT OF GYNAECOLOGICAL CANCER AND THE ASSOCIATED
TREATMENT ON NUTRITIONAL STATUS AND QUALITY OF LIFE OVER TIME
M. Ryan, K. White, C. Knight, Australia
697
AUDIT OF URGENT REFERRALS OF SUSPECTED GYNAECOLOGICAL
CANCERS UNDER A TWO WEEK WAIT SYSTEM
N. Massiah, J. Achiampong, K. Hale, F. Shamshudin, J. Charova, B. Winter Roach,
UK
698
COMPARISON OF REFERRALS FROM AN URGENT TWO WEEK WAIT SYSTEM
TO ALTERNATIVE ROUTES IN A GYNAECOLOGY CANCER CENTRE
N. Massiah, K. Hale, J. Achiampong, F. Shamshudin, J. Charova, B. Winter Roach,
UK
699
GYNECOLOGIC CANCER IMPACT ON COUPLE RELATION AND SEXUALITY. A
FRENCH PSYCHO-ANTHROPOLOGICAL STUDY
H. Hoarau, C. Giacomoni, E. Venturini, M. Mélin, V. Conri, A. Floquet, A. Ravaud,
France
700
MANAGEMENT OF FAMILIES AT HIGHER RISK FOR BREAST AND OVARIAN
CANCER: THE EXPERIENCE OF THE EUROPEAN INSTITUTE OF ONCOLGY
I. Feroce, M. Barile, P. Radice, L. Bernard, V. Pensotti, V. Aristarco, G. Villa,
S. Moroni, B. Bonanni, Italy
701
CANCER BREACH ANALYSIS IN A DISTRICT GENERAL HOSPITAL
K. Chin, UK
702
IS GYNAECOLOGICAL CANCER A REASON FOR EXTENDING THE LENGTH
OF HOSPITAL STAY?
M. Abu Freij, R. Cocker, N. Burbos, S. Crocker, T. Duncan, J. Nieto, UK
703
KNOWLEDGE AND SEXUAL BEHAVIOR REGARDING HPV INFECTION IN
YOUNG POLISH WOMEN
A. Abacjew-Chmylko, H. Olszewska, D. Wydra, J. Olszewski, L. Chmylko, Poland
704
COMPREHENSION LEVEL AND TIME REQUIRED TO COMPLETE EORTC-CX24
AND FACT-CX QUESTIONNAIRES
C.M.S. Fregnani, M.R.D.O. Latorre, J.H. Fregnani, A.M. Almeida, Brazil
705
EORTC-CX24 AND FACT-CX QUALITY OF LIFE QUESTIONNAIRES: A
BRAZILIAN STUDY FOR VALIDITY AND RELIABILITY
C.M.S. Fregnani, M.R.D.O. Latorre, J.H. Fregnani, A.M. Almeida, Brazil
122
Poster Session I
Poster No
706
NURSE-LED EDUCATION IN PRIVATE PRACTICE FOR WOMEN AT RISK OF
DEVELOPING LOWER LIMB LYMPHOEDEMA FOLLOWING TREATMENT OF
S. Moll, S. Valmadre, J. Maidens, Australia
707
WOMEN WITH GYNAECOLOGICAL CANCERS: 30 YEARS OLD AND UNDER
N. Massiah, B. Winter-Roach, R. Slade, UK
708
THE ENHANCED RECOVERY PROGRAMME IN GYNAECOLOGY- THE
CONCEPT AND THE EXPERIENCE
R. Crawford, N. Acheson, J. Roberts, UK
709
THE DEVELOPMENT OF A NURSE-LED PSYCHOSOCIAL INTERVENTION WITH
PEER SUPPORT FOR WOMEN BEING TREATED WITH RADIOTHERAPY FOR
GYNAECOLOGICAL CANCER (GC)
P. Schofield, R. Bergin, S. Grogan, K. Sharkey, I. Juraskova, L. Mileshkin,
M. Krishnasamy, A. Hocking, D. Bernshaw, S. Aranda, Australia
710
UNMET SUPPORTIVE CARE NEEDS OF YOUNG GYNAECOLOGICAL CANCER
PATIENTS AND SURVIVORS; THE FIRST STEP
A.-L. Lopez, P.N. Butow, K. Nattress, S. Philp, K. Hobbs, E. Phillips, I. Juraskova,
Australia
711
PERIPHERAL NEUROTOXICITY ASSOCIATED WITH A CHEMOTHERAPY IN
GYNECOLOGIC CANCER PATIENTS
J.H. Nho, E.J. Yang, J.H. Kim, Y.M. Kim, Y.T. Kim, J.H. Nam, Republic of Korea
712
THE EFFICACY OF VAGINAL DOUCHING WITH DILATOR VERSUS DILATOR
ALONE IN PREVENTING RADIATION THERAPY-INDUCED VAGINAL
ADHESION AFTER PELVIC RADIATION
F. Huang, J. Eng, S.P. Yap, Y.N. Chia, P. Yam, Singapore
713
EFFECT OF PHYSIOTHERAPEUTIC PROCEDURES ON POST-MAMECTOMY
CONDITIONS - OWN EXPERIENCES
R. Chrzan, T. Kulpa, Poland
123
124
Monday - Tuesday, October 25-26, 2010
Poster Session II
Uterine Cancer including Sarcoma
Poster No
1
PRIMARY UTERINE EXTRA NODAL NON-HODGKIN LYMPHOMA CASE
REPORT
F. Vafaiezadeh, Oncology Cancer Institute Group, Iran
2
ENDOMETRIAL SQUAMOUS CELL CARCINOMA. A CASE REPORT
K. Bakalianou, C. Iavazzo, N. Salakos, A. Liapis, A. Kondi-Pafiti, Greece
3
ABNORMAL PAPANICOLAOU SMEARS DURING PREGNANCY
K. Bakalianou, C. Iavazzo, N. Salakos, L. Skagias, V. Kyriakidou, K. Politou, Greece
4
CUTANEOUS METASTASIS FROM GYNAECOLOGIC MALIGNANCIES
M. Samaila, G. Waziri, Nigeria
5
AN INVESTIGATION OF THE INFLUENCE OF ESTROGEN BINDING TO ITS
RECEPTOR-Α ON THE INVASIVENESS OF AN ENDOMETRIAL CARCINOMA
HEC-1B
L. Qinping, China
6
THE EFFECT OF BEVACIZUMAB (VEGF MONOCLONAL ANTIBODY) WITH OR
WITHOUT CLASSIC CHEMOTHERAPEUTICS IN ENDOMETRIUM CARCINOMA
CELL CULTURE
C. Yıldız Eren, S.S. Ozalp, A.T. Koparal, R.B. Bostancıoglu, Turkey
7
BETA-ARRESTIN 2 MODULATES RESVERATROL-INDUCED APOPTOSIS AND
REGULATION OF AKT/GSK3Β PATHWAY IN HUMAN ENDOMETRIAL CANCER
CELLS
X. Sun, J. Wang, L. Wei, D. Yin, China
8
SURVIVAL AND DISEASE RELAPSE IN SURGICAL STAGE 1 ENDOMETRIOID
ADENOCARCINOMA OF UTERUS AFTER ADJUVANT VAGINAL VAULT
BRACHYTHERAPY (VVBT)
V. Kumar, C.Y. Nin, P. Yam, T. Lim Kuei, K.H. Tan, R. Yeo, India
9
THE EFFECTIVENESS OF LEVONORGESTREL RELEASING INTRAUTERINE
SYSTEM (LNG-IUS) IN THE TREATMENT OF ENDOMETRIAL HYPERPLASIA IN
KOREAN WOMEN
C.T. Park, S.Y. Lee, M.K. Kim, H. Park, B.S. Yoon, J.H. Kang, S.J. Seong, H.S. Jun,
Republic of Korea
10
THE CORRELATION OF LOWER UTERINE SEGMENT INVOLVEMENT WITH
LYMPH NODE METASTSIS IN ENDOMETRIAL CARCINOMA: A
RETROSPECTIVE ANALYSIS
G. Amparo, L.M. Cole, Philippines
11
ASSESSMENT OF GROSS EXAMINATION AND FROZEN SECTION OF UTERINE
SPECIMEN IN ENDOMETRIAL CANCER PATIENTS
F. Ghaemmaghami, S. Aminimoghaddam, F. Mahmoudzadeh, Iran
125
Poster Session II
Uterine Cancer including Sarcoma (contd.)
Poster No
12
ENDOMETRIOID ENDOMETRIAL CANCER AND OVARIAN SEX CORD TUMOR
WITH ANNULAR TUBULES IN WOMAN WITH PEUTZ-JECHERS SYNDROME
AND MULTIPLE PRIMARY CANCERS
A. Kondi-Pafiti, C. Iavazzo, K. Bakalianou, C. Dastamani, P. Mavrigiannaki,
K. Gennatas, Greece
13
DETECTION OF SUGAR CHAINS OF GLYCOPROTEINS EXPRESSED BY
NORMAL ENDOMETRIUM AND UTERINE ENDOMETRIAL CANCER(WELLDIFFERENTIATED AND POORLY-DIFFERENTIATED) WITH THE LECTIN
ARRAYS
Y. Nishijima, Y. Goto, T. Sugiyama, M. Harasawa, M. Miyazawa, T. Hirasawa,
T. Muramatsu, H. Ishimoto, S. Izumi, N. Suzuki, K. Kiguchi, M. Toyoda, A. Umezawa,
M. Mikami, Japan
14
A QUALITY CONTROL STUDY OF LYMPH NODE EVALUATION IN
ENDOMETRIAL CANCER
G. Forde, J. Carlson, G. Downey, B. Doss, A. Shoemaker, C. Harrison, USA
15
CLINICAL IMPLICATIONS OF POSITIVE PERITONEAL CYTOLOGY IN
ENDOMETRIAL CANCER
Y. Ren, H. Wang, B. Shan, China
16
ENHANCED EXPRESSION OF SULFATIDES IN THE WELL-DIFFERENTIATED
TYPE OF HUMAN ENDOMETRIAL ADENOCARCINOMA
T. Sugiyama, M. Mikami, M. Harasawa, M. Miyazawa, Y. Goto, Y. Nishijima,
T. Hirasawa, T. Muramatsu, M. Iwamori, Japan
17
EFFICACY OF SYSTEMATIC LYMPHADENECTOMY FOR SURVIVAL IN
PATIENTS WITH NON-ENDOMETRIOID ENDOMETRIAL CANCERS
J.-M. Lee, J.-K. Lee, J.W. Kim, C.-H. Cho, S.-M. Kim, S.-Y. Park, C.-Y. Park,
K.-T. Kim, S.-K. Lee, Republic of Korea
18
RECURRENCE PATTERNS AND PROGNOSIS OF LOW-GRADE ENDOMETRIAL
STROMAL SARCOMA AND THE POTENTIAL OF TYROSINE KINASEINHIBITING THERAPY
X. Cheng, G. Yang, X. Tu, J. Liu, K. Schmeler, R. Coleman, J. Kavanagh,
USA, China
19
THE INFLUENCE OF EARLY DIAGNOSIS OF ENDOMETROID ENDOMETRIAL
CANCER ON DISEASE STAGE AND SURVIVAL
F. Barak, M. Gdalevich, B. Piura, E. Antaby, O. Lavie, O. Gemer, Israel
20
A PHASE II TRIAL OF COMBINATION THERAPY WITH PACLITAXEL,
CARBOPLATIN AND MEGESTEROL ACETATE FOR ADVANCED
STAGE/RECURRENT ENDOMETRIAL CARCINOMA (NCT00584857)
C. Leath III, K. Bevis, L. Kilgore, R. Alvarez, J.M. Straughn Jr., USA
126
Poster Session II
Poster No
21
THE INSULINE-LIKE GROWTH FACTOR SYSTEM AND ENDOMETRIAL
CANCER WITH METABOLIC SYNDROME
N. Bochkareva, L. Kolomiets, I. Kondakova, A. Chernyshova, O. Asadchikova,
Russia
22
PROTEASOME ACTIVITY AND SUBUNIT COMPOSITION IN ENDOMETRIAL
HYPERPLASIA AND ENDOMETRIAL CANCER WITH METABOLIC SYNDROME
L. Spirina, I. Kondakova, A. Chernyshova, L. Kolomiets, Russia
23
MONITORING OF ENDOMETRIAL K-RAS MUTATION IN TAMOXIFEN-TREATED
PATIENTS WITH BREAST CANCER
S. Hikita, H. Tsujioka, M. Fukuoka, T. Ueda, S. Horiuchi, T. Yoshizato, M. Emoto,
T. Kawarabayashi, S. Miyamoto, T. Hachisuga, Japan
24
IMMUNOLOGICAL RESPONSE AFTER THERAPEUTIC VACCINATION WITH
WT1 MRNA-LOADED DENDRITIC CELLS IN A PATIENT WITH END STAGE
ENDOMETRIAL CARCINOMA
A. Coosemans, M. Wölfl, Z.N. Berneman, V. Van Tendeloo, I. Vergote, F. Amant,
S.W. Van Gool, Belgium
25
VAGINAL HYSTERECTOMY AS A TREATMENT OPTION IN PATIENTS WITH
ENDOMETRIAL CANCER AND SIGNIFICANT CO-MORBIDITIES
M. Abu Freij, H. Saleh, H. Rawlins, T. Duncan, S. Crocker, J. Nieto, UK
26
CASE REPORT LEIOMYOSARCOMA WITH LYMPHATIC DISSEMINATION OF
RETROPERITONEAL LEIOMYOMATOSIS
W.Y. Lee, J.W. Park, Republic of Korea
27
DOES POSTOPERATIVE RADIOTHERAPY PROVIDE ANY SURVIVAL
ADVANTAGE OVER OBSERVATION IN STAGE IC ENDOMETRIAL CANCER
AFTER COMPREHENSIVE SURGICAL STAGING?
F. Ortaç, S. Taskin, M. Güngör, D. Öztuna, Turkey
28
CLINICAL OUTCOMES OF UTERINE SARCOMAS AND THE ROLE OF
ADJUVANT TREATMENT
S. Taskin, M. Arvas, M. Güngör, T. Beşe, F. Demirkıran, C. Şanioğlu, F. Ortaç,
D. Kösebay, Turkey
29
TWO METHODS EVALUATION OF ENDOMETRIAL SAMPLING IN
POSTMENOPAUSAL UTERINE BLEEDING
F. Keshavarzi, A. Nankali, T. Fakheri, N. Jalilian, M. Yari, A. Khoshay, M. Khoshay,
Iran
30
FEMALE SEX HORMONAL EFFECTS ON CLUSTERIN EXPRESSION AND
PACLITAXEL RESISTANT IN ENDOMETRIAL AND BREAST CANCER CELL
LINE
S. Lee, E.Y. Shin, D.J. Kwon, D.C. Park, Republic of Korea
127
Poster Session II
Poster No
31
STRATEGIES IN THE HISTOLOGIC DIAGNOSIS OF LOW-GRADE GLANDULAR
ENDOMETRIAL NEOPLASM
N. Izadi-Mood, S. Sarmadi, S. Sanii, Iran
32
THE PROGNOSTIC ROLE OF DNA PLOIDY IN ENDOMETRIAL CANCER
M. Kudela, R. Pilka, P. Dzubak, S. Brychtova, P. Hejtmanek, M. Lubusky,
M. Dziechciarkova, P. Konecny, I. Frydrych, Czech Republic
33
ENDOMETRIAL CYTOLOGY IS USEFUL TO DETECT THE EARLY STAGE
ENDOMETRIAL CANCERS
Y. Sugiyama, K. Utsugi, M. Kino, M. Matsumura, H. Iwase, K. Umayahara,
N. Takeshima, K. Hasumi, K. Takizawa, Japan
34
EXPRESSION OF PTEN AND BETA- CATENIN AND THEIR RELATIONSHIP
WITH CLINICOPATHOLOGICAL FACTORS IN ENDOMETRIAL CANCER
V. Sal, F. Demirkiran, M. Arvas, T. Bese, H. Erenel, C. Sanioglu, Turkey
35
NOVEL CHEMOEMBOLIZATION USING CALCIUM-PHOSPHATE CERAMIC
MICROSPHERE INCORPORATING TNP-470, AN ANTI-ANGIOGENIC AGENT
FOR UTERINE SARCOMAS
M. Emoto, Y. Naganuma, B. Choijamts, K. Yano, N. Kanomata, S. Miyamoto,
T. Kawarabayashi, M. Aizawa, Japan
36
A NOVEL BIOMARKER, “AMINOINDEX” FOR EARLY DETCTION OF
ENDOMETRIAL CANCER USING PLASMA AMINO ACID PROFILE
E. Miyagi, Y. Ihata, R. Numazaki, M. Asai-Sato, T. Mogami, T. Muramatsu,
A. Imaizumi, H. Yamamoto, M. Yamakado, N. Okamoto, F. Hirahara, Japan
37
ENDOMETRIAL CANCER. PROGNOSTIC SIGNIFICANCE OF RELAPSE RISK
CLASSIFICATION BASED ON PRE-INTRAOPERATIVE FINDINGS
F. Maneschi, M. Sarno, A. Perugini, C. Pane, I. Ceccacci, F. Gagliardi, M. Parisella,
Italy
38
USE OF BISPHOSPHONATES ASSOCIATED WITH LOWER RISK OF MAJOR
GYNECOLOGICAL CANCERS
O. Lavie, M. Pinchev, Y. Segev, S. Sagie, O. Gemer, H. Rennert, G. Rennert, Israel
39
ROLE OF OMENTECTOMY AND APPENDECTOMY IN THE MANAGEMENT OF
ENDOMETROID ENDOMETRIUM CANCER
B. Özdal, Ö.L. Tapısız, H.R. Yalçın, I. Şahin, T. Güngör, A.T. Çağlar,
L. Mollamahmutoğlu, Turkey
40
RISK FACTORS FOR POSTOPERATIVE LOWER-EXTREMITY LYMPHEDEMA IN
ENDOMETRIAL CANCER SURVIVORS WHO HAD TREATMENT INCLUDING
LYMPHADENECTOMY
Y. Todo, Y. Suzuki, S. Minobe, K. Okamoto, Y. Ohba, H. Kato, Japan
128
Poster Session II
Poster No
41
RACIAL DISPARITY IN THE OUTCOME OF PATIENTS WITH EARLY STAGE
UTERINE ENDOMETRIOID CARCINOMAS
A.R. Munkarah, M. Elshaikh, M. Cote, S. Hensley Alford, O. Gayar, R. Ali-Fehmi,
USA
42
PREOPERATIVE CA 125 LEVEL AS A PREDICTOR FOR METASTASIS AND
SURVIVAL IN ENDOMETRIOID ENDOMETRIAL CANCER
H. Gorgen, P. Goksedef, M. Api, A. Cetin, Turkey
43
LAPAROSCOPIC RADICAL SURGERY FOR ENDOMETRIAL CANCER IN
RECENT 3YEARS IN OUR HOSPITAL
H. Kato, Japan
44
THERAPEUTIC IMPACT OF PARA-AORTIC LYMPHADENECTOMY IN PATIENTS
WITH HIGH-RISK, EARLY STAGE AND ADVANCED STAGE ENDOMETRIAL
CARCINOMA
Y. Suzuki, Y. Todo, K. Okamoto, S. Minobe, H. Kato, Japan
45
COMPARISON OF SURGICAL OUTCOMES AND COMPLICATIONS FOR
CLINICAL STAGE I ENDOMETRIAL CANCER: LAPAROSCOPY VERSUS
LAPAROTOMY
B. Reed, W.J. Lowery, E. Kost, M. Sundborg, C. Landt, C. Leath III, USA
46
THE VALUE OF THE NEW FIGO STAGING SYSTEM ON THE PROGNOSIS OF
UTERINE SARCOMA
J.W. Kim, S.H. Lee, J. Paek, G.W. Yim, M. Lee, E.J. Nam, S.W. Kim, Y.T. Kim,
Republic of Korea
47
THE COMPARISON OF 1988 AND 2009 FIGO STAGING SYSTEM FOR UTERINE
SARCOMA IN KING CHULALONGKORN MEMORIAL HOSPITAL DURING 19992007
A. Vanichtantikul, A. Vorasittha, W. Pongpinyopap, R. Lertkhachonsuk,
T. Manchana, Thailand
48
PAX2 EXPRESSION IN ENDOMETRIAL HYPERPLASIA AND CARCINOMA
M. Sotiropoulou, N. Thomakos, A. Rodolakis, D. Haidopoulos, S. Kolliantzaki,
S. Markaki, G. Vlachos, A. Antsaklis, Greece
49
CLINICAL UTILITY OF SERUM TUMOR MARKERS IN WOMEN WITH
MALIGNANT MIXED MULLERIAN TUMORS OF THE UTERUS
N. Thomakos, A. Rodolakis, N. Akrivos, G. Giannoulis, D. Haidopoulos, G. Vlachos,
M. Sotiropoulou, A. Antsaklis, Greece
50
THE EFFICACY OF UTEROBRUSH SYSTEM IN THE DETECTION OF
ENDOMETRIAL PATHOLOGY
C. Iavazzo, G. Vorgias, G. Stefanatou, G. Mastorakos, N. Kalinoglou, T. Akrivos,
S. Fotiou, Greece
129
Poster Session II
Poster No
51
PREOPERATIVE PREDICTION MODEL OF LYMPH NODE METASTASIS IN
ENDOMETRIAL CANCER
S. Kang, J.-Y. Lee, M.-C. Lim, D.-C. Jung, S.-S. Seo, S.-Y. Park, Republic of Korea
52
LEVONORGESTREL-IUD: AN ELEGANT TREATMENT-OPTION OF
ENDOMETRIAL (PRE) MALIGNANCY IN CASE OF SERIOUS CO-MORBIDITY
M. Snijders, The Netherlands
53
ASSOCIATIONS BETWEEN INTRATUMORAL LYMPHATIC MICROVESSEL
DENSITY (LMVD) AND CLINICOPATHOLOGIC FEATURES IN ENDOMETRIAL
CANCER
L. Kawamura, F. Carvalho, B. Almeida, C. Bacchi, J.C. Goes, M. Calil, E. Baracat,
J. Carvalho, Brazil
54
COST EFFECTIVENESS OF LAPAROSCOPIC VERSUS ABDOMINAL
HYSTERECTOMY IN EARLY STAGE ENDOMETRIAL CANCER
C.B.m. Bijen, K.M. Vermeulen, M.J.E. Mourits, H.J.G. Arts, H.G. ter Brugge, R. van
der Sijde, L. Paulsen, J. Wijma, M.Y. Bongers, A.G.J. van der Zee, G.H. de Bock,
The Netherlands
55
EXPLORATION OF BIOMARKERS FOR LYMPH NODE METASTASIS IN
PATIENTS WITH ENDOMETRIAL CANCER USING EXON-EXPRESSION
MICROARRAY
S. Sudo, Y. Konno, T. Odagiri, T. Kato, M. Hosaka, M. Takeda, H. Watari,
M. Kaneuchi, N. Sakuragi, Japan
56
SYMPTOMATIC PELVIC LYMPHOCYSTS AFTER BILATERAL PELVIC
LYMPHADENECTOMY FOR GYNECOLOGICAL CANCER
C. Grigoriadis, D. Zygouris, E. Andriotis, E. Terzakis, A. Tserkezoglou, Greece
57
HIGHER INCIDENCE OF ENDOMETRIAL CANCER IN YOUNG WOMEN IN
SINGAPORE COMPARED TO OTHER CENTERS. KK HOSPITAL EXPERIENCE.
AN UPDATE
Y. Kwai Lam Philip, N. Ramapadma, C. Yin Nin, L. Yong Kuei, Y. Richard,
Y. Swee Peng, S. Lay Tin, Singapore
58
PREOPERATIVE SERUM CA-125 IS HELPFUL IN THE CLINICAL MANAGEMENT
AND PROSNOSTICATION OF UTERINE PAPILLARY SEROUS CARCINOMA
PATIENTS
T. Roelofsen, M. Mingels, J. Hendriks, J. Bulten, M. van Ham, L. Massuger,
The Netherlands
59
INSULIN IN ENDOMETRIAL CARCINOMA CHEMOTHERAPY: A BENEFICIAL
DESIGN AND NOT A PROBLEM
H. Wang, X. Du, Y. Li, China
60
NEUROENDOCRINE CARCINOMA OF THE ENDOMETRIUM - CASE SERIES
AND A SYSTEMATIC REVIEW OF THE LITERATURE
X. Niu, L. Gilbert, L. Souhami, Uterine Cancer, China
130
Poster Session II
Poster No
61
USE OF ESTRADIOL-PROGESTIN THERAPY ASSOCIATES WITH INCREASED
RISK FOR UTERINE SARCOMAS
S. Jaakkola, H.K. Lyytinen, E. Pukkala, O. Ylikorkala, Finland
62
DESCRIBE THE TEN YEAR EXPERIENCE WITH TRACHELECTOMY AT THE
LAHEY CLINIC FOUNDATION, INCORPORATED
V. Soto-Wright, B. Nijjar, N. Petersen, R. McLellan, USA
63
LIPOSOMAL DOXORUBICIN (LD) AND CARBOPLATIN (CP) IN PRIMARY
ADVANCED OR RECURRENT ENDOMETRIAL CANCER - A PHASE-II-TRIAL OF
AGO AUSTRIA
B. Volgger, A. Reinthaller, C. Schauer, U. Sevelda-Schwarzgruber, M. Klein,
M. Mörtl, A. Zeimet, M. Deibl, C. Marth, AGO Austria - Arbeitsgemeinschaft für
Gynäkologische Onkologie Austria, Austria
64
EXPRESSIONS OF ANGIOTENSIN II TYPE I RECEPTOR AND MIR-155 IN
ENDOMETRIAL CANCER AND THEIR CORRELATIONS WITH PATIENT
SURVIVAL
C.H. Choi, T.-J. Song, H.-S. Park, M.K. Kim, H.J. Kim, W.S. Lee, Y.-Y. Lee,
J.-W. Lee, T.-J. Kim, B.-G. Kim, D.-S. Bae, Republic of Korea
65
RISK FACTORS IN WOMEN 40 YEARS OF AGE AND YOUNGER WITH
M. Simou, N. Akrivos, D. Haidopoulos, A. Rodolakis, G. Vlachos, N. Thomakos,
S. Fotiou, M. Sotiropoulou, I. Biliatis, A. Protopapas, A. Antsaklis, Greece
66
MULTIMODALITY TREATMENT WITH CARBOPLATIN AND TAXOL IMPROVES
SURVIVAL IN ADVANCED STAGE UTERINE SEROUS CARCINOMA
S. Ueda, A. Nickles-Fader, T. Diaz-Montes, R. Giuntoli, R. Bristow, USA
67
COMPARISON OF HER2/NEU AND CA125 AS A ROLE FOR TUMOR MARKER
IN OVARIAN CANCER
K. Sung Han, Republic of Korea
68
MICROARRAY ANALYSIS OF THE GENES INVOLVED IN ENDOMETRIAL
CARCINOGENESIS: UP-REGULATION OF LIPOCALIN2 IN NEOPLASTIC
ENDOMETRIA, AND ITS FUNCTIONAL RELEVANCE
T. Miyamoto, H. Kashima, A. Suzuki, N. Kikuchi, A. Takatsu, I. Konishi, N. Seki,
T. Shiozawa, Japan
69
OUR INITIAL EXPERIENCE WITH ROBOTIC SURGERY FOR UTERINE CANCER
IN SOUTH EAST ASIA (SEA)
P. Tong, J. Ng, Y.F. Fong, J. Low, Singapore
70
LOW RISK STAGE I ENDOMETRIAL CARCINOMA: PROGNOSTIC FACTORS
AND OUTCOMES
M. Unsal, A. Yoney, C. Yildirim, Y. Bati, Turkey
131
Poster Session II
Poster No
71
ADIPONECTIN TO LEPTIN RATIO AS A PREDICTOR OF ENDOMETRIAL
CANCER
K. Nowosielski, J. Pozowski, D. Dudkiewicz, Poland
72
PULMONARY AND SPLENIC SARCOIDOSIS MIMICKING RECURRENCES OF
ENDOMETRIAL CANCER
G. Cormio, V. Loizzi, L. Leone, D. Scardigno, A. Camporeale, L. Selvaggi, Italy
73
A CASE OF ENDOMETRIOID ADENOCARCINOMA CONSIDERED TO BE
OCCURRED FROM BROAD LIGAMENT
K. Sugita, S. Takada, C. Hayashi, J. Tomobe, T. Yamamoto, N. Watanabe,
Y. Kusumi, A. Sheikh, Japan
74
PROGNOSTIC SIGNIFICANCE OF TETRASPANIN CD151 IN POOR PROGNOSIS
ENDOMETRIAL CANCER
M. Voss, R. Ganesan, R. Gornall, L. Ludeman, N. Gordon, C. Foy, K. McCarthy,
F. Berditchevski, S. Sundar, UK
75
GLOBAL DNA METHYLATION IN BLOOD LYMPHOCYTES IN HUMAN UTERUS
AND BREAST CANCERS
K. Romanek, K. Postawski, G. Marek, Poland
76
EFFECTIVNESS AND LIMITATIONS IN THE PRESERVATION OF THE UTERUS
IN YOUNG PATIENTS WITH ENDOMETRIAL ADENOCARCINOMA TREATED
WITH MEDROXYPROGESTERONE ACETATE
I. Andonova, G. Dimitrov, E. Dzikova, E. Trajkovska, FYR Macedonia
77
ENDOMETRIAL POLYPS - RISK OF PREMALIGNANT AND MALIGNANT
PATHOLOGY
E. Trajkovska, G. Dimitrov, E. Dzikova, I. Andonova, FYR Macedonia
78
COMPARISION OF KAI 1 PROTEIN EXPRESSION IN STEROID POSITIVE AND
NEGATIVE ENDOMETRIAL CANCER
A. Gryboś-Jagielska, J. Bar, M. Gryboś, Poland
79
MULTICELLULAR SPHEROIDS OF EPITHELIAL ENDOMETRIAL CANCER:
CHARACTERISATION AND APPLICATION FOR ANTI-CANCER DRUG
SCREENING
K. Chitcholtan, A.P.J. Evans, P.H. Sykes, New Zealand
80
EFFECT OF THE TYPE OF HYSTERECTOMY ON PROGNOSIS IN CLINICAL
STAGE I ENDOMETRIAL CANCER
S.I. Kim, K.H. Lee, C.H. Han, T.C. Park, J.S. Park, Republic of Korea
81
PREOPERATIVE SERUM LEPTIN LEVELS IN PATIENTS WITH ENDOMETRIAL
CANCER AND ITS CORRELATION WITH PROGNOSTIC VARIABLES
E. Karahanoglu, I. Adanir, G. Boyraz, Z.S. Tuncer, Turkey
132
Poster Session II
Poster No
82
P53 SIGNATURE IN ENDOMETRIAL POLYP - SEROUS CARCINOMA
SEQUENCE
T. Hachisuga, T. Kawagoe, S. Kagami, T. Kurita, N. Toki, Y. Matsuura, Japan
83
PREOPERATIVE DIAGNOSIS OF UTERINE SARCOMA
T. Nagai, T. Akahori, M. Ichikawa, K. Baba, H. Seki, Japan
84
VORINOSTAT HISTONE DEACYLASE INHIBITOR INDUCES APOPTOTIC
ACTIVITY IN ENDOMETRIAL CANCER
I. Bruchim, R. Sarfstein, H. Werner, A. Fishman, Israel
85
APPLICATION OF NARROW BAND IMAGING (NBI) FOR HYSTEROSCOPY OF
ENDOMETRIAL LESIONS
I. Kisu, K. Banno, Y. Kobayashi, A. Ono, K. Masuda, A. Ueki, H. Nomura,
A. Hirasawa, N. Susumu, D. Aoki, Japan
86
THE INCIDENCE OF LYMPH NODE METASTASIS IN CASES OF ENDOMETRIAL
CANCER
G. Chakalova, Bulgaria
87
INTEROBSERVER REPRODUCIBILITY OF ASSESSMENT OF PTEN LOSS BY
IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL CARCINOMA
B. Djordjevic, R. Broaddus, R. Soslow, K. Garg, USA
88
QUALITY OF LIFE AND SEXUAL FUNCTIONING IN ENDOMETRIAL CANCER
SURVIVORS
M. Becker, T. Malafy, M. Stumpf, G. Gitsch, D. Denschlag, Germany
89
OVER-EXPRESSION OF ESTROGEN RECEPTOR-RELATED RECEPTOR Α IN
ENDOMETRIAL CARCINOMA CELLS MAY PROVIDE AN ER-INDEPENDENT
MECHANISM TO RESIST THE ENDOCRINE THERAPY
P. Sun, L. Cai, X. Mao, China
90
A STUDY OF ENDOMETRIUM OF PATIENTS WITH ABNORMAL UTERINE
BLEEDING AT GUANGZHOU CHINA
E. Shrestha, China
91
HYALURONAN SYNTHASES (HAS1-3) AND HYALURONIDASES (HYAL1-2) IN
THE ACCUMULATION OF HYALURONAN IN ENDOMETRIAL CARCINOMA
T. Nykopp, K. Rilla, M. Tammi, R. Tammi, R. Sironen, K. Hämäläinen, V.-M. Kosma,
S. Heinonen, M. Anttila, Finland
92
HIGH PROTEIN EXPRESSION OF IGF-1R AND BRCA1 IN UTERINE SEROUS
PAPILLARY CARCINOMA (USPC)
K. Amichay, A. Fishman, D. Kidron, Z. Attias, H. Schayek, R. Sarfstein, H. Werner,
I. Bruchim, Israel
133
Poster Session II
Poster No
93
THE INFLUENCE OF CERVICAL INVASION ON LYMPH NODE MAPPING IN
STAGE III ENDOMETRIAL CANCER
T. Turan, H.L. Keskin, B. Gundogdu, S. Ozer, A. Ozfuttu, N. Boran, G. Tulunay,
M.F. Kose, Turkey
94
APPLICATIONS OF INTRA-OPERATIVE FROZEN SECTION (IOFS) IN THE
MANAGEMENT OF ENDOMETRIAL CANCERS
G. Mehra, A.J. Papadopoulos, R. Wynne-Simmons, M. Coutts, S.A. Montalto,
O. Devaja, UK
95
FACTORS AFFECTING LYMPH NODE METASTASES IN ENDOMETRIAL
CANCER
N. Boran, T. Turan, H.L. Keskin, B. Gundogdu, S. Ozer, Z. Isıkdogan, G. Tulunay,
M.F. Kose, Turkey
96
ISOLATED PARA-AORTIC LYMPH NODE METASTASES IN ENDOMETRIAL
CANCER
G. Tulunay, T. Turan, H.L. Keskin, B. Gundogdu, S. Ozer, Z. Isıkdogan, N. Boran,
M.F. Kose, Turkey
97
DETAILED ANALYSIS OF ENDOMETRIAL CANCER PATIENTS WHO
UNDERWENT RESECTION OF UPPER AND LOWER PARA-AORTIC NODES
DURING A LYMPHADENECTOMY
S. Koc, S. Ozer, T. Turan, H.L. Keskin, A. Ozfuttu, N. Boran, G. Tulunay, M.F. Kose,
Turkey
98
VAGINAL HYSTERECTOMY AS AN ALTERNATIVE METHOD OF TREATMENT
OF ENDOMETRIAL CANCER
S. Łapińska-Szumczyk, D. Wydra, H. Olszewska, J. Kobierski,
A. Abacjew-Chmyłko, Poland
99
HEALTH-RELATED QUALITY OF LIFE OUTCOMES WITH ROBOTIC SURGERY
FOR ENDOMETRIAL CANCER: TIME TO STRAY FROM THE MIDLINE?
R. Salani, H.-C. Yang, J. Fowler, B. Anderson, D. Cohn, USA
100
FAILED CONSERVATIVE TREATMENT OF SYNCHRONOUS PRIMARY CANCER
OF ENDOMETRIUM AND OVARY IN YOUNG WOMAN: A CASE REPORT
K. Suwannarurk, K. Bhamarapravatana, Y. Thaweekul, K. Mairaing, Y. Poomtavorn,
N. Warnnissorn, Thailand
101
PROGNOSTIC SIGNIFICANCE OF LYMPHO-VASCULAR SPACE INVASION AND
NODAL INVOLVEMENT IN INTERMEDIATE AND HIGH RISK ENDOMETRIAL
CANCER PATIENTS
K. Narayan, S. Kondalsamy-Chennakesavan, Australia
102
ISOLATED PARA-AORTIC LYMPH NODES METASTASES IN PATIENTS WITH
ENDOMETRIAL CARCINOMA UNDERGOING EN BLOC PELVIC
LYMPHADENECTOMY
B. Shan, H. Wang, Y. Ren, China
134
Poster Session II
Poster No
103
TRANSVAGINAL ULTRASOUND EXAMINATION OF MYOMETRIAL
INFILTRATION BY ENDOMETRIAL CANCER
P. Miklos, M. Klacko, P. Babala, L. Masak, P. Fekete, D. Ondrus, Slovak Republic
104
IMMUNOHISTOCHEMICAL EXPRESSION OF SYNUCLEIN-Γ, ER, PR, MMP-2,
MMP-9 AND GLUT-1 IN EARLY AND ADVANCED ENDOMETRIOID TYPE
ENDOMETRIAL CANCER
D.G. Hong, G.O. Chong, I.S. Park, Y.L. Cho, Y.S. Lee, J.Y. Park, KNUH OG,
Republic of Korea
105
THE INCIDENCE OF PARAAORTIC LYMPH NODE METASTASIS IN PATIENTS
WITH SURGICALLY STAGED ENDOMETRIOID UTERINE CANCER: A
MULTICENTER, RETROSPECTIVE KOREAN STUDY
N.-H. Jeong, J.-M. Lee, J.-K. Lee, J.W. Kim, C.-H. Cho, S.-M. Kim, S.-Y. Park,
C.-Y. Park, K.-T. Kim, Republic of Korea
106
SIGNIFICANCE OF THE SUVMAX AND GLUT-1 EXPRESSION TO DETERMINE
TUMOR AGGRESSIVENESS IN CLINICAL STAGE I ENDOMETRIAL CANCER
G.O. Chong, N.Y. Park, D.G. Hong, Y.L. Cho, I.S. Park, Y.S. Lee, Republic of Korea
107
FERTILITY CONSERVATION IN A WOMAN WITH A UTERINE ADENOSARCOMA
K. Blanas, N. Burbos, C. Siozos, M. Theodora, UK, Greece
108
IMPACT OF TUMOR MORCELLATION DURING SURGERY ON THE OUTCOMES
OF PATIENTS WITH UTERINE LEIOMYOSARCOMA
J.-Y. Park, J.-H. Nam, D.-Y. Kim, J.-H. Kim, Y.-M. Kim, Y.-T. Kim, Republic of Korea
109
UTERINE MÜLLERIAN ADENOSARCOMA : THE CLINICOPATHOLOGIC
REVIEW OF 9 CASES IN A SINGLE CENTER, KOREA
S.H. Lee, Y.T. Kim, K.Y. Kong, K.R. Kim, J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim,
J.H. Nam, Republic of Korea
110
KI-67 AS A STRONG PROGNOSTIC INDICATOR IN ENDOMETRIAL STROMAL
SARCOMA
J.-Y. Park, J.-H. Nam, Y.B. Kim, D.-Y. Kim, J.-H. Kim, Y.-M. Kim, K.-R. Kim,
Y.-T. Kim, Republic of Korea
111
MORPHOLOGICAL, MOLECULAR AND GENETIC CHARACTERISTICS OF
ENDOMETRIAL MALIGNANT TRANSFORMATION STAGES: ENDOMETRIAL
HYPERPLASIA (EH), ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA (EIN),
ENDOMETRIAL ADENOCARCINOMA (EAC)
E. Kogan, N. Faizullina, Z. Glinkina, T. Demura, A. Asaturova, L. Ezhova,
O. Magirevskaya, Russia
112
CHARACTERISTICS AND SURVIVALS OF ENDOMETRIAL CANCER PATIENTS
ACCORDING TO THE PRIOR 1988 AND THE NEW 2009 FIGO STAGING
SYSTEMS
S. Tangjitgamol, S. Manusirivithaya, J. Khunnarong, S. Srijaipracharoen,
T. Thavaramara, K. Pataradool, Vajira Hospital, Thailand
135
Poster Session II
Poster No
113
CLAUDIN LOSS FROM THE SITE OF TIGHT JUNCTIONS IN ENDOMETRIAL
INTRAEPITHELIAL NEOPLASIA AND ENDOMETRIAL ADENOCARCINOMA
T. Demura, E. Kogan, N. Faizullina, A. Asaturova, L. Ezhova, O. Magirevskaya,
Russia
114
CLINICO-PATHOLOGICAL INCLUDING HORMONAL RECEPTORS
EXPRESSION AND SURVIVALS OF YOUNG ENDOMETRIAL CARCINOMA
PATIENTS: A CASE CONTROL STUDY
S. Tangjitgamol, S. Manusirivithaya, S. Srijaipracharoen, S. Tanvanich,
K. Katanyoo, J. Khunnarong, T. Thavaramara, K. Pataradool, S. Leelahakorn,
Thailand
115
HIGH BMI IS SIGNIFICANTLY ASSOCIATED WITH POSITIVE PROGESTERONE
RECEPTOR STATUS AND CLINICO-PATHOLOGIC MARKERS FOR NONAGGRESSIVE DISEASE IN ENDOMETRIAL CANCER
K. Mauland, J. Trovik, E. Wik, M.B. Ræder, I.M. Stefansson, A. Øyan, K.H. Kalland,
L.A. Akslen, H.B. Salvesen, Norway
116
PROGNOSTIC INDICATORS IN ENDOMETRIAL STROMAL SARCOMAS AND
UNDIFFERENTIATED ENDOMETRIAL SARCOMAS
W. Feng, K. Hua, E. Gudlaugsson, Y. Yu, S.-T. Nilsen, X. Zhou, J. Baak, China,
Norway, The Netherlands
117
PROGNOSTIC FACTORS AND TREATMENT OUTCOMES IN PATIENTS WITH
OPERATED ENDOMETRIAL CANCER: ANALYSIS OF 674 PATIENTS AT A
SINGLE INSTITUTION
A. Yoney, M. Unsal, C. Yildirim, L. Isikli, Turkey
118
PROGNOSIS OF INTERMEDIATE- OR HIGH-RISK STAGE Ⅰ ENDOMETRIOID
CARCINOMA WITH MODIFIED RADICAL HYSTERECTOMY
B. Shan, H. Wang, Y. Ren, Z. Sun, China
119
OVARIAN PRESERVATION IN YOUNG PATIENTS WITH EARLY STAGE
L. Lv, Z. Peng, Y. Sun, F. Deng, J. Lou, China
120
LYMPHADENECTOMY VERSUS NO LYMPHADENECTOMY IN ENDOMETRIAL
CARCINOMA: A RETROSPECTIVE ANALYSIS OF 410 PATIENTS
L. Selvaggi, V. Loizzi, G. Cormio, P. De Mitri, M. Lorusso, F. Magazzino,
D. Scardigno, A. Camporeale, L. Leone, Italy
121
NON PUERPERAL UTERINE INVERSION SECONDARY TO A MIXED
MULLERIAN TUMOUR OF THE CORPUS
V. Vadiveloo, M.F. Abdullah, A. Vijayananthan, N. Mustapha, H. Yahya, Malaysia
122
PHOTODYNAMIC DIAGNOSTICS OF A PATHOLOGY ENDOMETRIUM AFTER
INTRAUTERINE APPLICATION OF 5-AMINOLEVULINIC ACID
E. Novikova, O. Tchoulkova, L. Serova, E. Tchoulkova, Russia
136
Poster Session II
Poster No
123
ASSESSMENT OF MYOMETRIAL INVASION, HISTOLOGIC TYPE AND
GRADING IN ENDOMETRIAL CANCER BY TRANSVAGINAL ULTRASOUND
AND PREOPERATIVE SAMPLING. A MULTICENTER STUDY
M.P. Odorizzi, R. Maggi, T. Maggino, L. Selvaggi, M. Melpignano, on behalf of Mario
Negri Gynecologic Oncology Group (MaNGO), Italy
124
A CASE REPORT OF PELVIC LIPOSARCOMA IN A WOMAN PREVIOUSLY
TREATED WITH HYSTERECTOMY
D. Scardigno, G. Cormio, V. Loizzi, P. De Mitri, C. Nardelli, F. Magazzino,
A. Camporeale, L. Leone, L. Selvaggi, Italy
125
IMPORTANCE OF OPTIMAL CYTOREDUCTION IN ADVANCED STAGE
ENDOMETRIAL CANCER CASES
S. Taskin, F. Ortaç, M. Güngör, G. Goc, E. Kocbulut, F. Tülek, Turkey
126
IMMUNOHISTOCHEMICAL MARKERS IN ENDOMETRIAL HYPERPLASIA AND
ENDOMETRIOID CARCINOMA
J. Vasiljeva, V. Groma, R. Kleina, S. Andrejeva, L. Lidaka, L. Lauka, I. Barkane,
Latvia
127
THE PREVALENCE OF THE UTERINE CANCER IN POST MENOPAUSAL
PERIOD
G.O. Olaru, I.C. Bordinca, I. Livinti, Romania
128
OUTCOME OF INVESTIGATION FOR VAGINAL BLEEDING IN
POSTMENOPAUSAL WOMEN UNDER THE AGE OF 50 YEARS
129
FAILURE TO PERFORM AN OFFICE-BASED ENDOMETRIAL BIOPSY FOR THE
EVALUATION OF POSTMENOPAUSAL WOMEN WITH VAGINAL BLEEDING CAUSES AND MANAGEMENT
130
POSTMENOPAUSAL VAGINAL BLEEDING IN WOMEN WITH HISTORY OF
BREAST CANCER
131
BENIGN METASTASIZING LEIOMYOMA. SHOULD IT REALLY BE CONSIDERED
AS BENIGN? A CASE REPORT
M. Jedryka, M. Maciejewski, L. Huzarski, Poland
132
EARLY-ONSET ENDOMETRIAL CANCER IN METROPOLITAN DETROIT,
MICHIGAN: A 20 YEAR REVIEW
R. Ali-Fehmi, A. Munkarah, J.J. Ruterbusch, S. Bandyopadhyay, M.L. Cote, USA
133
RELATIONSHIP OF PREOPERATIVE HIGH CA-125 LEVELS WITH CLINIC AND
PATHOLOGIC PROGNOSTIC FACTORS IN ENDOMETRIUM CANCER
A. Yıldız, H. Yetimalar, S. Tatar, B. Kasap, K. Çukurova, A. Keklik, Turkey
137
Poster Session II
Poster No
134
DEMOGRAPHIC FACTORS ASSOCIATED WITH STAGE AT PRESENTATION IN
ENDOMETRIAL CANCER
E. Moss, S. Askew, P. Pearmain, K. Singh, UK
135
COMPARISON OF THE SURGICAL AND PATHOLOGIC FACTORS OF
ENDOMETRIAL CANCER PATIENTS WITH OR WITHOUT PARA-AORTIC
LYMPH NODE METASTASES
S. Ozer, T. Turan, H.L. Keskin, B. Gundogdu, A. Ozfuttu, N. Boran, G. Tulunay,
M.F. Kose, Turkey
136
A PROSPECTIVE CLINICO PATHOLOGICAL STUDY OF CARCINOMA
ENDOMETRIUM
V. Jain, S. Jain, A. Sood, India
137
TISSUE AND PLASMA PROTEIN MARKER PATTERNS OF ENDOMETRIAL
CANCER
M. Lomnytska, S. Becker, U. Hellman, U. Engström, A. Olsson, A.-C. Hellström,
K. Hellman, C. Lundgren, M. Mints, S. Andersson, G. Auer, Sweden,
138
OUTCOME OF PATIENTS WITH UTERINE SEROUS CARCINOMA (USC) USING
THE REVISED FIGO STAGING SYSTEM
S. Seward, A. Munkarah, A. Semaan, Z. Al-Wahab, S. Bandyopadhyay, M.L. Cote,
M.A. Elshaikh, R. Morris, R. Ali-Fehmi, USA
139
PATTERNS OF FAILURE IN STAGE III/IV UTERINE SEROUS CARCINOMA
AFTER ADJUVANT RADIOTHERAPY AND CARBOPLATIN/PACLITAXEL
CHEMOTHERAPY
E. Wiebe, B. Bahoric, K. Lupe, J. Kwon, D. D'Souza, Canada
140
PRESURGICAL STUDY AND LYMPHADENECTOMY IN ENDOMETRIAL
CANCER SUBTYPE ENDOMETRIOD
J.C. Muruzabal Torquemada, M. Ibarrola Vidaurre, S. Aguirre Gorospe,
S.S. Lapeña Calavia, I. Jiménez Ubieto, F.J. Elizalde Fernández, Spain
141
DNA PLOIDY IN ENDOMETRIAL CARCINOMA - A COMPARISON OF
PREOPERATIVE VS. POSTOPERATIVE AND PARAFFIN-EMBEDDED VS.
FRESH/FROZEN SAMPLES EVALUATION
P. Libalova, Z. Vernerova, L. Hubickova-Heringova, D. Pinterova, K. Kolostova,
K. Tikovsky, M. Kubecova, B. Svoboda, Czech Republic
142
FERTILITY-SPARING TREATMENT FOR EARLY STAGE ENDOMETRİOİD
ENDOMETRIAL ADENOCANCER
F. Demirkiran, T. Bese, M. Arvas, B. Aydogan, C. Sanioglu, Turkey
143
PITFALL IN THE DIAGNOSIS OF ENDOMETRIAL CANCER ARISING FROM
UTERINE ADENOMYOSIS: REPORT OF A CASE
A.-S. Boes, T. Tousseyn, I. Vandenput, I. Vergote, P. Moerman, F. Amant, Belgium
138
Poster Session II
Poster No
144
RESULTS OF THE AGO STUDIES ON OPERATIVE APPROACHES IN THE CARE
OF ENDOMETRIAL CANCER IN GERMANY FROM 2006 AND 2009
M.J. Battista, M. Schmidt, N. Zabel, J. Steetskamp, M. Mahlke, D. Boehm,
G. Naumann, E. Steiner, H. Koelbl,, Germany
145
THE APOPTOTIC AND CYTOTOXIC EFFECTS OF CYCLOOXYGENASE (COX)
ENZYME BLOCKER-NIMESULID AND CISPLATIN COMBINATION ON
ENDOMETRIAL CANCER (ISHIKAWA ) CELLS
C. Yildiz Eren, A.T. Koparal, S.S. Ozalp, R.B. Bostancıoglu, Turkey
146
DESCRITIVE ANALYSIS OF LYMPH NODE METASTASIS IN ENDOMETRIAL
CANCER
J.C. Muruzabal Torquemada, M. Ibarrola Vidaurre, S.S. Lapeña Calavia, S. Aguirre
Gorospe, B. Bezares Pérez, F.J. Elizalde Fernández, Spain
147
PREOPERATIVE MRI ASSESSMENT OF DEPTH OF MYOMETRIAL INVASION IN
ENDOMETRIAL CANCER: DOES MDM REVIEW IMPROVE ACCURACY?
S. Lin, A.L. Tan, L. Eva, New Zealand
148
PROGNOSIS AND IMPACT OF ADJUVANT TREATMENT OF UTERINE
CARCINOSARCOMA
S. Fortin, E. Sagr, P. Drouin, D. Provencher, S. Philippe, P. Gauthier, Canada
149
ESTIMATING THE RISK OF ENDOMETRIAL CANCER - A CLINICAL
PREDICTION ALGORITHM BASED ON PATIENT CHARACTERISTICS
N. Burbos, P. Musonda, I. Giarenis, A. Shiner, P. Giamougiannis, S. Crocker,
E. Morris, J. Nieto, UK
150
FERTILITY SPARING TREATMENT (FST) IN ENDOMETROID ENDOMETRIAL
CANCER G1 (EC) AND COMPLEX HYPERPLASIA WITH ATYPIA (CHA). OUR
EXPERIENCE
F. Gorosito, C. Ruhlmann, S. Provenzano, A. Bermudez, Argentina
151
AGE RELATED INCIDENCE AND DIFFERENTIAL DIAGNOSIS OF
POSTMENOPAUSAL VAGINAL BLEEDING
N. Burbos, P. Musonda, I. Giarenis, A. Shiner, P. Giamougiannis, S.G. Crocker,
E. Morris, J. Nieto, UK
152
PROGNOSIS OF SURVIVAL IN 104 CASES OF PAPILLARY SEROUS AND
CLEAR CELL ENDOMETRIAL CARCINOMAS
I. Biliatis, D. Haidopoulos, A. Rodolakis, G. Vlachos, N. Thomakos, N. Akrivos,
A. Antsaklis, Greece
153
TOTAL LAPARO-ENDOSCOPIC SINGLE SITE SURGERY (LESS)
HYSTERECTOMY IN LOW-RISK EARLY ENDOMETRIAL CANCER: TECHNIQUE
AND PRELIMINARY RESULTS
C. Rossitto, A. Fagotti, V. Gallotta, M.L. Gagliardi, S. Gueli Alletti, B. Costantini,
G. Vizzielli, G. Scambia, F. Fanfani, Italy
139
Poster Session II
Poster No
154
CORRELATION OF 18-FDG UPTAKE IN PET/CT WITH CLINICOPATHOLOGICAL
FEATURES AMONG 5 CASES OF RECURRENT LOW GRADE ENDOMETRIAL
STROMAL SARCOMA (LGESS)
R. Kanazawa, H. Tsubamoto, R. Sakane, Y. Ikeda, S. Komori, H. Hao, S. Hirota,
S. Kawata, Japan
155
SECOND CYTOREDUCTIVE SURGERY FOR TREATMENT OF RECURRENT
ENDOMETRIAL CANCER
Y. Ren, H. Wang, B. Shan, H. Yang, D. Shi, China
156
INTRAOPERATIVE ASSESSMENT OF MYOMETRIAL INVASION AND
HISTOLOGICAL GRADE IN ENDOMETRIAL CANCER USING REVISED FIGO
STAGING SYSTEM
H. Ugaki, T. Enomoto, T. Miyatake, T. Kimura, Y. Ueda, K. Yoshino, M. Fujita,
M. Takemura, T. Kimura, Japan
157
CPG ISLAND HYPERMETHYLATION OF WNT INHIBITORY FACTOR-1 (WIF-1)
AND E-CADHERIN (CDH1) IS ASSOCIATED WITH RECURRENCE AND
PROGNOSES OF ENDOMETRIAL CANCER
Y. Ren, H. Wang, X. Zhou, D. Shi, China
158
PROGNOSTIC FACTORS IN PATIENTS WITH UTERINE SARCOMA: DATA
FROM A SINGLE INSTITUTION IN BRAZIL
R.A. Perdomo, M.A. Vieira, A.A. Jacinto, T.B. Silva, A.T. Tsunoda,
C.E.M.C. Andrade, J.H.T.G. Fregnani, Brazil
159
UTERINE SMOOTH MUSCLE TUMOURS OF UNCERTAIN MALIGNANT
POTENTIAL (STUMPS) - A REPORT OF FIVE CASES
S.M. Wong, W.H. Li, Y.M.M. Chan, W.M. Pong, Hong Kong S.A.R.
160
A PRIMARY STUDY ON THE EXPRESSION OF TRPV6 GENE IN ENDOMETRIAL
CARCINOMA
W. Jianliu, M. Tian, China
161
A PRIMARY STUDY ON THE EXPRESSION OF ESTROGEN RECEPTOR Α36 IN
W. Jianliu, S. Lifang, China
162
UTERINE CANCER INCIDENCE AND PROGNOSIS AMONG INDIGENOUS AND
NON-INDIGENOUS WOMEN IN QUEENSLAND AUSTRALIA, 1997 TO 2006
S.P. Moore, A.C. Green, G. Garvey, M. Coory, P.C. Valery,, Australia
163
IMPACT OF HISTOCHEMICAL MARKER EXPRESSION PROFILES ON
SURVIVAL OF ENDOMETRIAL CANCER PATIENTS
Z. Chingisova, Z. Takhayev, M. Kairbayev, R. Shalbayeva, E. Kukubassov,
Kazakhstan
140
Poster Session II
Poster No
164
PATTERN OF FAILURES AND PROGNOSTIC FACTORS IN TYPE 2
ENDOMETRIAL CARCINOMA: A SINGLE INSTITUTION RETROSPECTIVE
STUDY
V. Zanfagnin, E. Tripodi, F. Marocco, E. Piovano, L. Fuso, A. Ferrero, N. Ravarino,
P. Zola, Italy
165
THE ANALYSIS OF QUALITY OF LIFE AND CORRELATION FACTORS IN
ENDOMETRIAL CANCER PATIENTS
W. Jianliu, B. Yun, China
166
UTERINE SARCOMA - OUR EXPERIENCE
M. Tîrnovanu, I. Dumitrascu, Romania
167
SURVIVAL OUTCOME OF WOMEN WITH SYNCHRONOUS CANCERS OF THE
ENDOMETRIUM AND OVARY: A 10 YEAR RETROSPECTIVE COHORT STUDY
Y.K. Lim, P. Rama, Y.N. Chia, K.L. Yam, L.T. Soh, J. Chia, R. Yeo, S.P. Yap,
E.J. Chua, Singapore
168
MULTIMODALITY THERAPY FOR PATIENTS WITH MALIGNANT MIXED
MULLERIAN TUMORS OF THE UTERUS
S.Z. Omar, D. Marsden, G. Robertson, N.F. Hacker, Malaysia, Australia
169
UTERINE EMBRYONAL RHABDOMYOSARCOMA (SARCOMA BOTRYOIDES) IN
A 13 YEAR-OLD GIRL SUCCESSFULLY TREATED CONSERVATIVELY WITH
HYSTEROSCOPIC RESECTION AND CHEMOTHERAPY
S. Erkanli, A. Erbay, E. Kilicdag, E. Kuscu, A. Haberal, A. Ayhan, Turkey
170
THE ACCURACY AND REPRODUCIBILITY OF “NON-THREE-LAYER”
ULTRASOUND IN PREMENOPAUSAL WOMEN WITH ABNORMAL BLEEDING:
A PROSPECTIVE STUDY
M. Abe, Y. Kojima, T. Doi, T. Uchida, H. Ogawa, A. Ayhan, Japan
171
MORBIDITY AND MORTALITY OF THE SURGICAL TREATMENT OF THE
OLDEST OLD WOMEN WITH ENDOMETRIAL CANCER
172
ADJUVANT PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH
COMPLETELY OR OPTIMALLY RESECTED CARCINOSARCOMAS (MIXED
MESODERMAL TUMORS) OF THE UTERUS
T. Takano, T. Otsuki, N. Yaegashi, T. Tase, K. Nakahara, Y. Yokoyama, D. Aoki,
H. Nakayama, K. Takehara, H. Katabuchi, H. Yamada, F. Kikkawa, T. Fujimoto,
M. Emoto, S. Kamoi, A. Arakawa, Y. Morimura, M. Hiura, Y. Aoki, H. Fujimoto,
S. Sato, K. Kotera, Japan Uterine Sarcoma Study Group, Japan
173
FEASIBILITY OF NEW BRACHYTHERAPY DEVICE FOR TREATMENT OF
CERVICAL AND UTERINE CARCINOMA
D. Scanderbeg, C. Yashar, USA
141
Poster Session II
Poster No
174
UTERINE CANCER IN THE “DR. SALVATORVUIA” CLINICAL OBSTETRICS
V. Daşcău, G. Furău, L. Păiuşan, C. Furău, Romania
175
ECHOSIMIOTICS OF MICROINVASIVE ENDOMETRIAL CANCER
L. Ashrafyan, A. Myagkova, S. Ivashina, T. Mockobili, S. Vashakmadze, Russia
176
MANAGEMENT OF EARLY STAGE ENDOMETRIAL CANCER USING THE DA
VINCI SYSTEM: THE BELGIAN EXPERIENCE
F. Goffin, I. Vergote, K. Traen, L. Voorhoof, X. De Cleer, P. Van Dam, Belgium
177
ASSESSMENT OF RISK FACTORS OF LYMPH NODE METASTASIS IN
ENDOMETRIAL CANCER
M. Cusido, S. Baulies, F. Fargas, I. Rodriguez, M.A. Pascual, R. Fabregas,
A. Alsina, Spain
178
RETROSPECTIVE REVIEW OF 187 WOMEN TREATED FOR
CARCINOSARCOMA BETWEEN 1970 AND 2008 AT GROOTE SCHUUR
HOSPITAL, CAPE TOWN, SOUTH AFRICA
N. Mbatani, L. Van Wijk, R. Soeters, L. Denny, South Africa
179
SYSTEMATIC PELVIC AND PARAAORTIC LYMPHADENECTOMY IN
ENDOMETRIAL CANCER: LYMPH NODE METASTASIS PATTERN AND
IDENTIFICATION OF PREDICTIVE FACTORS FOR LYMPH-NODE STATUS
A. El-Balat, C. Fotopoulou, J. Sehouli, F. Heitz, M.Z. Muallem, P. Harter,
R. Krätschell, A. du Bois, Germany
180
DIAGNOSTIC VALUE OF ENDOMETRIAL CYTOLOGY FROM DIRECT
SAMPLING BY BRUSHING
C. Manini, S. Mazzola, E. Bar, M. Puopolo, P.L. Montironi, Italy
181
TAXAN-PLATINUM BASED CHEMORADIATION IN ENDOMETRIAL CANCER IIIIV PRIMARY TREATMENT
V. Titova, J. Kreynina, L. Shevchenko, A. Shipilova, Russia
182
CHANGING PATTERNS OF RADIOTHERAPY FOR POST OPERATIVE
ENDOMETRIAL CANCER 2000-2008
G. Jacobson, USA
183
EVALUATION OF RISK FACTORS AND PROGRESSION HISTORY IN WOMEN
WITH RECURRENT POSTMENOPAUSAL BLEEDING
R. Dwivedi, M. Pann, R. Henry, J. Pampiglione, UK
184
PERSONALIZING ENDOMETRIAL CANCER TREATMENT BASED ON ERCC1
AND CLASS III Β-TUBULIN: RESULTS FROM AN IMMUNOHISTOCHEMICAL
STUDY
I. Vandenput, A. Capoen, G. Verbist, K. Leunen, P. Berteloot, P. Neven,
P. Moerman, I. Vergote, F. Amant, Belgium
142
Poster Session II
Poster No
185
THE KIT GENE IN ENDOMETRIAL CARCINOMA: AN IMMUNOHISTOCHEMICAL
AND MUTATIONAL ANALYSIS
I. Vandenput, M. Debiec-Rychter, A. Capoen, G. Verbist, I. Vergote, P. Moerman,
F. Amant, Belgium
186
THE WEEKLY PACLITAXEL-CARBOPLATIN REGIMEN IN PATIENTS WITH
PRIMARY ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA
I. Vandenput, I. Vergote, K. Leunen, P. Berteloot, P. Neven, F. Amant, Belgium
187
THE ROLE OF ADJUVANT CHEMOTHERAPY IN SURGICAL STAGE I-II
SEROUS ENDOMETRIAL CARCINOMA AND ENDOMETRIAL
CARCINOSARCOMA: A COLLABORATIVE STUDY
I. Vandenput, P. Moerman, J. Trovik, K. Leunen, P. Berteloot, P. Neven, I. Vergote,
H. Salvesen, F. Amant, Belgium
188
THIRTEEN-YEAR EXPERIENCE OF 832 PATIENTS WITH ENDOMETRIAL
CANCERS FROM A CHINESE INSTITUTION
H. Yang, B. Shan, Y. Ren, W. Yang, X. Tu, H. Wang, China
189
CLINICOPATHOLOGIC CLEAR CELL ENDOMETRIAL CANCER´S STUDY
M. Hernández Suárez, R. Rodriguez Reyes, O. Orribo Morales, S. García
Rodriguez, F.J. De la Torre Fernández Vega, Spain
190
BRAIN METASTASES ASSOCIATED WITH ENDOMETRIAL CANCER: A SERIES
OF 18 CASES
S. Uccella, J. Bakkum-Gamez, W. Cliby, K. Podratz, B. Gostout, S. Dowdy,
A. Mariani, USA
191
ADJUVANT RADIOTHERAPY FOR ENDOMETRIAL CANCER STAGE IB
HISTOLOGICAL GRADES 1 AND 2: COMPARISON BETWEEN TREATMENT
REGIMENS
A. Cairo, S. Esteves, C. Watanabe, M. Cunha, G. Souza, Brazil
192
THE STUDY OF MORPHOLOGICAL CHARACTERISTICS OF BLOOD CELLS IN
WOMEN WITH UTERINE TUMOURS
M. Alibegashvili, T. Tufinashvili, L. Ramishvili, I. Bochorishvili, M. Zibzibadze,
N. Veshapidze, A. Shukakidze, N. Kotrikadze, T. Kharaishvili, Georgia
193
STAGING SYSTEMS IN UTERINE SARCOMAS. CAN THE NEW STAGING
SYSTEM PREDICT THE SURVIVAL AND PROGNOSIS?
M. Ozekinci, A. Dogan, A. Karalök, Y. Yildirim, T. Simsek, Turkey
194
THE REGULATION OF BUB1 EXPRESSION IN ENDOMETRIAL CARCINOMA
CELL WITH ESTROGEN AND PACLITAXEL
C. Yonghua, L. Xiaoping, W. Yue, W. Jianliu, W. Lihui, China
143
Poster Session II
Poster No
195
FERTILITY-SPARING COMBINED HYSTEROSCOPIC AND MEDICAL
TREATMENT OF ATYPICAL ENDOMETRIAL LESIONS IN YOUNG WOMEN
G. Bifulco, A. Di Spiezio Sardo, N. De Rosa, G. Lavitola, M.L. Spinelli, I. Morra,
M. Scognamiglio, C. Nappi, Italy
196
FERTILITY-PRESERVING HIGH-DOSE MEDROXYPROGESTERONE ACETATE
(MPA) THERAPY FOR 4 YOUNG PATIENTS WITH GRADE 2 ENDOMETRIOID
ADENOCARCINOMA
N. Susumu, A. Hirasawa, W. Yamagami, I. Kisu, A. Ueki, Y. Kobayashi, T. Tsuruta,
H. Nomura, F. Kataoka, A. Suzuki, K. Banno, H. Tsuda, D. Aoki, Japan
197
MATRIX METALLOPROTEINASE-1 AND -9 PROMOTER POLYMORPHISMS AND
ENDOMETRIAL CARCINOMA RISK IN A JAPANESE POPULATION
S. Yoshida, Y. Miyahara, M. Amano, R. Hazama, M. Deguchi, H. Morita,
H. Yamada, Japan
198
ASSOCIATION STUDY OF VASCULAR ENDOTHELIAL GROWTH FACTOR
GENE POLYMORPHISMS IN ENDOMETRIAL CARCINOMAS IN A JAPANESE
POPULATION
M. Amano, S. Yoshida, Y. Miyahara, R. Hazama, M. Deguchi, M. Morizane,
H. Yamada, Japan
199
DETECTION OF THE MUCIN GENES (MUC1, MUC3, MUC4, MUC13, MUC15) IN
NORMAL AND NEOPLASTIC ENDOMETRIAL TISSUES
C.-H. Chen, C.-Y. Kao, M.-C. Huang, Taiwan R.O.C.
200
EFFECT OF PERI-OPERATIVE ALLOGENEIC BLOOD TRANSFUSION ON THE
RISK OF RECURRENCE IN ENDOMETRIAL CANCER PATIENTS
S. Uccella, G. Formenti, G. Bogani, N. Donadello, A. Cromi, F. Ghezzi, Italy
201
OUTCOMES OF LAPAROSCOPIC TREATMENT FOR ENDOMETRIAL CANCER
IN OVERWEIGHT AND OBESE PATIENTS
S. Uccella, A. Cromi, M. Serati, G. Formenti, G. Bogani, F. Ghezzi, Italy
202
LARGE-CELL NEUROENDOCRINE TUMOR OF THE UTERUS: A CASE REPORT
G. Formenti, G. Bogani, S. Uccella, C. Apolloni, S. Carollo, T. Rossi, A. Cromi,
F. Ghezzi, Italy
203
PELVIC LYMPHADENECTOMY , SILS VS ROBOT
F. Ciancio, France
204
MANAGEMENT OF RECURRENT ENDOMETRIAL CANCER BASED ON THE
TREATMENT FREE INTERVAL
Y. Kobayashi, K. Banno, I. Kisu, A. Ono, A. Ueki, K. Masuda, Y. Ichikawa,
H. Nomura, A. Hirasawa, N. Susumu, K. Tsukazaki, D. Aoki, Japan
205
THE VALUE OF IN VITRO BROMODEOXYURIDINE LABELING INDEX AS A
PROGNOSTIC FACTOR IN ENDOMETRIAL CANCER
A.C. Iyibozkurt, Y. Doğan, Y. Salihoglu, E. Bengisu, A. Bilir, Turkey
144
Poster Session II
Poster No
206
PROXIMAL-TYPE EPITHELIOID SARCOMA OF THE UTERINE CORPUS. A
CASE REPORT
K. Lathouras, M. Tzafettas, A. Daniilidis, P. Chatzis, E. Anagnostou, C. Nikolaidou,
I. Venizelos, Greece
207
ENDOMETRIAL CARCINOMA IN MONTENEGRO
V. Colakovic-Popovic, B. Colakovic, G. Vukcevic, Montenegro
208
DELAYS IN TREATING ENDOMETRIAL CANCER IN THE SOUTH WEST OF
ENGLAND
T. Miles, N. Johnson, D. Bailey, K. Tyko Hill, N. Das, G. Ahson, K. Waring,
N. Acheson, M. Voss, J. Gordon, S. Keates-Porter, G. Hughes, S. Golby, E. Fort,
L. Newton, V. Nallaswamy, J. Murdoch, South West (UK) Gynaecological Oncology
Group, UK
209
THE EXPRESSION OF GLYOXALASE IN ENDOMETRIAL CARCINOMA AND ITS
EFFECT ON CELL PROLIFERATION AND APOPTOSIS
L. Sui, Q.-S. Guo, H.-Y. Jin, Y.-H. Yu, Y.-J. Feng, China
210
L1-CAM REVEALS NON-ENDOMETRIOID HISTOLOGY IN A SET OF 101
ENDOMETRIOID ENDOMETRIAL CARCINOMAS
Y.P. Geels, L.C. van Kempen, B.B. Gordon, M.P. Snijders, J.M. Pijnenborg,
P. Altevogt, M. Fogel, R. Masadah, J. Bulten, L.F. Massuger, The Netherlands
211
LAPAROSCOPY VERSUS LAPAROTOMY FOR TREATMENT OF ENDOMETRIAL
NEOPLASIA IN OBESE PATIENTS
J. Hauspy, L. Knowles, M.L. Schmuck, Belgium
212
A NEW TREATMENT OF LUNG METASTASES FROM UTERINE SARCOMA:
HYPERTHERMIC PERFUSION WITH ANTICANCER DRUGS IN ISOLATED LUNG
G. Ratto, P. Pronzato, S. Vecchio, A. Puppo, A. Alloisio, P. Cristoforoni, Italy
213
ACCURACY OF PREOPERATIVE DIAGNOSIS OF GRADE 1 ENDOMETRIAL
ADENOCARCINOMA BY D&C
C. Iyibozkurt, O. Kuru, C. Cetin, S. Topuz, S. Kucucuk, E. Yavuz, Y. Salihoglu,
P. Saip, E. Bengisu, S. Berkman, Turkey
214
SURGICAL TREATMENT OF ENDOMETRIAL CANCER ELDERLY PATIENTS (≥
65 YEARS)
P. De Marzi, J. Ottolina, E. Rabaiotti, F. Pella, C. Sigismondi, A. Bergamini,
R. Viganò, Italy
215
DEVELOPMENT OF MICE MODEL FOR INQUIRY INTO THERAPEUTIC
TARGETS: AN ANTICANCER EFFECT OF DIENOGEST ON ENDOMETRIAL
NEOPLASM
F. Saito, H. Tashiro, Y. Miyahara, T. Ohba, H. Katabuchi, Japan
145
Poster Session II
Poster No
216
CERVICAL SARCOMA WITH AN INHUMOHISTOCHEMICAL GIST PROFILE
F.E. Michel Campos, M. Hernandez Suarez, E.C. Estevez Rodriguez, R.A. Vergara
Ibañez, F.J. de la Torre Fernandez de Vega, Spain
217
SURGICAL AND SURVIVAL OUTCOMES OF ENDOMETRIAL CANCER
TREATED WITH LAPAROSCOPIC STAGING SURGERY
C.-L. Lee, Taiwan R.O.C.
218
PROGNOSTIC FACTORS AND RADIOTHERAPY (RT) TOXICITY STAGES I-II
ENDOMETRIAL CARCINOMA (EC): A POPULATION-BASED STUDY IN
TARRAGONA PROVINCE (SPAIN)
M. Arenas, A. Ameijide, V. Hernández, J. Gumà, À. Rovirosa, S. Sabater, Spain
219
DEFINITION OF SURVININ (BIRC5A) IN ENDOMETRIUM BY MEANS OF TEST
SYSTEM «PEPTOSURVIM»
E. Tchoulkova, A. Fedotova, N. Sheshukova, E. Borovkova, I. Makarov, Russia
220
EXPERIENCE WITH STAGES III-IV ENDOMETRIAL CARCINOMA (EC): A
POPULATION-BASED STUDY IN TARRAGONA PROVINCE (SPAIN)
M. Arenas, S. Sabater, A. Rovirosa, A. Ameijide, I. López, V. Hernández, J. Gumà,
Spain
221
A COMPARISON OF ENDOMETRIAL SAMPLING METHODS ON ENDOMETRIAL
CANCER GRADING
S. Balci, P. Karabacakoglu, M. Koyuncuoglu, B. Saatli, U. Saygili, Turkey
222
A SURVEY OF PRACTICE PATTERNS REGARDING THE MANAGEMENT OF
COMPLEX ATYPICAL ENDOMETRIAL HYPERPLASIA (CAH) AMONG
GYNECOLOGIC ONCOLOGISTS
K.H. Kim, T.M. Numnum, G.G. Rao, B.S. Dudley, W.K. Huh, USA
223
CD1A AND S100 POSITIVE DENDRITIC CELLS IN HUMAN ENDOMETRIAL
CANCER
L. Zhao, X. Zhao, L. Wei, X. Li, J. Wang, D. Cacsire-Castillo, China
224
FROZEN SECTION ON PATIENTS WITH PREOPERATIVE DIAGNOSIS OF
COMPLEX ATYPICAL HYPERPLASIA
A. Papadia, M. Moioli, Y. Musizzano, J. Lucci rd, E. Fulcheri, USA
225
PATIENTS WITH EARLY-STAGE UTERINE PAPILLARY SEROUS CANCERS
MAY BENEFIT FROM ADJUVANT PLATINUM-BASED CHEMOTHERAPY
A. Mahdavi, T. Tajalli, U. Gujral, S. Vasilev, S. Lentz, M. Berman, USA
226
CORRELATION BETWEEN PREOPERATIVE D&C AND POSTOPERATIVE
PATHOLOGY IN MALIGNANT MIXED MULLERIAN TUMOR OF THE UTERUS
C. Iyibozkurt, S. Sen, O. Kuru, S. Topuz, Y. Eralp, S. Akhan, S. Tuzlalı, I. Aslay,
S. Berkman, E. Bengisu, Turkey
146
Poster Session II
Poster No
227
RELIABILITY OF PREOPERATIVE DIAGNOSIS OF SEROUS CARCINOMA OF
ENDOMETRIUM
C. Iyibozkurt, C. Cetin, S. Sen, S. Topuz, M. Guveli, Y. Salihoglu, A. Aydıner,
R. Ilhan, S. Berkman, E. Bengisu, Turkey
228
HOW CA-125 IS AFFECTED BY CHEMOTHERAPY IN PATIENTS WITH UTERINE
CANCER: THE BRITISH COLUMBIA CANCER AGENCY EXPERIENCE
R. Correa, N. Le, P. Hoskins, Canada
229
MUTATION OF K-RAS GENE IN CARCINOGENESIS OF ENDOMETRIAL
CARCINOMA
E. Krepinska, M. Chmelarova, V. Palicka, J. Spacek, Czech Republic
230
HYSTEROSCOPY IN DETECTION OF ENDOMETRIAL CARCINOMA IN
POSMENOPAUSAL WOMEN
V. Antovska, G. Kiproska, T. Nikolova, A. Daneva, FYR Macedonia
231
MALIGNANCY RISK OF ENDOMETRIAL POLYPS IN POSTMENOPAUSAL
WOMEN
N. Nikolova, G. Dimitrov, T. Nikolova, FYR Macedonia
232
ULTRASONOGRAPHY IN PREOPERATIVE ASSESSMENT OF MYOMETRIAL
INVASION IN PATIENTS WITH ENDOMETRIAL CANCER
M. Hadzi- Lega, G. Kiproska, M. Hadzi- Lega, T. Nikolova, N. Nikolova,
FYR Macedonia
233
MYXOID AND FIBROUS ENDOMETRIAL STROMAL SARCOMA OF THE
UTERUS: A REPORT OF TWO CASES
H. Kondo, A. Tozawa, J. Koike, N. Yahagi, T. Ohara, N. Suzuki, Y. Kobayashi,
K. Kiguchi, B. Ishizuka, Japan
234
A RETROSPECTIVE STUDY OF UTERINE SARCOMA OVER A PERIOD OF
8YRS AT A ONCOLOGY CENTER IN NORTHERN INDIA
T. Kaur, V. Jain, S. Jain, S. Jain, India
235
INHIBITORY EFFECT OF ROSIGLITAZONE BOMBINED WITH CISPLATIN ON
THE GROWTH OF ENDOMETRIAL CARCINOMA IN NUDE MICE
G. Zhang, Z. Zu, H. Wang, B. Ma, J. Liang, China
236
FOLATE RECEPTORS IN LEIOMYOSARCOMA: A PROMISING TARGET FOR
DIRECTED CHEMOTHERAPY
K. Guffey, R.W. Naumann, R.T. Burks, R.A. Messmann, N. Parker, C.P. Leamon,
USA
237
THE FOLLOW UP OF EARLY STAGE ENDOMETRIAL CANCER - IS IT
WORTHWHILE?
P. Mills, G. Walker, R. O'Donnell, UK
147
Poster Session II
Poster No
238
THE ROLE OF D2-40 (PODOPLANIN) AS A MARKER FOR LYMPH VESSEL
INVASION IN PRIMARY ENDOMETRIAL CANCER
S. Weber, A. Sauerwald, M. Poelcher, M. Braun, M. Debald, N. Serce, W. Kuhn,
C. Rudlowski, Germany
239
ROBOT-ASSISTED LAPAROSCOPIC STAGING OF ENDOMETRIAL CANCER IN
TAIWAN
C.-M. Han, P.-J. Wu, C. Lee, Taiwan R.O.C.
240
SURVIVAL OF WOMEN WITH UTERINE LEIOMIOSARCOMA: A SINGLE
INSTITUTION EXPERIENCE
A.L. Camporeale, V. Loizzi, G. Cormio, C. Nardelli, D. Scardigno, L. Leone,
P. De Mitri, A. Cazzolla, L. Selvaggi, Italy
241
EXPRESSION OF PHOSPHO-MTOR AND MAPK IN ENDOMETRIAL
CARCINOMA
M. Nikolaou, H.P. Kourea, V. Tselepi, P. Ravazoula, K. Koniari, C.D. Scopa,
C. Kalofonos, G. Decavalas, Greece
242
AUDIT OF UTERINE SARCOMAS AT THE UNIVERSITY OF BENIN TEACHING
HOSPITAL, BENIN-CITY, NIGERIA
C. Okonkwo, C. Ochuba, Nigeria
243
INTRAOPERATIVE LYMPHATIC MAPPING WITH 99MTC IN PATIENTS WITH
ENDOMETRIAL CANCER INCREASES THE RATE OF LYMPH NODES
RETRIEVAL
P. Zubor, K. Kajo, I. Reznak, I. Svecova, M. Culbova, J. Danko, Slovak Republic
244
DOWN-REGULATED PROGESTERONE RECEPTOR A AND B COINCIDING
WITH SUCCESSFUL TREATMENT OF ENDOMETRIAL HYPERPLASIA BY THE
LEVONORGESTREL IMPREGNATED IUD
A. Ørbo, Norway
245
HIGH GRADE ENDOMETRIAL STROMAL SARCOMA OF THE UTERUS
B.K. Karakaya, P. Dursun, E. Cabuk, B. Bildaci, N. Haberal, A. Ayhan, Turkey
246
THE SUME LEVELS OF 8-HYDROXY-2'-DEOXYGUANOSINE IN ENDOMETRIAL
AND OVARIAN NEOPLASMS
K. Postawski, K. Romanek, R. Stettner, M. Monist, A. Semczuk, Poland
247
CLINICAL CHARACTERISTICS OF PATIENTS IN CASE OF ENDOMETRIAL
HYPERPLASIA (EH)
J. Vasiljeva, S. Andrejeva, V. Groma, L. Lidaka, I. Barkane, Latvia
248
THE ROLE OF MULTIDISCIPLINARY TEAM MEETINGS IN MANAGEMENT OF
ENDOMETRIAL CANCER
S. Daayana, J. Hunt, P.H.C. Kitchener, D.R.D. Clayton, UK
148
Poster Session II
Poster No
249
CURRENT STATUS OF CLINICAL MANAGEMENT IN ENDOMETRIAL CANCER:
A NATIONAL SURVEY OF THE NORTH-EASTERN GERMAN SOCIETY OF
GYNAECOLOGIC ONCOLOGY (NOGGO)
R. Kraetschell, S. Mahner, O. Camara, C. Fotopoulou, J. Sehouli, Germany
250
MANAGEMENT OF SIMPLE ENDOMETRIAL HYPERPLASIA: QUESTIONNAIRE
SURVEY AND LITERATURE REVIEW
S. Lahiri, UK
251
UTILITY OF NARROW BAND IMAGING TARGETED BIOPSIES IN THE
CONSERVATIVE MANAGEMENT OF ENDOMETRIAL ATYPICAL HYPERPLASIA
V. Masciullo, M. Scarciglia, C. Rossitto, G. Amadio, I. Raimondo, G. Scambia, Italy
252
MORTALITY AND MORBIDITY ASSOCIATED WITH SURGERY FOR
ENDOMETRIAL CANCER IN WOMEN ≥70 YEARS
M. Nourmoussavi, L. Souhami, L. Portelance, R. Agnihotram, J. Arseneau,
C. Martins, A. Giovanni, C. Reinhold, G. Stainimir, L. Gilbert, Canada
253
ACCURACY OF PRE-OPERATIVE ENDOMETRIAL BIOPSY AND MAGNETIC
RESONANCE IMAGING IN PREDICTION OF HISTOLOGICAL TYPE, GRADE
AND STAGE OF ENDOMETRIAL CANCER
S. Daayana, J. Hunt, P.H.C. Kitchener, R.D. Clayton, UK
254
THE CONSIDERABLE FACTORS TO REQUIRE ENDOMETRIAL BIOPSY IN
TAMOXIFEN-TREATED BREAST CANCER PATIENTS
S.W. Lee, Y.-M. Kim, D.-Y. Kim, J.-H. Kim, J.-H. Nam, Y.-T. Kim, Republic of Korea
255
A STUDY OF EXPRESSION AND PROMOTER METHYLATION OF RUNX3 IN
ENDOMETRIAL CANCER TISSUE AND CELL LINE
S. Jeon, D.H. Bae, G.H. Nam, Republic of Korea
256
FIRST CASE REPORT OF A HIGHLY MALIGNANT UTERINE PECOMA
EXPRESSING ESTROGEN AND PROGESTOGEN RECEPTORS: POTENTIAL
FOR A NEW THERAPEUTIC MODALITY
G. Dreyer, N. Mathonsi, R. Makwela, E. Marais, South Africa
257
PTEN-LOSS AND NUCLEAR ATYPIA OF EIN IN ENDOMETRIAL BIOPSIES CAN
PREDICT THE EXISTENCE OF A CONCURRENT ENDOMETRIAL CARCINOMA
K. Pavlakis, I. Messini, T. Vrekoussis, D. Chryssanthakis, P. Yiannou,
E. Stathopoulos, T. Panoskaltsis, Greece
258
MELF INVASION IN ENDOMETRIAL CANCER AS A RISK FACTOR FOR LYMPH
NODE METASTASIS
K. Pavlakis, I. Messini, T. Vrekoussis, D. Chryssanthakis, P. Yiannou, Z. Voulgaris,
T. Panoskaltsis, Greece
149
Poster Session II
Gestational Trophoblastic Neoplasia
Poster No
259
THE STUDY OF GESTATIONAL TROPHOBLASTI DISEASE IN KERMANSHAH,
IRAN
N. Jalilian, F. Keshavarzi, T. Fakheri, A. Nankali, Iran
260
SALVAGE COMBINATION CHEMOTHERAPY WITH FLOXURIDINE,
DACTINOMYCIN, ETOPOSIDE, VINCRISTINE (FAEV) FOR PATIENTS WITH
RELAPSED/CHEMO-RESISTANT GESTATIONAL TROPHOBLASTIC
NEOPLASIA
F. Feng, Y. Xiang, X. Wan, S. Geng, T. Wang, China
261
EARLY PREDICTION OF POSTMOLAR GESTATIONAL TROPHOBLASTIC
NEOPLASM BY USING REGRESSION RATE OF HCG FROM WEEKLY
MEASUREMENT
B. Kim, D. Chay, S. Kim, E. Nam, Y. Kim, J.-H. Kim, Republic of Korea
262
COMPARISON OF ΒHCG REGRESSION CURVE IN MOLAR PREGNANCY AND
GESTATIONAL TROPHOBLASTIC NEOPLASIA
M. Hasanzadeh Mofrad, F. Homaee, Z. Yosefe, M. Afzalaghaee, H. Malakuti,
A. Yousefe, Iran
263
OUTCOME OF GTD CASES OVER A PERIOD OF 5 YEARS IN A TERTIARY
CARE TEACHING HOSPITAL OF INDIA
N. Singh, India
264
INTER- AND INTRA-OBSERVER VARIABILITY IN THE DIAGNOSIS OF
HYDATIDIFORM MOLE AND HISTOLOGICAL DIAGNOSTIC CRITERIA
S. Sarmadi, N. Izadi Mood, M.A. Afandi, S. Sanii, L. Roozbeh Karger, Iran
265
LUNG LOBECTOMY IN THE TREATMENT OF CHEMO-RESISTANT
GESTATIONAL TROPHOBLASTIC NEOPLASIA WITH LUNG METASTASIS
WOTHIN NORMAL RANGE SERUM HCG
F. Feng, Y. Jin, Y. Xiang, L. Ma, X. Wan, China
266
HYPOXIA MODULATES CLUSTERIN OVEREXPRESSION IN THE HUMAN
CHORIOCARCINOMA CELL LINE JEG-3
M.-T. Ha, E.-J. Kim, D.-H. Lee, J.-E. Park, I.-A. Cho, J.-H. Cho, J.-K. Park,
J.-K. Shin, W.-J. Choi, S.-A. Lee, J.-H. Lee, W.-S. Choi, W.-Y. Paik,
Republic of Korea
267
SUCCESSFUL TREATMENT OF PLACENTAL SITE TROPHOBLASTIC TUMOR -3 CASES REPORT AND REVIEW OF LITERATURE
Y. Hu, P. Qu, China
268
GESTATIONAL TROPHOBLASTIC DISEASE: ASPECTS OF CLINICAL
PRESENTATION, MANAGEMENT AND OUTCOME IN UNIVERSITY OF BENIN
TEACHING HOSPITAL, NIGERIA
C. Okonkwo, S. Okoigi, A. Olagbuji, Nigeria
150
Poster Session II
Gestational Trophoblastic Neoplasia (contd.)
Poster No
269
TWO NEW FAMILIES WITH RECURRENT COMPLETE HYDATIDIFORM MOLE:
ONE HAS BIPARENTAL GENOTYPE WITH A NEW MUTATION, OTHER HAS
ANDROGENETIC GENOTYPE
S. Buyukkurt, R.A. Fisher, M.A. Vardar, C. Evruke, Turkey
270
RISK FACTORS FOR COMPLETE MOLAR PREGNANCY, A STUDY IN IRAN
M. Kashanian, H.R. Baradaran, N. Teimoori, Iran
271
UTERUS CHORIOCARCINOMA WITH CERVIX INVASION, A CASE REPORT
E. Karagiannidou, K. Lathouras, M. Tzafettas, G. Pratilas, P. Chatzis,
A. Karagiannidis, K. Papathanasiou, Greece
272
PREGNANCY OUTCOMES AFTER GESTATIONAL TROPHOBLASTIC DISEASE:
A 30-YEAR REVIEW
A.A. Lertkhachonsuk, S. Wilailak, S. Tangtrakul, Thailand
273
DOES PRIMARY HYSTERECTOMY IN ELDERLY HYDATIDIFORM MOLE
DECREASE THE INCIDENCE OF POSTMOLAR GTN?
R. Lertkhachonsuk, A.A. Lertkhachonsuk, Thailand
274
A CASE OF MOLAR ECTOPIC PREGNANCY
A. Hoxha, A. Dokle, Albania
275
GESTATIONAL TROPHOBLASTIC DISEASE AS SEEN IN A UNIVERSITY
TEACHING HOSPITAL: A 5-YEAR REVIEW
Z. Shahverdi, F. Farzaneh, M.S. Hosseini, A. Mashhoori, M. Rafizadeh, Iran
276
WHO SCORE, THE ONLY PREDICTOR OF TREATMENT OUT COME FOR LOW
RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA IN WEEKLY
INTRAMUSCULAR METHOTREXATE REGIMEN
F. Behnamfar, N. Behtash, T. Mohandes, Iran
277
REMARKABLE INCREASE OF GESTATIONAL TROPHOBLASTIC DISEASE IN
THE NETHERLANDS
C. Lybol, C. Thomas, J. Bulten, F. Sweep, L. Massuger, The Netherlands
278
REPRODUCTIVE OUTCOME, MALIGNANT SEQUELAE AND MOLECULAR
GENETICS IN RECURRENT MOLAR PREGNANCIES
R. Bagga, R. Srinivasan, W. Chebaro, R. Slim, India
279
WEEKLY VINCRISTINE PLUS HIGH ESCALATED DOSES OF METHOTREXATE
FOR THE TREATMENT OF CNS METASTASES OF CHORIOCARCINOMA (A
CASE REPORT)
H. Djedi, K. Bouzid, Algeria
280
METHOTREXATE ASSOCIATED PNEUMONITIS: SUCCESSFUL TREATMENT
WITH SECOND LINE SINGLE AGENT ACTINOMYCIN D FOR LOW-RISK
GESTATIONAL TROPHOBLASTIC DISEASE
I.O. Baas, R.H.M. Verheijen, P.O. Witteveen, The Netherlands
151
Poster Session II
Gestational Trophoblastic Neoplasia (contd.)
Poster No
281
SINGLE AGENT CHEMOTHERAPY IN THE TREATMENT OF LOW RISK
GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN)
A. El-Shalakany, A. Abou Louz, A.I. Osman, K.K. Ali, M.N. El-Mahallawi, Egypt
282
MATERNAL AGE AND GESTATIONAL TROPHOBLASTIC TUMORS
G. Mangili, C. Gentile, S. Montoli, E. Garavaglia, M. Petrone, A. Bergamini, Italy
283
THE EVOLUTION OF TREATMENT FOR GESTATIONAL TROPHOBLASTIC
NEOPLASIA(GTN): THE FIRST FIVE DECADES AT THE JOHN I BREWER
TROPHOBLASTIC DISEASE CENTER
J. Schink, J. Lurain, USA
Phase I/II multi-site clinical trails
285
A PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH DEFINITIVE
CHEMORADIOTHERAPY IN UNTREATED PATIENTS WITH LOCALLY
ADVANCED CERVIX CARCINOMA
D. Gaffney, K. Winter, J. Kwon, K. Stuhr, M. Rotman, B. Yaremko, W. Small,
T. Schefter, RTOG, USA
286
PHASE II STUDY OF VEGF-TRAP IN RECURRENT/METASTATIC
GYNECOLOGIC SOFT-TISSUE SARCOMAS. TRIAL OF PMH, CHICAGO AND
CALIFORNIA CANCER PHASE II CONSORTIA
R. Correa, R. Buckanovich, H. Hirte, J. Biagi, P. Hoskins, L. Martin, G. Fleming,
H. Mackay, L. Wang, R. Polintan, A.M. Oza, Canada
Ovarian Cancer
288
EXPRESSION PATTERN OF THE CLASS I HOMEOBOX (HOX) GENES IN
OVARIAN CARCINOMA
J.H. Hong, J.K. Lee, J.J. Park, N.W. Lee, K.W. Lee, J.Y. Na, Republic of Korea
289
VALUES OF SERUM MICRORNAS IN DIAGNOSIS OF EPITHELIAL OVARIAN
CANCER
W. Shi, X. Wan, China
290
GROWING TERATOMA SYNDROME
A.V. Dy Echo, J.T.P. Luna, Philippines
291
RECTO-SIGMOID RESECTION AT THE TIME OF PRIMARY CYTOREDUCTION
FOR ADVANCED OVARIAN CANCER. A MULTI-CENTER ANALYSIS OF
SURGICAL AND ONCOLOGICAL OUTCOMES
M. Peiretti, R.E. Bristow, M. Gerardi, V. Zanagnolo, N. Colombo, L. Bocciolone,
F. Sanguineti, S. Boveri, A. Maggioni, Italy
152
Poster Session II
Poster No
292
TREATMENT OF PSEUDOMYXOMA PERITONEI BY INTRAOPERATIVE AND
INTRAPERITONEAL CHEMOTHERAPY
D. Salehin, W. Poleska, J. Baltzer, M. Friedrich, Germany
293
THE SAFETY AND EFFICACY OF LAPAROSCOPIC SURGICAL STAGING,
DEBULKING OF APPARENT ADVANCED STAGE OVARIAN, FALLOPIAN TUBE,
AND PRIMARY PERITONEAL CANCERS
F. Nezhat, S. DeNoble, C. Liu, J. Cho, D. Brown, L. Chuang, H. Gretz, P. Saharia,
USA
294
THE SAFETY AND EFFICACY OF LAPAROSCOPIC CYTOREDUCTION OF
RECURRENT OVARIAN, FALLOPIAN TUBE, AND PRIMARY PERITONEAL
CANCERS
F. Nezhat, S. DeNoble, D. Brown, J. Cho, L. Chuang, H. Gretz, E. Soto, P. Saharia,
USA
295
LAPAROSCOPIC PRIMARY CYTOREDUCTION OF ADVANCED OVARIAN
CANCER
F. Nezhat, D. Brown, S. DeNoble, P. Saharia, USA
296
NEW RISK -OF -MALIGNANCY INDEX IN PREOPERATIVE EVALUATION OF
ADNEXAL MASSES IN IRANIAN WOMEN
F. Farzaneh, M. Saboury, J. Mohsenifar, Iran
297
THE ASSESSMENT OF LYMPH NODE METASTASES DISTRIBUTION IN
OVARIAN CANCER PATIENTS
L. Gmyrek, J. Jonska-Gmyrek, M. Bidziński, P. Sobiczewski, R. Krynicki,
B. Lindner, J. Staniaszek, A. Zolciak-Siwińska, Poland
298
ANALYSIS OF 3057 CASES OF OVARIAN TUMOR IN NORTHWEST OF CHINA
X. Ma, China
299
CLINICAL AND OPERATIVE OUTCOME OF TERTIARY SURGICAL
CYTOREDUCTION IN EPITHELIAL OVARIAN CANCER RELAPSE
C. Fotopoulou, R. Richter, E.-I. Braicu, S.-C. Schmidt, P. Neuhaus, W. Lichtenegger,
J. Sehouli, Germany
300
SYSTEMATIC REVIEW OF PACLITAXEL INTENSIVE THERAPY FOR OVARIAN
EPITHELIAL CANCER
M. Cheng, C. Xie, D.Q. Wang, R.T. Yin, D.Y. Kang, China
301
A SELECTIVE IMPACT ON GROWTH AND METASTASIS OF OVARIAN CANCER
BASED ON N-TRIMETHYL CHITOSAN CHLORIDE-ENCAPSULATED
CAMPTOTHECIN
L. Zhou, X. Chen, Z. Qian, X. Zhao, China
302
CT SCAN DOES NOT PREDICT OPTIMAL DEBULKING IN ADVANCED
OVARIAN CANCER: A MULTICENTRE VALIDATION STUDY
M. MacKintosh, R. Rahim, B. Rajashanker, D. Barton, E. Brockbank, R. Clayton, UK
153
Poster Session II
Poster No
303
GROWING TERATOMA SYNDROME AFTER SURGICAL TREATMENT AND
CHEMOTHERAPY FOR OVARIAN IMMATURE TERATOMA
N. Cheng, H. Huang, L. Lian, China
304
ADULT GRANULOSA CELL TUMORS OF THE OVARY: TUMOR
DISSEMINATION PATTERN AT PRIMARY AND RECURRENT SITUATION,
SURGICAL OUTCOME AND IMMUNOHISTOCHEMICAL CHARACTERISTICS
C. Fotopoulou, K. Savvatis, E.-I. Braicu, V. Brink-Spalink, C. Denkert,
W. Lichtenegger, J. Sehouli, Germany
305
PEGYLATED-NANOPARTICLES OF CDP BOUND TO MULTITARGETED SIRNA
AGAINST BMI1 AND SURVIVIN CONJUGATED WITH MIR-373 (SEVIN-A)
ERADICATES METASTATIC OVARIAN CARCINOMA
J. Giannios, S. Giannios, J. Peristeris, K. Peristeris, Greece
306
IMMUNOCHEMOGENIC TREATMENT WITH STEALTH NANOPARTICLE
FORMULATION CONSISTING OF CLAMP PNA AGAINST MRNA-FOXC2,ANTICD44 CHIMERIC-MAB,AND TAXOTERE ERADICATED ADVANCED OVARIAN
EPITHELIAL CA
307
COMPARISON OF DIAGNOSTIC VALUE OF SCORING SYSTEMS THAT ARE
USED AT BENIGN-MALIGN DISTINGUISHING OF ADNEXAL MASSES
E. Akturk, I. Alanbay, R. Karaca, M. Dede, M.C. Yenen, I. Başer, Turkey
308
PROGNOSIS AND PROGNOSTIC FACTORS OF A LARGE RETROSPECTIVE
SERIES OF MUCINOUS BORDERLINE TUMORS OF THE OVARY (EXCLUDING
PERITONEAL PSEUDOMYXOMA)
M. Koskas, C. Uzan, S. Gouy, P. Pautier, C. Lhomme, C. Balleyguier,
C. Haie-Meder, J. Duclos, P. Duvillard, P. Morice, France
309
HOW TO FOLLOW-UP ADVANCED-STAGE SEROUS BORDERLINE TUMORS
OF THE OVARY: ANALYSIS OF THE MODE OF DIAGNOSIS OF RECURRENCE
A. Kane, C. Uzan, S. Gouy, P. Pautier, C. Lhomme, C. Haie-Meder, J. Duclos,
P. Duvillard, P. Morice, France
310
PROGNOSTIC FACTORS OF A LARGE SERIES OF PATIENTS WITH SEROUS
BORDERLINE TUMORS OF THE OVARY AND PERITONEAL IMPLANTS
A. Kane, C. Uzan, S. Gouy, A. Rey, P. Pautier, C. Lhomme, J. Duclos, P. Duvillard,
P. Morice, France
311
PROGNOSIS AND PROGNOSTIC FACTORS OF THE MICROPAPILLARY
PATTERN IN PATIENTS TREATED FOR ADVANCED STAGE SEROUS
BORDERLINE TUMORS OF THE OVARY
C. Uzan, A. Kane, S. Gouy, A. Rey, P. Pautier, C. Lhomme, J. Duclos, P. Duvillard,
P. Morice, France
154
Poster Session II
Poster No
312
LNA MODIFIED OLIGONUCLEOTIDES TARGETING MRNA-DICER IN
PEGYLATED COLLOIDAL NANOPARTICLES WITH LINKED ABS AGAINST
CD44 ERADICATE OVARIAN CANCER STEM CELLS (OCSCS)
313
ADMINISTRATION OF GENE-MODIFIED-CELLULAR-VACCINE COMPOSED OF
AUTOLOGOUS- ADIPOSE-DERIVED MESENCHYMAL-STEM-CELLS
TRANSFECTED WITH LIPID-CATION-HSP70 ACTIVATES INNATE AND
ADAPTIVE IMMUNITY ERADICATING METASTATIC OVARIAN CARCINOMA
J. Giannios, Greece
314
RELAPSE OF DYSGERMINOMA DURING PREGNANCY
I. Gounaris, J. Brenton, H. Earl, UK
315
COLLOIDAL-CDNA ENCODING RECOMBINANT PROTEINS-RMDVA
COMPRISING DISINTEGRIN/CYSTEINE-RICH-DISULFIDE BOND 2RGD,AND CTERMINAL DOMAIN ,METALLOPROTEASE-DOMAIN,AND DIMERIC
DISINTEGRIN/MLD-VGD DOMAIN (VADD) INDUCED APOPTOSIS IN OVARIAN
CA
316
TREATED OVARIAN CANCER PATIENTS WITH GENERIC PACLITAXEL, IS IT
EFFECTVE?
P. Suprasert, C. Cheewakriangkrai, K. Charoenkwan, S. Siriaree, C. Kietpeerakool,
C. Saeteng, C. Phongnarisorn, J. Srisomboon, Thailand
317
EXPRESSION OF COX-2 ENZYME IN PLATIN SENSITIVE AND RESISTANT
T. Bese, F. Demirkıran, O. Guralp, R. Sultan, S. Ilvan, C. Sanioglu, M. Arvas, Turkey
318
COMPARISON OF SERUM YKL-40 AND CA125 IN THE EARLY DETECTION OF
OVARIAN CANCER
J. Zhang, L. Zou, X. He, China
319
COMPARISON OF FOUR RISK OF MALIGNANCY INDICES IN EVALUATION OF
OVARIAN MASSES IN SINGAPORE
C. Ong, A. Biswas, J. Low, Singapore
320
THE GENE PROTEIN EXPRESSION OF ERCC1 AND SURVIVIN IN EPITHELIAL
OVARIAN CARCINOMA
C. Xie, China
321
EVALUATION OF IL-10 AND TGF-BETA IN THE PLASMA AND PERITONEAL
FLUID OF PATIENTS WITH ADVANCED OVARIAN CANCER
I. Wertel, N. Stachowicz, E. Rogala, A. Nowicka, G. Polak, J. Kotarski, Poland
322
OVARIAN MASSES IN CHILDREN AND ADOLESCENTS IN CHINA: ANALYSIS
OF 203 CASES
H. Liu, G. Shi, China
155
Poster Session II
Poster No
323
THE IMPACT OF INDUCTION CHEMOTHERAPY FOLLOWED BY INTERVAL
DEBULKING SURGERY IN ADVANCED OVARIAN CANCER - CHANGING
TREND...
K.U. Devi, U.D. Bafna, K. Shobha, V.R. Pallavi, P. Rathod, C. Ramesh, India
324
THE EFFECT OF ENDOSTATIN MEDIATED BY HUMAN MESENCHYMAL STEM
CELLS ON OVARIAN CANCER CELLS IN VITRO
L. PeiLing, China
325
RISK OF MALIGNANT INDICES TO DETECT MALIGNANT PELVIC MASSES IN
THE PREOPERATIVE EVALUATION
H.J. Lee, Y.J. Kim, S.H. Cho, K.T. Kim, Republic of Korea
326
THE CUT-OFF VALUE INVESTIGATION OF SERUM CA125 FOR EVALUATING
THE DISEASE RECURRENCE OF THE EPITHELIAL OVARIAN CARCINOMA
Z. Peng, N. Guo, China
327
CAN CADET (CANCER RISK EVALUATION & EARLY DETECTION) SOFTWARE
IDENTIFY ABNORMAL OVARIAN FINDINGS AS A TOOL FOR OVARIAN
CANCER SCREENING?
J. Hasson, G. Ratttan, I. Heller, D. Grisaru, Israel
328
PROGNOSTIC IMPACT OF CONCOMITANT P53 AND PTEN ON OUTCOME IN
EARLY STAGE (FIGO I-II) EPITHELIAL OVARIAN CANCER (EOC)
I. Skirnisdottir, B. Sorbe, K. Lindborg, T. Seidal, Sweden
329
MECHANISMS OF DYSREGULATION OF EFEMP1 AND CDKN1C IN
EPITHELIAL OVARIAN CARCINOMA
J. Press, K. Wurz, C. Pennil, K. Agnew, R. Garcia, E. Swisher, USA
330
LEPTIN RECEPTORS EXPRESSION IN NEOPLASTIC AND NORMAL OVARIAN
AND ENDOMETRIAL TISSUE
F. Μantzos, G. Wozniak, M. Rekliti, Z. Roupa, Greece, Cyprus
331
WOMEN WITHOUT OVARIAN CANCER WHO REPORT DISEASE-SPECIFIC
SYMPTOMS
E. Pavlik, J. Ubellacker, I. Norris, I. Podzielinski, R. Ware, S. Goodrich,
C. Desimone, F. Ueland, L. Seamon, J. van Nagell, USA
332
HI-CON1, A FACTOR VII-IGGFC CHIMERIC PROTEIN TARGETING TISSUE
FACTOR, FOR IMMUNOTHERAPY OF CHEMOTHERAPY RESISTANT OVARIAN
CARCINOMA
A. Santin, E. Cocco, S. Bellone, C. Richter, F. Casagrande, M. Bellone,
P. Todeschini, N. Buza, R. Tassi, D.-A. Silasi, M. Azodi, E. Ratner, S. Pecorelli,
P. Schwartz, C. Lockwood, T. Rutherford, USA
333
MICRORNA EXPRESSION PATTERN OF HUMAN AGING WITH HISTOTYPES
OVARIAN CANCER
S. Cui, Y. Ding, L. Yang, J. Zhao, Y. Du, G. Guo, China
156
Poster Session II
Poster No
334
RISK OF MALIGNANCY INDEX IN EVALUATION OF PELVIC MASSES
T. Ashrafganjooei, Iran
335
EXTRAOVARIAN CONDITIONS MIMICKING OVARIAN CANCER - A SINGLE
CENTER EXPERIENCE OF 15 YEARS
M. Ozat, S.O. Altinkaya, T. Gungor, M. Caglar, S. Zergeroglu, L. Mollamahmutoglu,
Turkey
336
MICRORNA-31 MODULATES SENSITIVITY TO PACLITAXEL IN AN OVARIAN
CANCER CELL LINE
H. Watari, M. Hassan, T. Mitamura, N. Sakuragi, Japan
337
SYNCHRONOUS OVARIAN ENDOMETRIOID ADENOCARCINOMA WITH A
FUNCTIONING STROMA AND ENDOMETRIAL ENDOMETRIOID
ADENOCARCINOMA DEMONSTRATED DIFFERENT MICROSATELLITE
INSTABILITY FINDINGS
N. Takai, K. Kai, K. Nasu, K. Kashima, H. Narahara, Japan
338
POSSIBLE PROTECTIVE EFFECT OF STATINS IN GYNECLOGICAL CANCERS
O. Lavie, M. Pinchev, Y. Segev, O. Gemer, S. Sagie, H. Rennert, G. Rennert, Israel
339
DO WOMEN WITH SYNCHRONOUS CARCINOMAS OF THE ENDOMETRIUM
AND OVARY HAVE A FAVOURABLE PROGNOSIS COMPARED WITH
EPITHELIAL OVARIAN CANCER PATIENTS?
A.M. van Altena, Y.P. Geels, J. Bulten, L.A. Kiemeney, J.A. de Hullu,
L.F.A.G. Massuger, The Netherlands
340
ANALYSIS OF RNA BINDING PROTEINS IMP1, IMP2, IMP3, LIN 28B
EXPRESSION IN OVARIAN CANCER
K.-F. Hsu, C.-L. Ho, Y.-M. Cheng, Y.-F. Huang, M.-R. Shen, Y.-Y. Chen, C.-Y. Chou,
Taiwan R.O.C.
341
SERUM KL-6 FOR DIAGNOSIS OF OVARIAN CANCER ASSOCIATED WITH
DERMATOMYOSITIS: TWO CASE REPORTS AND CLINICOPATHOLOGICAL
FACTORS
T. Mogami, H. Saji, N. Yokota, Y. Ihata, R. Suzuki, A. Sukegawa, M. Asai-Sato,
E. Miyagi, F. Hirahara, Japan
342
OVARIAN CANCER: OLDER AGE, ADVANCED STAGE AND TIME PERIOD
FREE OF RELAPSE SHOW LINEAR CORRELATION WITH THE DISEASE
RECCURENCE
M. Sprindzuk, M.V. Fridman, Y.E. Demidchik, E.E. Shelkovich, Belarus
343
GRANULOSA CELL - STROMAL TUMORS : AN IMMUNOHISTOCHEMICAL
STUDY INCLUDING A COMPARISON OF CALRETININ AND INHIBIN
Z. Yousefi, M. Dehghani Dashtabi, N. Sharifi, Iran
344
ALTERED PROX1 GENE EXPRESSION IN OVARIAN CANCER
J.C. Kotarski, B. Marzec-Kotarska, M. Cybulski, E. Rogala, A. Nowacka, J. Kocki,
W. Bednarek, Poland
157
Poster Session II
Poster No
345
THE EFFECT OF PRE- AND THROUGHOUT CHEMOTHERAPY HEMOGLOBIN
LEVELS IN PATIENTS WITH PRIMARY EPITHELIAL OVARIAN CARCINOMA
TREATED WITH PLATINUM-BASED CHEMOTHERAPY
M. Benjapibal, K. Pongsanon, I. Ruengkhachorn, Thailand
346
A NEW TREATMENT STRATEGY USING AN M-TOR INHIBITOR (EVEROLIMUS)
FOR OVARIAN CLEAR CELL CARCINOMA (CCC)
T. Hirasawa, Y. Nishijima, T. Sugiyama, M. Ikeda, M. Shida, T. Muramatsu,
M. Mikami, Japan
347
THE LYMPHADENECTOMY COMPLICATIONS IN OVARIAN CANCER PATIENTS
L. Gmyrek, J. Jonska-Gmyrek, P. Sobiczewski, M. Bidzinski, J. Staniaszek,
A. Zolciak-Siwinska, B. Lindner, R. Krynicki, Poland
348
ID1 EXPRESSION WITH SERUM EGF/EGF-R CONCENTRATION ASSESSMENT
IN MALIGNANT OVARIAN TUMORS
A. Czekierdowski, S. Czekierdowska, J. Danilos, A. Nowakowski, N. Stachowicz,
Poland
349
ENCOURAGING RESPONSES WITH BEVACIZUMAB IN RECURRENT LOWGRADE SEROUS OVARIAN CANCER
K. Schmeler, X. Tao, C. Sun, A. Malpica, M. Deavers, A. Sood, R. Coleman,
D. Bodurka, J. Kavanagh, D. Gershenson, USA
350
A RETROSPECTIVE ANALYSIS OF NEOADJUVANT PLATINUM-BASED
CHEMOTHERAPY VERSUS UP-FRONT SURGERY IN ADVANCED EPITHELIAL
OVARIAN CANCER
A. Garcia-Arias, L. Heras, J. Perez de Olaguer, F. Losa, P. Regueiro, L. Camacho,
J. Mas, Spain
351
SIGNIFICANCE OF SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE
(SPARC) EXPRESSION IN EPITHELIAL OVARIAN CANCER
D.S. Suh, K.H. Kim, M.S. Yoon, Republic of Korea
352
SIGNIFICANCE OF PERIOSTIN EXPRESSION IN EPITHELIAL OVARIAN
CANCER
D.S. Suh, K.H. Kim, M.S. Yoon, Republic of Korea
353
COMPUTED TOMOGRAPHY- GUIDED HIGH-DOSE-RATE BRACHYTHERAPY
(HDRBT) ABLATION OF LIVER METASTASIS FROM OVARIAN CANCER INITIAL EXPERIENCE
F. Collettini, A. Poellinger, T. Denecke, P. Wust, J. Sehouli, B. Hamm, B. Gebauer,
Germany
158
Poster Session II
Poster No
354
PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RELAPSED, PLATINUMSENSITIVE OVARIAN CANCER (ROC): RESULTS FROM A LARGE
RANDOMIZED PHASE III TRIAL
J.B. Vermorken, J. Kelley, D. Provencher, S. Vasanthan, C. Krasner, J.A. Arranz,
H. Andersson, L. Dirix, E. Angellier-Lucchi, M. Beltran, J. Cassinello, C. Lebedinsky,
J. Gómez, A. Tanovic, T. Parekh, Y.C. Park, B. Monk, Belgium
355
COST-EFFECTIVENESS OF COMBINATION VERSUS SEQUENTIAL
DOCETAXEL AND CARBOPLATIN FOR THE TREATMENT OF PLATINUM
SENSITIVE RECURRENT OVARIAN CANCER
L. Havrilesky, R. Pokrzywinski, D. Revicki, R. Higgins, L. Nycum, M. Kohler,
E. Myers, A. Alvarez Secord, USA
356
SUSPECTED OVARIAN CANCER AND THE PATHS TO DIAGNOSIS
L. Hess, M. Method, F. Stehman, T. Weathers, P. Gupta, J. Schilder, USA
357
DIFFERENTIAL MICRORNA EXPRESSION IN CISPLATINUM RESISTANT VS.
SENSITIVE OVARIAN CANCER CELL LINES
A. Sherman, L. Hu, C. Melton, D. Kapp, J. Chan, USA
358
IS IT MORE COST EFFECTIVE TO USE BEVACIZUMAB IN THE PRIMARY
TREATMENT SETTING OR AT RECURRENCE? - AN ECONOMIC ANALYSIS
359
SURVIVAL BENEFIT OF NEOADJUVANT CHEMOTHERAPY IN ADVANCED
EPITHELIAL OVARIAN CANCER WITH HIGH CA-125 LEVEL
S. Kang, T.-J. Kim, S.-S. Seo, B.-G. Kim, D.-S. Bae, S.-Y. Park, Republic of Korea
360
COMBINED GYNAECO-PLASTIC APPROACH TO PROPHYLACTIC SURGERY
FOR OVARIAN AND BREAST CANCERS
M. McComiskey, M. Khadim, P. Morrison, K. Khan, J. Price, UK
361
THE IMPACT OF P53 PROTEIN EXPRESSION ON TOPOISOMERASE I,
TOPOISOMERASE IIΑ IMMUNOPOSITIVITY IN OVARIAN CARCINOMAS
J. Bar, P. Grelewski, L. Noga, J. Rabczyński, M. Gryboś, M. Jeleń, Poland
362
CEDIRANIB IN RELAPSED OVARIAN CANCER: STAGE I DATA FROM A
RANDOMIZED, DOUBLE-BLIND PHASE III TRIAL (ICON6)
F. Raja, C. Griffin, W. Qian, A.M. Swart, M. Parmar, H. Hirte, J. Ledermann,
On behalf of ICON6 Collaborators, UK
363
OVARIAN SERTOLI-LEYDIG CELL TUMORS- A CLINIC-PATHOLOGICAL
ANALYSIS OF 40 CASES
D. Cao, Y. Jiaxin, S. Keng, China
364
EAG AND HERG POTASSIUM CHANNELS AS NEW THERAPEUTIC TARGETS
IN OVARIAN CANCER
V. Asher, A. Warren, R. Shaw, H. Sowter, A. Bali, R. Khan, UK
159
Poster Session II
Poster No
365
EXPRESSION OF THE K2P CHANNELS TREK1 (KCNK2) AND TREK2 (KCNK10)
IN EPITHELIAL OVARIAN CANCER
A. Innamaa, V. Asher, A. Bali, R. Khan, H. Sowter, UK
366
GENE EXPRESSION OF OVARIAN CANCER AND THEIR IN VITRO CELL LINES
- ADDRESSING THE PROBLEM OF TRANSLATIONAL CELL CULTURE
RESEARCH
F. Hilpert, A. Sommer, S. Hammer, K. Bräutigamm, A. Strauss, W. Jonat, N. Arnold,
Germany
367
NEOADJUVANT CHEMOTHERAPY PLUS SURGERY VERSUS PRIMARY
SURGERY IN ADVANCED EPITHELIAL OVARIAN CARCINOMA
M.A. Vardar, A.B. Güzel, M. Katar, S. Büyükkurt, Ü. Güleç, D. Gümürdülü, Turkey
368
PREVENTION AND EARLY DETECTION OF METASTATIC OVARIAN TUMORS.
IS IT POSSIBLE?
R. Hemida, Egypt
369
SECONDARY CYTOREDUCTIVE SURGERY FOR RECURRENCE OF
MULLËRIAN CALCINOMA
T. Goto, M. Takano, A. Watanabe, M. Miyamoto, M. Kato, H. Sasa, K. Furuya,
Japan
370
BORDERLINE AND MALIGNANT OVARIAN TUMOURS REVIEW OF 105
PATIENTS
C. Rodrigues, G. Mendinhos, S. Pereira, Portugal
371
MIGHT TGFΒ HAVE AN INFLUENCE FOR PROGRESSION OF CLEAR CELL
ADENOCARCINOMA OF THE OVARY? - A PRELIMINARY STUDY
S. Komiyama, Y. Torii, R. Ichikawa, R. Kato, K. Hasegawa, Y. Udagawa, Japan
372
CONSERVATIVE TREATMENT OF EARLY STAGE MALIGNANT EPITHELIAL
OVARIAN CANCER: ONCOLOGICAL AND FERTILITY OUTCOME IN A SERIES
OF 189 PATIENTS
S. Corso, R. Fruscio, L. Ceppi, A. Garbi, D. Garavaglia, F.P. Sina, I. Floriani,
M.C. Bonazzi, C. Mangioni, R. Milani, Italy
373
ID-2 PROTEIN EXPRESSION AND MICROVESSEL DENSITY ASSESSMENT IN
VARIOUS TYPES OF MALIGNANT OVARIAN TUMORS
A. Czekierdowski, S. Czekierdowska, W. Bednarek, J. Danilos, D. Morawska,
Poland
374
RETROSPECTIVE ANALYSIS OF PATIENTS WITH ADVANCED EPITHELIAL
OVARIAN CANCER WHOSE OVERALL SURVIVAL TIME IS BEYOND FIVE
YEARS
Z. Liu, H. Wen, China
375
MALIGNANT EPITHELIAL OVARIAN CANCERS UNDER THE AGE OF 30 YEARS
KK HOSPITAL EXPERIENCE
N. Ramapadma, Y. Kwai Lam Philip, C. Yin Nin, L. Yong Kuei, S. Lay Tin, Singapore
160
Poster Session II
Poster No
376
A STUDY OF SYMPTOMS FOLLOWING TREATMENT FOR OVARIAN CANCER
C. Stavraka, A. Ford, H. Gabra, R. Agarwal, S. Blagden, UK
377
INTRAPERITONEAL ALPHA-PARTICLE RADIOIMMUNOTHERAPY OF OVARIAN
CANCER PATIENTS: PHARMACOKINETICS AND DOSIMETRY OF AT-211-MX35
F(AB´)2 - A PHASE I STUDY
H. Andersson, E. Cederkrantz, T. Bäck, C. Divgi, J. Elgqvist, J. Himmelman,
G. Horvath, L. Jacobsson, H. Jensen, S. Lindegren, S. Manouchrpour, S. Palm,
R. Hultborn, Sweden
378
HEPATIC SAFETY PROFILE OF TRABECTEDIN IN PHASE II AND III CLINICAL
TRIALS IN RELAPSED OVARIAN CANCER (ROC)
C. Sessa, C. Krasner, J. Rolski, M. Bidzinski, M. Gore, I. Vergote, F. De Braud,
P. Ghatage, H.-G. Meerpohl, B. Monk, C. Poole, I. Ray-Coquard, K. Boman,
J.M. Del Campo, A. Nieto, M.I. De la Riba, P. Zintl, T. Parekh, A. Poveda,
Switzerland
379
CORRELATION OF CA-125 AND RECIST IN THE MANAGEMENT OF
PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER (ROC): RESULTS FROM
OVA-301 PHASE-III RANDOMIZED STUDY
B. Slangen, J. Rolski, P. Gathage, M.B. Sawyer, V. Trillet-Lenoir, S. Pledge, L. Dirix,
W. Zieger, C. Balañá, H. Andersson, J. Gomez, C. Lebedinsky, P. Santabárbara,
T. Parekh, G. Scambia, The Netherlands
380
PREOPERATIVE PLATELET LYMPHOCYTE RATIO AS AN INDEPENDENT
PROGNOSTIC MARKER IN OVARIAN CANCER
V. Asher, J. Lee, A. Innamma, A. Bali, UK
381
STRATIFY, ADJUST OR INTERACT IN TIME-TO-EVENT ANALYSIS IN OVARIAN
CANCER PATIENTS? LESSON TO BE LEARNED
E. Banu, D. Pelau, A. Porutiu, C. Floares, R. Buiga, M. Gal, A. Irimie, Romania
382
THE EFFECTS OF HOPE AND SPIRITUALITY ON QUALITY OF LIFE (QOL) IN
NEWLY DIAGNOSED OVARIAN CANCER PATIENTS
L. Ramondetta, D. Zhukovsky, D. Urbauer, A. Brown, K. Basen-Enquist,
C. Levenback, M. Bevers, P. Thacker, S. Rodriguez, C. Sun, USA
383
THE USE OF FLUOROURACIL (5FU) WITH LEUCOVORIN IN WOMEN WITH
HEAVILY PRETREATED ADVANCED OVARIAN CARCINOMA
R. Eitan, Y. Peled, L. Binyamin, G. Sabah, H. Levavi, Israel
384
THE DIAGNOSTIC VALUE OF PREOPERATIVE SERUM M-CSF LEVELS ALONE
AND IN COMBINATION WITH CONVENTIONAL TUMOR MARKERS IN OVARIAN
CANCER
A.O. Ozdemir Karabag, T. Güngör, N. Taşdemir, Turkey
161
Poster Session II
Poster No
385
MALIGNANT TRANSFORMATION ARISING FROM MATURE CYSTIC
TERATOMA OF THE OVARY: A RETROSPECTIVE STUDY OF 20 CASES
H. Tokunaga, M. Sakuma, A. Otsuki, N. Shiga, T. Otsuki, K. Yoshinaga,
H. Utsunomiya, S. Nagase, T. Takano, H. Niikura, K. Ito, K. Otomo, T. Tase,
Y. Watanabe, N. Yaegashi, Japan
386
COLON AND RECTAL RESECTIONS DURING PERITONECTOMY PLUS HIPEC
IN PATIENTS WITH DIFFUSE OVARIAN PERITONEAL CARCINOMATOSIS
S. Sibio, P. Sammartino, M. Cardi, F. Accarpio, D. Biacchi, A. Baccheschi,
387
IDENTIFICATION OF PROTEOMIC BIOMARKERS IN OVARIAN CANCER
C. Truntzer, J.-M. Riedinger, L. Arnould, L. Favier, F. Mayer, P. Fumoleau,
P. Ducoroy, France
388
AN ECONOMIC ANALYSIS OF BEVACIZUMAB IN RECURRENT TREATMENT
OF OVARIAN CANCER
J. Chan, B. Monk, K. Fuh, R. Urban, L. Hu, A. Caughey, X. Yu, USA
389
MICRORNA EXPRESSION PROFILES THAT PREDICT FOR DISTANT
METASTASIS IN SEROUS OVARIAN CANCER
A. Sherman, A. Sultan, D. Kapp, J. Chan, USA
390
TUBULOGLANDULAR-VARIANT OF HIGH-GRADE OVARIAN SEROUS
CARCINOMA: CLINICOPATHOLOGIC FEATURES OF AN UNCOMMON
AGGRESSIVE TUMOR EASILY MISDIAGNOSED AS LOW GRADE
ENDOMETRIOID ADENOCARCINOMA
A. Aysal, I. Medhi, J. Grenert, J. Rabban, USA
391
COMBINATION OF INTRA-PERITONEAL HYPERTHERMIA AND ALPHAGALACTOSYLCERAMIDE IN TREATING OVARIAN CANCER
C.-L. Chang, Y.-H. Huang, K.-L. Wang, Y.-C. Yang, Taiwan R.O.C.
392
NOVEL ROLE OF METFORMIN IN THE TREATMENT OF OVARIAN CANCER
K.-L. Wang, C.-S. Wong, Y.-C. Yang, C.-L. Chang, Taiwan R.O.C.
393
PREOPERATIVE ANGIOPOIETIN-2 SERUM LEVELS - A MARKER OF
MALIGNANT POTENTIAL IN OVARIAN NEOPLASMS AND POOR PROGNOSIS
IN EPITHELIAL OVARIAN CANCER
H. Sallinen, T. Heikura, S. Laidinen, V.-M. Kosma, S. Heinonen,, S. Yla-Herttuala,
M. Anttila, Finland
394
THE RISK OF LAPAROSCOPY COMPLICATION IN OVARIAN TUMOR
EXTRACTION
N. Kiriakopoulos, I. Kotsidas, E. Gavalas, V. Valentino, P. Mantas, Greece
395
CISPLATIN AND HYPERTHERMIA IN OVARIAN CANCER CELL LINE COC1,
COC1/DDP APOPTOSIS AND DRUG RESISTANCE
R. Yin, Y. Li, China
162
Poster Session II
Poster No
396
RECURRENT EPITHELIAL OVARIAN CANCER - WHICH CHEMOTHERAPY LINE
SHOULD BE THE LAST ONE?
A. Jakobson-Setton, T. Perril, H. De Castro, J. Korach, L. Irmin, M. Beiner, H. Aloni,
N. Zmira, G. Ben Baruch, Israel
397
DOES INTRAPERITONEAL CHEMOTHERAPY BENEFIT OPTIMALLY
DEBULKED EPITHELIAL OVARIAN CANCER PATIENTS AFTER
NEOADJUVANT CHEMOTHERAPY?
H. Latifah, T. Le, L. Jolicoeur, W. Faught, M. Fung Kee Fung, Women with
Advanced Ovarian Cancer Treated with IP Chemotherapy Following Interval
Debulking Surgery, Canada
398
THE CLINICAL BENEFIT OF CIS-PLATIN-ADRIAMYCIN COMBINATION IN
HEAVILY PRETREATED OVARIAN CANCER PATIENTS
M. Steiner, O. Lavie, M. Leviov, Israel
399
A RAPID DECREASE FOLLOWED BY A PLATEAU CONCENTRATION OF
CA125 IN OVARIAN CANCER DURING ADJUVANT CHEMOTHERAPY COULD
PREDICT PATHOLOGICAL RESPONSE
G. Tisi, E. Sartori, F. Ferrari, M. Ragnoli, M. Ratti, F. Odicino, S. Pecorelli, Italy
400
CYTOREDUCTIVE SURGERY AND SEQUENTIAL MAINTENANCE
CHEMOTHERAPY WITH TAXANE AND ORAL ETOPOSIDE FOR ADVANCED
OVARIAN CANCER AND PERITONEAL CANCER
H. Nagano, M. Minabe, K. Kawahara, S. Ide, E. Hata, H. Sanai, S. Sato, A. Kurata,
M. Muraoka, K. Takagi, Japan
401
CONCURRENT SEROUS BORDERLINE TUMORS PREDICT BETTER OUTCOME
IN LOW GRADE SEROUS OVARIAN CARCINOMAS
S. Ueda, D. Swing, T. Diaz-Montes, R. Giuntoli, I.M. Shih, R. Bristow, USA
402
THE UP-REGULATION OF MITOCHONDRIAL ANTI-OXIDATION SIGNAL IN
OVARIAN CANCER CELLS WITH AGGRESSIVE BIOLOGIC BEHAVIORS
Y. Wang, L. Dong, H. Cui, D.H. Shen, Y. Wang, X.H. Chang, T.Y. Fu, X. Ye,
Y.Y. Yao, China
403
BODY MASS INDEX (BMI) DOES NOT AFFECT THE SURVIVAL IN PATIENTS
WITH OVARIAN CANCER
D.H. Suh, H.S. Kim, H.H. Chung, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang,
Republic of Korea
404
RESTAGING IN BORDERLINE OVARIAN TUMORS: SINGLE INSTITUTION
EXPERIENCE AND REVIEW OF THE LITERATURE
P. Rosenberg, I. Zapardiel, M. Peiretti, V. Zanagnolo, A. Maggioni, N. Colombo, Italy
405
SECOND LINE CHEMOTHERAPY WITH GEMCITABINE AND CARBOPLATINUM
REGIMEN IN PATIENTS WITH PERSISTENT OVARIAN CANCER
Z. Samizadeh Nikoy Tabalvandani, M. Modarres Gilani, M. Aghaei, Iran
163
Poster Session II
Poster No
406
ABERRANT METHYLATION OF BRCA1 IN CHEMOSENSITIVE HUMAN
OVARIAN CANCER CELLS DOES NOT INVOLVE THE
PHOSPHATIDYLINOSITOL 3′-KINASE-AKT PATHWAY
Y. Wang, J. Zhang, S. Li, Y. He, Y. Yang, X. Liu, X. Wan, China
407
GENETIC DIAGNOSIS FOR CHEMOSENSITIVITY WITH PACLITAXELSENSITIVE GENES IN EPITHELIAL OVARIAN CANCER
H. Nishi, Y. Nagamitsu, T. Sasaki, Y. Takaesu, F. Terauchi, C. Higuma,
M. Takanashi, M. Kuroda, K. Isaka, Japan
408
NUCLEAR KARYOPHERIN Α2 IS A POTENTIAL PROGNOSTIC MARKER FOR
HUMAN EPITHELIAL OVARIAN CANCER
L. Huang, M. Zheng, H. Ding, Q.-M. Zhou, W.-H. Jia, H.-Y. Wang, China
409
ANTIANGIOGENIC GENE THERAPY WITH SOLUBLE VEGF RECEPTOR-1, -2
AND -3 PROLONGS SURVIVAL OF MICE WITH HUMAN OVARIAN CARSINOMA
M. Sopo, M. Anttila, H. Sallinen, L. Tuppurainen, A. Laurema, S. Laidinen,
K. Hamalainen, P. Tuunanen, V.-M. Kosma, S. Heinonen, K. Alitalo, S. Yla-Herttuala,
Finland
410
TUMOR MARKER CA 125 AS A RESPONSE INDICATOR IN ADVANCED
OVARIAN CANCER AND PREDICTOR OF OVERALL SURVIVAL, TIME TO
PROGRESSION
M. Milovic, L. Stamatovic, I. Popov, I. Kezic, S. Vasovic, Serbia
411
THE ROLE OF REGULAR SURVEILLANCE IN THE DETECTION OF OVARIAN
CANCER RECURRENCE
M. Modaresgillani, T. Ashrafganjooei, F. Ghaemmaghami, Iran
412
PLATINUM-RESISTANCE IN OVARIAN CANCER IS MEDIATED BY THE IL-6CIAP-2 AXIS
I. Bruchim, S. Cohen, D. Graiver, R. Eitan, Z. Evron, V. Oron-Karni,
M. Pasmanic-Chor, H. Hanoch Levavi, A. Fishman, E. Flescher, Israel
413
CYTOKINE GENE EXPRESSION SIGNATURE IN OVARIAN CANCER
N. Yanaihara, A. Okamoto, M. Saito, K. Ochiai, T. Tanaka, Japan
414
PREOPERATIVE LEVELS OF PLASMA FIBRINOGEN AS A PREDICTOR FOR
STAGE, OPTIMAL DEBULKING, AND PLATINUM-RESISTANCE IN EPITHELIAL
OVARIAN CARCINOMA
J.Y. Seoung, H.H. Chung, T.S. Lee, Y.T. Jeon, J.W. Kim, N.H. Park, Y.S. Song,
S.B. Kang, H.P. Lee, Republic of Korea
415
OUTCOMES OF RESTAGING PATIENTS INITIALLY PRESUMED AS STAGE I
EPITHELIAL OVARIAN MALIGNANCY REFERRED FROM PRIMARY CLINIC
K.-C. Chun, Y.-M. Kim, D.-Y. Kim, J.-H. Kim, E.-S. Lee, J.-H. Nam, Y.-T. Kim,
Republic of Korea
164
Poster Session II
Poster No
416
UPREGULATION OF TGFΒ PATHWAY IN OVARIAN CANCER METASTASIS
AND THERAPEUTIC EFFECTS OF ITS INHIBITION
S. Yamamura, N. Matsumura, M. Mandai, T. Baba, J. Hamanishi, K. Yamaguchi,
H.S. Kang, T. Okamoto, K. Abiko, B. Karma, I. Konishi, Japan
417
VEGFR-3 INHIBITION WITH MONOCLONAL ANTIBODY IN METASTATIC
OVARIAN CANCER
K. Zakashansky, S. Podgrabinska, S. Das, B. Pytowski, P. Dottino, M. Skobe, USA
418
A FEASIBILITY STUDY OF INTRAVENOUS PACLITAXEL, INTRAPERITONEAL
CARBOPLATIN AND INTRAPERITONEAL PACLITAXEL IN PATIENTS WITH
S. Nagao, Y. Sogawa, Y. Mizugami, A. Kurosaki, R. Oishi, N. Iwasa, K. Hasegawa,
K. Fujiwara, Japan
419
INVOLVEMENT OF MISMATCH REPAIR (MMR) ABNORMALITY IN THE
MALIGNANT TRANSFORMATION OF OVARIAN ENDOMETRIOSIS
C. Fuseya, A. Horiuchi, A. Hayashi, N. Kikuchi, A. Suzuki, A. Takatsu, R. Osada,
T. Shiozawa, Japan
420
EVALUATION OF HUMAN EPIDIDYMAL SECRETORY PROTEIN E4 (HE4) FOR
MONITORING FOR OVARIAN CANCER RECURRENCE
K. Chan, K.F. Tam, H. Ngan, Hong Kong S.A.R.
421
THE PATTERN OF PERITONEAL SEEDING AND LYMPH NODE METASTASIS IN
PATIENTS WITH ADVANCED AND RECURRENT OVARIAN CANCER
J.H. Hwang, S.Y. Park, S.Y. Jung, S.W. Kim, S.H. Park, M.C. Lim, S. Kang, S.-S.
Seo, S.-Y. Park, Republic of Korea
422
WHOLE BLOOD RNA EXPRESSION PROFILES IN OVARIAN CANCER
PATIENTS WITH OR WITHOUT RESIDUAL TUMOR AFTER THE PRIMARY
CYTOREDUCTIVE SURGERY
H. Isaksson, B. Sorbe, T.K. Nilsson, Sweden
423
BRCA1 MUTATIONS, ALLELIC LOSS AND PROTEIN EXPRESSION IN OVARIAN
CANCERS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL AND MOLECULAR
DATA
I. Rzepecka, L. Szafron, A. Stys, A. Rembiszewska, A. Felisiak, R. Madry,
A. Danska-Bidzinska, E. Skasko, J. Markowska, J. Kupryjanczyk, Poland
424
MERCURY AND ARSENIC LEVELS IN URINE OF PATIENTS WITH
ENDOMETRIOSIS AND ENDOMETRIOID OVARIAN CANCER
R. Sozanski, M. Grybos, Poland
425
A SUCCESSFUL THERAPEUTIC REGIMEN FOR RECURRENT EPITHELIAL
OVARIAN CARCINOMA: CHEMOTHERAPY COMBINED WITH SURGERY AND
RADIOTHERAPY
X. Huang, S.M. Cai, J. Tang, R.Y. Zang, X.H. Wu, Z.T. Li, H.Y. Wang, China
165
Poster Session II
Poster No
426
TISSUE FACTOR-FACTOR VIIA COMPLEX INDUCES EPITHELIAL OVARIAN
CANCER CELL INVASION AND METASTASIS THROUGH A MONOCYTESDEPENDENT MECHANISM
X. Wang, T. Zhang, China
427
CLINICAL AND PROGNOSTIC ROLE OF E-CADHERIN EXPRESSION IN
OVARIAN PERITONEAL CARCINOMATOSIS TREATED BY PERITONECTOMY
AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC)
F. Accarpio, S. Sibio, P. Sammartino, M. Cardi, D. Biacchi, A. Baccheschi,
428
ENDOMETRIOSIS AND ASSOCIATED OVARIAN MALIGNANCY ARISING IN THE
POSTMENOPAUSAL PATIENTS: A RETROSPECTIVE ANALYSIS OF
PRESENTATION, TREATMENT, AND OUTCOME
L. Garrett, W.B. Growdon, C. McCann, D. Boruta, M. del Carmen, J.O. Schorge,
R. Penson, A. Russell, A. Goodman, USA
429
HEATED INTRAPERITONEAL CHEMOPERFUSION IN THE MANAGEMENT OF
PATIENTS WITH CARCINOMA OF THE OVARY
B. Benigno, USA
430
A RETROSPECTIVE STUDY OF 43 BORDERLINE TUMORS OF THE OVARY A
REVIEW OF CLINICOPATHOLOGIC FEATURES AND TREATMENT
MODALITIES
A. Dokle, A. Hoxha, S. Celiku, Albania
431
SURGERY TREATMENT PATTERNS AND OUTCOMES OF OVARIAN CANCER
PATIENTS WITH NON-EPITHELIAL TUMORS: RESULTS FROM A CDC STUDY,
UNITED STATES
S.H. Rim, S.L. Stewart, T.D. Thompson, J.M. Wike, R.D. Cress, C.D. O'Malley,
A.R. Kahn, M.J. Schymura, K. Bauer, USA
432
LEAD-TIME OF RISING CA-125 LEVELS IN NORMAL RANGE (< 35 U/ML) TO
RADIOLOGIC RECURRENCE IN PATIENTS WITH EPITHELIAL OVARIAN
CANCER
J. Bandyopadhyay, S. Ghamande, L. Zhang, L. Lan, M. Macfee, USA
433
LEAD-TIME OF RISING CA-125 LEVELS >35 U/ML TO RADIOLOGIC
CONFIRMATION OF RECURRENT DISEASE IN PATIENTS WITH EPITHELIAL
OVARIAN CANCER (EOC)
J. Bandyopadhyay, S. Ghamande, L. Zhang, L. Lan, M. Macfee, USA
434
REDUCTION IN ONE LOGARITHM BETWEEN PREOPERATIVE AND
POSTOPERATIVE CA-125 LEVEL IS AN INDEPENDENT FACTOR FOR
SURVIVAL IN ADVANCED OVARIAN CANCER
J. Brañes, J. Cartagena, M. Cuello, D. Mayerson, J. Badía, C. Vera, Chile
166
Poster Session II
Poster No
435
GYNECOLOGIC ONCOLGY GROUP(GOG)´S OVARIAN CANCER
TRIALS,RESEARCH INTEGRITY,WORLDWIDE ECONOMIC AND MEDICOLEGAL IMPLICATIONS
M. Yoonessi, USA
436
MTOR IS A PROMISING THERAPEUTIC TARGET BOTH IN CISPLATINSENSITIVE AND CISPLATIN-RESISTANT CLEAR CELL CARCINOMA OF THE
OVARY
S. Mabuchi, Japan
437
THE VALUE OF GRIM-19 PROTEIN EXPRESSION IN THE ETIOLOGY OF
X. Wang, X. Cheng, W. Lv, C. Zhou, X. Xie, China
438
ANALYSIS OF CA-125 AS A PROGNOSTIC FACTOR IN OVARIAN CANCER
PATIENTS
S.Y. Han, J.Y. Song, N.W. Lee, J.K. Lee, T. Kim, K.W. Lee, Republic of Korea
439
COMPARISON OF FOUR RISK OF MALIGNANCY INDICES IN DETECTION OF
MALIGNANT OVARIAN MASSES
E. Akturk, R. Karaca, I. Alanbay, M. Dede, E. Karasahin, M.C. Yenen, I. Baser,
Turkey
440
TRIAGE WITH RMI RESULTS IN BETTER TREATMENT OF EARLY AND
ADVANCED OVARIAN CANCER: A PROSPECTIVE POPULATION STUDY
J. van der Velden, R. Verheijen, M. van Beurden, M. Buist, W. Wegdam, I. Mulder,
O. Visser, The Netherlands
441
ACTIVATION OF THE MEK/ERK PATHWAY MAY OVERCOMES THE
CISPLATIN-RESISTANCE IN OVARIAN CARCINOMA CELLS
H. Itamochi, M. Nonaka, W. Kawaguchi, K. Uegaki, J. Naniwa, S. Sato, M. Shimada,
T. Oishi, N. Terakawa, T. Harada, J. Kigawa, Japan
442
DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT OVARIAN TUMORS
DURING PREGNANCY
D. Doi, N. Tateyama, N. Nishida, M. Nakagawa, Y. Boh, T. Fukami, T. Matsushima,
H. Asakura, T. Takeshita, Japan
443
IMPACTS OF N-FACTOR ON PROGNOSIS OF T3C OVARIAN CANCER AFTER
OPTIMAL SURGERY
F. Terauchi, J. Nagafuji, R. Oomura, K. Wake, H. Shimada, T. Ishikawa, S. Jinbo,
T. Sasaki, Y. Wada, A. Mitsumori, Y. Takaesu, Y. Sagawa, H. Nishi, K. Isaka, Japan
444
PREVALENCE OF SOMATIC MUTATION HOT SPOTS IN GRADE 2 AND 3
ADVANCED STAGE SEROUS PAPILLARY OVARIAN CANCER
E. Despierre, B. Yesilyurt, B. Claes, K. Wetzels, K. Drijkoningen, K. Leunen,
P. Neven, F. Amant, D. Lambrechts, I. Vergote, Belgium
167
Poster Session II
Poster No
445
SECOND LINE CHEMOTHERAPY FOLLOWED BY CYTOREDUCTIVE SURGERY
IN THE MANAGEMENT OF RECURRENT EPITHELIAL OVARIAN CANCER
T. Dell'Anna, C. Pirovano, R. Fruscio, F.P. Sina, M. Signorelli, A. Buda, L. Ceppi,
R. Milani, Italy
446
PHASE II TRIAL OF BIWEEKLY DOCETAXEL AND MONTHLY CARBOPLATIN
IN THE TREATMENT OF PLATINUM SENSITIVE RECURRENT OVARIAN OR
TUBAL CANCER
K. Ushijima, H. Kobayashi, T. Hachisuga, S. Miyamoto, T. Shimamoto, K. Iio,
N. Ohkura, H. Matsumoto, M. Yokoyama, K. Tamura, T. Kamura, West Japan
Gynecologic Oncology Group (WJGOG), Japan
447
THE DIFFERENT CLINICAL FEATURES OF EARLY STAGE MUCINOUS
OVARIAN CANCER ACCORDING TO THE PATHOLOGIC EXTENT OF STROMAL
INVASION
K.Y. Kong, D.J. Kim, J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, K.R. Kim, J.H. Nam,
Y.T. Kim, Republic of Korea
448
COST-EFFECTIVENESS ANALYSIS OF PER-OPERATIVE INTRA-PERITONEAL
CHEMOTHERAPY (POIPCT) IN ADVANCED EPITHELIAL OVARIAN CANCER
(EOC) MANAGEMENT
V. Nerich, M. Demarchi, B. Heyd, D. Delroeux, B. Royer, E. Kalbacher, C. Borg,
X. Pivot, M.-C. Woronoff-Lemsi, S. Limat, France
449
EFFECTS OF PHOTODYNAMIC THERAPY IN COMBINATION WITH 2METHOXYESTRADIOL ON APOPTOSIS IN HUMAN OVARIAN CLEAR
CARCINOMA CELL LINE (OVBH-1)
J. Saczko, J. Kulbacka, A. Chwiłkowska, M. Drag-Zalesinska, M. Dumanska,
T. Wysocka, J.K. Bar, Poland
450
OVARIAN MALIGNANT GERM CELL TUMORS COEXISTING WITH OR
FOLLOWING COMMON OVARIAN BENIGN TUMORS
T.C. Chen, T.Y. Wang, Y.H. Huang, C.C. Shih, J.R. Chen, S.J. Chang, C.L. Chang,
K.L. Wang, Y.C. Yang, Taiwan R.O.C.
451
TREATMENT OUTCOME OF CARCINOSARCOMA OF OVARY: COMPARISON
WITH SEROUS EPITHELIAL OVARIAN CARCINOMA
J.-H. Kim, D.J. Kim, J.-Y. Park, D.-Y. Kim, Y.-M. Kim, Y.-T. Kim, J.-H. Nam,
Republic of Korea
452
ONCOLOGIC AND REPRODUCTIVE OUTCOMES OF PATIENTS WITH OVARIAN
YOLK SAC TUMOR AFTER BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP)
CHEMOTHERAPY FOLLOWING SURGERY
J.-H. Kim, Y.B. Kim, J.-Y. Park, D.-Y. Kim, Y.-M. Kim, Y.-T. Kim, J.-H. Nam,
Republic of Korea
453
CA125-SPECIFIC CYTOTOXIC T LYMPHOCYTES FOR THE TREATMENT OF
ADVANCED OVARIAN CANCER
T. Akahori, T. Nagai, Y. Takai, M. Okubo, S. Takeda, H. Maeda, H. Seki, Japan
168
Poster Session II
Poster No
454
EVALUATION OF THE IMMUNE ACTIVATION STATUS OF T-CELLS
INFILTRATING OVARIAN CANCER
A. Nowicka, I. Wertel, W. Bednarek, E. Rogala, J. Daniłoś, J. Kotarski, Poland
455
SURVIVAL IN OVARIAN CANCER PATIENTS WITH RECURRENCES: DOES
DETECTION MODE MATTER?
S.M.E. Geurts, J.A.A.M. van Dijck, F. de Vegt, A.M. van Altena,
V.C.G. Tjan-Heijnen, L.F.A.G. Massuger, A.L.M. Verbeek, The Netherlands
456
EXPRESSION OF NEUROPILIN-1 IN OVARIAN CANCER
M. Mazurek-Kociubowska, W. Bednarek, M. Sobstyl, B. Marzec, Poland
457
INTRACELLULAR EXPRESSION OF INTERLEUKIN-17 (IL-17) IN THE
PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS WITH OVARIAN CANCER
E. Rogala, I. Wertel, W. Bednarek, A. Nowicka, J. Kotarski, A. Kondracka,
J. Kotarski, Poland
458
BRCA1 PROTEIN EXPRESSION IN PATIENTS WITH OVARIAN AND BREAST
CANCER
G. Shechter Maor, I. Bruchim, A. Fishman, Israel
459
INFLUENCE OF SIRNA MEDIATED MESOTHELIN-SCILENCE ON GROWTH OF
HUMAN OVARIAN SKOV3 CELL XENOGRAFT IN NUDE MICE
W. Xiaohua, China
460
TREATMENT EFFECT OF MESOTHELIN TARGETED SIRNA GENE THERAPY
ON OVARIAN EXNOGRAFTS IN NUDE MICE
Y. Bo, China
461
VALUE OF SERUM MESOTHELIN IN DIAGNOSIS AND CONDITION
MONITORING OF EPITHELIAL OVARIAN CANCER
L. Dongxiu, China
462
EVALUATION OF OBATOCLAX FOR THE TREATMENT OF OVARIAN CANCER
V. Stamelos, H. Bamrah Singh, C. Allen, C. Redman, A. Richardson, UK
463
PROGNOSTIC SIGNIFICANCE OF THE RELATIVE DOSE INTENSITY OF
CHEMOTHERAPY IN PRIMARY TREATMENT OF EPITHELIAL OVARIAN
CANCER
J. Fauci, J. Whitworth, A. Subramaniam, K. Schneider, P. Frederick, B. Zhang,
J.M. Straughn, L. Kilgore, USA
464
SYNCHRONOUS PRIMARY CANCERS OF THE ENDOMETRIUM AND OVARY: A
RETROSPECTIVE CLINICOPATHOLOGICAL STUDY
S. Perotto, E. Tripodi, V. Zanfagnin, N. Ravarino, L. Fuso, P. Zola, A. Ferrero, Italy
169
Poster Session II
Poster No
465
EXTERNAL VALIDATION OF THE ADAPTED RISK OF MALIGNANCY INDEX
INCORPORATING TUMOR SIZE IN THE PREOPERATIVE EVALUATION OF
ADNEXAL MASSES
P. van den Akker, K. Kluivers, P. Zusterzeel, A. Aalders, M. Snijders, R. Samlal,
J. Vollebergh, L. Massuger, The Netherlands
466
CHARACTERIZATION OF SYNCHRONOUS GYNECOLOGIC CANCERS: A
SINGLE INSTITUTION REVIEW OF 44 CASES
M.K. Kim, Y.Y. Lee, C.H. Choi, T.J. Kim, J.W. Lee, B.G. Kim, D.S. Bae,
Republic of Korea
467
A RETROSPECTIVE REVIEW OF COMBINATION LOW DOSE ORAL
CYCLOPHOSPHAMIDE, TAMOXIFEN AND PROPHYLACTIC WARFARIN IN
HEAVILY PRETREATED OVARIAN CANCER
M. Hall, G. Rustin, UK
468
PHASE II STUDY OF IFOSFAMIDE AND CISPLATIN IN RECURRENT OVARY
CANCER
M.K. Kim, H.J. Kim, W.S. Lee, T.J. Song, H.S. Park, Y.Y. Lee, J.-W. Lee, D.-S. Bae,
J.H. Lee, B.-G. Kim, Republic of Korea
469
FACTORS INFLUENCING THE USE OF FROZEN SECTION ANALYSIS IN THE
DIAGNOSIS OF ADNEXAL MASSES: WHICH FACTORS ARE LEGITIMATE?
P. van den Akker, P. Zusterzeel, K. Kluivers, A. Aalders, M. Snijders, R. Samlal,
J. Vollebergh, L. Massuger, The Netherlands
470
ASSOCIATION OF LYMPHADENECTOMY AND SURVIVAL IN STAGE I
R.V. Sicam, J.T. Luna, Philippines
471
TEN YEARS RESULTS OF OVARIAN CANCER TREATMENT IN A SINGLE
CENTER
E. Verweij, I.O. Baas, H.W.R. Schreuder, P.O. Witteveen, The Netherlands
472
IS MICROINVASION A RISK FACTOR FOR RELAPSES OF BORDERLINE
OVARIAN TUMORS?
B. Di Marcoberardino, P. De Iaco, A. Ferrero, L. Ricci Maccarini, I. Strada,
M.J. Tsivian, F. Pozzati, N. Biglia, S. Venturoli, Italy
473
ROMA ALGORYTHM IN THE TRIAGE OF PELVIC MASSES
R. Passerini, M.T. Sandri, D. Franchi, S. Boveri, M. Peiretti, P. Lentati, S. Ronzoni,
P. Fenili, M. Sideri, Italy
474
INTERNATIONAL COOPERATION FOR CANCER CARE: PROTOCOL
DEVELOPMENT FOR OVARIAN CANCER TREATMENT IN KENYA
L. van Lonkhuijzen, L. Sterling, J. Nyangena, E. Orango, B. Rosen, Canada
170
Poster Session II
Poster No
475
UNSPECIFIC CANCER-RELATED INFLAMMATION SUBVERTS THE ADAPTIVE
ANTI-TUMOR IMMUNE RESPONSE MOUNTED AT THE OVARIAN CANCER
SITE
A. Wagener, D. Reimer, C. Marth, A.G. Zeimet, Austria
476
(PRE)MALIGNANCIES IN THE FALLOPIAN TUBE OF BRCA-MUTATION
CARRIERS: A SITE OF ORIGIN FOR SEROUS PELVIC CARCINOMA OR A
PHYSIOLOGICAL FINDING?
T. Roelofsen, M. Smink-Bol, J. de Hullu, J. Bulten, M. van Ham, L. Massuger,
The Netherlands
477
VIDEO-ASSISTED THORACIC SURGERY (VATS) EVALUATION OF
INTRATHORACIC DISEASE IN PATIENTS WITH FIGO III AND IV EPITHELIAL
OVARIAN CANCER
M. Stumpf, M. Klar, C. Stremmel, G. Gitsch, G. Pache, A. Hasenburg, Germany
478
FEASIBILITY AND MORBIDITY OF INTERVAL DEBULKING SURGERY AFTER
SIX CICLES OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH
OVARIAN CANCER
I. Strada, L. Ricci Maccarini, L. Orazi, C. Zamagni, M. Rosati, D. Santini, G. Caprara,
D. Caruso, F. Pozzati, M.J. Tsivian, P. De Iaco, S. Venturoli, Italy
479
COMPARISON OF PRIMARY DEBULKING SURGERY WITH NEOADJUVANT
CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY IN
ADVANCED STAGES OF OVARIAN CANCER
F. Ortaç, M. Güngör, S. Taskin, Turkey
480
THE UNIQUE TUMOUR MICROENVIRONMENT OF OVARIAN CLEAR CELL
CARCINOMA
S. Deen, L. Quattrocchi, M. Sisson, S. Martin, L. Durrant, UK
481
ADNEXAL MASSES: RISK FACTORS EVALUATION
M. Terzic, I. Likic, J. Dotlic, J. Micic, S. Milenkovic, I. Pilic, S. Aksam, Serbia
482
SERUM PROTEOMIC BIOMARKERS FOR OVARIAN CANCER
C. Coveney, A. Miles, V. Asher, I. Spendlove, G. Ball, I. Scott, G. Van Schalkwyk,
R. Rees, R. Shaw, B. Matharoo-Ball, UK
483
VALUE OF RISK OF MALIGNANCY INDEX AS A PREDICTOR OF ADNEXAL
MASSES NATURE
M. Berisavac, M. Terzic, J. Micic, J. Dotlic, I. Likic, J. Atanackovic, Serbia
484
PARTIAL RESPONSE TO IMATININ MESYLATE IN RELAPSING GRANULOSE
CELL TUMORS (GCTS) OF THE OVARY
F. Raspagliesi, F. Martinelli, B. Grijuela, F. Hanozet, E. Solima, V. Guadalupi,
F. Zanaboni, A. Ditto, Italy
171
Poster Session II
Poster No
485
FINAL RESULTS OF A GERMAN SURVEY IN 676 PATIENTS: WHAT DO
OVARIAN CANCER PATIENTS EXCEPT FROM THEIR DOCTOR?
G. Oskay-Özcelik, R. Chekerov, S. Neubert, K. Münstedt, C. Liebrich, L.-C. Hanker,
R. Lorenz, P. Wimberger, S. Mahner, R. Langenberg, U. Ulrich, M. Aydogdu,
J. Sehouli, NOGGO North Eastern Gynecologic Oncology Group, Germany
486
CARSINOSARCOMA OF THE OVARY: AN UPDATED SERIES
J.A. Rauh-Hain, W.B. Growdon, N. Rodriguez, A.K. Goodman, J.O. Schorge,
D.M. Boruta II, N.S. Horowitz, M.G. del Carmen, USA
487
CLINICAL OUTCOMES IN BRCA1 AND BRCA2 MUTATION CARRIERS WITH
EARLY STAGE OVARIAN OR FALLOPIAN TUBE CANCER
M. Yates, L. Meyer, M. Deavers, M. Daniels, D. Urbauer, S. Mok, K. Lu, USA
488
PATTERN OF FAILURES OF PATIENTS WITH RECURRENT EPITHELIAL
OVARIAN CANCER
C. Cassani, E. Di Silverio, S. Salamano, C. Klersy, S. Tateo, Italy
489
OVA1 HAS HIGH SENSITIVITY IN IDENTIFYING EARLY STAGE OVARIAN
CANCERS
F. Ueland, C. Desimone, L. Seamon, R. Ware, S. Goodrich, I. Podzielinski, A. Smith,
J. Santoso, J. van Nagell, Jr., Z. Zhang, USA
490
MORPHOLOGIC, IMMUNOHISTOCHEMICAL AND MOLECULAR
CORRELATIONS OF OVARIAN AND TUBAL DYSPLASIA IN PROPHYLACTIC
OOPHORECTOMIES FOR GENETIC RISK
G. Chene, F. Penault-Llorca, I. Raoelfils, E. Pierre, P. Vago, Y.-J. Bignon,
I. Ray-Coquard, C. Pomel, J. Dauplat, France
491
THE SAFETY OF CONSERVATIVE TREATMENT OF BORDERLINE OVARIAN
TUMORS
H. Olszewska, S. Łapińska-Szumczyk, J. Kobierski, A. Abacjew-Chmyłko, D. Wydra,
Poland
492
ANTI-MÜLLERIAN HORMONE (AMH) IS A GROWTH INHIBITOR OF OVARIAN
GRANULOSA CELL TUMORS
M. Anttonen, A. Färkkilä, H. Tauriala, M. Kauppinen, L. Unkila-Kallio, R. Butzow,
M. Heikinheimo,, Finland
493
ROLE OF FROZEN SECTION DURING CONIZATION OF THE UTERINE CERVIX
FOR THE EVALUATION OF HIGH GRADE CIN II-III
N. Saghafi, M. Hasanzadeh, S. Bahman, V. Tetedeg, A. Bahman, Iran
494
SYNCHRONOUS PRIMARY CARCINOMAS OF THE ENDOMETRIUM AND
OVARY
B. Djordjevic, Lj. Jankovic Velickovic, S. Stojanovic, D. Zivanovic, Serbia
172
Poster Session II
Poster No
495
NOMOGRAM FOR 30-DAY MORBIDITY AFTER PRIMARY CYTOREDUCTIVE
SURGERY FOR ADVANCED STAGE OVARIAN CANCER
G.M. Nieuwenhuyzen-de Boer, C.G. Gerestein, M.J. Eijkemans, C.W. Burger,
G.S. Kooi, The Netherlands
496
KRUKENBERG TUMORS OF THE OVARY - TEN YEARS OF OCCURRENCES
D. Coelho, R. Miguelote, R. Santos, L. Alves, P. Vieira de Castro, F. Tavares,
Portugal
497
EXPRESSION OF NUCLEAR FACTOR-KAPPA B FAMILY PROTEINS IN
OVARIAN CANCER AND THEIR POTENTIAL LIKE PROGNOSTIC FACTORS
R.D. Garcia Marrero, J. de la Torre, F. Rojo, M.M. Alonso Socas, J. Oramas
Rodriguez, L.M. Rodriguez Rodriguez, E. Rodriguez Rodriguez, R. Hernández San
Gil, N. Batista López, Spain
498
IN VITRO BROMODEOXYURIDINE LABELING INDEX MAY BE VALUABLE AS A
PROGNOSTIC FACTOR FOR PREDICTING RECURRENCE IN OVARIAN
CANCER
Y. Doğan, A. Bilir, Y. Salihoglu, S. Topuz, S. Berkman, C. Iyibozkurt, Turkey
499
ACCURACY OF INTRAOPERATIVE FROZEN SECTION ANALYSIS REPORTED
AS BORDERLINE OR UNDECIDED IN EPITHELIAL OVARIAN TUMORS
T. Simsek, H. Komur, E. Pestereli, Turkey
500
GENETIC POLYMORPHISM OF NAT2 IN PATIENTS WITH OVARIAN
CARCINOMAS
S. Shelkovich, N. Chakova, E. Krupnova, N. Chebotareva, E. Mikhalenko,
Y. Demidchik, Belarus
501
THE ROLE OF THROMBOCYTOSIS IN PREOPERATIVE ASSESSMENT FOR
OVARIAN MASSES
E. Myriokefalitaki, N. Burbos, C. Siozos, K. Blanas, M. Abu-Freij, S. Crocker,
J. Nieto, T. Duncan, UK
502
DO DIFFERENT RISK MALIGNANCY INDICES PERFORM EQUALLY IN THE
PREOPERATIVE EVALUATION OF PREMENOPAUSAL AND
POSTMENOPAUSAL WOMEN WITH OVARIAN MASSES?
N. Burbos, C. Siozos, K. Blanas, M. Abu-Freij, E. Greig, S. Crocker, J. Nieto,
T. Duncan, UK
503
MANAGEMENT OF METASTATIC NEUROECTODERMAL TUMOUR IN
PREGNANCY
L. Tan, J. Kaur, M. Gore, J. Bridges, UK
504
CHEMOSENSITIVITY TESTING: DO IN-VITRO RESULTS MIRROR EMPIRICAL
RESPONSE RATES?
S. Richard, T. Herzog, T. Krivak, M. Cibull, C. Leath, R. Coleman, USA
505
THE MALIGNANT TRANSFORMATION OF ATYPICAL ENDOMETRIOSIS
L. Tan, J. Kaur, R. Richardson, J. Bridges, UK
173
Poster Session II
Poster No
506
LARCIST: A NEW PROPOSED METHOD FOR THE ASSESSMENT OF
RESPONSE TO CHEMOTHERAPY IN ADVANCED OVARIAN CANCER
PATIENTS
G. Vizzielli, F. Fanfani, B. Costantini, V. Gallotta, M.L. Gagliardi, M. Vigliotta,
L. Tortorella, G. Scambia, A. Fagotti, Italy
507
U.S. GOG 218 VS. EURO ICON7 - A COST ANALYSIS OF BEVACIZUMAB IN
THE PRIMARY TREATMENT OF OVARIAN CANCER
508
SELECTED RARE TUMORS OF THE FEMALE REPRODUCTIVE TRACT AND
PELVIC AREA - CLINICO-PATHOLOGICAL ANALYSIS OF SIX CASES AND
LITERATURE REVIEW
M. Klimek, K. Urbanski, J. Ryś, Poland
509
VITAMIN D RECEPTOR POLYMORPHISMS AND PROGNOSIS OF PATIENTS
WITH EPITHELIAL OVARIAN CANCER
A. Okamoto, N. Yanaihara, M. Saito, Y. Hirata, A. Kitanishi, H. Tanabe,
S. Takakura, K. Yamada, T. Tanaka, K. Ochiai, Japan
510
TRIPLE COLLISION TUMOR OF THE OVARY
S.L. Rivera-Enghog, L.S. Rivera, E.E. Espino-Strebel, Philippines
511
SURGICAL MANAGEMENT OF ADVANCED OVARIAN CANCER: A 20-YEARS
EXPERIENCE IN A TERTIARY GYNECOLOGIC ONCOLOGY UNIT
F. Fanfani, A. Fagotti, L. Mereu, M.L. Gagliardi, V. Gallotta, G. Vizzielli,
B. Costantini, S. Gueli Alletti, G. Scambia, Italy
512
PELVIC DISEASE IN PRIMARY ADVANCED OVARIAN CANCER: THE ROLE OF
PERITONECTOMY OF DOUGLAS COMPARED WITH RECTOSIGMOID
RESECTION
V. Gallotta, F. Fanfani, G. Vizzielli, G. Panico, M.L. Gagliardi, B. Costantini,
G. Scambia, A. Fagotti, Italy
513
INTERVAL DEBULKING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY
USING INTRAPERITONEAL CHEMOTHERAPY FOR ADVANCED EPITHERIAL
OVARIAN CANCER
N. Iwasa, Japan
514
HYPOXIA INDUCIBLE FACTOR 1-Α EXPRESSION: ITS EFFECT ON
PROGNOSIS AND RESPONSE TO TAXANE AND PLATINUM CHEMOTHERAPY
IN OVARIAN CANCER
S.S. Han, D.H. Kim, J.M. Bae, Y.S. Song, Republic of Korea
515
NOVEL MARINE COMPOUNDS TO TREAT OVARIAN CANCER
V. Edwards, F. Young, K. Benkendorff, Australia
516
HIGH THROUGHPUT DRUG SCREENING USING OVARIAN CANCER STEM
CELLS IDENTIFIES NOVEL COMPOUNDS FOR OVARIAN CANCER THERAPY
H.-C. Lai, H.-Y. Lee, Y.-C. Wang, Y.-T. Yo, M.-H. Yu, Taiwan R.O.C.
174
Poster Session II
Poster No
517
LONG TERM FOLLOW-UP OF ADVANCED OVERIAN CANCER PATIENTES
TREATED WITH BIWEEKLY PACLITAXEL/CARBOPALTIN (TC) COMBINATION
CHEMOTHERAPY
K. Yoneyama, H. Konishi, T. Yahata, K. Fujita, D. Doi, S. Honma, S. Kodama,
H. Katoh, H. Nakayama, K. Kurose, Y. Aoki, H. Asakura, K. Tanaka, T. Takeshita,
Gynecologic Cancer Network, Japan
518
DOES NEOADJUVANT CHEMOTHERAPY INCREASE THE NUMBER OF
OPTIMALLY DEBULKED PATIENTS WITH ADVANCED OVARIAN CANCER? A
RETROSPECTIVE STUDY
M. Kairbayeva, E. Kukubassov, R. Shalbayeva, M. Kairbayev, M. Gurtovenko,
Kazakhstan
519
METHYLATION MARKERS IN FREE CIRCULATING DNA AS THE BASIS OF A
BLOOD TEST FOR EARLY SEROUS OVARIAN CANCER
K. Warton, T. Navin, B. Gloss, C. Montavon, N. Hacker, R. Sutherland, S. Clark,
P. O'Brien, Australia
520
THE CLINICAL SIGNIFICANCE OF EVALUATION OF PLEURAL EFFUSIONS IN
PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA AND
PRIMARY PERITONEAL CARCINOMA
X. Yan, Y. Gao, G. Jiang, M. Gao, H. Zheng, W. Wang, N. An, China
521
PREDICTION BY SERUM BIOMARKERS OF RESPONSE TO TREATMENT WITH
PACLITAXEL AND CARBOPLATIN IN SEROUS CYSTADENOCARCINOMA OF
THE OVARY
Y. Kikuchi, M. Takano, T. Asakawa, M. Shiwa, R. Kikuchi, K. Kudoh, J. Kigawa,
T. Sugiyama, T. Goto, T. Oishi, NPO KKKS Clinical Proteomic Analyses Group,
Japan
522
HYPER-METHYLATION OF DAPK, E-CADHERIN AND BLU GENES AS
BIOMARKER OF SURVIVAL IN OVARIAN SEROUS CARCINOMA
W.-F. Cheng, Y.-C. Chiang, C.-A. Chen, C.-Y. Hsieh, Taiwan R.O.C.
523
MICROARRAY ANALYSIS OF ONCOGENIC PATHWAYS IN ADVANCED
SEROUS PAPILLARY OVARIAN CARCINOMA
X.B. Trinh, W. Tjalma, L. Dirix, P. Vermeulen, D. Peeters, L. Sas, I. Van der Auwera,
F. Tjin Asjoe, S. Van Laere, P. van Dam, Belgium
524
IS THIRD-LINE CHEMOTHERAPHY EFFECTIVE IN OVARIAN CARCINOMA?
A. Watanabe, Japan
525
THE PROGNOSTIC IMPACT OF ANEMIA IN ADVANCED EPITHELIAL OVARIAN
CANCER
J.H. Kim, J.M. Lee, K.S. Ryu, Republic of Korea
526
PATTERN OF IMMUNOREACTIVITY IN PRIMARY OVARIAN MUCINOUS
ADENOCARCINOMA AT KING CHULALONGKORN MEMORIAL HOSPITAL
N. Pohthipornthawat, P. Tantbirojn, R. Lertkhachonsuk, Thailand
175
Poster Session II
Poster No
527
PHASE II TRIAL OF WEEKLY IRINOTECAN AND CARBOPLATIN FOR
RELAPSED OVARIAN CANCER - A KANSAI CLINICAL ONCOLOGY GROUP
STUDY
H. Tsubamoto, R. Kawaguchi, S. Takeuchi, Y. Itani, A. Arakawa, T. Shiozaki,
T. Tabata, S. Toyoda, K. Itoh, Kansai Clinical Oncology Group, Japan
528
THE ROLE OF IL-6 AND OSTEOPONTIN IN DIAGNOSIS OF OVARIAN CANCER
M. Tîrnovanu, I. Dumitrascu, A. Luca, Romania
529
PROGNOSTIC DNA COPY NUMBER ALTERATION IN OVARIAN CANCER
B. Marzec-Kotarska, J.C. Kotarski, M. Cybulski, A. Semczuk, J. Sajewicz,
H. Antosz, J. Kotarski, J. Kocki, Poland
530
OVARIAN TISSUE CRYOPRESERVATION FOR GYNECOLOGICAL MALIGNANT
TUMOR SURVIVORS
H. Guo, J. Wang, L. Yan, J. Qiao, X. Song, J. Han, China
531
PREDICTING OVARY MALIGNANCIES BY EVALUATING CA125+HE4
COMBINED WITH ROMA METHOD IN ADNEXAL MASSES
N. Saghafi, S. Bahman, H. Monsef, M.T. Shakeri, Iran
532
INTRAOPERATIVE EVALUATION AT RISK-REDUCING SALPINGOOOPHORECTOMY FOR BRCA1/2 MUTATION CARRIERS: A RADIOLOGIC,
SURGICAL, AND PATHOLOGIC CORRELATION STUDY OF OPTIMAL
INTRAOPERATIVE MANAGEMENT
J. Rabban, A. Mackey, S. Chan, B. Crawford, J. McClennan, B. Powell, C. Zaloudek,
L.-M. Chen, USA
533
A CASE OF ACUTE LYMPHOBLASTIC LEUKAEMIA MIMICKING AN OVARIAN
MALIGNANT TUMOR
A.L. Camporeale, V. Loizzi, G. Cormio, D. Scardigno, C. Nardelli, P. De Mitri,
L. Leone, F.P. Magazzino, M. Lorusso, L. Selvaggi, Italy
534
CLINICAL SIGNIFICANCES OF GALECTIN-3 EXPRESSION IN OVARIAN
CARCINOMAS
J.-W. Lee, M.K. Kim, C.O. Sung, Y.-Y. Lee, C.H. Choi, T.-J. Kim, B.-G. Kim,
D.-S. Bae, Republic of Korea
535
IMPORTANCE OF CA 125 IN THERAPEUTIC MONITORING OF THE OVARIAN
CANCER CASE REPORT
T. Nedeljković, J. Nedovic, D. Lukic, S. Igumanovic, S. Ljesevic, S. Radivojevic,
Z. Vuckovic, J. Radovanovic, M. Djokic-Lisanin, U. Golubovic, Serbia
536
PACLITAXEL CARBOPLATIN CHEMOTHERAPY FOR EPITHELIAL OVARIAN
CANCER CURES SEVERE PSORIASIS OF 25 YEARS DURATION
S. Erkanli, A. Eryilmaz, H. Abali, E. Kuscu, A. Haberal, A. Ayhan, Turkey
537
PRIMARY OVARIAN LYMPHOMA. AN EXPANDED SURGERY IS NEEDED?
R. Rodríguez Reyes, M. Hernández Suárez, S. García Rodríguez, O. Orribo
Morales, M. Carrancho Montero, J. De la Torre Fernández de Vega, Spain
176
Poster Session II
Poster No
538
CLINICAL ANALYSIS AND MENAGEMENT OF SWYER SYNDROME: ABOUT 7
CASES
T. Makhlouf, R. Ben Temime, N. Mathlouthi, A. Koubaa, L. Attia, A. Chachia, Tunisia
539
LAPAROSCOPIC SPLENECTOMY FOR SOLITARY SPLENIC RECURRENCE OF
OVARIAN CANCER
J.H. Choi, D.-G. Shin, Republic of Korea
540
INCREASED CIRCULATING HEPATOCYTE GROWTH FACTOR (HGF) LEVELS;
AN INDICATOR OF EPITHELIAL OVARIAN CANCER AND POORER
PROGNOSIS
G. Aune, A.M. Lian, S. Tingulstad, S.H. Torp, S. Forsmo, J.E. Reseland,
U. Syversen, Norway
541
CHEMOTHERAPY OR UPFRONT SURGERY FOR NEWLY DIAGNOSED
ADVANCED OVARIAN CANCER: THE MRC CHORUS TRIAL
S. Kehoe, M. Nankivell, J. Cairns, G. Jayson, T. Lopes, D. Luesley, H. Kitchener,
T. Perren, M. Parmar, A.M. Swart, UK
542
PRIMARY LYMPHOBLASTIC LYMPHOMA OF OVARY - CASE REPORT
M. Banumathy, G. Deepa, India
543
FACTORS ASSOCIATED WITH ENROLMENT IN OVARIAN CANCER CLINICAL
TRIALS AND THE IMPACT ON OUTCOME
S. Ananda, P. Gibbs, O. McNally, M. Quinn, Australia
544
INITIAL APPROACH TO BRCA1 GENE MUTATIONS IN EPITHELIAL OVARIAN
CANCER
H. Guo, T. Ye, China
545
CYTOKINE PROFILES IN OVARIAN CYST FLUID: CORRELATION WITH
MALIGNANCY
R. Yigit, P.L.M. Zusterzeel, J.M. Pots, C.G. Figdor, R. Torensma,
546
LONG TERM FOLLOW UP OF WOMEN WITH RECURRENT FIGO STAGE III
OVARIAN CANCER: OVERALL SURVIVAL AND PROGNOSTIC FACTORS
J.-M. Classe, I. Jaffre, J.S. Frenel, V. Bordes, M. Dejode, F. Dravet, N. Andrieux,
D. Berton Rigaud, D. Loussouarn, L. Campion, France
547
EXPRESSION OF COX AND VEGF-C IN PERITONEAL METASTASES OF
OVARIAN SEROUS CARCINOMA AND THEIR RELETIONSHIP TO LYMPH NODE
STATUS
A. Brncic Fischer, M. Krasevic, H. Haller, Croatia
548
CYTOKINE PROFILE IN OVARIAN CANCER RELATED ASCITES FAVORS
TUMOR SURVIVAL
R. Yigit, P.L.M. Zusterzeel, J.M. Pots, C.G. Figdor, R. Torensma,
177
Poster Session II
Poster No
549
EXPRESSION OF THE LECTIN PATHWAY ACTIVATION FACTORS IN THE
D. Wydra, A. Swierzko, A. Szala, S. Sawicki, J. Szemraj, A. Kaluzynski, L. Pulaski,
J. Szymanski, M. Cedzynski, Poland
550
LOW CD4/CD8 T-CELL RATIO'S IN ASCITES PREDICT A BETTER CA125
RESPONSE AFTER THREE CYCLES OF CHEMOTHERAPY IN OVARIAN
CANCER
R. Yigit, P.L.M. Zusterzeel, T. Duiveman-de Boer, C.G. Figdor, R. Torensma,
551
QUANTITATION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH
EPITHELIAL OVARIAN CANCER
G. Tognon, A. Ravaggi, E. Bignotti, C. Almici, R. Verardi, R. Tassi, E. Bandiera,
C. Romani, L. Zanotti, A. Gambino, V. Zizioli, A. Gorio, S. Pecorelli, Italy
552
RISK OF MALIGNANCY INDICES IN DETECTION OF BORDERLINE OVARIAN
TUMORS
M.C. Yenen, I. Alanbay, E. Akturk, M. Dede, R. Karaca, E. Karasahin, H. Ozan,
S. Dilek, I. Baser, Turkey
553
SIGNIFICANCE OF SYSTEMATIC LYMPHADENECTOMY IN PATIENTS WITH
MACROSCOPIC STAGEⅠEPITHELIAL OVARIAN CARCINOMA
H. Wen, K. Ma, Q. Liao, China
554
OVARIAN CANCER IN THE “DR. SALVATORVUIA” CLINICAL OBSTETRICS
C. Furău, L. Păiuşan, G. Furău, V. Daşcău, Romania
555
A PHASE 2 STUDY OF PEMETREXED IN COMBINATION WITH CARBOPLATIN
IN PATIENTS WITH PLATIN-SENSITIVE RECURRENT OVARIAN OR
PERITONEAL CANCER
J. Sehouli, A. Alvarez, S. Manouchehrpour, P. Ghatage, C. Szczylik,
A. Zimmermann, T. Bauknecht, K. Look, G. Oskay-Özcelik, Germany
556
TREATMENT OF BORDERLINE OVARIAN TUMOURS WITH GONADOTROPIN
RELEASING HORMONE ANALOGUES
B. Grijuela, E. Solima, F. Hanozet, R. Fontanelli, A. Ditto, F. Zanaboni, G.B. Spatti,
F. Martinelli, M. Carcangiu, B. Valeri, F. Raspagliesi, Italy
557
EXPRESSION OF COX-2 AND VEGF-C IN PERITONEAL METASTASES OF
OVARIAN SEROUS CARCINOMA AND THEIR RELATIONSHIP TO LYMPH
NODE STATUS
A. Brncic Fischer, M. Krasevic, H. Haller, S. Rupcic, O. Mamula, S. Behrem,
J. Gobic, D. Cuk, Croatia
178
Poster Session II
Poster No
558
MULTIPLE BOWEL PERFORATIONS ASSOCIATED WITH NEOADJUVANT
CHEMOTHERAPY IN A PATIENT WITH ADVANCED EPITHELIAL OVARIAN
CANCER
M. Mohit, N. Rahmanijoo, A. Jenabian, R. Darabi, Iran
559
THE SIGNIFICANCE OF SEROUS OVARIAN CANCER HISTOLOGY ON LYMPH
NODE METASTASES
O. Mamula, H. Haller, M. Krasevic, S. Rupcic, A. Brncic Fischer, S. Behrem,
M. Stamatovic, I. Saftic, M. Manestar, D. Perovic, Croatia
560
EARLY STAGE EPITHELIAL OVARIAN CANCER: WHAT DETERMINES THE
OUTCOME?
L. Kumar, R. Hariprasad, A. Mookerjee, S. Kumar, N. Bhatla, S. Thulkar, India
561
A SUBGROUP WITH BRCA1 PROMOTOR HYPERMETHYLATION IS
ASSOCIATED WITH POOR DIFFERENTIATED, SEROUS, ADVANCED OVARIAN
CANCER
D. Dimitrova, E.I. Braicu, R. Richter, T. Schwachula, R. Chekerov,
G. Oskay-Özcelik, W. Lichtenegger, S. Olek, J. Sehouli, Tumor Bank Ovarian
Cancer Network, Germany
562
WEEKLY CLINICOPATHOLOGICAL MEETING: APPLICATION AND IMPACT ON
MANAGEMENT OF OVARIAN CANCER
A. Mookerjee, L. Kumar, R. Hariprasad, P. Ganeshan, A. Gupta, S. Mathur, India
563
CLINICAL OUTCOMES FOR MICROSCOPIC FALLOPIAN TUBE AND OVARIAN
CARCINOMAS DIAGNOSED IN BRCA MUTATION CARRIERS UNDERGOING
RISK-REDUCING SALPINGO-OOPHORECTOMY
M. Yates, L. Meyer, M. Deavers, M. Daniels, E. Keeler, S. Mok, K. Lu, USA
564
CLINICAL, PATHOLOGICAL AND BIOMARKER CHARACTERIZATION OF
PATIENTS WITH ADVANCED OVARIAN CANCER ACCORDING TO THE AGE
R. Chekerov, I.E. Braicu, G. Oskay-Özcelik, R. Richter, W. Lichtenegger, J. Sehouli,
North-Eastern German Society of Gynecological Oncology, Germany
565
RESEARCH ON BRCA1 /2 MUTATIONS IN PATIENTS WITH HEREDITARY
OVARIAN CANCER AND PATIENTS WITH SPORADIC OVARIAN CANCER IN
MAINLAND CHINA
K. Shen, T. Tao, J. Yang, D. Cao, J. Lang, M. Wu, H. Huang, L. Guo, China
566
THE EFFICACY OF HYALURONIC ACID ON ADHESION FORMATION AND
TUMOR RECURRENCE
I. Bekes, J. Roos, R. Kreienberg, S. Rimbach, Germany
567
EXPRESSION PROFILE AND MUTATION OF EGFR GENE IN EPITHELIAL
OVARIAN CANCER
H. Qidan, J. Liu, China
179
Poster Session II
Poster No
568
PLATINUM RESISTANT EPITHELIAL OVARIAN CANCER- ISSUES OF QUALITY
OF LIFE AND COST-EFFECTIVE RATIO
C. Basu, India
569
MANAGEMENT OF EXTRAVASATION IN OVARIAN CANCER PATIENTS
RECEIVING TRABECTIDIN
T. Loverre, P. De Mitri, D. Scardigno, V. Loizzi, G. Cormio, L. Leone,
A. Camporeale, C. Nardelli, L. Selvaggi, Italy
570
THE CHANGES IN FOXP3+REGULATORY T CELL EXPRESSION BEFORE AND
AFTER RECURRENCE OF OVARIAN CANCER
S.-M. Park, Y.-M. Kim, D.-Y. Kim, J.-H. Kim, J.-H. Nam, Y.-T. Kim, Republic of Korea
571
M2 MACOPHAGES IN THE ASCITES OF ADVANCED EPITHELIAL OVARIAN
CANCER PROMOTE TUMOR PROGRESSION VIA STAT3 ACTIVATION
K. Takaishi, H. Tashiro, Y. Komohara, M. Takeya, H. Katabuchi, Japan
572
PROGNOSTIC FACTORS AND REPRODUCTIVE OUTCOMES OF BORDERLINE
OVARIAN TUMORS: A REVIEW OF 186 PATIENTS
D. Cao, T. Tao, J. Yang, J. Lang, L. Guo, K. Shen, China
573
CAVEOLIN-1 EXPRESSION IN LOW-MALIGNANT POTENTIAL (LMP) AND
EPITHELIAL OVARIAN CANCERS (EOC)
C. Verschraegen, H. Arias-Pulido, L. Lomo, C. Qualls, H. Smith, USA
574
WHAT VALUE DOES THE RISK OF MALIGNANCY INDEX (RMI) HAVE IN
PATIENTS WITH NON-SEROUS EPITHELIAL OVARIAN CANCERS?
L. Jepson, S. Fegan, UK
575
BRCA1- ASSOCIATED OVARIAN CANCER - CLINICAL FEATURES AND
RESPONSE TO TREATMENT
P. Blecharz, W. Szatkowski, K. Urbanski, Poland
576
OUTCOME AND RISK FACTORS FOR RECURRENCE IN MALIGNANT OVARIAN
GERM CELL TUMORS:A MITO-9 RETROSPECTIVE STUDY
G. Mangili, C. Sigismondi, D. Lorusso, L. Selvaggi, A. Gadducci, R. Angioli,
A. Savarese, S. Scalone, M. Candiani, S. Pignata, MITO Group, Italy
577
IS ADJUVANT CHEMOTHERAPY REQUIRED IN INCOMPLETELY SURGICALLY
STAGED IA PURE OVARIAN DYSGERMINOMA (POD)? A MITO-9
RETROSPECTIVE STUDY
G. Mangili, C. Sigismondi, L. Frigerio, G. Cormio, F. Narducci, G. Scibilia, S. Tateo,
G. Ferrandina, R. Viganò, D. Lorusso, MITO Group, Italy
578
IS CLEAR-CELL EPITHELIAL OVARIAN CANCER A POOR PROGNOSTIC
FACTOR?
M. Miyamoto, M. Takano, H. Soyama, T. Akimoto, T. Goto, Japan
180
Poster Session II
Poster No
579
DISPARITIES IN TREATMENT FOR EPITHELIAL OVARIAN CANCER IN A
LARGE UNITED STATES POPULATION
S.L. Stewart, A.R. Kahn, M.J. Schymura, J.S. Townsend, J.M. Wike, R.D. Cress,
K. Bauer, C.D. O'Malley, USA
580
FEASIBILITY OF MUSICAL PRAYER TO ENHANCE THE QUALITY OF SLEEP IN
PERSONS WITH OVARIAN CANCER
S. Deesamer, S. Terathongkum, N. Piaseu, S. Wilailak, Thailand
581
HISTONE DEACETYLASE INHIBITORS ANTI-TUMOUR ACTIVITY AND THE
EFFECT ON ATP-BINDING CASSETTE IN OVARIAN CARCINOMA CELLS
K.-C. Chao, C.-C. Chang, P.-H. Wang, Taiwan R.O.C.
582
DETECTION OF OVARIAN CANCER RECURRENCE AND RESPONSE TO
THERAPY USING A CA125 AND HE4 DUPLEX ASSAY
J. Baker, S. Sathischandra, Y. Bratcher, D. Purnell, H. Doobay, A. Berchuck,
P. Braun, V. Crews, L. Hall, D. Russell, A. Secord, R. Swan, D. Malinowski,
L. Havrilesky, USA
583
FEASIBILITY OF BEVACIZUMAB PLUS CHEMOTHERAPY IN HEAVILY PRETREATED OVARIAN CANCER PATIENTS. A RETROSPECTIVE STUDY
I. Asmane, J.-E. Kurtz, A. Bajard, J.-P. Guastalla, P. Meeus, O. Tredan,
I. Labidi Galy, I. Moullet, P. Ardisson, L. Vincent, D. Coeffic, A. Dufresne,
J.-P. Bergerat, I. Ray-Coquard, France
584
OVARIAN CYSTS: WHEN TO OBSERVE, WHEN TO INTERVENE, AND WHEN
TO REFER?
R.D. Meneni, M. George, UK
585
HEPATIC RESECTION IS A POTENTIAL TREATMENT FOR RECURRENT
METASTATIC OVARIAN CARCINOMA OR PERITONEAL CARCINOMA
X. Yan, Y. Gao, Q. Bao, N. An, G. Jiang, M. Gao, H. Zheng, W. Wang, China
586
NOVEL PLATFORM TECHNOLOGY FOR EFFICIENT UTILIZATION OF WATER
INSOLUBLE DRUGS
N. Teng, K.-S. Kim, USA, Republic of Korea
587
HISTOPATHOLOGICAL CHANGES IN RESIDUAL CANCER BURDEN AFTER
INTERVAL DEBULKING SURGERY ARE EFFECTIVE IN EVALUATING THE
RESPONSE TO ADJUVANT CHEMOTHERAPY
X.-P. Li, L.-L. Kong, J.-R. Li, L.-H. Wei, H. Cui, J.-L. Wang, S.-J. Wang, Y. Zhao,
China
588
THE PATTERN OF CA 125 CHANGES AS A PROGNOSTIC FACTOR FOR
ADVANCED EPITHELIAL OVARIAN CANCER
J.W. Shin, H.H. Lee, Republic of Korea
181
Poster Session II
Poster No
589
OVARIAN GONADOBLASTOMA WITH DYSGERMINOMA COEXISTING WITH
TUBAL ECTOPIC PREGNANCY IN A 15-YEAR-OLD GIRL WITH 46XX
KARYOTYPE
S. Esin, T. Kucukozkan, I. Bebitoglu, Turkey
590
CA125 AS A PREDICTIVE MARKER FOR OPTIMAL INTERVAL DEBULKING
SURGERY
N. Furukawa, H. Shigetomi, Y. Tanase, R. Kawaguchi, S. Yoshida, Y. Yamada,
H. Oi, H. Kobayashi, Japan
591
IMMUNOREACTIVE SCORE OF EP-CAM MIGHT PREDICT SURVIVAL IN EARLY
M.J. Battista, J. Steetskamp, S. Gebhard, C. Cotarelo, A. Victor, I.B. Petry,
M. Schmidt, H. Koelbl, Germany
592
A GENE EXPRESSION PROFILE PREDICTS SURVIVAL OF PATIENTS WITH
ADVANCED STAGE OVARIAN CANCER
K. Yoshihara, T. Yahata, K. Tanaka, Japanese Serous Ovarian Cancer Study
Group, Japan
593
OVARIAN CLEAR CELL ADENOFIBROMATOUS TUMOR OF BORDERLINE
MALIGNANCY. A CASE REPORT
K. Lathouras, T. Tantanasis, I. Stergioudas, P. Chatzis, E. Anagnostou,
C. Nikolaidou, E. Katsiki, Greece
594
OVARIAN CANCER: CLINICAL EXPERIENCE OF A 10-YEARS PERIOD
K. Papathanasiou, K. Lathouras, A. Pantelis, I. Mitsakis, M. Tzafettas, S. Kasmas,
P.D. Loufopoulos, Greece
595
LONG-TERM SURVIVAL IN A PATIENT OF OVARIAN JUVENILE GRANULOSA
CELL TUMOR WITH PARAAORTIC LYMPH NODE METASTASIS
M.-L. Cheong, T.-Y. Chien, Taiwan R.O.C.
596
REGULATORY T CELLS AND CYTOTOXIC T CELLS IN PATIENTS WITH
OVARIAN CANCER
A. Kondracka, I. Wertel, E. Rogala, A. Nowicka, M. Sobstyl, W. Bednarek,
J. Kotarski, Poland
597
BORDERLINE OVARIAN TUMORS: HOW DO PATIENTS ESTIMATE THEIR
MALIGNANT POTENTIAL AND THEIR OVERALL PROGNOSIS?
C. Fotopoulou, M. Bugariu, E.-I. Braicu, W. Lichtenegger, J. Sehouli, Germany
598
MALIGNANT MIXED MULLERIAN TUMOR OF THE OVARY - CASE REPORT
AND REVIEW
E. Pereira, V. Cunha, H. Nabais, A. Gomes, S. Mineiro, A.F. Jorge, Portugal
599
THE INVOLVEMENT OF THE APPENDIX IN OVARIAN MUCINOUS
ADENOCARCINOMA
J. Kaur, C. Jameson, D. Barton, T. Ind, J. Shepherd, J. Bridges, UK
182
Poster Session II
Poster No
600
DOES THE PRESENCE OF ENDOMETRIOSIS ALTER THE BEHAVIOUR OF
CLEAR CELL CARCINOMA?
J. Kaur, C. Jameson, A. Attygalle, D. Barton, T. Ind, J. Shepherd, J. Bridges, UK
601
EXPRESSION OF CXCR4 PREDICTS POOR PROGNOSIS OF PATIENTS WITH
CLEAR CELL CARCINOMA OF OVARY
R. Sekiya, H. Kajiyama, K. Sakai, M. Higashi, T. Umezu, K. Shibata, E. Yamamoto,
A. Nawa, F. Kikkawa, Department of Obstetrics and Gynecology, Nagoya University
Graduate School of Medicine, Japan
602
MUCINOUS OVARIAN CANCER MARKER, MA2, PROMOTES CELL
PROLIFERATION AND MIGRATION
K. Park, B. Kim, D. Bae, J.H. Lee, Republic of Korea
603
FALLOPIAN TUBE SQUAMOUS CANCER SUSPECTED BY ENDOMETRIAL
CYTOLOGY
L. Mereu, R. Marinelli, G. Carri, A. Pontis, M. Muzzi, L. Mencaglia, Italy
604
OVARIAN GERM CELL TUMORS: A 10-YEAR STUDY
H. Ayatollahi, S. Naji, E. Mohammadpour, F. Bahadori, Iran
605
SMAC PEPTIDE POTENTIATES TRAIL OR PACLITAXEL MEDIATED DRUGRESISTANT OVARIAN CANCER CELL DEATH IN VIVO
H. Mao, P. Liu, China
606
OVARIAN CANCER MORBIDITY IN TULA REGION (RUSSIA) WITHIN 10 YEARS
V.G. Volkov, G.M. Chibissova, Russia
607
SURGICAL TREATMENT OF RELAPSING MALIGNANT OVARIAN TUMORS SURGICAL EFFORT
K. Mastilović, P. Novakoviš, D. Ņikiš, J. Rajoviš, M. Ņivaljeviš, Serbia
608
DETECTION OF P16 CDKN2A GENE ALTERATIONS IN OVARIAN CANCER WITH
FISH ANALYSIS
C. Aravidis, A. Panani, Z. Kosmaidou, G. Kreatsas, A. Rodolakis, N. Thomakos,
A. Antsanklis, Greece
609
DELETION (10)(P12) A NOVEL RECURRENT CHROMOSOMAL ABERRATION IN
ADVANCED STAGE OF OVARIAN CANCER
C. Aravidis, A. Panani, Z. Kosmaidou, A. Rodolakis, N. Thomakos, G. Kreatsas,
A. Antsanklis, Greece
610
THE OUTCOME OF 3RD LINE CHEMOTHERAPY IN PATIENTS WITH
RECURRENT EPITHELIAL OVARIAN CANCER
L. Gortzak- Uzan, J. Menczer, E. Ben-Shem, A. Golan, T. Levy, Israel
611
DOES SELECTING THE FERTILITY-SPARING SURGERY IN YOUNG WOMEN
WITH STAGE I OVARIAN CANCER LEAD TO A POORER SURVIVAL
OUTCOME?
H. Kajiyama, Japan
183
Poster Session II
Poster No
612
A NOVEL TREATMENT STRATEGY FOR OVARIAN GRANULOSA CELL
TUMORS BASED ON IMMUNIZATION AGAINST ZP3
H.J.T. Coelingh Bennink, N.A. Rahman, M. Chrusciel, V. Sharp, Y. Zimmerman,
A. Ellonen, A. Rivero-Müller, X. Li, S. Dilworth, O. Vainio, I. Huhtaniemi,
The Netherlands
613
THE ROLE OF TREG CELLS IN PARIENTS WITH OVARAIN CANCERS
A. Samsami, N. Erfani, A. Ghaderi, Z. Sarraf, M. Momtahan, M. Robati, Iran
614
PROGNOSTIC SIGNIFICANCE OF HUMAN EPIDIDYMIS PROTEIN 4 IN
ENDOMETRIAL CANCER PATIENTS
A. Ravaggi, E. Bignotti, B. Elisabetta, L. Zanotti, P. Todeschini, R.A. Tassi,
C. Romani, S. Bergamelli, S. Calza, M. Ragnoli, G. Tisi, G. Tognon, F.E. Odicino,
S. Pecorelli, Italy
615
CUTANEOUS MELANOMA METASTATIC TO THE OVARY: A CASE REPORT
A. Cazzolla, E. Naglieri, L. Resta, G. Cormio, V. Loizzi, P. De Mitri, F. Magazzino,
L. Leone, A. Camporeale, L. Selvaggi, Italy
616
SPLENIC PELIOSIS IN ASSOCIATION WITH BENIGN OVARIAN TUMOUR
(CASE REPORT)
M. Abu Freij, T. Duncan, S. Crocker, J. Nieto, UK
617
PRIMARY OVARIAN CHORIOCARCINOMA PRESENTING WITH ACUTE
ABDOMEN MIMICKING AN ECTOPIC PREGNANCY
M. Abu Freij, H. Saleh, T. Duncan, S. Crocker, J. Nieto, UK
618
SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE
TREATED WITH CONSERVATIVE SURGERY
S. Giudici, A. Festi, F. Gotsch, T. Sava, E. Piazzola, M. Franchi, Italy
619
IMPORTANCE TOPO I, TOPO II, MDR EXPRESSION LEVELS AT ADVANCED
OVARIAN CANCER
H. Maisei, R. Smolaykova, N. Krutilina, Belarus
620
HYTADID CYST CONCOMITANT WITH OVARIAN TUMOR IN
POSTMENOPAUSAL WOMEN
F. Ayatollahi, R. Doosti, F. Bahadori, S. Akhavan, H. Ayatollahi, N. Badpa, Iran
621
THE PREDICTIVE VALUE OF PREOPERATIVE TRANSVAGINAL SONOGRAPHY
IN THE STAGING OF TUMOR PATTERN IN OVARIAN CANCER CASES
G. Kiproska, V. Antovska, T. Nikolova, M. Hadzi- Lega, N. Nikolova,
FYR Macedonia
622
CLINICAL CHARACTERISTICS OF LONG-TERM SURVIVORS OF ADVANCED
G. Glaser, A. Gonik, P. Hanjani, M. Shahin, M. Edelson, USA
184
Poster Session II
Poster No
623
NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGICAL
CYTOREDUCTION IN STAGE IV OVARIAN CANCER: A RETROSPECTIVE CASE
CONTROL STUDY
J. Dowaji, Germany
624
LOW PREVALENCE OF GERM-LINE BRCA MUTATIONS IN EARLY ONSET
M. Zikan, P. Pohlreich, I. Pinkavova, J. Slama, D. Fischerova, D. Cibula,
Czech Republic
625
RISK OF NASCENCY OF THE HYPERSENSITIVITY REACTIONS ASSOCIATED
WITH CARBOPLATIN AND PACLITAXEL TREATMENT OF OVARIAN CANCER
A. Řezáč, J. Ńpaţek, P. Ńkapinec, I. Sedláková, E. Křepinská, J. Tońner,
Czech Republic
626
ABERRANT HYPERMETHYLATION OF PROMOTER SITE IN TUMOR
SUPPRESSOR GENES MAY BE THE MARKER FOR EARLY DETECTION OF
OVARIAN CANCER
M. Culbova, Z. Lasabova, P. Zubor, K. Kajo, R. Fiolka, J. Danko, J. Visnovsky,
Slovak Republic
627
SET-UP OF AN OVARIAN CANCER BIOBANK WITHIN THE CONTEXT OF A
MULTICENTRE INTERNATIONAL RANDOMISED PHASE 3 TRIAL (ICON7)
F. Collinson, S. Jackson, G. Jayson, R. Banks, on behalf of ICON7 GCIG
Investigators, UK
628
THE THERAPEUTIC VALUE OF LYMPHADENECTOMY IN OVARIAN CANCER
PATIENTS
L. Gmyrek, J. Jonska-Gmyrek, P. Sobiczewski, M. Bidzinski, G. Panek, Poland
629
SPERM PROTEIN 17 VACCINATION REDIRECTS T-HELPER DIFFERENTIATION
PROGRAM IN A MURINE MODEL OF OVARIAN CANCER
M. Chiriva-Internati, Y. Yu, L. Mirandola, M.R. Jenkins, C. Chapman, M. Cannon,
E. Cobos, W.M. Kast, USA
630
IS THERE SURVIVAL BENEFITS PERFORMING RETROPERITONEAL
SYSTEMIC LYMPHADENECTOMY IN ADVANCED EPITHELIAL OVARIAN
CANCER?
T. Hirosawa, H. Kajiyama, R. Sekiya, K. Shibata, F. Kikkawa, Japan
631
CASE REPORT OF MASSIVE OVARIAN EDEMA: A BENIGN CONDITION THAT
CAN MIMIC OVARIAN CANCER
L.H.A. Ventura, C.E.M.C. Andrade, A.T. Tsunoda, J.H.T.G. Fregnani, Brazil
632
CHARACTERIZATION OF THE CELLULAR IMMUNE RESPONSE IN WOMEN
WITH OVARIAN CANCER
S.O.C. Paula, T.M.R.F. Franco, A.T. Carvalho, G.F. Freitas, E.L. Lages, P. Traiman,
A. Silva-Filho, Brazil
185
Poster Session II
Poster No
633
PRIMARY OVARIAN ENDOMETRIOID ADENOCARCINOMA: INCIDENCE AND
CLINICAL SIGNIFICANCE OF MORPHOLOGIC AND IMMUNOHISTOCHEMICAL
MARKERS OF MISMATCH REPAIR PROTEIN DEFECTS
A. Aysal, I. Medhi, J.P. Grenert, C. Zaloudek, J. Rabban, USA
634
CLINICAL IMPACT OF FDG-PET ON THE MANAGEMENT OF REFRACTORY
AND RECURRENT OVARIAN CANCER
H.-H. Chou, Taiwan R.O.C.
635
CA125 VALUES: THREAT OR COMFORT TO OVARIAN CANCER SURVIVORS
ON ACTIVE TREATMENT
A. Mahdavi, L. Wenzel, K. Osann, L. McClure, P. Anastasia, B. Karlan, B. Monk,
USA
636
IS RISK MALIGNANCY INDEX A USEFUL TOOL FOR PREDICTING MALIGNANT
OVARIAN MASSES IN DEVELOPING COUNTRIES?
A. Aziz, N. Najmi, Pakistan
637
EXTENDED CYTOREDUCTION OF TUMOR AT PORTA HEPATIS WITH
EPITHELIAL OVARIAN CANCER BY INTERDISCIPLINARY TEAM APPROACH
Y.J. Song, M.C. Lim, S.Y. Park, S.Y. Jung, J.A. Park, S. Kang, S.-S. Seo, S.H. Kim,
S.-S. Han, S.-Y. Park, C.-W. Yoo, Republic of Korea
638
“INTRAPERITONEALISM” IN CHEMOTHERAPY (IPCT) OF OVARIAN CANCERS
M. Sharma, R. Arora, A. Sharma, India
639
THROMBOCYTOSIS IN OVARIAN CANCER: EFFECT ON PLASMA PROTEIN
PROFILES AND SURVIVAL
Y. Wang, Y. Ling, J. Chatterjee, N. Rama, E. Stronach, S. Blagden, H. Gabra,
R. Agarwal, UK
640
PREDICTIVE VALUES OF THE ULTRASOUND PARAMETERS, CA-125 AND
RISK OF MALIGNANCY INDEX IN PATIENTS WITH OVARIAN MALIGNANCY
V. Antovska, V. Iliev, G. Dimitrov, G. Kiproska, I. Kaev, FYR Macedonia
641
HOW LONG? HOW TO TREAT RECURRENT OVARIAN CANCER
Y. Onishi, T. Kawabata, F. Yamamoto, T. Nakamura, M. Hatae, Japan
642
THE ROLE OF SECONDARY SURGICAL DEBULKING IN RELAPSED OVARIAN
CANCER. A RETROSPECTIVE STUDY
F. Odicino, E. Buccheri, M. Ragnoli, G. Giorda, E. Sartori, E. Campagnutta,
S. Pecorelli, Italy
643
BORDERLINE TUMORS: DIAGNOSIS AND MANAGEMENT: ABOUT 15 CASES
B. Zouaoui, I. Najar, E. Sfar, H. Chelli, Tunisia
644
A CASE OF PORTAL VENOUS GAS WITH SEPTIC SHOCK IN A PATIENT
TREATED WITH IRINOTECAN FOR OVARIAN CANCER
N. Iwata, Japan
186
Poster Session II
Poster No
645
EXTREME DRUG RESISTANCE (EDR) ASSAY DIRECTED THERAPY OF
PLATINUM RESISTANT OVARIAN CANCER
S. Bush, S. Ghamande, C.-S. Han, J. Bandyopadhyay, M. Macfee, USA
646
HE4 - NEW TUMOR MARKER
Z. Novotny, O. Topolcan, J. Vrzalova, J. Presl, M. Casova, V. Kokes, Z. Rokyta,
M. Prazakova, S. Svobodova, Czech Republic
647
MOLECULAR PATHOGENESIS OF OVARIAN SEROUS CARCINOMA WITH
PSAMMOMA BODIES; INTERPRETATION OF LONG-TERM ONCOLOGICAL
OUTCOMES
Y. Miyahara, T. Motohara, H. Tashiro, I. Sakaguchi, T. Ohba, H. Katabuchi, Japan
648
THE TEST OF MULTIPLEX PANEL FOR OVARIAN CARCINOMA
J. Vrzalova, Z. Novotny, J. Presl, V. Kokes, Z. Rokyta, M. Prazakova, M. Peńta,
S. Svobodova, Czech Republic
649
CLINICOPATHOLOGICAL ANALYSIS OF OVARIAN CANCER ARISING FROM
ENDOMETRIOSIS
K. Kurose, A. Yamamoto, A. Miura, D. Doi, K. Yoneyama, S. Kamoi, T. Takeshita,
Japan
650
THE IMPACT OF STAGING LAPAROSCOPY FOR CLINICALLY EVIDENT
OVARIAN MALIGNANCY ON TREATMENT STRATEGY
B. Kobal, B. Cvjetiţanin, L. Megliţ, A. Vakselj, Ń. Smrkolj, M. Jakimovska, Slovenia
651
THE ROLE OF CA 125 AND A NEW TUMOR MARKER HE4 IN THE
DISCRIMINATION OF ADNEXAL MASSES
Z.N. Dolgun, C. Kabaca, A. Karateke, I. Sanverdi, Turkey
652
WHOLE ABDOMEN RADIATION FOR PALLIATION OF PLATINUM RESISTANT
OVARIAN CANCER
D. Bernshaw, K. Narayan, J. Martin, Australia
653
TOLERABILITY OF PLD/OXALIPLATIN REGIMEN IN HIGH RISK OVARIAN
CANCER PATIENTS
M. Dalla Palma, G. Lombardi, M. Donach, L. Borgato, M.O. Nicoletto, Italy, USA
654
IMRT IN THE TREATMENT OF SMALL-VOLUME RELAPSE OR RESIDUAL IN
PRE-TREATED OVARIAN CANCER PATIENTS: A PILOT STUDY
A. Savarese, A. Micheli, M.D. Pellegrini, A. Torsello, F. Cognetti, Italy
655
MORBIDITY AND MORTALITY ANALYSIS OF UPPER ABDOMINAL SURGERY
FOR GYNECOLOGICAL CANCERS
A. Ayhan, P. Dursun, G. Coban, S. Yuksel, T. Tekelioglu, L. Mutlu, Turkey
656
AQUAPORIN-1(AQP1) EXPRESSION IN SEROUS EPITHELIAL OVARIAN
CANCERS AND ITS RELATIONSHIP WITH CONVENTIONAL PROGNOSTIC
FACTORS
M.K. Takal, P. Dursun, O. Ozen, B. Caylak, C. Baykal, A. Ayhan, Turkey
187
Poster Session II
Poster No
657
TERTIARY CYTOREDUCTIVE SURGERY VERSUS THIRD LINE
CHEMOTHERAPY FOR RECURRENT OVARIAN CANCER. A PROSPECTIVE
STUDY
F. Bellati, I. Ruscito, M.L. Gasparri, C. Marchetti, F. Tomao, M. Pernice, A. Rossi,
R. Zito, N. Manci, A. De Vivo, P. Benedetti Panici, Italy
658
MALIGNANT PERITONEAL MESOTHELIOMAS
R. Macuks, H. Ozdemir, N. Haberal, O. Ozen, P. Dursun, A. Ayhan, Turkey
659
UMBILICAL METASTASIS (SISTER MARY JOSEF'S NODE) IN ADVANCED
OVARIAN CANCER-A CASE REPORT
M. Nikolaou, H.P. Kourea, K. Koniari, G. Adonakis, V. Tsapanos, G. Decavalas,
C. Kalofonos, Greece
660
MANAGEMENT STRATEGIES IN OLDER PATIENTS WITH ADVANCED
OVARIAN AND PRIMARY PERITONEAL CANCER
D. Tootill, L. Carter, H. Wong, R. Lord, UK
661
BRAIN METASTASIS IN GYNECOLOGIC CANCERS: ANALYSIS OF 12
PATIENTS
P. Dursun, A. Ayhan, E. Cabuk, B. Bildaci, B.K. Karakaya, S. Sen, H. Caner, Turkey
662
HER2 PROTEIN OVEREXPRESSION IN OVARIAN CANCER- AN ASSOCIATION
WITH OTHER PROGNOSTIC FACTORS
T. Ivkovic Kapicl, T. Dugandņija, A. Mandiš, Serbia
663
THE IMPACT OF 2ND TO 4TH LINE THERAPY ON SURVIVAL OF RELAPSED
OVARIAN CANCER AFTER PRIMARY TAXANE/PLATINUM BASED THERAPY
L.C. Hanker, S. Loibl, J. Pfisterer, W. Meier, N. Burchardi, E. Pujade-Lauraine,
I. Ray-Coquard, J. Sehouli, P. Harter, A. du Bois, Germany
664
GIANT STRUMA OVARII MIMICKING ADVANCED STAGE EPITHELIAL
OVARIAN CARCINOMA
B. Bildaci, B.K. Karakaya, E. Cabuk, P. Dursun, A. Ayhan, Turkey
665
FIRST EXPERIENCE OF SURGICAL TREATMENT IN ADVANCED OVARIAN
CANCER AFTER INTRAPERITONEAL APPLICATION OF THE TRIFUNCTIONAL
ANTIBODY CATUMAXOMAB
G. Papanikolaou, C. Fotopoulou, E.-I. Braicu, R. Chekerov, S.-C. Schmidt,
W. Lichtenegger, J. Sehouli, Germany
666
CA-125 IN STEROID CELL TUMOR
E. Sosa Comino, Y. Suárez Hernández, M. Hernández Suárez,
J. de la Torre Fernández de Vega, Spain
667
DRUG RESISTANCE/SENSITIVITY IN VITRO AND CLINICAL OUTCOMES IN
I. Sedláková, M. Ţervinka, J. Tońner, J. Laco, K. Brigulová, A. Řezáţ, J. Ńpaţek,
P. Ńkapinec, Czech Republic
188
Poster Session II
Poster No
668
OVARIAN CARCINOSARCOMA
E. Sosa Comino, Y. Suárez Hernández, M. Hernández Suárez, L. Melgar Vilaplana,
J. Carballo Lorenzo, J. de la Torre Fernández de Vega, Spain
669
MALINGNANT BRENNER TUMOR
E. Sosa Comino, Y. Hernández, M. Hernández Suárez, L. Melgar Vilaplana,
L. Álvarez González, J. de la Torre Fernández de Vega, Spain
670
HIGH PREOPERATIVE PLASMA CONCENTRATION OF HE4, SUPAR AND
CA125 DISCRIMINATE BETWEEN BENIGN AND MALIGNANT OVARIAN
TUMORS
C. Borgfeldt, E. Henic, I.J. Christensen, B. Casslén, G. Hoyer-Hansen, Sweden
671
OVARIAN LUTEOMA. DIFERENCIAL DIAGNOSIS OF ADNEXIAL MASS IN
PREGNANCY
Y. Suárez Hernández, E. Sosa Comino, R. Rodríguez Reyes, F. Amaya Hernández,
J.M. Troyano Luque, J. de la Torre Fernández de Vega, Spain
672
THE CT ENHANCING FRACTION PREDICTS RESPONSE TO NEO-ADJUVANT
CHEMOTHERAPY IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN
CARCINOMA
C. Parkinson, L.A. Grant, N. Griffin, S. Vowler, K. Sayal, M. Iddawela, H. Earl,
J.D. Brenton, E. Sala, UK
673
MODIFIED OUTPATIENT REGIMEN OF INTRAVENOUS / INTRA-PERITONEAL
PACLITAXEL AND CISPLATINUM FOR OPTIMALLY DEBULKED STAGE III
S.S. Tedjarati, L. Kessler, USA
674
OVARIAN LYMPHOMA
Y. Suárez Hernández, E. Sosa Comino, R. Rodríguez Reyes, C. García Castro,
M. Carrancho Montero, J. de la Torre Fernández de Vega, Spain
675
NEOADJUVANT CARBOPLATIN, PACLITAXEL (NACT) FOR ADVANCED
STAGE (AS) EPITHELIAL OVARIAN CANCER (EOC) COMPARED TO
SURGICAL CYTOREDUCTION (USC) FOLLOWED BY CP
P. Schwartz, H. Yu, M. Glasgow, M. Azodi, A. Santin, D.-A. Silasi, T. Rutherford,
USA
676
COMPARATIVE STUDY OF INTRAPERITONEAL CHEMOTHERAPY
ASSOCIATED GRADE 3 / 4 TOXICITIES AFTER PRIMARY VERSUS INTERVAL
SURGICAL DEBULKING
H. Latifah, L. Jolicoeur, T. Le, W. Faught, M. Fung Kee Fung, Canada
189
Poster Session II
Poster No
677
FACTORS INFLUENCING UPTAKE OF RISK REDUCING SALPINGOOOPHORECTOMY (RRSO) IN WOMEN AT HIGH RISK OF FAMILIAL OVARIAN
CANCER
R. Manchanda, A. Abdelraheim, M. Johnson, A. Rosenthal, E. Benjamin,
C. Brunell, M. Brunell, L. Side, S. Gessler, E. Saridogan, D. Oram, I. Jacobs,
U. Menon, UK
678
EPIDIDYMAL TISSUE PRESENTING IN A PHENOTYPIC MOSAIC FEMALE WITH
A MALIGNANT MIXED GERM CELL TUMOR OF THE OVARY
J. Saldivar, D. Wilson, L. de las Casas, V. Tonk, USA
679
HIGH CUMULATIVE DOSES OF PEGYLATED LIPOSOMAL DOXORUBICIN ARE
NOT ASSOCIATED WITH CARDIAC TOXICITY IN PATIENTS WITH OVARIAN
CANCER
K. Ma, L. Egan, T. Pejovic, USA
680
RADIOTHERAPY IN RECURRENT AND PERSISTENT OVARIAN CANCER:
LONG-TERM OUTCOMES
R. Rome, S. Leung, Australia
681
PREDICTIVE FACTORS IN RELAPSED OVARIAN CANCER FOR COMPLETE
TUMOR REDUCTION
B. Gil, G. Oskay-Öezcelik, R. Richter, U. Neumann, P. Neuhaus, W. Lichtenegger,
J. Sehouli, Germany
682
CLINICAL OUTCOME OF CONSERVATIVE SURGERY FOR BORDERLINE
OVARIAN TUMORS WITH NONINVASIVE IMPLANTS AND STAGE I DISEASE
C.H. Jeong, Y.I. Ji, D.H. Jeong, K.B. Lee, K.T. Kim, Republic of Korea
683
NRF2 SIGNALING - A POTENTIAL MECHANISM FOR CISPLATIN -RESISTANCE
IN OVARIAN CANCER
X. Yi, Z. Li, H. Sun, China
684
SYMTOMATIC TREATMENT OF ASCITES WITH IP-CHEMOTHERAPY IN
ADVANCED RELAPSING OVARIAN CANCER SEEMS EFFECTIVE AND SAFE
S. Malander, S. Ljungblad, H. Kristiansson, K. Bergfeldt, Sweden
685
PROGNOSTIC FACTOR IN THE PATIENTS OF EARLY-STAGE (PT1/PT2)
CLEAR CELL CARCINOMA OF THE OVARY
K. Okamoto, Y. Suzuki, Y. Todo, H. Kato, Japan
Other
687
ESTROGEN REPLACEMENT INDUCES A UNIQUE GENE EXPRESSION
PROFILE IN OVARIAN CANCER THAT DIFFERS FROM BREAST CANCER
M. Spillman, N. Manning, W. Dye, B. Jacobsen, K. Horwitz, USA
190
Poster Session II
Other (contd.)
Poster No
688
CURCUMIN ENHANCED THE ANTITUMOR EFFECT OF HERPES SIMPLEX
VIRUS THYMIDINE KINASE IN HUMAN BREAST CANCER THROUGH
MODULATION OF ANTI-APOPTOTIC PATHWAY
Y.-F. Chang, C.-H. Hsu, H.-Y. Chuang, J.-J. Hwang, Taiwan R.O.C.
689
HIGHLY EFFECTIVE RISK STRATIFICATION BY HUMAN PAPILLOMAVIRUS
TESTING IN WOMEN WITH ABNORMAL CERVICAL CYTOLOGY; 17.5 YEARS
PROSPECTIVE COHORT STORY
M. Kocken, J.A. Louwers, A. Zaal, J. Berkhof, M.A.E. Nobbenhuis, P.J.F. Snijders,
C.J.L.M. Meijer, T.J.M. Helmerhorst, The Netherlands
690
DIAGNOSTIC PERFORMANCE OF CONTRAST ENHANCED CT AND FDGPET/CT IN THE ASSESSMENT OF LYMPH NODE METASTASIS IN OPERABLE
CERVICAL CANCER
A. Maheshwari, H.B. Tongaonkar, N.C. Purandare, India
691
EVALUATION OF NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED
CERVICAL CANCER AND ANALYSIS OF RISK FACTORS
L. Gong, Z. Peng, China
692
OBESITY: A PREDICTIVE FACTOR OF SIGNIFICANT DISEASE FOLLOWING A
DIAGNOSIS OF CERVICAL GLANDULAR DYSKARYOSIS?
T.O. Adedipe, S.J. Vine, UK
693
FORTY YEARS REVIEW FOR THE TREATMENT OF VAGINA CARCINOMA: AN
INSTITUTIONAL EXPERIENCE
T. Wan, J. Liu, Q. Huang, China
191
192
Aguirre, Gorospe, S.
138, 139
Ahmed, I.
79, 82, 103
Ahn, T.
94
Ahn, T.G.
61, 104
Ahn, W.S.
61
Ahson, G.
145
Aizawa, M.
128
Ajenifuja, K.
93
Akahira, J.I.
88
Akahori, T.
133, 168
Akers, R.
80
Akhan, S.
146
Akhavan, S.
111, 184
Akhter, K.
82
Akimoto, T.
180
Akiya, T.
45, 101
Akrivos, N.
67, 129, 131, 139
Akrivos, T.
129
Aksam, S.
171
Akslen, L.A.
27, 55, 136
Aktas, D.
55
Akter, S.
116
Akturk, E.
85, 105, 154, 167, 178
Akyüz, A.
77
Al, Kadri, H.
86
Al, Rawahi, T.
28
Alanbay, I.
85, 105, 114, 154, 167, 178
Alazzam, M.
30, 54, 71, 120
Albaracin, N.
50
Al-Beiti, M.
85
Albela, S.
65
Aldakhil, L.
78
Aldinhas, P.
89
Aldini, A.
47
Aleksievska, I.
119
Aleksievska, N.
119
Aleksioska, I.
112
Alektiar, K.
10
Alemany, L.
86
Aleshikova, O.
105
Alessandria, S.
81
Alessandro, L.
119
Aletti, G.
49
Alexandropoulos, N.
32, 155
Ali, K.K.
30, 152
Ali, M.
103
Ali, R.
27
Ali, S.
20
Ali Syed, A.
84
Ali, W.
103
Alibegashvili, M.
75, 143
Ali-Fehmi, R.
47, 75, 129, 137, 138
A
Aalders, A.
170
Abacjew-Chmyłko, A.
122, 134, 172
Abali, H.
176
Abbasi, F.
67, 71
Abbasi, S.
73
Abbud, A.
67, 78, 88
Abdelraheim, A.
44, 190
Abdullah, M.F.
136
Abdullakhodjaeva, M.
84
Abe, A.
89
Abe, M.
141
Abeler, V.
116
Abiko, K.
165
Abou Louz, A.
152
Abu Freij, M. 80, 90, 102, 122, 127, 173, 184
Abulafia, O.
91
Abu-Rustum, N.
1, 8, 30, 35
Accarpio, F.
74, 162, 166
Achariyapota, V.
117
Acheson, N.
123, 145
Achiampong, J.
122
Achilli, C.
63
Achimas-Cadariu, P.
50
Achleitner, R.
73
Acioglu, H.
63
Adamson, S.P.
28
Adanir, I.
99, 132
Adaramewa, T.
106
Adebami, B.
93
Adedipe, T.O.
191
Adegbesan, M.A.
106, 110
Adenan, N.A.M.
95
Adewuyi, S.
119
Adonakis, G.
188
Adya, R.
31
Afandi, M.A.
150
Afonso, N.
102
Afsal, Aghaee, M.
89
Afzalaghaee, M.
150
Agarwal, R.
161, 186
Agarwal, S.
101
Agboola, O.
84
Aggeli, S.
107
Aghaei, M.
163
Aghili, M.
90
Agıllı, M.
105
Agnew, K.
156
Agnihotram, R.
149
Agramunt, S.
65
193
Alikasifoglu, M.
55
Alitalo, K.
164
Allen, C.
169
Allen, K.
55
Alloisio, A.
145
Alloub, M.
116
Almeida, A.M.
122
Almeida, B.
89, 107, 130
Almeida Reis, S.A.
105
Almici, C.
178
Alobaid, A.
78
Alobaid, S.
78
Aloni, H.
163
Alonso Socas, M.M.
173
Alsina, A.
142
Altevogt, P.
145
Altinkaya, S.O.
157
Altıntaş, A.
109
Aluloski, I.
70, 112, 113
Alvarez, A.
44, 178
Álvarez González, L.
189
Alvarez, R.
126
Alvarez, R.D.
2, 61
Alvarez Secord, A.
2, 23, 159
Alves, B.
97, 106
Alves, L.
173
Al-Wahab, Z.
138
Amadio, G.
104, 149
Amalinei, C.
111, 115
Amano, M.
107, 144
Amant, F.
19, 27, 31, 36, 49, 50, 60
63, 100, 127, 138, 142, 143, 167
Amaro, T.
87
Amaya Hernández, F.
189
Ameijide, A.
146
Amichay, K.
133
Amin, A.
74
Aminimoghaddam, S.
125
Ammari, A.
72
Amouzegar-Hashemi, F.
90
Amparo, G.
125
An, N.
51, 175, 181
Anagnostou, E.
145, 182
Ananda, S.
51, 177
Anantharachagan, A.
33, 119
Anastasia, P.
186
Anastasopoulos, N.
107
Anderson, B.
134
Anderson, C.
32
Andersson, H.
159, 161
Andersson, S.
138
Andersson, T.
45, 100
Andi, A.A.
96
Andonova, I.
94, 132
Andrade, C.E.M.C.
30, 64, 69, 140, 185
Andrade, D.A.P.
77
Andrade, S.P.
61
Andrae, B.
45, 100
Andrejeva, S.
137, 148
Andrews, P.
62
Andreyev, H.J.N.
119
Andrieux, N.
177
Andriotis, E.
130
Andruschuk, V.
82
Angellier-Lucchi, E.
159
Angioli, R.
33, 37, 38, 180
Anglade, E.
74
Anil Onan, M.
41
Ankathil, R.
77
Ann, H.S.
98
Anorlu, R.I.
106, 110
Ansari, M.
73
Antaby, E.
126
Antonova, I.
105
Antosz, H.
176
Antovska, V.
113, 147, 184, 186
Antsaklis, A.
26, 67, 100, 129, 131, 139
Antsanklis, A.
183
Anttila, M.
133, 162, 164
Anttonen, M.
172
Ao, L.
84
Aoki, D.
9, 62, 133, 141, 144
Aoki, F.
20, 46, 112
Aoki, Y.
85, 91, 95, 141, 175
Api, M.
129
Api, O.
63
Apolloni, C.
144
Apter, D.
20, 46, 112
Aragona, A.
49, 102
Arakawa, A.
93, 141, 176
Araki, J.
58
Aranda, S.
123
Aravidis, C.
183
Arbós, A.
113
Ardeleanu, C.M.
58
Ardisson, P.
181
Arduini, D.
63
Arenas, M.
146
Argirovic, R.
70
Argüelles Cabrera, H.
71
Argyri, E.
107
Arias-Pulido, H.
180
Aristarco, V.
122
Armstrong, D.K.
2
Arnold, N.
160
Arnould, L.
162
Arora, R.
186
Arora, V.
78
Arranz, J.A.
23, 159
Arseneau, J.
149
194
Arslan, G.
115, 116
Arslan, H.
114
Arteiro, D.
77
Arts, H.J.G.
51, 130
Arvas, M.
83, 94, 127, 128, 138, 155
Asadchikova, O.
127
Asai-Sato, M.
58, 128, 157
Asakawa, S.
62
Asakawa, T.
175
Asakura, H.
167, 175
Asato, K.
85, 91
Asaturova, A.
135, 136
Asher, V.
159, 160, 161, 171
Ashkvary, P.
73
Ashrafganjooei, T.
157, 164
Ashrafyan, L.
105, 142
Ashton, Y.
96
Askew, S.
101, 138
Aslan, B.
83
Aslay, I.
146
Asmane, I.
181
Atanackovic, J.
93, 171
Atasoy, L.
114
Athanassiadou, A.M.
76
Athanassiadou, P.
76
Attard, Montalto, S.
62
Attia, L.
177
Attias, Z.
53, 59, 60, 133
Attygalle, A.
183
Aubin, S.
81
Auer, G.
138
Auge, J.M.
54, 120
Ault, K.
46
Aune, G.
177
Aureli, T.
65
Auslender, R.
64
Åvall-Lundqvist, E.
10, 47
Averkin, Y.
75
Avsar, F.
114
Ayatollahi, F.
111, 184
Ayatollahi, H.
183, 184
Aydıner, A.
147
Aydogan, B.
94, 138
Aydogdu, M.
172
Aydogmus, H.
114
Ayhan, A.
33, 55, 71, 114, 141, 148
176, 187, 188
Aykul, S.
114
Aysal, A.
162, 186
Aziz, A.
186
Azodi, M.
26, 71, 82, 156, 189
Baak, J.P.
25
Baalbergen, A.
109
Baas, I.O.
151, 170
Baba, K.
133
Baba, T.
22, 57, 165
Babaei, A.
89
Babala, P.
135
Babusku, J.
70
Baccheschi, A.
74, 162, 166
Bacchi, C.
89, 107, 130
Bäck, T.
161
Badía, J.
166
Badpa, N.
184
Badzakov, N.
80
Bae, D.
183
Bae, D.H.
61, 149
Bae, D.S.
88, 91, 104, 131, 159, 170, 176
Bae, J.-H.
86
Bae, J.M.
100, 110, 174
Bafna, U.D.
156
Bagga, R.
151
Bahadori, F.
183, 184
Bahman, A.
172
Bahman, S.
172, 176
Bahoric, B.
138
Baidekalna, I.
78
Bailey, D.
145
Baima, Poma, C.
64
Baiocco, E.
83
Bajard, A.
181
Bajwa, S.
74
Bakalianou, K.
66, 125, 126
Baker, J.
181
Bakers, F.
59
Bakinovskaya, I.
30, 82
Bakkers, J.M.J.E.
92
Bakkum-Gamez, J.
143
Balan, R.
111, 115
Balañá, C.
161
Balas, C.
31
Balasubramani, L.
82, 121
Balci, S.
146
Bali, A.
159, 160, 161
Ball, A.
82
Ball, G.
171
Balleyguier, C.
154
Balocco, P.
68
Baloglu, A.
58
Balsat, C.
61, 104, 109
Baltzer, J.
153
Bammidi, L.S.
61
Bamrah, Singh, H.
169
Bandarian, M.
67
Bandiera, E.
106, 178
Bandyopadhyay, J.
166, 187
B
Baak, J.
47, 136
195
Bandyopadhyay, S.
47, 75, 137, 138
Banks, R.
185
Bankuti, E.
93
Banno, K.
133, 144
Baños, N.
65
Bansal, S.
91
Banu, E.
161
Banumathy, M.
177
Bao, Q.
51, 181
Baptista, M.Z.
76
Bar, E.
142
Bar, J.
132, 159
Bar, J.K.
168
Baracat, E.
89, 107, 130
Baradaran, H.R.
151
Barak, F.
126
Barakat, R.
11, 56
Barel, E.
108
Barile, M.
122
Barkane, I.
137, 148
Barlow, E.
68
Barnes, M.N.
61
Barouti, E.
90
Barrena Medel, N.
7, 29, 47, 141
Barriga, M.
59
Barriga, M.I.
28
Barton, D.
25, 82, 121, 153, 182, 183
Barton, D.P.J.
119
Bartos, P.
51
Basen-Enquist, K.
161
Baser, E.
114
Başer, I.
85, 154, 167, 178
Bashesha, N.
70
Basta, P.
61, 106
Basu, C.
75, 180
Basu, S.
116
Bati, Y.
131
Batista, C.B.
69
Batista López, N.
173
Bats, A.-S.
28
Battista, M.J.
76, 139, 182
Bauer, K.
52, 166, 181
Bauerschlag, D.
55
Bauknecht, T.
44, 178
Baulies, S.
81, 142
Baumann, K.
26, 55
Baykal, C.
187
Bayrak, D.
121
Beale, P.
20
Bebis, H.
121
Bebitoglu, I.
182
Becker, M.
133
Becker, S.
138
Becsi, J.
79
Bednarek, W.
157, 160, 169, 182
Beer, B.
Behnamfar, F.
Behrem, S.
Behtash, N.
Beiner, M.
Bekes, I.
Bekkers, R.L.M.
Belau, A.
Belau, A.K.
Béliard, A.
Bell, S.
Bellati, F.
Beller, U.
Bellone, M.
Bellone, S.
Belloti, J.A.
Belo, A.V.
Bělobrádek, Z.
Beltrami, C.
Beltran, M.
Ben, Arie, A.
Ben, Baruch, G.
Ben, Shachar, I.
Ben, Temime, R.
Benedetti-Panici, P.
Bengisu, E.
Benigno, B.
Benitez, G.
Benjamin, E.
Benjapibal, M.
Benkendorff, K.
Bensalem, A.
Ben-Shem, E.
Benti, R.
Bentley, J.
Berchuck, A.
Berditchevski, F.
Berek, J.
Bergamelli, S.
Bergamini, A.
Berger, J.
Bergerat, J.-P.
Bergfeldt, K.
Bergin, R.
Berisavac, M.
Berkhof, J.
Berkman, S.
Berman, M.
Bermudez, A.
Bernard, L.
Bernardini, M.
Berneman, Z.N.
Berns, E.
Bernshaw, D.
Bersinger, N.
196
73
151
178, 179
88, 151
163
179
45, 92, 104
33
53, 120
61, 109
69
63, 188
13, 49
26, 156
26, 156
115
61
83
4
23, 53, 120, 159
49
163
49
177
18, 21, 63, 188
144, 145, 146, 147
166
83
44, 190
112, 117, 158
174
72
183
63
82
15, 23, 181
132
11, 15, 20, 33, 56
184
145, 152
100
181
190
123
171
31, 45, 46, 92, 99, 191
145, 146, 147, 173
146
37, 81, 139
122
49, 105
127
22
31, 45, 84, 123, 187
68
Berteloot, P.
100, 142, 143
Berton, Rigaud, D.
177
Berugoda, N.
80
Beşe, T.
83, 94, 127, 128, 138, 155
Beugeling, M.
66
Beugelink, S.
22
Bevers, M.
161
Bevis, K.
126
Bevis, K.S.
92
Beynon, G.
79
Bezares, Pérez, B.
139
Bhamarapravatana, K.
134
Bhatla, N.
33, 63, 179
Bhatnagar, S.
91
Bhavsar, D.
92
Biacchi, D.
74, 162, 166
Biagi, J.
55, 152
Bidziński, M.
67, 83, 84, 89, 107, 153,
158, 161, 185
Biernat, W.
57, 66
Biewenga, P.
24
Biffi, R.
119
Bifulco, G.
144
Biggiogero, M.
4
Biglia, N.
170
Bignon, Y.-J.
43, 172
Bignotti, E.
106, 178, 184
Bijen, C.B.m.
51, 130
Bildaci, B.
71, 114, 148, 188
Biliatis, I.
67, 131, 139
Biliatis, J.
26, 100
Bilir, A.
144, 173
Billen, J.
60
Bilyk, O.
62
Bindra, S.
108
Binyamin, L.
161
Birciu, S.
96
Birnie, E.
111
Birrer, M.
5
Biswas, A.
155
Biswas, M.
91
Bitelman, C.
53, 60
Bjurberg, M.
85
Blacher, S.
61, 109
Black, A.
8
Black, L.
118
Blagden, S.
161, 186
Blanas, K.
135, 173
Ble, C.
66
Blecharz, P.
180
Blinman, P.
54, 120
Blumstein, C.
62
Blumstein, N.M.
62
Bo, Y.
169
Bobek-Pstrucha, E.
67
Bocciolone, L.
Bochkareva, N.
Bochorishvili, I.
Bodur, S.
Bodurka, D.
Boehm, D.
Boente, M.
Boes, A.-S.
Bogani, G.
Bogliolo, S.
Bogomolniy, F.
Boguslaw, L.
Boh, Y.
Boivin, J.-F.
Bojadziev, A.
Bol, G.
Bolan, P.
Bolger, N.
Boman, K.
Bonanni, B.
Bonates, T.C.
Bonavia, E.
Bonazzi, C.
Bonazzi, C.M.
Bonazzi, M.C.
Bongers, M.Y.
Bonner, C.
Bonsu, A.
Bookman, M.
Boran, N.
Bordes, V.
Bordinca, I.C.
Bordinhao, R.W.
Borg, C.
Borgato, L.
Borgfeldt, C.
Borovkova, E.
Borowiak, J.
Boruta, D.
Boruta, II, D.M.
Bosch, F.X.
Bostancıoglu, R.B.
Botha, M.H.
Boubli, L.
Bouda, J.
Boudova, L.
Boulanger, J.C.
Boulouh, I.
Boulvain, M.
Bouman, C.
Bourne, T.
Bouzid, K.
Bover, I.
Boveri, S.
Bovin, N.
197
49, 83, 152
127
75, 143
121
158
139
20
138
108, 144
69
59
67
167
86
80
60
65
112
161
122
114, 115
102
74
54, 120
43, 102, 160
51, 130
32
79
20, 33
106, 134, 138
177
137
30
168
187
189
146
67
166
172
86
125, 139
50, 110
91, 112
101
101
85
72
102
58
63
72, 151
23
152, 170
53, 57
Boyanova, M.
Boyd, J.
Boyle, F.
Boyle, J.
Boyraz, G.
Bradford, A.
Brady, M.
Braicu, E.I.
Braicu, I.E.
Brain, E.
Brand, A.
Brañes, J.
Bratcher, Y.
Braun, M.
Braun, P.
Bräutigamm, K.
Brennan, D.
Brentani, R.R.
Brenton, J.
Brenton, J.D.
Bresciani, V.
Bridges, J.
Brigulová, K.
Brin, S.
Brink-Spalink, V.
Bristow, R.
Bristow, R.E.
Brncic Fischer, A.
Broaddus, R.
Brockbank, E.
Broďák, M.
Brown, A.
Brown, B.
Brown, D.
Browne, J.
Bruchim, I.
Brun, E.
Brunell, C.
Brunell, M.
Bryant, A.
Brychtova, S.
Buccheri, E.
Buchynska, L.G.
Buckanovich, R.
Buda, A.
Budiningsih, S.
Bugariu, M.
Buhrmann, C.
Buiga, R.
Buist, M.
Buist, M.R.
Bujko, K.
Bulbul, D.
Bulten, H.
Bulten, J.
96
10
77
93
99, 132
61
20
153, 154, 179, 182, 188
179
39
28, 79, 121
59, 166
181
48, 148
181
160
31
74
155
189
70
82, 121, 173, 182, 183
188
81
154
47, 131, 163
152
177, 178, 179
36, 133
153
83
69, 161
5
153
81
53, 59, 60, 133, 164, 169
85
44, 190
44, 190
7, 92
128
186
62
152
168
31
182
49
161
43, 167
24
89
106
28
45, 66, 92, 109, 130, 145
Buqueras, C.
Burbos, N.
Burchardi, N.
Buresova, I.
Burger, C.
Burger, C.W.
Burger, H.
Burger, M.P.M.
Burger, R.
Burges, A.
Burke, W.
Burks, R.T.
Burnett, A.
Bush, S.
Butler, J.
Butler-Manuel, S.
Butow, P.
Butow, P.N.
Butzow, R.
Buyrukcu, B.A.
Büyükkurt, S.
Buza, N.
Buzaglo, K.
Buzrla, P.
Byrne, H.J.
Byun, J.C.
Byun, J.-M.
151, 157, 171
75
27, 80, 90, 102, 122, 135
137, 139, 173
188
106
22, 24, 41, 111
109, 173
68
24
2, 20
26
7, 29, 47, 118, 141
147
30, 81
83, 187
25, 121
64, 65, 78, 79, 80
55, 77, 119
123
172
88
30, 67, 109, 151, 160
156
81
7
113
98
98
C
Cabuk, E.
71, 114, 148, 188
Cacsire-Castillo, D.
146
Caesarini, M.
122
Çağlar, A.T.
128
Caglar, M.
157
Cai, L.
87, 133
Cai, S.M.
165
Cairns, J.
177
Cairo, A.
143
Cakici, C.
88
Calaguas, M.J.
108
Calil, M.
89, 107, 130
Calvo, E.
23
Calza, S.
184
Camacho, L.
158
Camara, O.
149
Cameroni, I.
102
Campagnutta, E.
186
Campion, L.
177
Camporeale, A. 111, 132, 136, 137, 180, 184
Camporeale, A.L.
148, 176
Campos, S.
14
Can, F.
114
198
Can, M.F.
76
Candiani, M.
180
Caner, H.
188
Cannon, M.
185
Cannone, F.
30
Cantù, D.
7, 103
Cantù, M.
54, 120
Canzler, U.
20, 26, 33, 53, 55, 120
Cao, D.
159, 179, 180
Cao, Z.-Y.
64, 69, 81
Capilna, M.E.
79, 96
Capitanescu, R.
65
Capoen, A.
142, 143
Caprara, G.
171
Carballo, Lorenzo, J.
189
Carcangiu, M.
80, 178
Carcopino, X.
91, 112
Cardi, M.
74, 162, 166
Carey, M.
20
Carlos Zuloaga, C.
103
Carlson, J.
126
Carmeliet, P.
60
Carmichael, J.
22
Carollo, S.
108, 144
Carrancho Montero, M.
176, 189
Carrera González, M.D.P.
73
Carreras, R.
65, 113
Carri, G.
183
Carroll, A.R.
53, 60
Carroll, S.
119
Cartagena, J.
166
Carter, J.
11, 32, 65, 78, 110, 119
Carter, L.
188
Caruntu, I.D.
111, 115
Caruso, D.
171
Carvalho, A.T.
62, 185
Carvalho, F.
89, 107, 130
Carvalho, J.
89, 107, 130
Carvalho, S.
97, 106
Casado, A.
23
Casagrande, F.
26, 156
Casali-da-Rocha, J.C.
59
Casey, C.
117, 118
Casova, M.
187
Cassani, C.
172
Cassano, E.
30
Cassinello, J.
159
Casslén, B.
189
Cassorelli, A.
63
Castellsagué, X.
7, 20, 25, 34, 45, 46, 96
112
Castro, F.
76
Castro, J.
68
Catala, L.
74
Caughey, A.
43, 159, 162, 174
Caylak, B.
187
Cazzolla, A.
111, 148, 184
Ceballos, K.
110
Ceccacci, I.
80, 128
Cederkrantz, E.
161
Cedzynski, M.
178
Ţegan, M.
92
Celiku, S.
166
Ceppi, L.
43, 54, 102, 120, 160, 168
Cerbinskaite, A.
23
Cernea, N.
65
Cerone, M.
4
Cerovic, R.
93
Cervantes, A.
20, 23
Ţervinka, M.
188
Cetin, A.
129
Cetin, C.
145, 147
Cetina, L.
7, 103
Šetkoviš, A.
105, 111
Cha, M.S.
98
Cha, S.D.
99
Chachan, S.
64, 80
Chachia, A.
177
Chaengchenvate, C.
118
Chakalov, B.
118
Chakalova, G.
118, 133
Chakova, N.
173
Challapalli, A.
26
Chan, F.
28
Chan, H.-S.
61
Chan, J. 43, 55, 81, 117, 118, 159, 162, 174
Chan, K.
165
Chan, M.
95
Chan, P.
95
Chan, S.
23, 176
Chan, Y.M.M.
140
Chandran, P.A.
114
Chang, C.
103
Chang, C.C.
181
Chang, C.J.
111
Chang, C.L.
111, 162, 168
Chang, D.Y.
94
Chang, H.P.
111
Chang, K.H.
95
Chang, M.D.T.
26
Chang, S.J.
26, 61, 95, 111, 168
Chang, T.
103
Chang, T.C.
58, 111, 113, 114
Chang, X.H.
163
Chang, Y.F.
51, 75, 191
Chang, Y.Y.
62
Changwatchai, J.
121
Chanona, J.
7, 103
Chansilpa, Y.
108
Chao, A.
103, 111
199
Chao, K.C.
60, 181
Chaopotong, P.
117
Chapman, C.
185
Charakorn, C.
93, 107
Charoenkwan, K.
155
Charova, J.
122
Chase, D.
11
Chatterjee, J.
186
Chatzis, P.
115, 145, 151, 182
Chaudary, N.
93
Chaves, C.B.P.
59
Chay, D.
51, 150
Chebaro, W.
151
Chebotareva, N.
173
Chee, C.Y.I.
118
Cheewakriangkrai, C.
155
Chekerov, R.
172, 179, 188
Chelli, H.
186
Chen, C.A.
175
Chen, C.H.
144
Chen, C.K.
74
Chen, C.L.
64, 69, 81
Chen, J.
31, 84, 86, 95
Chen, J.R.
111, 168
Chen, L.H.
58
Chen, L.M.
25, 62, 117, 118, 176
Chen, M.
103
Chen, M.R.
57
Chen, M.Y.
113
Chen, T.C.
111, 168
Chen, X.
87, 96, 153
Chen, Y.R.
111
Chen, Y.S.
62
Chen, Y.Y.
157
Chen, Z.
98
Chene, G.
43, 172
Cheng, M.
153
Cheng, N.
154
Cheng, S.L.
114
Cheng, W.F.
175
Cheng, X.
97, 126, 167
Cheng, Y.M.
108, 157
Cheong, M.L.
182
Chernyshova, A.
127
Cheruy, C.
110
Cheung, A.N.Y.
97
Cheung, T.
95
Chi, D.
1, 17
Chi, D.S.
33
Chi, S.G.
57, 59
Chia, J.
141
Chia, Y.N.
123, 141
Chiang, Y.C.
175
Chiantera, V.
64
Chiappa, V.
54, 120
Chiavarini, M.
104
Chibissova, G.M.
183
Chien, T.Y.
182
Chin, K.
82, 102, 122
Chingisova, Z.
100, 140
Chiriva-Internati, M.
185
Chitcholtan, K.
47, 132
Chiu, H.
63
Chiu, M.L.
111
Chmelarova, M.
147
Chmylko, L.
122
Cho, C.H.
99, 126, 135
Cho, C.K.
90
Cho, I.A.
150
Cho, J.
153
Cho, J.H.
150
Cho, S.H.
156
Cho, Y.L.
80, 135
Choi, C.H.
88, 91, 104, 131, 170, 176
Choi, H.S.
102
Choi, I.J.
98
Choi, J.H.
177
Choi, S.C.
78
Choi, W.J.
150
Choi, W.S.
150
Choi, Y.J.
86
Choijamts, B.
128
Chong, G.O.
80, 135
Choschzick, M.
24, 70
Chou, C.Y.
157
Chou, H.
103
Chou, H.H.
58, 111, 113, 186
Chow, S.N.
20, 46, 112
Choy, C.
71
Christe, D.M.
99
Christensen, I.J.
189
Chrusciel, M.
44, 184
Chryssanthakis, D.
149
Chrzan, R.
77, 123
Chu, W.
70
Chua, E.J.
141
Chua, L.M.K.
98
Chuang, H.Y.
51, 75, 191
Chuang, L.
153
Chuang, Y.J.
61
Chulkova, O.
104
Chun, K.C.
94, 105, 164
Chung, H.H.
45, 59, 69, 99, 103, 163, 164
Chung, H.W.
94
Churuksaeva, O.
107
Chwiłkowska, A.
168
Ciancio, F.
30, 144
Cibula, D.
1, 28, 65, 87, 119, 185
Cibull, M.
25, 173
Cibulska, P.
105
200
Cilaker, Micili, S.
60
Cimino, M.
83
Cinieri, S.
74
Cinquino, M.
50
Claes, B.
167
Clark, M.A.
66
Clark, S.
175
Classe, J.M.
74, 177
Clayton, D.R.D.
148
Clayton, R.
153
Clayton, R.D.
149
Cleary, S.
112
Cleghorn, G.
53, 58
Clelland, C.
91
Cliby, W.
143
Coates, A.
77
Coban, G.
114, 187
Cobos, E.
185
Cocco, E.
26, 156
Cocker, R.
122
Coeffic, D.
181
Coelho, D.
173
Coelingh, Bennink, H.J.T.
44, 184
Coenegrachts, L.
60
Coens, C.
49
Cognetti, F.
187
Cohen, S.
164
Cohn, D.
134
Cojocaru, M.
58
Colakovic, B.
145
Colakovic-Popovic, V.
145
Cole, L.M.
125
Coleman, R.
54, 120, 126, 158, 173
Coleman, R.L.
2, 20, 31, 53, 60
Collee, M.
22
Collet, J.-P.
86
Collettini, F.
158
Collinson, F.
185
Colombo, N.
6, 22, 23, 49, 152, 163
Colomé, C.
113
Comanescu, A.
65
Conri, V.
30, 122
Coory, M.
140
Coosemans, A.
127
Corkhill, V.
71
Cormio, G.
33, 111, 132, 136, 137, 148
176, 180, 184
Cornain, S.
101
Cornali, T.
74, 162, 166
Cornell, M.
106
Cornes, P.
7
Cornitescu, F.
65
Coronel, J.
7, 103
Corrado, G.
83, 119
Correa, R.
147, 152
Correia, A.
Corso, S.
Costa, A.
Costa, A.R.
Costa, C.
Costa, F.
Costa, S.
Costantini, B.
Cotarelo, C.
Cote, M.
Cote, M.L.
Cotterell, S.
Coucke, P.
Coussens, L.
Couto, M.R.
Coutts, M.
Coveney, C.
Cowen, D.
Crandley, E.
Crandon, A.
Crawford, B.
Crawford, R.
Creasman, W.T.
Cress, R.D.
Creutzberg, C.L.
Crews, V.
Cricca, M.
Cristoforoni, P.
Crocker, S.
Crocker, S.G.
Cromi, A.
Crossley, B.
Cruz-Pires, M.
Cseh, J.
Cuello, M.
Cui, H.
Cui, L.
Cui, S.
Cuk, D.
Çukurova, K.
Culbova, M.
Cuneo, N.
Cunha, M.
Cunha, V.
Curiel, D.T.
Currie, J.
Curtin, J.
Curtin, J.P.
Curtin, N.
Cusido, M.
Cvancarova, M.
Cvjetiţanin, B.
Cybulka, S.
Cybulski, M.
201
77
43, 54, 102, 120, 160
30
77
77, 87
77
69
81, 139, 174
182
129
47, 75, 137, 138
78
104
31
76, 102
28, 134
171
85
118
28, 53, 58
176
24, 29, 76, 82, 123
18
52, 166, 181
7, 10
181
69
145
27, 80, 90, 102, 122, 127
137, 139, 173, 184
139
108, 144
116
87
113
59, 166
5, 163, 181
86
156
178
98, 137
148, 185
49, 102
143
106, 182
61
69
121
13
23, 61
81, 142
88
187
49
58, 157, 176
Czekierdowska, S.
Czekierdowski, A.
158, 160
158, 160
de los Reyes, R.
106, 108
De Marzi P.
145
De Meerleer, G.
105
De Mitri, P. 111, 136, 137, 148, 176, 180, 184
De Neve, W.
105
De Padova, F.
119
de Pádua, J.B.
71
De Rosa, N.
144
de Roy, S.C.
45, 92
de Sanjosé, S.
86
de Vegt, F.
169
De Vivo, A.
188
de Wit, R.
24
Deavers, M.
158, 172, 179
Debald, M.
48, 148
Debiec-Rychter, M.
143
Decavalas, G.
148, 188
Decleer, W.
80
Dede, M.
76, 85, 105, 114, 154, 167, 178
Deen, S.
171
Deepa, G.
177
Deesamer, S.
181
Defilippi, K.
3
Deguchi, M.
144
Degueldre, M.
81
Dehghani, Dashtabi, M.
73, 157
Deibl, M.
47, 131
Dejode, M.
177
deJong, S.
58
Del Campo, J.M.
7, 161
del Carmen, M.
166
del Carmen, M.G.
172
Deland, C.
81
Delbecque, K.
61, 104, 109, 110
Delforge, M.
31
Delimpalta, C.
77
Dell'Anna, T.
168
Delroeux, D.
168
Delrue, L.
105
Delvenne, P.
61, 109
Demande, I.
63
Demarchi, M.
168
Demidchik, Y.
173
Demidchik, Y.E.
157
Demidova, L.
104
Demirkiran, F.
80, 94, 99, 101, 128, 138
Demirkıran, F.
83, 127, 155
Demura, T.
135, 136
DeNardo, D.
31
Denecke, T.
158
Denehy, T.
68
Deng, F.
136
Denisov, M.
75
Denkert, C.
154
Denny, L.
142
D
Daayana, S.
148, 149
Dalla Palma, M.
187
Dalrymple, C.
78
Damaso-Rayel, C.
67
Damian Junior, J.C.
115
Dandekar, T.
75
Danese, E.
70
Daneva, A.
147
Daneva Markova, A.
119
D'Angelo, E.
27
Daniels, M.
172, 179
Daniilidis, A.
115, 145
Danilos, J.
158, 160
Daniłoś, J.
169
Danko, J.
65, 111, 148, 185
D'Anna, E.
4
Danska-Bidzinska, A.
165
Dao, F.
59
Darabi, R.
179
Daraï, E.
28
Darsow, M.
75
Das, N.
145
Das, S.
165
Daşcău, V.
70, 105, 142, 178
Daskalopoulou, D.
107
Dastamani, C.
126
Datta, M.
116
Dauplat, J.
43, 172
Daya, D.
110
Dayube, C.M.S.
110, 115
de Bie, R.P.
45, 92
de Bock, G.H.
51, 130
De Braud, F.
161
de Bruijn, E.
31
De Castro, H.
163
De Cleer, X.
142
de Hoon, J.
31
de Hullu, J.
171
de Hullu, J.A.
28, 66, 69, 157
De Iaco, P.
64, 170, 171
De Jonge, E.
63
De la, Garza, J.
7, 103
De La, Rey, M.
113
De la, Riba, M.I.
161
de la Torre Fernandez de Vega, F.J. 71,76
146, 143, 176, 188, 189
de la Torre, J.
113, 173
De Laco, P.
68
De Landsheere, L.
110
de las Casas, L.
190
202
DeNoble, S.
153
Denschlag, D.
35, 133
Denys, H.
105
Deo, S.
33
Descamps, D.
20, 46, 112
Descamps, P.
74
Deshmukh, H.
117
Desimone, C.
43, 156, 172
Desoyza, N.
121
Despierre, E.
60, 167
Devaja, O.
28, 62, 79, 82, 134
Devan, P.
99
Devi, K.U.
37, 45, 156
Deville, J.L.
108
Dewitz, T.
55
Dexeus, S.
65
Di Donato, V.
63
di Giorgio, A.
74, 162, 166
Di Giovanni, A.
63
Di Marcoberardino, B.
170
Di Silverio, E.
172
Di Spiezio, Sardo, A.
144
Di Stefano, A.
119
Diaz, D.
59
Diaz-Montes, T.
47, 131, 163
Dickinson, H.
92
Dicle, N.
58
Diederich, C.
25
Dijkgraaf, E.
101
Dijkstra, M.G.
45, 92
Dijmarescu, L.
65
Dilek, S.
178
Dillner, J.
45, 100
Dilworth, S.
44, 184
DiMaria, N.D.
80
Dimitrov, G.
94, 112, 113, 132, 147, 186
Dimitrova, D.
179
Ding, H.
94, 96, 164
Ding, Y.
156
Dirix, L.
43, 159, 161, 175
Disu, S.
87
Ditto, A.
79, 80, 171, 178
Divgi, C.
161
Dixon, R.
85
Dizon, D.
66
Djakovic, M.
111
Djedi, H.
72, 151
Djekic, J.
67
Djmeli-Bensmaine, A.
91
Djokic-Lisanin, M.
176
Djolai, M.
85
Djordjevic, B.
133, 172
Djurdjevic, S.
66
Do, J.H.
61
Do, V.
121
Dobbs, S.
28
Dodd, M.
92, 121
Dodge, J.
49, 63, 105
Dodge, R.C.
22
Dogan, A.
143
Dogan, S.
114
Doğan, Y.
144, 173
Doganov, A.
96
Doh, A.S.
102
Doi, D.
167, 175, 187
Doi, T.
141
Dokle, A.
151, 166
Dolek, Y.
116
Doleņel, M.
90
Dolgun, Z.N.
187
Dolomanova, E.
82
Domanska, K.
53, 120
Domingo E.
30
Dommerholt, R.G.
66
Donach, M.
187
Donadello, N.
144
Donde, B.
100
Dong, L.
163
Dong, P.
31
Dongxiu, L.
169
Donina, S.
78
Donnelly, E.
93
Donovan, H.
55
Doobay, H.
181
Doosti, R.
184
Dorer, D.J.
7
Doss, B.
126
Dotlic, J.
171
Dottino, P.
165
Dovern, E.
49, 100
Dowaji, J.
97, 185
Dowdy, S.
143
Dowdy, S.C.
9
Downey, G.
126
Downs, L.
65, 110
Drag-Zalesinska, M.
168
Draskovic, B.
65
Dravet, F.
177
Drazdaková, M.
87
Dreyer, G.
115, 116, 149
Drijkoningen, K.
167
Drouin, P.
139
Drummond, N.
81
D'Souza, D.
53, 120, 138
du, Bois, A.
17, 20, 26, 33, 35, 38, 49
51, 55, 142, 188
Du, Toit, N.
46, 99, 112
Du, X.
130
Du, Y.
156
Duan, H.
91
203
Dubin, G.
20, 46, 112
Dubuc, J.
50
Duclos, J.
154
Ducoroy, P.
162
Dudkiewicz, D.
132
Dudley, B.S.
146
Dueñas, A.
103
Dueñas, G., A.
7
Duffaud, F.
108
Dufresne, A.
181
Dugandņija, T.
67, 73, 188
Duiveman-de Boer, T.
178
Dumanska, M.
168
Dumitrascu, I.
141, 176
Dunberger, G.
3
Duncan, T.
27, 80, 90, 102, 122, 127
137, 173, 184
Dundar, B.
106
Dundr, P.
87
Dunselman, G.
59
Durchschein, F.
93
Duric, V.
54, 120
Durrant, L.
171
Dursun, P.
71, 114, 148, 187, 188
Dusková, J.
87
Dutsch-Wicherek, M.
106
Duvillard, P.
85, 154
Dvořák, P.
83
Dvořáková, D.
111
Dwivedi, R.
98, 142
Dy, Echo, A.V.
152
Dye, W.
51, 190
Dziechciarkova, M.
128
Dzikova, E.
94, 132
Dzubak, P.
128
Dzvinţuk, P.
79
Ekwall, E.
El-Balat, A.
El-Boghdadly, K.
Elgqvist, J.
Elisabetta, B.
Elit, L.
Elizalde Fernández, F.J.
Eljuga, D.
Ellatar, A.
Elliot, M.
Ellonen, A.
El-Mahallawi, M.N.
Elmasry, K.
Elsahwi, K.
ElSawy, M.
Elshaikh, M.
Elshaikh, M.A.
El-Shalakany, A.
Ember, I.
Emerich, J.
Emoto, M.
Eng, J.
Engelen, M.
Engin, R.
Engström, U.
Enomoto, T.
Erak, M.
Eralp, Y.
Erbay, A.
Erenel, H.
Erfani, N.
Ergin, Y.
Erkanli, S.
Eryilmaz, A.
Escudero, J.M.
Eser, S.
Esin, S.
Esmailnia, A.
Espinosa, I.
Espino-Strebel, E.E.
Esposito, F.
Esteves, S.
Estevez, Rodriguez, E.C.
Etchepareborda, M.
Eulenburg, C.
Eva, L.
Evaggelinos, D.
Evans, A.P.J.
Evron, Z.
Evruke, C.
Ewald-Riegler, N.
Ewing, P.
Exacoustos, C.
Ezhova, L.
Ezzat, E.A.
E
Earl, H.
Eccles, S.
Edelson, M.
Edmondson, R.
Edwards, R.P.
Edwards, V.
Eedarapalli, P.
Efe, E.
Eftekhar, Z.
Egan, L.
Eglitis, J.
Ehlen, T.
Eifel, P.
Eijkemans, M.J.
Eisenhauer, E.
Eitan, R.
155, 189
25
184
23, 61
22
174
98
116
86
190
75
49
67, 119
173
20, 49
49, 161, 164
204
4
51, 142
79
161
184
49, 105
138, 139
88
23, 61
80
44, 184
152
50
82
102
129
138
30, 152
113
28, 57, 66
127, 128, 141
123
49, 100
121
138
47, 86, 140
110
146
141
101, 128
184
114
141, 176
176
54, 120
58
182
90
27
174
5
143
146
67
24, 33, 70
139
66, 77
47, 132
164
151
49
66
63
135, 136
30
Filiaci, G.
25
Filipczyk-Cisarz, E.
23
Finci, S.
49
Fink, D.
53, 57
Finlayson, S.
49, 105
Fiolka, R.
185
Fischerová, D.
63, 65, 87, 119, 185
Fisher, R.A.
151
Fishman, A.
53, 59, 60, 133, 164, 169
Fleming, G.
20, 55, 152
Flescher, E.
164
Fleuren, G.J.
69, 101
Fleury, A.
78
Floares, C.
161
Flobbe, K.
49, 100
Floquet, A.
122
Floriani, I.
43, 160
Florimonte, L.
63
Fogel, M.
145
Foidart, J.M.
61, 63, 104, 109, 110
Foj, L.
54, 120
Foley, M.
31
Fomina, I.
112
Fondrinier, E.
74
Fong, W.F.
73
Fong, Y.F.
131
Fonseca, A.M.R.M.
71
Fontanelli, R.
178
Forbes, J.F.
77
Ford, A.
161
Forde, G.
126
Formánek, R.
92
Formenti, G.
108, 144
Forshed, J.
68
Forsmo, S.
177
Fort, E.
145
Fortin, S.
139
Fossati, R.
23
Fotiou, S.
129, 131
Fotopoulou, C. 51, 142, 149, 153, 154, 182
188
Fowler, J.
20, 134
Foy, C.
132
Franchi, D.
63, 170
Franchi, M.
70, 184
Franckena, M.
109
Franco, T.M.R.F.
62, 71, 185
Frederick, P.
169
Freeman-Wang, T.
96
Fregnani, C.M.S.
97, 122
Fregnani, J.H.
68, 77, 97, 122
Fregnani, J.H.T.G. 30, 64, 69, 74, 140, 185
Freitag, P.
87
Freitas, G.F.
61, 62, 185
Frenel, J.S.
177
F
Faber, J.
76
Fabregas, R.
81, 142
Fagotti, A.
81, 139, 174
Faizullina, N.
135, 136
Fakheri, T.
68, 84, 127, 150
Falasca, A.
69
Falchook, G.
29
Fanfani, F.
81, 139, 174
Fanta, M.
87
Fanti, S.
64
Fargas, F.
81, 142
Farghaly, S.
57, 78
Farhan, F.
90
Färkkilä, A.
172
Farrell, R.
28
Farshidy, F.
89
Farzaneh, F.
90, 151, 153
Fastrez, M.
81
Fauci, J.
169
Faught, W.
163, 189
Favero, G.
64
Favier, L.
162
Fayed, S.T.
30
Fedotova, A.
146
Fegan, S.
180
Fekete, P.
135
Felisiak, A.
165
Feng, F.
150
Feng, W.
47, 136
Feng, Y.
97
Feng, Y.J.
98, 145
Fenili, P.
170
Feranec, R.
70, 109
Ferdous, N.E.
116
Fernandes, D.
87
Fernandez, M.
28
Fernández Robayna, C.F.
76
Feroce, I.
4, 122
Ferrandina, G.
119, 180
Ferrari, F.
163
Ferreira, A.P.M.
71
Ferrero, A.
23, 68, 141, 169, 170
Ferris, D.
46, 101
Ferron, G.
24, 108
Festi, A.
70, 184
Fiander, A.
33
Fidan, I.
113
Figdor, C.G.
177, 178
Figueiredo, E.M.
71
Figueiredo, E.M.A.
110, 114, 115
Figueiredo, J.A.
110, 114, 115
Filella, X.
54, 120
Filho, A.
68
205
Freyer, G.
39
Fridman, M.V.
157
Friedlander, M.
54, 55, 120
Friedrich, M.
29, 66, 77, 153
Frigerio, L.
180
Frossard, P.M.
50
Frumovitz, M.
67
Fruscio, R.
43, 54, 63, 102, 120, 160, 168
Frydrych, I.
128
Fu, S.
29
Fu, T.Y.
163
Fuh, K.
43, 55, 159, 162, 174
Fujii, S.
21, 22, 24
Fujii, T.
62
Fujimoto, H.
141
Fujimoto, T.
141
Fujita, H.
88
Fujita, K.
175
Fujita, M.
47, 140
Fujiwara, K.
18, 41, 86, 165
Fukami, T.
57, 167
Fuksiewicz, M.
107
Fukui, A.
88
Fukuoka, M.
127
Fulcheri, E.
146
Fumoleau, P.
162
Fung, Kee, Fung, M.
163, 189
Fuoco, G.
119
Furău, C.
70, 105, 142, 178
Furău, G.
70, 105, 142, 178
Furukawa, N.
93, 182
Furumoto, H.
89
Furuya, K.
160
Fuseya, C.
95,165
Fuso, L.
23, 141,169
Fyles, A.W.
93
Fyles, T.
108
Ganesan, R.
132
Ganeshan, P.
179
Gao, M.
51, 175, 181
Gao, W.
118
Gao, Y.
51, 118, 175, 181
Garavaglia, D.
43, 160
Garavaglia, E.
152
Garba, E.S.
119
Garbi, A.
43, 54, 120, 160
García Castro, C.
189
García Hernández, S.
71
Garcia Marrero, R.D.
173
Garcia, R.
156
García Rodríguez, S.
113, 143, 176
García-Arias, A.
75, 158
García-Lopez, M.J.
73
Garenstroom, K.N.
69
Garg, K.
133
Garland, S.
20, 46, 112
Garrett, A.
28
Garrett, L.
166
Garrido, G.
49, 81
Garrido-Laguna, I.
29
Garvey, G.
140
Garzarelli, S.
69
Gasparini, M.
63
Gasparri, M.L.
188
Gathage, P.
161
Gauthier, A.
106
Gauthier, P.
139
Gauzere, R.
30
Gavalas, E.
93, 162
Gayar, O.
129
Gdalevich, M.
49, 126
Gebauer, B.
158
Gebhard, S.
62, 182
Gebski, V.
28
Geels, Y.P.
145, 157
Gehrmann, R.
66
Gelmon, K.
22
Gemer, O.
43, 49, 126, 128, 157
Gemzell, Danielsson, K.
68
Geng, L.
69
Geng, S.
150
Gennatas, K.
126
Gennigens, C.
104, 110
Gentile, C.
152
Gentile, M.
93
George, M.
115, 181
Georgiou, A.
76
Gerardi, M.
152
Gerestein, C.G.
173
Geretschlaeger, A.
62
Gershenson, D.
158
Gerundini, P.
63
G
Gaarenstroom, K.
Gabra, H.
Gadallah, M.
Gadducci, A.
Gaffney, D.
Gagliardi, F.
Gagliardi, M.L.
Gainford, C.
Gal, M.
Galaal, K.
Galdos, O.
Galimberti, V.
Gallagher, W.
Gallotta, V.
Gambino, A.
49
5, 161, 186
30
23, 74, 180
53, 120, 152
80, 128
81, 139, 174
54, 120
161
82
101
74
31
81, 139, 174
178
206
Gessler, S.
44, 190
Geurts, S.M.E.
169
Ghaderi, A.
184
Ghaemmaghami, F.
125, 164
Ghaem-Maghami, S.
25
Ghamande, S.
83, 166, 187
Ghatage, P.
44, 161, 178
Ghebre, R.
110
Ghezzi, F.
108, 144
Giacomoni, C.
122
Giamougiannis, P.
76, 82, 139
Giannios, J.
24, 32, 72, 73, 154, 155
Giannios, S.
24, 32, 154, 155
Giannoulis, G.
129
Giarenis, I.
139
Gibbs, P.
51, 177
Giede, C.
49, 105
Gieseking, F.
24, 70
Giesinger, J.
73
Gil, B.
190
Gilbert, L.
50, 130, 149
Gilks, C.B.
27
Gillespie, A.
30
Gillies, K.
55
Gil-Moreno, A.
113
Giorda, G.
186
Giovanni, A.
149
Gitsch, G.
55, 57, 58, 59, 60, 133, 171
Giudici, S.
70, 184
Giuntoli, R.
47, 131, 163
Giusca, S.
111
Giusiano-Courcambeck, S.
91
Glaser, G.
184
Glasgow, M.
189
Glinkina, Z.
135
Gloss, B.
175
Gmyrek, L.
84, 89, 153, 158, 185
Gobic, J.
178
Goc, G.
137
Goel, S.
117
Goes, J.C.
89, 107, 130
Goff, B.
5
Goffin, F.
61, 63, 80, 104, 109, 110, 142
Gogacz, M.
58
Gok, S.
114
Goker, Tamay, A.
60
Goksedef, P.
129
Golan, A.
183
Golby, S.
145
Gold, M.
20
Goldberg, Y.
64
Goldstein, D.
53, 57
Golubovic, U.
176
Gomes, A.
182
Gomez, J.
161
Gómez, J.
Gong, L.
Gonidi, M.
Gonik, A.
Gonzalez, E., A.
Gonzalez-Martin, A.
Goodman, A.
Goodman, A.K.
Goodrich, S.
Gordon, B.B.
Gordon, J.
Gordon, L.
Gordon, N.
Gore, M.
Gorgen, H.
Görgülü, S.
Gorio, A.
Gornall, R.
Gorosito, F.
Gortzak-, Uzan, L.
Gosens, K.C.M.
Gostout, B.
Gotlieb, W.
Goto, T.
Goto, Y.
Gotsch, F.
Gounaris, I.
Gourdji, I.
Gouttenoire, F.
Gouy, S.
Goyal, B.K.
Grac, P.
Gráf, P.
Graiver, D.
Grant, L.A.
Graziano, M.
Graziosi, G.
Greco, A.
Green, A.C.
Green, J.
Greenberg, D.
Greer, B.
Grefte, J.M.M.
Greig, E.
Greimal, E.
Grelewski, P.
Grenert, J.
Grenert, J.P.
Gretz, H.
Gridneva, T.D.
Griffin, C.
Griffin, N.
Grifi, F.
Grigoriadis, C.
Grijuela, B.
207
159
47, 191
76
184
7
6, 23
118, 166
172
43, 156, 172
145
145
58
132
35, 161, 173
129
76
178
132
139
183
104
143
17, 22, 81
23, 160, 175, 180
126
184
155
81
85
85, 154
91
65
7, 92
164
189
63
31
49
140
5
29
20
69
173
26
159
162
186
153
121
159
189
72
130
79, 80, 171, 178
Grimm, C.
Grisaru, D.
Grogan, S.
Groma, V.
Gropp, M.
Grossi, E.
Growdon, W.B.
Grubińiš, G.
Gryboś, M.
Gryboś-Jagielska, A.
Grzbiela, H.
Guadalupi, V.
Guang, W.
Guastalla, J.P.
Gudlaugsson, E.
Gueli, Alletti, S.
Guerra, E.
Guffey, K.
Guidi, G.
Gujral, U.
Güleç, Ü.
Gulhan, I.
Gultekin, E.
Gultekin, M.
Gumà, J.
Gümürdülü, D.
Gunawan, R.
Gundogdu, B.
Guner, H.
Güngör, M.
Güngör, T.
Guo, G.
Guo, H.
Guo, L.
Guo, N.
Guo, Q.S.
Guo, Y.
Gupta, A.
Gupta, H.P.
Gupta, P.
Guralp, O.
Gurtovenko, M.
Gurzanova, T.
Gustafsson, U.
Guveli, M.
Guvenal, T.
Güzel, A.B.
104
156
123
137, 148
26, 33
63, 74
166, 172
88
132, 159, 165
132
95
171
85
181
25, 47, 136
139, 174
23
147
70
146
30, 67, 109, 160
58
114
9, 22, 55, 117, 120
146
30, 67, 109, 160
50
134, 138
88, 113, 114
78, 127, 137, 171
128, 157, 161
156
69, 176, 177
179, 180
156
145
69, 84
111, 179
94
159
83, 94, 155
175
112, 113
101
147
60
30, 67, 109, 160
Hacker, N.
15, 68, 175
Hacker, N.F.
141
Haddad, P.
90
Hadzi-Lega, M.
147, 184
Hagburg, H.
23
Hager, M.
24, 70
Haider, I.
84
Haidopoulos, D. 26, 67, 100, 129, 131, 139
Haie-Meder, C.
85, 154
Haji-Mollahosseini, F.
73
Halaska, M.
41, 45, 75, 100, 106
Halaska, M.J.
31
Haldar, K.
76, 82
Hale, K.
122
Haliday, D.
81
Halkia, E.
69
Hall, L.
181
Hall, M.
170
Haller, H.
177, 178, 179
Halperin, R.
49
Haluska, F.
7
Hämäläinen, K.
133, 164
Hamanishi, J.
22, 57, 165
Hamann, U.
74
Hameed, S.
84
Hamm, B.
158
Hammer, S.
160
Hammond, I.
28
Han, C.
80
Han, C.H.
132
Han, C.M.
148
Han, C.S.
187
Han, J.
176
Han, M.S.
98
Han, S.
94
Han, S.J.
61, 104, 110
Han, S.S.
174, 186
Han, S.Y.
167
Hancock, B.
54, 120
Hanhan, M.
58
Hanif, F.
50
Hanjani, P.
184
Hanker, L.
55
Hanker, L.C.
26, 74, 172, 188
Hanoch Levavi, H.
164
Hanozet, F.
79, 80, 171, 178
Hanucharurnkul, S.
92, 121
Hao, H.
140
Harada, T.
167
Harasawa, M.
126
Hardt, K.
20, 46, 112
Hariprasad, R.
33, 179
Harley, I.
28
Harrand, R.
96, 99, 100
Harris, V.
26
H
Ha, M.T.
Haberal, A.
Haberal, N.
Habibi, M.
Hachisuga, T.
150
141, 176
148, 188
73
127, 133, 168
208
Harrison, C.
126
Harter, P.
20, 26, 33, 49, 51, 142, 188
Hasanzadeh, M.
172
Hasanzadeh, Mofrad, M.
150
Hasegawa, K.
160, 165
Hasenbein, K.
64
Hasenburg, A.
50, 55, 171
Hassan, M.
157
Hassiakos, D.
66
Hasson, J.
156
Hasumi, K.
128
Hata, E.
163
Hatae, M.
117, 186
Haughney, R.
101
Haupt, R.
46
Hauspy, J.
82, 110, 145
Havanond, P.
108
Havlicek, F.
101
Havrilesky, L.
23, 159, 181
Haw, W.L.
96
Hayashi, A.
165
Hayashi, C.
132
Hayat, N.
84
Hazama, R.
107, 144
He, L.
96
He, X.
155
He, Y.
164
Hedley, D.
93
Hedrick, J.
20, 46, 112
Hefler, L.
85, 104
Heger, L.
11
Hegmane, A.
75
Heideman, D.
99
Heideman, D.A.M.
45, 92
Heijkoop, S.T.
109
Heikinheimo, M.
172
Heikura, T.
162
Heinonen, S.
133, 162, 164
Heinrich, G.
53, 120
Heinze, G.
85
Heinzelmann-Schwarz, V.
53, 57
Heitz, F.
49, 51, 142
Hejtmánek, P.
79, 128
Helfrich, B.
61
Helland, H.
27
Hellberg, D.
104
Heller, I.
156
Hellevik, T.
114
Hellman, K.
94, 100, 138
Hellman, U.
138
Hellström, A.-C.
94, 100, 138
Helmerhorst, T.
109
Helmerhorst, T.J.M.
46, 99, 109, 191
Hemida, R.
160
Hendel, H.W.
78
Henderson, F.C.
Hendriks, J.
Hendriks, J.C.M.
Henic, E.
Henry, M.
Henry, R.
Hensley, Alford, S.
Heras, L.
Herbst, U.
Hermesse, J.
Hernández San, Gil, R.
Hernández, Suárez, M.
Hernández, V.
Hernández, Y.
Herrero, A.
Hertman, V.
Heruc, G.
Herzog, T.
Hes, O.
Hess, L.
Heyd, B.
Heydari, L.
Heyns, L.
Higashi, M.
Higgins, R.
Higuma, C.
Hikita, S.
Hill, M.
Hill, R.P.
Hillemanns, P.
Hilpert, F.
Hils, R.
Himmelman, J.
Hinojosa, J.
Hinten, F.
Hirahara, F.
Hirakawa, M.
Hirasawa, A.
Hirasawa, T.
Hirashima, Y.
Hirata, Y.
Hirosawa, T.
Hirota, S.
Hirschfeld, M.
Hirte, H.
Hiura, M.
Ho, C.L.
Ho, K.
Hoarau, H.
Hobbs, K.
Hocking, A.
Hoehn, M.
Hogg, R.
209
31
130
28
189
112
142
129
75, 158
115
104, 110
173
76, 113, 143, 146
176, 188, 189
146
189
23
93
32
7, 18, 22, 29, 39, 47, 118,
141, 143, 173
101
159
168
73
31
183
159
164
57, 127
78
93
55
53, 55, 120, 160
49
161
7
28
58, 128, 157
85, 91, 95
133, 144
126, 158
93
174
185
140
57, 58, 59, 60
22, 50, 55, 152, 159
117, 141
157
95
122
123
123
100
28
Hollema, H.
Holtrich, U.
Holzner, B.
Homae, F.
Homaee, F.
Homaei, Shandiz, F.
Homesley, H.
Honarei, S.
Hong, D.
Hong, D.G.
Hong, J.H.
Hongo, A.
Honma, S.
Hoo, C.
Hoogwerf, D.
Hoon Seng, K.T.
Hooning, M.
Horiuchi, A.
Horiuchi, S.
Horowitz, N.S.
Horton, A.
Horvath, G.
Horwitz, K.
Hosaka, M.
Hoskins, P.
Hosonuma, S.
Hosseini, M.S.
Hou, M.F.
Houvenaeghel, G.
Hoxha, A.
Hoyer-Hansen, G.
Hrehorcak, M.
Hsieh, C.Y.
Hsu, C.H.
Hsu, I.C.
Hsu, K.F.
Hsueh, S.
Hu, D.N.
Hu, L.
Hu, T.F.
Hu, Y.
Hua, K.
Huang, C.C.
Huang, F.
Huang, G.S.
Huang, H.
Huang, H.J.
Huang, K.
Huang, K.G.
Huang, L.
Huang, L.C.
Huang, M.C.
Huang, Q.
Huang, X.
Huang, Y.F.
66
74
73
73
150
89, 117
20
117
29
80, 135
103, 152
29
175
67
22
98
22
95, 165
57, 127
172
116
161
51, 190
88, 104, 130
17, 147, 152
117
151
72, 74
85
151, 166
189
106
175
51, 191
25
157
111
57
43, 159, 162, 174
26
150
47, 136
103
123
62
20, 98, 103, 154, 179
103, 111
80, 103
64, 82, 83, 105, 111
59, 84, 94, 96, 164
62
144
52, 191
165
157
Huang, Y.H.
111, 162, 168
Huang, Y.T.
111
Huang, Y.W.
57
Hubalek, M.
73
Hubickova-Heringova, L.
138
Huflejt, M.
53, 57
Hughes, G.
145
Huh, W.
7, 34, 46, 92, 96, 112
Huh, W.K.
146
Huhtaniemi, I.
44, 184
Hultborn, R.
161
Hung, Y.C.
62
Hunt, J.
148, 149
Hunter, J.
103
Huntsman, D.
22
Huober, J.
33
Hur, S.Y.
89, 108
Hurduc, C.
111
Husband, A.
71
Hussain, F.
65
Hussain, R.
68
Hussein, Y.
75
Huzarski, L.
137
Hwang, J.H.
109, 165
Hwang, J.J.
51, 75, 191
Hyza, P.
70
I
Ianiri, P.
Iavazzo, C.
Ibarrola Vidaurre, M.
Iborra, S.
Ichikawa, M.
Ichikawa, R.
Ichikawa, Y.
Iddawela, M.
Ide, S.
Ignatov, A.
Igumanovic, S.
Igwe, N.
Ihata, Y.
Iida, T.
Iio, K.
Ikeda, M.
Ikeda, S.
Ikeda, S.I.
Ikeda, Y.
Ilancheran, A.
Ileana, E.
Ilhan, R.
Iliescu, D.
Iliev, V.
Iltis, I.
Ilvan, S.
210
80
66, 125, 126, 129
138, 139
59
133
160
144
189
163
58
176
115
128, 157
58
168
158
86
92
140
118
108
147
65
186
65
155
Ilyas, A.
Imaizumi, A.
Inada, M.
Inamine, M.
Inayama, Y.
Ince, U.
Ind, T.
Innamaa, A.
Innamma, A.
Inthasorn, P.
Irahara, M.
Iramaneerat, K.
Irimie, A.
Irmin, L.
Irvin, W.
Irvine, A.
Isaka, K.
Isaksson, H.
Ishikawa, M.
Ishikawa, T.
Ishimoto, H.
Ishiwata, T.
Ishizuka, B.
Isıkdogan, Z.
Isikli, L.
Itamochi, H.
Itani, Y.
Itho, K.
Ito, K.
Itoh, K.
Ittichaikulthol, W.
Ittichaikulthon, W.
Ivanov, S.
Ivanova, D.
Ivashina, S.
Ivkovic, Kapicl, T.
Ivkovic-Kapicl, T.
Ivy, S.P.
Iwamori, M.
Iwasa, N.
Iwase, H.
Iwata, N.
Iyer, R.
Iyibozkurt, A.C.
Iyibozkurt, C.
Iyigün, E.
Izadi-Mood, N.
Izumi, S.
103
128
58
85, 91, 95
58
99
82, 121, 182, 183
160
161
112
89
60
161
163
118
65
164, 167
165
57, 86, 92
167
126
90
97, 103, 117, 147
134
136
167
93, 176
88
93, 162
60, 176
117
118
67, 78, 88
70
105, 142
67, 73, 188
64, 86
55
126
165, 174
30, 128
186
119
144
145, 146, 147, 173
77
86, 89, 128, 150
126
Jackson, T.
Jacob, F.
Jacobs, I.
Jacobsen, B.
Jacobson, G.
Jacobsson, L.
Jaeger, M.
Jaenicke, F.
Jaffre, I.
Jager, A.
Jäger, G.
Jäger, M.
Jain, S.
Jain, V.
Jaisamrarn, U.
Jaishuen, A.
Jakimovska, M.
Jakobson-Setton, A.
Jalilian, N.
Jalůvková, Z.
James, M.
Jameson, C.
Jamshed, A.
Janda, M.
Jang, P.R.
Janjic, Z.
Janku, F.
Janssen, E.A.M.
Janssen, N.
Janusicova, V.
Jao, M.
Jarruwale, P.
Jashar, D.
Jaspers, L.
Jayson, G.
Jedrus, S.
Jedryka, M.
Jefferies, H.
Jeffery, D.
Jeleń, M.
Jena, A.
Jenabian, A.
Jenkins, M.R.
Jennifer, D.
Jensen, H.
Jeon, M.K.
Jeon, S.
Jeon, Y.T.
Jeong, C.H.
Jeong, D.H.
Jeong, D.H.
Jeong, E.J.
Jeong, N.H.
Jepson, L.
Jeremy, W.
J
Jaakkola, S.
Jaberipour, M.
Jacinto, A.A.
Jackson, S.
131
110
140
185
211
61
53, 57
8, 44, 190
51, 61, 190
142
161
57, 60
24, 70
177
22
62
58, 59
73, 91, 138, 147
73, 91, 138, 147
20, 46, 112
112
187
163
84, 127, 150
7, 92
46
182, 183
84
28, 53, 58
91
66
29
25
110
111
103
82
80
31
177, 185
95
69, 137
3
119
159
73
179
185
3
161
94
149
164
98, 190
190
98
98
135
180
91
Jhingran, A.
Ji, Y.I.
Jia, W.H.
Jiang, G.
Jiang, J.
Jiang, R.
Jianliu, W.
Jiaxin, Y.
Jimenez, C.
Jimenez Fiedler, W.
Jimènez, R.
Jiménez Ubieto, I.
Jimenez, W.
Jin, H.Y.
Jin, L.
Jin, Y.
Jin, Z.Y.
Jinbo, S.
Jo, H.J.
Jo, I.H.
Jobling, T.
Johann, S.
Johnson, M.
Johnson, N.
Jolicoeur, L.
Jonat, W.
Jonska-Gmyrek, J.
Joo, W.D.
Jorge, A.F.
Joseph, R.
Joura, E.
Jovanovska, V.
Jovcevski, S.
Jozwik, M.
Ju, X.
Judson, P.
Jumah, N.A.
Jun, H.S.
Jung, D.C.
Jung, S.M.
Jung, S.Y.
Juraskova, I.
53, 119, 120
190
59, 94, 164
51, 175, 181
86, 98, 108
33
140, 141, 143
159
119
105
7
138
49
145
97
150
63
167
82
98
28
68
44, 190
7, 49, 102, 145
163, 189
160
67, 84, 89, 107, 153
158, 185
82, 87
182
87
46
112, 113
119
58
112
20
24
125
130
114
165, 186
32, 67, 77, 112, 119, 123
Kahraman, K.
76
Kai, K.
157
Kainantidis, A.
68
Kairbayev, M.
100, 140, 175
Kairbayeva, M.
175
Kajiyama, H.
183, 185
Kajo, K.
65, 111, 148, 185
Kakumanu, S.
99, 100
Kalaghchi, B.
90
Kalbacher, E.
168
Kalinoglou, N.
69, 129
Kalis, V.
101
Kalland, K.H.
55, 136
Kalofonos, C.
148, 188
Kalok, A.
71
Kaluzynski, A.
178
Kambale, Sahani, M.
99
Kaminska, J.
107
Kamiura, S.
86
Kamoi, S.
141, 187
Kamura, T.
60, 88, 90, 168
Kanapuram, R.D.
61
Kanazawa, R.
140
Kanchana, M.P.
99
Kandiah, M.
72
Kane, A.
154
Kaneuchi, M.
104, 130
Kang, D.Y.
153
Kang, H.
70
Kang, H.S.
165
Kang, J.H.
125
Kang, S.
130, 159, 165, 186
Kang, S.B. 45, 59, 69, 99, 103, 110, 163, 164
Kang, W.
102
Kankipati, Raju, S.
79
Kanomata, N.
128
Kao, C.Y.
144
Kao, K.
62
Kapp, D.
43, 55, 159, 162, 174
Kapur, S.
80
Kapuśniak, E.
101, 102
Karabacakoglu, P.
146
Karaca, R.
85, 105, 114, 154, 167, 178
Karagiannidis, A.
151
Karagiannidou, E.
115, 151
Karahanoglu, E.
132
Karakaya, B.K.
71, 114, 148, 188
Karalök, A.
143
Karasahin, E.
167, 178
Karateke, A.
187
Karimi, Zarchi, M.
74, 88
Karlan, B.
186
Karma, B.
165
Karn, T.
74
Karpeykina, M.
75
K
Kabaca, C.
Kabacam, S.
Kachel-Flis, A.
Kadieva, E.
Kadija, S.
Kadkhodayan, S.
Kaev, I.
Kagami, S.
Kahn, A.R.
187
55
101, 102
104
70
89
186
133
52, 166, 181
212
Kars, B.
Kartsiounis, C.
Kartsiounis, V.
Kasamatsu, T.
Kasap, B.
Kashanian, M.
Kashima, H.
Kashima, K.
Kasmas, S.
Kast, W.M.
Katabuchi, H.
Katagiri, A.
Katanyoo, K.
Kataoka, F.
Katar, M.
Kato, H.
Kato, K.
Kato, M.
Kato, R.
Kato, S.
Kato, T.
Katoh, H.
Katsiki, E.
Katsoulakis, E.
Katz, A.
Kaufer, R.
Kauff, N.
Kaufmann, M.
Kauppinen, M.
Kaur, J.
Kaur, T.
Kaushik, S.
Kavallaris, A.
Kavanagh, J.
Kawabata, T.
Kawagoe, T.
Kawaguchi, R.
Kawaguchi, W.
Kawahara, K.
Kawamata, Y.
Kawamura, L.
Kawana, K.
Kawano, K.
Kawarabayashi, T.
Kawase, R.
Kawata, S.
Kaye, S.
Ke, G.
Keates-Porter, S.
Keeler, E.
Kehoe, S.
Keklik, A.
Keleher, V.
Kelley, J.
Kelly, M.
63
77
66, 77
86, 90, 92, 95
98, 114, 137
151
47, 131
157
182
185
141, 145, 180, 187
57
136
144
160
48, 128, 129, 190
26, 81
160
160
59, 108
86, 89, 92, 104, 130
175
182
91
117
81
10, 59
74
172
173, 182, 183
147
82
79, 118
126, 158
186
133
176, 182
167
163
30
130
95
60, 88
127, 128
90
140
2, 18, 23
112
145
179
91, 177
98, 137
118
159
71
Kemetli, L.
45, 100
Kemmler, G.
73
Keng, S.
159
Kenter, G.
116
Kenter, G.G.
101
Kern, P.
75
Kersh, C.R.
118
Keshavarzi, F.
68, 84, 127, 150
Kesic, V.
37, 45, 50
Keskin, H.L.
134, 138
Keskin, L.
114
Kessler, L.
189
Kezic, I.
164
Khadim, M.
159
Khajedaluee, M.
117
Khalil, A.
86
Khan, F.
82, 102
Khan, K.
67, 159
Khan, R.
60, 159, 160
Kharaishvili, T.
143
Kheck, M.
111
Khemapech, N.
60, 108
Khorprasert, C.
108
Khoshay, A.
127
Khoshay, M.
127
Khunnarong, J.
135, 136
Khunova, L.
105
Ki, K.D.
57, 59
Kidron, D.
133
Kiemeney, L.A.
157
Kieser, K.
82
Kietpeerakool, C.
155
Kigawa, J.
167, 175
Kiguchi, K.
97, 103, 117, 126, 147
Kikkawa, F.
141, 183, 185
Kikuchi, N.
47, 131, 165
Kikuchi, R.
175
Kikuchi, Y.
23, 175
Kilgore, L.
126, 169
Kilicdag, E.
141
Kim, B.
51, 150, 183
Kim, B.G.
88, 91, 104, 131, 159, 170, 176
Kim, B.J.
78, 90
Kim, D.H.
174
Kim, D.J.
168
Kim, D.Y. 105, 135, 149, 135, 164, 168, 180
Kim, E.
119
Kim, E.-J.
150
Kim, H.-B.
78
Kim, H.J.
45, 88, 91, 99, 103, 131, 170
Kim, H.S.
45, 99, 103, 110, 163
Kim, H.W.
121
Kim, J.
103
Kim, J.H. 51, 103, 105, 121, 123, 135, 149
150,164, 168, 175, 180
213
Kim, J.W.
45, 59, 69, 95, 99, 103, 110, 126
129,135, 163, 164
Kim, J.Y.
45, 99
Kim, K.
78, 90
Kim, K.H.
61, 146, 158
Kim, K.R.
86, 135, 168
Kim, K.S.
181
Kim, K.T.
98, 126, 135, 156, 190
Kim, M.H.
78, 90
Kim, M.K. 45, 69, 88, 91, 99, 104, 109, 110,
125, 131, 170, 176
Kim, N.
94
Kim, N.H.
98
Kim, S.
51, 70, 102, 150
Kim, S.H.
186
Kim, S.I.
132
Kim, S.L.
95
Kim, S.-M.
126, 135
Kim, S.N.
100, 110
Kim, S.W.
95, 129, 165
Kim, T.
167
Kim, T.J.
88, 91, 104, 131, 159, 170, 176
Kim, Y.
51, 150
Kim, Y.-A.
94
Kim, Y.B.
45, 99, 135, 168
Kim, Y.H.
59
Kim, Y.J.
156
Kim, Y.M.
105, 121, 123, 135, 149, 164,
168, 180
Kim, Y.N.
98, 121
Kim, Y.S.
61
Kim, Y.T.
86, 95, 105, 121, 123, 129, 135
149, 164, 168, 180
Kimball, K.J.
61
Kimura, M.
26, 81
Kimura, T.
47, 140
King, M.
55
Kino, M.
128
Kiproska, G.
147, 184, 186
Kırdar, S.
114
Kiriakopoulos, N.
93, 162
Kirkinen, P.
64
Kiseleva, M.
75
Kiss, I.
113
Kisu, I.
58, 133, 144
Kitajewski, J.
22
Kitaka, S.
119
Kitanishi, A.
174
Kitchener, H.
18, 20, 42, 46, 112, 177
Kitchener, P.H.C.
148, 149
Kiyokawa, T.
24
Kjellén, E.
85
Klacko, M.
135
Klapsinou, E.
107
Klar, M.
171
Klát, J.
7, 92
Klein, M.
47, 131
Kleina, R.
137
Klersy, C.
172
Klimek, M.
174
Klopp, A.
119
Kluivers, K.
170
Knight, C.
122
Knowland, E.
3
Knowles, L.
145
Ko, H.J.
61
Ko, M.-C.
60
Kobal, B.
187
Kobayashi, H.
168, 182
Kobayashi, N.
104
Kobayashi, Y.
97, 103, 117, 133, 144, 147
Kobierski, J.
134, 172
Koc, S.
106, 134
Kocbulut, E.
137
Kochar, S.P.S.
91
Kock, L.
24
Kocken, M.
31, 46, 99, 109, 191
Kocki, J.
157, 176
Kodama, S.
175
Kodampur, M.
79
Kodampur, M.A.
82
Koelbl, H.
76, 139, 182
Kogan, E.
135, 136
Koh, W.J.
24, 37, 38
Köhler, C.
64
Kohler, M.
159
Koike, J.
147
Koizumi, H.
97
Kojima, A.
24
Kojima, Y.
141
Kokes, V.
187
Koko, S.
67, 78, 88
Kolarik, D.
75
Kolářová, I.
111
Kolliantzaki, S.
129
Kolomainen, D.
33, 82, 121
Kolomiets, L.
127
Kolomiets, L.A.
121
Kolostova, K.
138
Kolowski, B.M.
114
Komatsu, N.
88
Komiyama, S.
160
Kommoss, S.
49
Komohara, Y.
180
Komori, S.
140
Komur, H.
173
Kondakova, I.
127
Kondalsamy-Chennakesavan, S. 28, 32, 45
51, 53, 58, 84, 134
Kondi-Pafiti, A.
66, 125, 126
214
Kondo, H.
Kondracka, A.
Konecny, P.
Kong, B.
Kong, K.Y.
Kong, L.L.
Koniari, K.
Konishi, H.
Konishi, I.
Konno, Y.
Kooi, G.S.
Koparal, A.T.
Koper, P.
Korach, J.
Korch, C.
Kornafel, J.
Korneeva, I.
Korun, Z.E.
Kose, M.F.
Kose, S.
Kösebay, D.
Końec, V.
Kosenko, I.
Koshima, I.
Koskas, M.
Kosma, V.M.
Kosmaidou, Z.
Kost, E.
Kostal, M.
Kostevich, G.
Kostova, P.
Kotarski, J.
Kotarski, J.C.
Kotek, A.
Kotera, K.
Kotowicz, B.
Kotrikadze, N.
Kotsidas, I.
Kotsopoulos, I.
Kotzen, J.
Koubaa, A.
Kourea, H.P.
Koutlaki, N.
Kowalska, M.
Koyamatsu, Y.
Koyuncu, F.M.
Koyuncuoglu, M.
Kozarcic, T.
Kozevnikova, R.
Kraetschell, R.
Kraft, O.
Krakhmalev, V.
Krämer, S.
Krasevic, M.
Krasner, C.
103, 117, 147
169, 182
128
23
135, 168
181
148, 188
175
9, 22, 47, 57, 131, 165
104, 130
173
125, 139
24
163
61
69
104
113
55, 106, 134, 138
114, 121
127
88
94, 112, 115
58
154
133, 162, 164
183
129
90
115
96
115, 155, 169, 176, 182
157, 176
116
141
84, 89, 107
75, 143
93, 162
66, 77
100
177
148, 188
93
107
45, 101
60
146
85
75
149
7, 92
84
75
177, 178, 179
159, 161
Krasny, S.
Krätschell, R.
Kreatsas, G.
Kreienberg, R.
Krejci, E.
Křepinská, E.
Kreynina, J.
Kridelka, F.
Kriege, M.
Kriplani, A.
Krishnamurthy, S.
Krishnasamy, M.
Kristensen, G.
Kristensen, G.B.
Kristiansson, H.
Krivak, T.
Krivus, S.
Kroulik, T.
Kruger, T.F.
Krugovaja, I.
Kruitwagen, R.F.P.M.
Krupnova, E.
Kruse, A.J.
Krutilina, N.
Krynicki, R.
Kubar, A.
Kubecová, M.
Kubelka, K.
Kuboyama, A.
Kucucuk, S.
Kucukmetin, A.
Kucukozkan, T.
Kudaka, W.
Kudela, M.
Kudo, M.
Kudoh, J.
Kudoh, K.
Kuehn-Hajder, J.
Kuglik, P.
Kuhn, W.
Kukubassov, E.
Kulbacka, J.
Kulkarni, Y.
Kulpa, T.
Kumar, L.
Kumar, R.
Kumar, S.
Kumar, V.
Kumari, C.
Kupryjanczyk, J.
Kurata, A.
Kurchina, T.
Kurita, T.
Kurman, R.J.
Kuroda, M.
215
112
51, 142
183
55, 179
70
83, 147, 185
116, 142
61, 104, 109, 110
22
63
50
123
20, 88
49
190
173
65
90
50, 110
93
49, 100
173
59
184
67, 84, 89, 153, 158
85
111, 138
80
26
145
82
182
85, 91, 95
79, 128
104
62
175
65
107
48, 148
100, 140, 175
168
95
77, 123
33, 51, 63, 179
63
33, 179
125
65
165
163
112
133
4
164
Kurosaki, A.
Kurose, K.
Kurt, Y.
Kurtz, J.E.
Kuru, O.
Kurzeder, C.
Kurzrock, R.
Kusanagi, Y.
Kuscu, E.
Kushnir, C.
Kusumanto, A.
Kusumi, Y.
Kusunoki, S.
Kuzel, D.
Kuzuya, K.
Kwai Lam Philip, Y.
Kwon, D.J.
Kwon, J.
Kwon, S.H.
Kwong, C.
Kyle, S.
Kyriakidou, V.
165
175, 187
105
181
145, 146
26, 33, 55, 62
29
24
114, 141, 176
78
122
132
26, 81
87
23
68, 91, 130, 160
127
138, 152
99
119
23
76, 125
Langley, R.R.
53, 60
Lanowska, M.
64
Lanzillotta, V.
63
Lapeña Calavia, S.S.
138, 139
Łapińska-Szumczyk, S.
134, 172
Lapsekili, E.
76
Larrazábal, F.
65, 113
Larson, B.
68
Lasabova, Z.
185
Lataifeh, I.
83
Lathouras, K.
68, 115, 145, 151, 182
Latifah, H.
163, 189
Latorre, M.R.D.O.
122
Lau, A.
84
Lau, S.
81
Lauka, L.
137
Laurema, A.
164
Lavie, O.
43, 49, 64, 126, 128, 157, 163
Lavitola, G.
144
Lay, Tin, S.
91, 130, 160
Le, N.
147
Le, T.
163, 189
Leamon, C.P.
147
Leath, C.
173
Leath, III, C.
92, 126, 129
Lebedinsky, C.
23, 159, 161
Leblanc, E.
28, 35
Lebrecht, A.
76
Lécuru, F.
28
Ledermann, J.
6, 20, 96, 159
Lee, A.
86
Lee, A.W.
108
Lee, C.
80, 95, 148
Lee, C.H.
27
Lee, C.L.
64, 82, 83, 105, 146
Lee, D.H.
150
Lee, D.W.
97
Lee, E.D.
78
Lee, E.S.
94, 164
Lee, G.H.
86
Lee, H.H.
181
Lee, H.J.
156
Lee, H.N.
97
Lee, H.P.
45, 99, 100, 103, 164
Lee, H.Y.
43, 74, 174
Lee, J.
161
Lee, J.H.
88, 91, 150, 170, 183
Lee, J.K.
109, 126, 135, 152, 167
Lee, J.M.
57, 59, 126, 135, 175
Lee, J.W.
88, 91, 104, 131, 170, 176
Lee, J.Y.
130
Lee, K.B.
98, 190
Lee, K.H.
97, 132
Lee, K.M.
118
Lee, K.W.
109, 152, 167
L
La Rosa F.
Labidi Galy, I.
Laco, J.
Ladjevic, N.
Lages, E.L.
Lahiri, S.
Lai, C.
Lai, C.H.
Lai, H.C.
Laidinen, S.
Lajtman, E.
Lakkadi, N.
Laky, B.
Lal, P.
Lalisang, R.I.
Lambein, K.
Lambert, B.
Lambert, P.
Lambrechts, D.
Lan, L.
Lancaster, J.
Lancaster, L.
Lanceley, A.
Land, R.
Landoni, F.
Landt, C.
Laney, M.
Lang, J.
Lang, J.H.
Langenberg, R.
104
181
188
70
61, 62, 185
149
103
58, 103, 111, 113, 114
43, 74, 174
162, 164
78, 101
65
53, 58
63
49, 100
105
105
45, 100
167
166
23
79
26
28, 53, 58
49
129
28
179, 180
32, 108
172
216
Lee, M.
129
Lee, N.W.
109, 152, 167
Lee, P.
23
Lee, S.
70, 86, 103, 127
Lee, S.-A.
150
Lee, S.H.
86, 95, 98, 129, 135
Lee, S.-J.
82, 87
Lee, S.K.
59, 100
Lee, S.K.
57, 126
Lee, S.W.
86, 149
Lee, S.Y.
125
Lee, T.S.
45, 99, 103, 164
Lee, W.
88, 91
Lee, W.L.
60
Lee, W.M.
90
Lee, W.S.
131, 170
Lee, W.Y.
127
Lee, Y.
86
Lee, Y.C.
74, 91
Lee, Y.S.
80, 97, 135
Lee, Y.Y.
88, 91, 104, 131, 170, 176
Leelahakorn, S.
136
Leelaphatanadit, C.
112
Lehnert, H.
31
Lehtinen, M.
20, 46, 112
Lehtiö, J.
68
Leitao, M.
17
Leite, V.P.
59
Lejarcegui, J.
54, 120
Lekka, I.
69
Lentati, P.
170
Lentz, S.
146
Leo, E.
69
León, H.
88
Leone, L.
111, 132, 136, 137, 148, 176
180, 184
Lepusic, D.
84
Lertkhachonsuk, A.
93
Lertkhachonsuk, A.A.
151
Lertkhachonsuk, R.
129, 151, 175
Lessey, B.
61
Leunen, K.
100, 142, 143, 167
Leung, S.
190
Leung, Y.
28
Levavi, H.
49, 161
Levenback, C.
8, 67, 161
Levenback, C.F.
20
Leveque, J.
85
Levine, D.
15, 36, 59
Leviov, M.
163
Levy, T.
183
Lewin, S.
7, 29, 47, 118, 141
Lhomme, C.
85, 154
Li, H.
69, 84
Li, J.
53, 59, 86, 112, 113
Li, J.-R.
Li, L.Q.
Li, S.
Li, W.
Li, W.H.
Li, X.
Li, X.P.
Li, Y.
Li, Y.L.
Li, Z.
Li, Z.T.
Lian, A.M.
Lian, L.
Liang, J.
Liang, S.
Liao, Q.
Liapis, A.
Libalova, P.
Lichtenegger, W.
Lidaka, L.
Lieberman, R.
Liebrich, C.
Lifang, S.
Lihui, W.
Likic, I.
Likic Ladjevic, I.
Liliac, L.
Lim, B.K.
Lim, C.E.E.
Lim, H.S.
Lim, K.
Lim Kuei, T.
Lim, M.C.
Lim, S.E.
Lim, S.Y.
Lim, Y.K.
Lima, J.P.S.N.
Limat, S.
Limson, G.
Lin, C.
Lin, C.T.
Lin, F.
Lin, S.
Lin, W.H.
Lin, Y.G.
Lin, Z.
Lindawati, M.
Lindborg, K.
Lindegren, S.
Lindell, G.
Lindeque, G.
Lindner, B.
Lindner, C.
Lindsay, G.
217
108, 181
64, 69, 81
164
95, 101
140
44, 146, 184
108, 181
20, 73, 130, 162
98
112, 190
165
177
154
147
20
83, 178
66, 125
138
18, 153, 154,
179, 182, 188 190
137, 148
101
79, 172
140
143
171
70
111, 115
95, 96, 114
118
103
10
125
130, 165, 186
118
99
141
77
168
20, 46, 112
87, 96, 103
103, 111
87
139
62
53, 60
84, 90
45, 84
43, 156
161
68
115
84, 89, 153, 158
76
121
Ling, Y.
186
Liodantonaki, P.
107
Liou, W.S.
58
Lippi, G.
70
Lissoni, A.A.
23, 63
Litvinova, T.
94, 115
Liu, C.
153
Liu, C.B.
58
Liu, D.
20
Liu, F.S.
57
Liu, H.
86, 155
Liu, J.
20, 52, 98, 126, 179, 191
Liu, P.
183
Liu, S.
86
Liu, X.
85, 164
Liu, Z.
20, 160
Livik, M.
114
Livinti, I.
137
Liyanage, S.
64
Ljesevic, S.
176
Ljungblad, S.
190
Lobb, E.
67
Locatelli, A.
102
Lockwood, C.
156
Loibl, S.
188
Loizzi, V.
111, 132, 136, 137, 148, 176,
180, 184
Lombardi, G.
187
Lomnytska, M.
138
Lomo, L.
180
Longacre, T.A.
4
Look, K.
44, 178
Lopes, A.
49
Lopes, C.
97, 106
Lopes, T.
177
Lopez, A.-L.
123
López, I.
146
Lopez-Graniel, C.
7
Lord, R.
188
Lorenz, R.
172
Lorusso, D.
20, 180
Lorusso, M.
136, 176
Losa, F.
75, 158
Lotocki, R.
49
Lou, B.
84
Lou, J.
136
Loufopoulos, P.D.
68, 182
Lourenço, A.
97
Lourenço, A.V.
97
Loussouarn, D.
177
Louwers, J.
31, 99
Louwers, J.A.
46, 99, 191
Loverre, T.
180
Low, J.
131, 155
Low, J.J.H.
118
Lowery, W.J.
Loya, A.
Lu, D.
Lu, K.
Lu, X.
Lubotzky, F.
Lubusky, M.
Luca, A.
Lucci, rd, J.
Lucic, N.
Lück, H.J.
Ludeman, L.
Ludwig, D.
Luengsukcharoen, S.
Luengsukcharoern, S.C.
Luesley, D.
Lukic, D.
Lum, D.
Luna, J.T.
Luna, J.T.P.
Lundgren, C.
Lundin, L.
Lupe, K.
Lurain, J.
Lurain, J.R.
Lusenko, A.
Lutgens, L.C.H.W.
Luyten, A.
Lv, L.
Lv, W.
Lybol, C.
Lymberis, V.
Lyng, F.M.
Lyytinen, H.K.
129
74
20
10, 172, 179
85
119
128
176
146
115
26
132
59
118
93
92, 177
176
81
26, 170
91, 152
138
109
138
48, 93, 152
22
82
49, 100
79
136
97, 167
151
93
113
131
M
Ma, B.
Ma, K.
Ma, L.
Ma, S.Q.
Ma, X.
Ma, Z.
Maas, K.
Mabuchi, S.
Macalpine, K.
Maccauro, M.
Macfee, M.
Mach, P.
Maciejewski, M.
Mackay, H.
Mackey, A.
MacKintosh, M.
Maclean, A.B.
Macpherson, E.
218
147
178, 190
150
108
153
84
116
167
50, 108
79
83, 166, 187
61, 106
137
22, 50, 93, 108, 152
176
153
50
22
Mandiš, A.
64, 65, 66, 86, 92, 188
Maneo, A.
102
Maneschi, F.
80, 128
Manestar, M.
179
Mangena, M.
115
Mangili, G.
152, 180
Mangioni, C.
43, 160
Manini, C.
142
Mannel, R.
20, 25
Mannelqvist, M.
55
Manning, N.
51, 190
Manolescu, S.
84
Manolitsas, T.
28
Manouchehrpour, S.
44, 178
Manouchrpour, S.
161
Mantas, P.
162
Μantzos, F.
156
Manusirivithaya, S.
135, 136
Mao, H.
183
Mao, X.
87, 133
Marais, E.
149
Marcellusi, A.
69
Marchetti, C.
188
Marcickiewicz, J.
27
Marek, G.
132
Mariani, A.
143
Marinas, C.
65
Marinelli, R.
183
Markaki, S.
129
Markowska, J.
165
Marnitz, S.
64
Marocco, F.
141
Marra, E.
69
Marret, H.
28
Marsden, D.
141
Marth, C.
14, 18, 20, 35, 47, 73, 131, 171
Martin, C.
76, 80, 113
Martin, J.
187
Martin, L.
152
Martin, S.
171
Martinelli, F.
79, 80, 171, 178
Martinez, A.
1, 24, 108
Martinez, D.
102
Martínez-Martos, J.M.
73
Martínez-Roman, S.
65
Martinho Simoes, M.
106
Martins, C.
50, 149
Martins-Filho, O.A.
62
Martra, F.
64
Martyn, J.
55
Marzec, B.
169
Marzec-Kotarska, B.
157, 176
Mas, J.
158
Masadah, R.
145
Masak, L.
135
Macuks, R.
78, 188
Madhuri, T.
64, 79
Madhuri, T.K.
65, 78, 80
Madry, R.
165
Maeda, H.
168
Mäenpää, J.U.
64
Magazzino, F.
111, 136, 137, 184
Magazzino, F.P.
176
Maggi, R.
137
Maggino, T.
137
Maggioni, A.
17, 49, 83, 119, 152, 163
Magiakos, G.
107
Magirevskaya, O.
135, 136
Mahdavi, A.
146, 186
Maheshwari, A.
51, 191
Mahlke, M.
139
Mahmoudzadeh, F.
125
Mahner, S. 24, 26, 33, 53, 70, 120, 149, 172
Maidens, J.
123
Maillard, C.
110
Mainhard, K.
96
Mairaing, K.
134
Maisei, H.
30, 82, 184
Majeed, U.
84
Majeed, U.N.
103
Makanjang, M.J.
95
Makar, A.
105
Makarov, I.
146
Makhlouf, T.
177
Makihara, N.
108
Maksimovic, S.
72
Makwe, C.C.
110
Makwela, R.
71, 149
Malafy, T.
133
Malaggese, M.
119
Malakuti, H.
150
Malander, S.
190
Malekzadeh, M.
117
Malenkovic, G.
64, 67, 73
Maletin, R.
85
Malhotra, R.
63
Malinowski, D.
181
Malkin, A.
113
Mallik, A.
117
Malpica, A.
25, 158
Mamanov, A.
49
Mamede, Branca, R.
68
Mamula, O.
178, 179
Mancebo, G.
65, 113
Manchana, T.
129
Manchanda, R.
44, 190
Manci, N.
188
Mancini, E.
83
Mancini, J.
112
Mandai, M.
22, 165
219
Masaki, M.
57
Masciullo, V.
104, 149
Mashhoori, A.
151
Masood, A.
103
Massiah, N.
122, 123
Massuger, L.
130, 151, 170, 171
Massuger, L.F.
66, 145
Massuger, L.F.A.G. 28, 45, 69, 92, 104, 157
169, 177, 178
Mastiloviš, K.
183, 65
Mastorakos, G.
129
Masuda, K.
133, 144
Matana, F.
80
Matejka, M.
78, 101
Matharoo-Ball, B.
171
Mathevet, P.
28
Mathlouthi, N.
177
Mathonsi, N.
149
Mathur, S.
179
Matsueda, S.
88
Matsumoto, H.
168
Matsumoto, K.
95
Matsumura, M.
128
Matsumura, N.
22, 57, 165
Matsushima, T.
167
Matsuura, Y.
133
Maturi, R.
103
Matylevich, O.
94, 112, 115
Mauad, E.C.
74, 77
Mauland, K.
136
Mavrichev, S.
30, 82
Mavrigiannaki, P.
126
Mavrova, L.
74
Mayas, M.D.
73
Mayer, F.
162
Mayerson, D.
59, 166
Mazurek, U.
101, 102
Mazurek-Kociubowska, M.
169
Mazurkiewicz, D.
28
Mazzini, X.
71
Mazzola, S.
142
Mbatani, N.
142
Mc, Conell, Y.
88
McAlpine, J.
49, 105
Mccaffery, K.
112
McCahill, R.
99
McCann, C.
166
McCarey, C.
102
McCarthy, K.
132
Mccarthy, N.
77
Mccarthy, S.
71
McCartney, A.
28
McClelland, H.
28
McClennan, J.
176
McCluggage, W.G.
4, 19
McClure, L.
186
McComiskey, M.
67, 159
McCormack, M.
96
McKinnon, B.
68
McLellan, R.
131
McNally, O.
51, 177
Medhi, I.
162, 186
Medina Fernández, L.E.
75, 106
Meechan, D.
29
Meerpohl, H.G.
161
Meeus, P.
181
Megliţ, L.
187
Mehra, G.
28, 82, 134
Mehrotra, S.
94
Mehta, M.
55, 92
Meier, W.
26, 33, 55, 188
Meijer, C.
31, 99, 109
Meijer, C.J.L.M.
45, 46, 92, 99, 191
Meirovitz, A.
49
Melchers, W.J.G.
45, 92, 104
Melgar, L.
76
Melgar, Vilaplana, L.
189
Mélin, M.
122
Mell, L.
10, 106
Melo, A.
77, 87, 97, 106
Melpignano, M.
137
Melson, L.
109
Melton, C.
159
Mencaglia, L.
183
Menczer, J.
183
Mendinhos, G.
160
Mendiola, C.
23
Meneni, R.D.
181
Menezes, M.
85, 87
Mennini, F.S.
69
Menon, U.
8, 44, 190
Menoud, P.A.
106
Mens, J.W.
111
Meraner, V.
73
Mereu, L.
174, 183
Merritt, W.M.
53, 60
Mery, E.
24, 108
Meseci, E.
80, 99, 101
Messini, I.
149
Messmann, R.A.
147
Method, M.
159
Metindir, J.
114
Meunier, P.
104
Meyer, L.
172, 179
Michailakis, E.
72, 73, 154
Michalopoulou, E.
66
Michalski, B.
101, 102
Michalski, M.
101, 102
Michalski, W.
83
Michel Boulos, S.
30
220
Michel Campos, F.E.
146
Micheli, A.
187
Michikami, H.
95
Michnová, L.
79
Micic, J.
171
Miedzinska, M.
67
Miguelote, R.
173
Mihajlovic, O.
86
Mihaldņiš-Tubiš, S.
85
Mihara, M.
58
Mikami, M.
126, 158
Mikami, Y.
24
Mikhalenko, E.
173
Miklos, P.
135
Miladinov Mikov, M.
67, 73
Milani, A.
4
Milani, R.
43, 54, 102, 120, 160, 168
Milczek, T.
28
Mildenberger, E.
76
Milenkovic, S.
171
Miles, A.
171
Miles, T.
7, 102, 145
Mileshkin, L.
31, 123
Millan, D.
69, 70
Miller, A.B.
30
Miller, B.
55
Miller, B.E.
53, 120
Miller, D.
49, 56, 105
Miller, D.S.
21
Mills, P.
147
Milosevic, M.
93, 108
Milovic, M.
164
Milross, C.
119
Minabe, M.
163
Minaguchi, T.
95
Mineiro, S.
182
Minelli, L.
104
Miner, T.
117
Mingels, M.
130
Minig, L.
119
Minobe, S.
48, 128, 129
Mints, M.
138
Mir Mazloumi, S.H.
74
Mirandola, L.
185
Mirfaizi, M.
73
Misson, G.
65
Misurelli, E.
4
Mitamura, T.
104, 157
Mitsakis, I.
68, 182
Mitsube, K.
119
Mitsumori, A.
167
Mittra, I.
30
Miura, A.
187
Miyagi, E.
58, 128, 157
Miyahara, Y.
107, 108, 144, 145, 187
Miyake, K.
45, 101
Miyamoto, M.
160, 180
Miyamoto, S.
57, 127, 128, 168
Miyamoto, T.
47, 95, 131
Miyatake, T.
47, 86, 140
Miyazaki, K.
57
Miyazawa, M.
126
Miyoshi, A.
86
Mizugami, Y.
165
Mizutani, K.
95
Mleczko, W.
101, 102
Mlyncek, M.
78
Mlynţek, M.
101
Mnisi, E.
116
Mockobili, T.
142
Mocko-Kacanski, M.
85
Modaffari, P.
64, 68
Modaresgillani, M.
164
Modarres, Gilani, M.
163
Modarres, M.
67
Moe, B.G.
114
Moens, F.
55, 82
Moerman, P.
138, 142, 143
Mogami, T.
58, 128, 157
Mohammadpour, E.
183
Mohandes, T.
151
Mohar, A.
7
Mohit, M.
179
Mohsenifar, J.
153
Moioli, M.
146
Mok, S.
172, 179
Mol, B.W.J.
24
Molchanov, S.
121
Molegraaf, M.J.
101
Molina, R.
54, 120
Moll, S.
123
Mollamahmutoğlu, L.
128, 157
Momen, A.
78
Momtahan, M.
110, 184
Monist, M.
148
Monk, B. 20, 25, 43, 159, 161, 162, 174, 186
Monk, B.J.
14, 23, 37, 38
Monsef, H.
176
Montagnana, M.
70
Montalto, S.A.
28, 134
Montalvo, G.
7
Montavon, C.
175
Monteiro, M.V.C.
71
Montironi, P.L.
142
Montoli, S.
152
Monville, J.F.
104, 110
Mookerjee, A.
179
Moon, H.S.
94, 98
Moore, C.
119
Moore, R.G.
5
221
Moore, S.P.
Mor, G.
Morawska, D.
Moreira, F.C.B.
Moretti, R.
Morgan, R.
Morice, P.
Morimura, Y.
Morita, H.
Moriya, T.
Morizane, M.
Moroni, S.
Moroz, E.
Morra, I.
Morris, E.
Morris, R.
Morrison, P.
Mörtl, M.
Mosgaard, B.
Mosgaard, B.J.
Moskovic, E.
Moss, E.
Mota, A.
Motohara, T.
Mottet, C.
Moukova, L.
Moulder, S.
Moullet, I.
Mourits, M.J.E.
Moussei, A.
Mouton, A.
Moysich, K.B.
Mrklovsky, M.
Muallem, M.Z.
Mueller, M.D.
Muggia, F.
Mukama, P.K.
Mukherjee, D.G.
Mukhopadhyay, A.
Mulder, I.
Mulligan, E.
Mulvany, G.
Munaut, C.
Mundt, A.
Munk, A.C.
Munkarah, A.
Munkarah, A.R.
Muñoz, D.
Muñoz, N.
Munsell, M.
Münstedt, K.
Muraji, M.
Murakoshi, H.
Muramatsu, T.
Muraoka, M.
140
71
160
59
71
55
28, 41, 85, 154
141
144
23
144
122
112
144
27, 137, 139
138
159
47, 131
49
78
25
101, 138
7
187
63
70, 107, 109
29
181
51, 130
72
71, 112
22
90
49, 51, 142
68
35, 41
99
74
23, 61, 116
43, 167
61
3
61, 109
106
25
47, 137, 138
129
7
86
119
172
87
93
126, 128, 158
163
Murayama, Y.
Murdoch, J.
Muroya, T.
Murphy, S.
Muruzabal Torquemada, J.C.
Musallam, K.
Musizzano, Y.
Musonda, P.
Mustapha, N.
Musto, A.
Mutch, D.
Mutirangura, A.
Mutlu, L.
Mutumwa, D.M.M.
Muzzi, M.
Myagkova, A.
Myers, E.
Mylona, C.
Myriokefalitaki, E.
Mysliveţek, M.
Mzallassi, Z.
62
145
45, 101
61
138, 139
86
146
139
136
64
21
60
187
99
183
142
159
69
173
92
66
N
Na, J.Y.
Nabais, H.
Nagafuji, J.
Nagai, T.
Nagai, Y.
Nagamitsu, Y.
Nagano, H.
Naganuma, Y.
Nagao, S.
Nagar, H.
Nagase, S.
Nagashima, Y.
Nagata, T.
Naglieri, E.
Naguib, S.
Nahleh, Z.
Naik, R.
Naing, A.
Naito, Z.
Najar, I.
Naji, S.
Najib, F.A.
Najmi, N.
Nakagawa, M.
Nakagawa, S.
Nakahara, K.
Nakamura, T.
Nakano, M.
Nakayama, H.
Nakayama, K.
Naki, M.
222
152
106, 182
167
133, 168
85, 91, 95
164
163
128
165
28
162
58
58
184
30
75
82
29
90
186
183
110
186
167
95
141
186
45, 101
141, 175
57
63
Nakrangsee, S.
114
Nallaswamy, V.
145
Nam, B.H.
90
Nam, E.
51, 150
Nam, E.J.
95, 129
Nam, G.H.
149
Nam, J.
102
Nam, J.H.
10, 105, 121, 123, 135, 149
164, 168, 180
Nam, K.H.
100
Namkoong, S.
70
Nandwani Patel, P.
55, 89, 92
Nanini, C.
93
Naniwa, J.
167
Nankali, A.
68, 84, 127, 150
Nankivell, M.
177
Nappi, C.
144
Narahara, H.
157
Narayan, K.
31, 45, 51, 84, 134, 187
Narayan, P.
64
Nardelli, C.
111, 137, 148, 176, 180
Narducci, F.
180
Nartthanarung, A.
83
Nascimento, M.
28
Nastasia, S.
96
Nasu, K.
157
Nattress, K.
3, 32, 78, 119, 123
Naud, P.
20, 46, 112
Naumann, G.
139
Naumann, R.W.
2, 16, 34, 80, 147
Navales, I.
65
Navarria, I.
106
Navin, T.
175
Navrátil, P.
83
Nawa, A.
183
Nedeljkoviš, T.
176
Nedovic, J.
176
Neerukonda, G.N.
61, 103
Neesham, D.
28
Nemsadze, G.
75
Nerich, V.
168
Ness, R.B.
22
Nessa, A.
116
Neto, G.B.
97
Neubert, S.
172
Neuhaus, P.
153, 190
Neumann, U.
190
Neven, P.
100, 142, 143, 167
Newton, L.
145
Nezhat, F.
17, 153
Ng, J.
131
Ng, J.S.
118
Ng, T.
28
Ngan, H.
28, 32, 165
Ngan, H.Y.S.
31, 82, 97
Nho, J.H.
Nick, A.M.
Nickles-Fader, A.
Nicklin, J.
Nicoara, A.
Nicolau, S.M.
Nicoletto, M.O.
Nicoletto, O.
Nieto, A.
Nieto, J.
121, 123
53, 60
47, 131
28, 53, 58
108
71
187
23
23, 161
27, 80, 90, 102, 122, 127
137, 139, 173, 184
Nieuwenhuyzen-de Boer, G.M.
173
Niikura, H.
88, 162
Nijjar, B.
131
Nikolaidou, C.
145, 182
Nikolaidou, M.E.
107
Nikolaidou, M.E.
107
Nikolaou, M.
148, 188
Nikolova, N.
112, 147, 184
Nikolova, T.
112, 113, 147, 184
Nikolovski, S.
112
Nilbert, M.
53, 120
Nilsen, S.T.
47, 136
Nilsson, T.K.
165
Nimalasena, S.
116
Nin, C.Y.
125
Nincic, D.
64, 65
Nishi, H.
164, 167
Nishida, N.
167
Nishijima, Y.
126, 158
Nishimura, R.
24
Nishio, S.
90
Nitta, H.
85
Niu, X.
130
Njolstad, T.S.
27
Nobbenhuis, M.
82, 121
Nobbenhuis, M.A.E.
46, 191
Noceti, A.
69
Noël, A.
61, 109
Noens, L.
31
Noga, L.
159
Noh, H.J.
87
Noli, S.
63, 74
Nomura, H.
133, 144
Nonaka, M.
167
Noor Azmi, M.A.
114
Nordin, A.
26
Nordström Källström, B.
68
Norris, I.
43, 156
Nourmoussavi, M.
149
Novac, L.
65
Novaes, L.C.
117
Novaes, M.R.
72, 117
Novakovic, P.
64, 86, 110
Novakoviš, P.
183
223
Novetsky, A.
Novikava, N.
Novikova, E.
Novotny, Z.
Nowacka, A.
Nowakowski, A.
Nowicka, A.
Nowosielski, K.
Numazaki, R.
Numnum, T.M.
Nunes, C.
Nunes, J.S.
Nuñez, F.
Nyangena, J.
Nycum, L.
Nykopp, T.
Nyongesa, C.
121
75
104, 136
187
157
115, 158
155, 169, 182
132
128
92, 146
89
74, 77
28
170
159
133
100
Okada, S.
95
Okamoto, A.
164, 174
Okamoto, K.
48, 128, 129, 190
Okamoto, N.
128
Okamoto, S.
45, 101
Okamoto, T.
22, 165
Okazawa, M.
86
Oki, A.
95
Okoigi, S.
150
Okonkwo, C.
148, 150
Okubo, E.
85
Okubo, M.
168
Olagbuji, A.
150
Olaru, G.O.
137
Olcayto, E.
117, 120
Olcha, P.
58
O'Leary, J.J.
113
Olek, S.
179
Olive, D.
91, 112
Oliveira, A.
68
Oliveira, J.
76, 102
Olsson, A.
138
Olszewska, H.
122, 134, 172
Olszewski, J.
122
Olvera, N.
59
O'Malley, C.D.
52, 166, 181
Omar, S.Z.
95, 114, 141
Omilabu, S.A.
110
Onal, C.
115, 116
Onan, A.
88, 114
Onan, M.
113
Onculoglu, C.
80, 99, 101
Onda, T.
86, 92
Ondrus, D.
135
Ong, C.
155
Onishi, Y.
186
Ono, A.
133, 144
Ono, M.
57
Onuki, M.
95
Onuma, K.
110
Oomura, R.
167
Oostendorp, J.
101
Opalic, J.
70, 93
Oram, D.
44, 190
Oramas Rodriguez, J.
173
Orango, E.
170
Orazi, L.
64, 68, 171
Ørbo, A.
148
Orchel, J.
101, 102
Oron-Karni, V.
164
Orribo Morales, O.
76, 143, 176
Orsós, Z.
113
Ortaç, F. 55, 76, 78, 87, 118, 127, 137, 171
Oruc Koltan, S.
60
Osada, R.
165
O
Oberacher, H.
73
Oberguggenberger, A.
73
Obermair, A.
13, 16, 20, 28, 32, 34, 53, 58
O'Brien, P.
175
Obrzut, B.
58
Ochi, H.
95
Ochiai, K.
45, 101, 117, 164, 174
Ochuba, C.
148
O'Connell, C.
82
Odagiri, T.
104, 130
Odicino, F.
106, 163, 186
Odicino, F.E.
184
O'Donnell, R.
80, 147
Odor, K.
115
Odorizzi, M.P.
137
Odrazka, K.
90
Odunsi, K.
62
Oehler, M.
28
Offit, K.
15
Ogawa, H.
141
Ogawa, K.
95
Ogishima, D.
100
Oguntayo, A.
119
Oh, Y.
89
Ohara, N.
107, 108
Ohara, T.
103, 117, 147
Ohba, T.
145, 187
Ohba, Y.
128
O'Herlihy, C.
31
Ohkura, N.
168
Ohno, A.
62
Ohno, T.
108
Oi, H.
182
Oishi, R.
165
Oishi, T.
167, 175
224
Osaki, M.
Osann, K.
Osipova, T.
Oskay-Özcelik, G.
57
186
112
44, 53, 120, 172
178, 179 190
Osman, A.I.
152
Ostrowska, K.M.
113
Ota, Y.
86
Otomo, K.
162
Otsuki, A.
162
Otsuki, T.
141, 162
Ottevanger, P.B.
31, 49
Ottolina, J.
145
Otton, G.
28
Ouyang, Y.Q.
58
Øvestad, I.
25
Owen, G.
59
Oyakawa, M.
85
Oyama, J.
101
Øyan, A.
136
Oyan, A.M.
55
Oymak, E.
115, 116
Oza, A.
2, 7, 20, 22, 50, 55, 108
Oza, A.M.
55, 152
Ozalp, S.S.
125, 139
Ozan, H.
178
Ozat, M.
157
Özcan, E.S.
87
Özdal, B.
128
Ozdemir, H.
188
Ozdemir, Karabag, A.O.
161
Ozdemir, R.
58
Ozekinci, M.
143
Ozen, O.
71, 114, 187, 188
Ozer, S.
106, 134, 138
Ozfuttu, A.
134, 138
Ozgul, N.
22, 117, 120
Ozgurtas, T.
105
Ozisik, M.S.
113
Ozogul, C.
60
Ozols, R.
15
Ozsaran, A.
58
Ozsváth, Z.
113
Öztuna, D.
78, 127
Öztürk, E.
76
Paik, D.
Paik, W.Y.
Păiuşan, L.
Paiziev, A.
Palaia, I.
Palicka, V.
Pallavi, V.R.
Palm, S.
Pampiglione, J.
Pan, L.
Pan, S.-A.
Panani, A.
Panchevski, N.
Pande, N.
Pandey, D.
Pane, C.
Panek, G.
Panico, G.
Pann, M.
Panoskaltsis, T.
Panotopoulou, E.
Pantelis, A.
Papadia, A.
Papadopoulos, A.
Papadopoulos, A.J.
Papadopoulos, V.
Papaefthimiou, M.
Papagiannakis, E.
Papanikolaou, G.
Papaspiridakos, S.
Papaspyridakos, S.
Papathanasiou, K.
Paramanathan, A.
Paraskevaidis, E.
Pardo, B.
Paredes, P.
Parekh, T.
Parisella, M.
Park, C.
Park, C.T.
Park, C.Y.
Park, D.C.
Park, E.K.
Park, H.
Park, H.S.
Park, I.S.
Park, J.
Park, J.A.
Park, J.-E.
Park, J.J.
Park, J.K.
Park, J.S.
Park, J.W.
Park, J.Y.
Park, K.
P
Paavonen, J.
Pabucçu, E.
Pache, G.
Pacioles-Flavier, C.M.
Padwick, M.
Paek, J.
Pahisa, J.
20, 46, 112
76, 118
171
91
85, 87
129
54, 65, 120
225
26
150
70, 105, 142, 178
84
63
147
156
161
142
98
62
183
80
62
31
80, 128
185
174
109, 142
149
107
68, 182
146
28, 62, 79
134
77
100
31
188
107
107
68, 115, 151, 182
31
42
23
65
23, 159, 161
80, 128
70, 102
125
98, 126, 135
86, 127
97
125
88, 91, 104, 131, 170
80, 135
103
186
150
152
150
86, 89, 97, 108, 132
127
135, 168
183
Park, N.H. 45, 59, 69, 99, 103, 110, 163, 164
Park, N.Y.
80, 135
Park, S.H.
78, 165
Park, S.I.
78, 90
Park, S.M.
105, 180
Park, S.T.
89
Park, S.Y.
126, 130, 135, 159, 165, 186
Park, T.C.
132
Park, Y.C.
23, 159
Parker, N.
147
Parkinson, C.
189
Parmar, M.
159, 177
Parmenter, G.
68
Parsa, P.
72
Parvataneni, N.B.
61, 103
Pascual, M.A.
142
Pasmanic-Chor, M.
164
Passerini, R.
170
Paszkowski, T.
16
Pataradool, K.
135, 136
Patel, A.
82
Patel, P.
78
Pateraki, E.
69
Pather, S.
28, 78
Patnayak, R.
73
Patrizi, L.
83
Pattaranutaporn, P.
112
Patterson, M.
71
Pattij, T.
65
Paula, S.O.C.
62, 185
Paulsen, L.
51, 130
Pautier, P.
85, 154
Pavaleanu, M.
115
Pavlakis, K.
149
Pavlik, E.
43, 156
Pázsit, E.
113
Pearmain, P.
101, 138
Peccatori, F.
74
Pecha, V.
75
Pecorelli, S.
13, 21, 26, 106, 156, 163
178, 184, 186
Peeters, D.
43, 175
PeiLing, L.
156
Peiretti, M.
49, 83, 152, 163, 170
Peixoto, A.
76
Pejovic, T.
62, 190
Pelau, D.
161
Peled, Y.
161
Pella, F.
145
Pellegrini, M.D.
187
Pelusi, G.
69
Penault-Llorca, F.
43, 172
Peng, Z.
47, 136, 156, 191
Pennil, C.
156
Penson, R.
166
Pensotti, V.
Perdomo, R.A.
Pereira, D.
Pereira, da, Silva, D.
Pereira, E.
Pereira, S.
Pèrez, D.
Perez de Olaguer, J.
Perez, G.
Perez Tomasone, I.
Perissinotti, A.
Peristeris, J.
Peristeris, K.
Perner, S.
Pernice, M.
Perniola, G.
Peroglio Carus, A.
Perotto, S.
Perovic, D.
Perren, T.
Perri, T.
Perril, T.
Perrin, L.
Perugini, A.
Pesaresi, M.
Peńta, M.
Pestereli, E.
Pesterli, E.
Peter, R.S.
Peters, A.A.W.
Petersen, N.
Peterson, M.
Petignat, P.
Petiz, A.
Petrone, M.
Petru, E.
Petry, I.B.
Petry, K.U.
Pettersson, B.F.
Pfisterer, J.
Phadnis, S.
Philippe, M.
Philippe, S.
Phillips, E.
Philp, S.
Phongnarisorn, C.
Piaseu, N.
Piazzola, E.
Piccardo, A.
Piedmonte, S.
Pienaar, H.
Pierotic, M.
Pierre, E.
Pieterse, Q.
Pignata, S.
226
122
64, 140
76, 102
89
182
160
7, 103
158
46
49
65
24, 32, 154, 155
24, 32, 154, 155
62
188
63
69
169
179
20, 177
81
163
28, 53, 58
80, 128
69
187
173
30
115
31, 69, 101
131
110
102, 106
87, 97, 106
152
53, 120
182
20, 79
94, 100
20, 33, 188
85, 87
63
139
123
78, 119, 123
155
181
184
69
50
113
88
43, 172
116
180
Piha-Paul, S.
Pijnenborg, J.M.
Pilchard, J.
Pilic, I.
Pilka, R.
Pils, S.
Pinchev, M.
Pinkavová, I.
Pinterova, D.
Pintilie, M.
Pinto, G.A.
Piovano, E.
Pirek, D.
Pirens, T.
Pirovano, C.
Pisal, N.
Piura, B.
Pivot, X.
Plank, L.
Plante, M.
Plate, S.
Pledge, S.
Plouet, J.
Pluta, M.
Podgrabinska, S.
Podratz, K.
Podzielinski, I.
Poelcher, M.
Poellinger, A.
Pohlreich, P.
Pohthipornthawat, N.
Poilblanc, M.
Poitevin, A.
Pokrzywinski, R.
Polacek, H.
Polak, G.
Pölcher, M.
Poleska, W.
Poli, U.R.
Polintan, R.
Politou, K.
Polterauer, S.
Polverino, G.
Polyakov, S.
Pomel, C.
Ponce, J.
Pong, W.M.
Pongpanich, S.
Pongpinyopap, W.
Pongsanon, K.
Pongthavornkamol, K.
Pons, F.
Pontis, A.
Poole, C.
Poole, J.
29
145
25
171
79, 128
85
43, 128, 157
87, 65, 119, 185
138
93
76
64, 141
102
59
168
96
49, 126
168
111
105
75
161
32
45, 49, 100, 106
165
18, 26, 143
43, 156, 172
48, 148
158
185
175
74
7
159
65
155
20
29, 66, 77, 153
103
152
125
104
74
112
43, 172
76
140
93
129
158
92
65
183
161
29
Poomtavorn, Y.
Popadiuk, C.
Popov, I.
Popovic, M.
Poppe, W.
Portelance, L.
Porutiu, A.
Postawski, K.
Pots, J.M.
Poveda, A.
Powell, B.
Powell, C.B.
Powell, R.
Power, J.
Pozowski, J.
Pozzati, F.
Prabhu, T, R.B.
Prakash, P.
Prat, J.
Pratilas, G.
Prazakova, M.
Prendiville, W.
Presl, J.
Press, J.
Preti, E.
Preuss, M.A.
Price, J.
Pronzato, P.
Protopapas, A.
Provencher, D.
Provenzano, S.
Prvulovic, N.
Prvuloviš, N.
Pua, T.
Puente, R.
Puga, O.
Puhl, A.
Puiac, C.I.
Pujade-Lauraine, E.
Pujol, M.
Pukkala, E.
Pulaski, L.
Puopolo, M.
Puppo, A.
Purandare, N.C.
Purnell, D.
Purwoto, G.
Putri, H.M.A.R.
Pytowski, B.
134
62
164
65, 92
20, 46, 112
53, 120, 149
161
132, 148
177
6, 7, 23, 161
176
118
112
3
132
64, 68, 170, 171
99
25
4, 19, 27
151
187
112
187
156
49
61
28, 67, 159
145
131
139, 159
81, 139
64, 73
92
121
21
28
76
79, 96
33, 38, 188
75
131
178
142
145
51, 191
181
101
122
165
Q
Qian, W.
Qian, Z.
Qiao, J.
227
159
153
176
Qidan, H.
Qinping, L.
Qiu, J.
Qiu, J.-T.
Qiu, L.
Qu, P.
Qualls, C.
Quattrocchi, L.
Querleu, D.
Quinn, M.
Quint, W.
Quintos, J.
179
125
103
58, 111
86
150
180
171
24, 28, 108
32, 42, 51, 177
109
108
Randall, M.
25
Randeva, H.S.
31
Ranganathan, A.
91
Rao, G.G.
146
Rao, R.
91
Raoelfils, I.
43, 172
Rashid, M.H.U.
116
Rashid, M.U.
74
Raspagliesi, F.
1, 21, 23, 79, 80, 171, 178
Rasty, G.
96
Rathod, P.
156
Ratner, E.
156
Rattanatunyong, P.
60
Ratti, M.
163
Rattigan, D.
65
Ratto, E.
69
Ratto, G.
145
Ratttan, G.
156
Rau, J.
33, 55
Rauh-Hain, J.A.
172
Ravaggi, A.
106, 178, 184
Ravarino, N.
141, 169
Ravaud, A.
122
Ravazoula, P.
148
Rawlins, H.
127
Ray-Coquard, I.
6, 33, 43, 161, 172
181, 188
Reaby, L.
77
Reade, C.
82
Reato, C.
80
Reddy, M.K.
73
Redman, C.
169
Reed, B.
129
Reed, N.
96, 99, 100
Reed, N.S.
49
Rees, R.
171
Regueiro, P.
158
Reich, O.
93
Reimer, D.
171
Reinhold, C.
149
Reinthaller, A.
47, 53, 85, 104, 120, 131
Reis, N.
121
Reis, R.
68
Rekliti, M.
156
Rembielak-Stawecka, B.
101, 102
Rembiszewska, A.
165
Ren, Y.
126, 134, 136, 140, 143
Ren, Y.F.
96
Renard, V.
31
Rennert, G.
43, 128, 157
Rennert, H.
43, 128, 157
Reseland, J.E.
177
Reske, S.N.
62
Resta, L.
184
Reuss, A.
20, 26, 33
R
Rabaiotti, E.
145
Rabban, J.
162, 176, 186
Rabczyński, J.
159
Rabinovich, A.
49
Rabow, M.
118
Raczek-Zwierzycka, K.
95
Rada, C.
84
Rademaker, A.
93
Radice, P.
122
Radivojevic, S.
176
Radley, S.
71
Radlovic, P.
105, 111
Radovanovic, J.
176
Ræder, M.B.
55, 136
Rafizadeh, M.
151
Ragnoli, M.
163, 184, 186
Rahhal, J.
104
Rahim, R.
153
Rahman, N.A.
44, 184
Rahmanijoo, N.
179
Raimondo, I.
149
Raja, F.
96, 159
Rajagopalan, A.
110
Rajashanker, B.
153
Rajasooriyar, C.
45, 84
Rajcevic, S.
67
Rajoviš, J.
65, 86, 92, 110, 183
Raju, S.
79
Raju, S.K.
62, 82
Rama, N.
186
Rama, P.
141
Ramachandra, S.
96
Ramalho, D.M.P.
59
Ramapadma, N.
68, 91, 130, 160
Ramesh, C.
156
Ramirez, P.
67
Ramírez-Expósito, M.J.
73
Ramishvili, L.
75, 143
Ramondetta, L.
11, 161
Ramsey, P.
92
228
Revicki, D.
159
Rexhepaj, E.
31
Rey, A.
85, 154
Reyes, C.
49, 102
Reynolds, K.
30
Řezáţ, A.
83, 185, 188
Rezai, M.
75
Reznak, I.
148
Reznek, R.
64
Rhim, C.-C.
91, 118
Ribas, P.
97, 106
Ricci Maccarini, L.
64, 68, 170, 171
Richard, A.
7
Richard, S.
173
Richard, Y.
91, 130
Richardson, A.
169
Richardson, K.M.
118
Richardson, R.
173
Richter, B.
33, 55
Richter, C.
26, 156
Richter, K.
116
Richter, R.
153, 179, 190
Ridder, R.
93
Riedinger, J.M.
162
Riethdorf, S.
66
Riganelli, L.
63
Riley, D.
29
Rilla, K.
133
Rim, S.H.
166
Rimbach, S.
179
Riscado, I.
106
Ristic, M.
73
Rivera, L.
7, 103
Rivera, L.S.
174
Rivera-Enghog, S.L.
174
Rivero-Müller, A.
44, 184
Rob, L.
7, 8, 11, 16, 31, 35, 45, 100
106, 113
Robati, M.
110, 184
Roberts, J.
123
Robertson, G.
141
Robidoux, A.
22
Robinson, A.
67
Roble, D.
114
Robova, H.
45, 100, 106, 113
Robova,H..
26
Rocha, M.
89
Rocha, M.A.
61
Rocha, P.
76
Rockall, A.
64
Rodolakis, A.
26, 67, 100, 129, 131
139, 183
Rodrigues, A.
76, 102
Rodrigues, C.
160
Rodrigues, H.
76
Rodrigues, T.
77
Rodriguez, I.
81, 142
Rodriguez, L.
103
Rodriguez, N.
172
Rodríguez, R.
113
Rodríguez Reyes, R.
71, 143, 176, 189
Rodriguez Rodriguez, E.
173
Rodriguez Rodriguez, L.M.
173
Rodriguez, S.
161
Rodriguez, T.
28
Rodriguez Zea, B.
75, 106
Rody, A.
74
Roelofsen, T.
130, 171
Rogala, E.
155, 157, 169, 182
Roger, J.
82
Rogers, L.
92
Roh, H.J.
82
Rohani, A.
96
Rojo, F.
173
Rokyta, Z.
101, 187
Rolevich, A.
112
Rolski, J.
161
Roman, J.
30, 81
Romanek, K.
132, 148
Romani, C.
106, 178, 184
Romanini, M.E.
63
Romanowski, B.
20, 46, 112
Rome, R.
71, 190
Romestaing, P.
85
Ronina, E.
104
Ronzoni, S.
170
Roos, J.
179
Roozbeh Karger, L.
150
Rosario, D.
71
Rosati, M.
171
Rosberger, Z.
81
Rosen, B.
13, 24, 49, 105, 170
Rosenberg, P.
163
Rosenthal, A.
44, 190
Rossi, A.
188
Rossi, F.
63
Rossi, T.
108, 144
Rossitto, C.
139, 149
Rossochacka, B.
69
Rota, S.
113
Rotman, M.
152
Rouanet, P.
85
Roukos, D.
42
Roupa, Z.
156
Rouzbahman, M.
96
Roviglione, G.
49
Rovirosa, À.
146
Rovski, D.
30, 82
Roy, M.
23
Royer, B.
168
229
Rozenberg, S.
Rozendaal, L.
Roztoţil, A.
Ru, Y.
Rubabaza, P.
Rubio, M.J.
Ruckhäberle, E.
Rudlowski, C.
Ruengkhachorn, I.
Ruff, P.
Rufford, B.
Rugina, C.
Ruhlmann, C.
Rulic, B.
Rupcic, S.
Ruscito, I.
Russell, A.
Russell, D.
Rustin, G.
Rusu, S.C.
Ruterbusch, J.J.
Rutherford, T.
Rutherford, T.J.
Ruzzenente, O.
Ryan, M.
Ryd, W.
Ryoichi, H.
Ryś, J.
Ryss, B.
Ryu, H.S.
Ryu, K.S.
Ryu, S.Y.
Rząca, M.
Rzepecka, I.
81
45, 92, 99
111
84
110
23, 53, 120
74
48, 148
158
100
82
79
139
111
178, 179
188
166
181
49, 170
96
47, 137
26, 71, 156, 189
82
70
3, 122
45, 100
108
174
49
95
175
78, 90
69
165
Saghafi, N.
172, 176
Sagie, S.
43, 128, 157
Sagr, E.
139
Saharia, P.
153
Sahdev, A.
64
Şahin, I.
128
Saip, P.
145
Saito, F.
145
Saito, M.
164, 174
Sajadian, A.
73
Sajewicz, J.
176
Saji, H.
157
Sakaguchi, I.
187
Sakaguchi, S.
57
Sakai, K.
183
Sakakibara, H.
58
Sakamoto, M.
45, 101
Sakane, R.
140
Sakuma, M.
162
Sakuragi, N.
88, 104, 130, 157
Sal, V.
128
Sala, E.
13, 189
Salaheen, D.
50
Salakos, N.
66, 125
Salamano, S.
172
Salame, G.
91
Salani, R.
134
Saldivar, J.
190
Saldivar, J.S.
111
Saleh, H.
127, 184
Salehin, D.
29, 66, 77, 153
Salehpour, M.R.
53, 120
Salehpour, S.
90
Salfinger, S.
28
Salihoglu, Y.
144, 145, 147, 173
Sallinen, H.
162, 164
Salman, M.C.
114
Salmeron, J.
46, 112
Salmerón, J.
20
Salutari, V.
119
Salvagno, G.
70
Salvesen, H.
36, 143
Salvesen, H.B.
27, 55, 136
Samaila, M.
125
Sami, S.
72
Samizadeh Nikoy Tabalvandani, Z.
163
Samlal, R.
170
Sammartino, P.
74, 162, 166
Sammugam, S.
118
Samsami, A.
184
Sanai, H.
163
Sanchez-Muñoz, A.
23
Sanci, M.
114
Sanday, K.
58
Sandberg, A.
68
S
Saarelainen, S.K.
Saatli, B.
Saavedra, M.
Sabah, G.
Sabater, S.
Sabbatini, P.
Sabolovic-Rudman, S.
Saboury, M.
Saczko, J.
Sadeghi, E.
Sadeghie, N.
Saeedneia, S.
Saeidi Borojeni, H.
Saeteng, C.
Saftic, I.
Sagae, S.
Sagawa, Y.
Sager, G.
64
146
28
161
146
21
88
153
168
68
74
117
68
155
179
23
167
114
230
Sandjong, I.
106
Sando, Z.
106
Sandri, M.T.
170
Sandvei, R.
49
Sanguineti, F.
49, 152
Sanii, S.
128, 150
Sanioglu, C.
83, 94, 128, 138, 155
Şanioğlu, C.
127
Sankhwar, P.
117
Sant, Cassia, L.J.
31
Santaballa, A.
23
Santabárbara, P.
23, 161
Santin, A.
26, 156, 189
Santin, A.D.
82, 106
Santini, D.
69, 171
Santos, C.
76, 101
Santos, R.
173
Santoso, J.
172
Sanusi, F.A.
85, 87
Sanverdi, I.
187
Sardi, J.
49
Sardzovski, B.
80
Sarfstein, R.
53, 60, 133
Sarian, L.O.
76
Saridogan, E.
44, 190
Sarmadi, S.
128, 150
Sarno, M.
128
Sarraf, Z.
110, 184
Sarris, K.
26
Sartori, E.
163, 186
Saruhan, Z.
30
Sas, L.
43, 175
Sasa, H.
160
Sasada, T.
60, 88
Sasajima, Y.
86, 90, 92
Sasaki, T.
164, 167
Sastre, M.
65
Sathischandra, S.
181
Sato, S.
141, 163, 167
Satoh, T.
95
Sauerwald, A.
48, 148
Sava, T.
184
Savarese, A.
180, 187
Savelli, L.
63
Savone, D.
63
Savvatis, K.
154
Sawada, M.
86
Sawicki, S.
178
Sawyer, M.B.
161
Sayal, B.
114
Sayal, K.
189
Saygili, U.
58, 146
Scalone, S.
180
Scambia, G.
81, 104, 139, 149, 161, 174
Scanderbeg, D.
106, 141
Scarciglia, M.
Scardigno, D.
149
111, 132, 136, 137
148, 176, 180
Scarfone, G.
74
Schauer, C.
47, 131
Schayek, H.
133
Schefter, T.
152
Schilder, J.
159
Schilthuis, M.S.
24
Schink, J.
22, 48, 93, 152
Schmalfeldt, B.
33
Schmeink, C.E.
92, 104
Schmeler, K.
119, 126, 158
Schmid, B.
85
Schmidt, M.
76, 139, 182
Schmidt, S.C.
153, 188
Schmuck, M.L.
82, 145
Schneider, A.
16, 35, 64
Schneider, J.
76
Schneider, K.
169
Schneider-Stock, R.
58
Schofield, P.
123
Schorge, J.O.
166, 172
Schoumackers, A.
63
Schreuder, H.
65
Schreuder, H.W.R.
170
Schröder, W.
26, 33
Schroedel, A.
93
Schroeder, W.
33
Schutzer, M.
66
Schwachula, T.
179
Schwartz, P.
26, 71, 156, 189
Schwartz, P.E.
82
Schwarz, J.
24, 70
Schwarz, T.
20, 46, 112
Schymura, M.J.
52, 166, 181
Scibilia, G.
180
Scognamiglio, M.
144
Scopa, C.D.
148
Scott, I.
171
Seamon, L.
43, 156, 172
Sebestova, O.
45, 100
Seccombe, M.
77
Secord, A.
181
Secq, V.
91
Sedláková, I.
185, 188
Seebacher, V.
104
Seeber, L.
60
Seetatanee, C.
93
Segaert, A.
80
Segev, Y.
43, 64, 128, 157
Sehirali, S.
114
Sehouli, J.
1, 5, 18, 20, 26, 33, 44, 51
53, 55, 120, 142, 149, 153,154, 158, 172
178, 179, 179, 182, 188, 190
231
Seidal, T.
Seki, H.
Seki, N.
Sekiya, R.
Selle, F.
Selvaggi, L.
43, 156
133, 168
47, 131
183, 185
20
111, 132, 136, 137, 148,
176 180, 184
Semaan, A.
138
Semczuk, A.
58, 148, 176
Sen, S.
146, 147, 188
Seo, S.S.
130, 159, 165, 186
Seoane, J.M.
49
Seong, S.J.
125
Seoud, M.
53, 86
Seoung, J.Y.
164
Serati, M.
144
Serce, N.
48, 148
Serova, L.
136
Serra, O.
75
Serrano, A.
103
Sert, B.
116
Sessa, C.
161
Ńevţík, L.
7, 92
Sevelda-Schwarzgruber, U.
47, 131
Sever, B.
30
Seward, S.
138
Seynaeve, C.
22
Sfar, E.
186
Shafer, A.
69
Shah, M.
22, 84, 118
Shahin, M.
184
Shah-Pradhan, T.
91
Shahverdi, Z.
151
Shaikh, G.
100
Shakeri, M.T.
176
Shalbayeva, R.
100, 140, 175
Shamshudin, F.
122
Shan, B.
126, 134, 136, 140, 143
Sharifi, N.
157
Sharkey, K.
123
Sharma, A.
52, 60, 98, 186
Sharma, M.
52, 60, 98, 186
Sharp, V.
44, 184
Shaw, R.
159, 171
Shechter Maor, G.
169
Sheikh, A.
132
Shelkovich, E.E.
157
Shelkovich, S.
173
Shen, D.H.
163
Shen, K.
32, 63, 108, 179, 180
Shen, M.R.
157
Shen, X.
73
Shepherd, J.
33, 82, 121, 182, 183
Sherman, A.
55, 81, 117, 118, 159, 162
Sheshukova, N.
146
Shevchenko, L.
Shi, D.
Shi, G.
Shi, W.
Shibata, K.
Shida, M.
Shiga, N.
Shigetomi, H.
Shih, C.C.
Shih, I.M.
Shih, N.Y.
Shikov, N.
Shimada, H.
Shimada, M.
Shimamoto, T.
Shimizu, N.
Shin, D.G.
Shin, E.Y.
Shin, J.-K.
Shin, J.W.
Shin, S.J.
Shiner, A.
Shiozaki, T.
Shiozawa, T.
Shipilova, A.
Shirota, K.
Shitijyou, S.
Shityakov, S.
Shiwa, M.
Shobha, K.
Shoemaker, A.
Shrestha, E.
Shrestha, P.
Shukakidze, A.
Shukla, N.
Siadat, F.
Siarapo-Ngam, Y.
Sibio, S.
Sicam, R.V.
Sicuri, M.
Siddiqui, G.
Siddiqui, N.
Side, L.
Sideri, M.
Sidhu, V.
Siegal, G.P.
Siegel, E.
Sieunarine, K.
Sigismondi, C.
Signolle, N.
Signorelli, M.
Silasi, D.-A.
Silfverdal, L.
Silva, B.P.
Silva, D.
232
142
140
20, 155
152
183, 185
158
162
182
111, 168
163
75
80
167
167
168
62
177
127
150
181
99
139
176
47, 95, 131, 165
142
57
88
75
175
156
126
133
86, 95
143
33
96
121
74, 162, 166
170
102
50
69, 70
44, 190
170
79
61
26
85, 87
145, 180
61, 109
168
26, 71, 82, 156, 189
45, 100
59
97
Silva, E.G.
4
Silva, L.M.
61
Silva, M.C.
64
Silva, P.C.S.
97
Silva, T.B.
77, 140
Silva-Filho, A.
62, 71, 185
Silva-Filho, A.L.
61
Silver, D.
78
Silverberg, S.
19
Simcock, B.
13, 28
Ńimetka, O.
7
Simonds, H.
46, 99, 112
Simou, M.
67, 131
Simsek, T.
30, 143, 173
Sina, F.P.
43, 54, 102, 120, 160, 168
Sinesat, S.
49, 105
Singh, D.
93
Singh, K.
101, 138
Singh, N.
117, 150
Singh, U.
94, 117
Singh-Carlson, S.
72
Single, N.
73
Sings, H.
46
Siozos, C.
135, 173
Siriaree, S.
155
Sironen, R.
133
Sis, A.
121
Sisson, M.
171
Siu, S.S.N.
92
Sivaloganathan, S.
50
Skafida, P.
66, 77
Skagias, L.
125
Skaland, I.
25
Skapa, P.
45, 100, 106, 113
Ńkapinec, P.
185, 188
Skasko, E.
165
Skinner, R.
20, 46, 112
Skirnisdottir, I.
43, 156
Skobe, M.
165
Skomra, D.
58
Skorupskaite, K.
80
Skovajsova, M.
75
Skovlund, V.R.
78
Skret-Magierlo, J.
106
Skrzypulec-Plinta, V.
101, 102
Slade, R.
123
Slama, J.
119, 185
Sláma, J.
87
Slamova, I.
107
Slangen, B.
59, 161
Slangen, B.F.M.
49, 100
Slim, R.
151
Slonov, A.
105
Smagulova, K.
100
Small, W.
42, 53, 120, 152
Small, Jr., W.
93
Smedts, F.
109
Smink-Bol, M.
171
Smirnova, S.
78
Smith, A.
172
Smith, B.
77
Smith, D.
96
Smith, H.
180
Smitha Raghavan, M.V.
115
Smolaykova, R.
184
Smoleń, A.
115
Smrkolj, Ń.
187
Sneddon, M.
3
Snijders, M.
130, 170
Snijders, M.P.
145
Snijders, M.P.M.L.
45, 92
Snijders, P.
31, 99, 109
Snijders, P.J.
31
Snijders, P.J.F.
45, 46, 92, 99, 191
So, K.A.
109
Soares, F.A.
76
Soares, M.
87
Sobiczewski, P.
83, 153, 158, 185
Sobstyl, M.
169, 182
Soderini, A.
49, 102
Soenen, H.
60
Soeters, R.
142
Sogawa, Y.
165
Soh, L.T.
141
Sohaib, A.
25, 64
Solima, E.
79, 80, 171, 178
Solomayer, E.
26
Somaiah, N.
52, 98
Somasundaram, K.
74
Sommer, A.
160
Sommer, H.
53, 120
Song, J.Y.
167
Song, M.J.
89
Song, T.J.
88, 91, 104, 131, 170
Song, X.
176
Song, Y.
87, 96
Song, Y.J.
186
Song, Y.S.
45, 59, 69, 99, 103, 110
163, 164, 174
Sonmez, A.
115
Sonmez, S.
116
Sood, A.
119, 138, 158
Sood, A.K.
53, 60
Soohoo, S.
23, 61
Soon, R.
95
Soonthornkul Na Chonburi, J.
118
Sopo, M.
164
Sorbe, B.
4, 43, 156, 165
Sorosky, J.
69
Sosa, Comino, E.
71, 188, 189
233
Soslow, R.
4, 133
Sostegni, B.
23
Sotiropoulou, M.
26, 67, 129, 131
Soto, E.
153
Soto-Wright, V.
131
Sottner, O.
75
Souhami, L.
53, 120, 130, 149
Sousa, S.
102
Souza, G.
143
Souza, G.A.
76
Sowter, H.
159, 160
Soyama, H.
180
Sozanski, R.
165
Ńpaţek, J.
83, 147, 185, 188
Spaliaras, D.
69
Spanne, O.
114
Sparén, P.
45, 100
Spatti, G.B.
178
Speiser, P.
85
Spencer, J.
62
Spencer, K.
118
Spendlove, I.
171
Sperner-Unterweger, B.
73
Spillman, M.
51, 61, 190
Spinelli, M.L.
144
Spirina, L.
127
Spirtos, N.
25, 78
Spitzer, D.
90
Sprindzuk, M.
157
Spruijt, J.
31
Sreedharan, H.
77
Sridharan, S.
84
Sriintravanit, N.
117
Srijaipracharoen, S.
135, 136
Srinivasan, R.
151
Srisomboon, J.
155
Srivastava, A.N.
94
Srivastava, S.
94
Stachowicz, N.
155, 158
Staehle, A.
33
Staff, A.C.
27
Stähle, A.
26, 33, 53, 120
Stainimir, G.
149
Stalpers, L.J.A.
24
Stamatovic, L.
164
Stamatovic, M.
179
Stamelos, V.
169
Standlova, K.
70
Staniaszek, J.
67, 84, 89, 153, 158
Stanicek, J.
109
Stanley, M.
24, 34
Stassen, J.-M.
60
Stathopoulos, E.
149
Stavraka, C.
161
Steenbergen, R.
31
Steetskamp, J.
139, 182
Stefanatou, G.
129
Stefansson, I.M.
27, 136
Stehman, F.
159
Steiner, E.
139
Steiner, M.
163
Stejskal, J.
111
Stenlake, A.
121
Stephenson, R.
68
Stergioudas, I.
68, 115, 182
Sterling, J.
24
Sterling, L.
170
Stettner, R.
148
Stevens, A.
81
Stewart, S.L.
52, 166, 181
Stickeler, E.
57, 58, 59, 60
Stockler, M.
54, 55, 120
Stone, P.
30, 81
Stone, R.L.
53, 60
Stracci, F.
104
Strada, I.
64, 68, 170, 171
Strander, B.
45, 100
Straughn, J.M.
169
Straughn, Jr., J.M.
92, 126
Strauss, A.
160
Strauss, J.
93
Strebel, E.
26
Stremmel, C.
171
Stronach, E.
186
Strossova, N.
107
Struyf, F.
20, 46, 112
Stuckey, A.
66
Stuhr, K.
152
Stumpf, M.
133, 171
Stys, A.
165
Su, H.
64, 105
Su, Y.
96
Suárez, Hernández, Y.
71, 188, 189
Subramaniam, A.
169
Subramaniam, S.
95
Sudo, S.
104, 130
Sudo, T.
24
Suga, S.
26, 80, 81
Sugimoto, A.
55
Sugita, K.
132
Sugiyama, T.
23, 117, 126, 158, 175
Sugiyama, Y.
30, 128
Suh, D.H.
163
Suh, D.S.
158
Sui, L.
145
Suijkerbuijk, K.
60
Sukegawa, A.
157
Sukhin, V.
93
Sukhina, E.
93
Sukonko, O.
112
234
Sulay, R.
Sultan, A.
Sultan, R.
Sumar, N.
Sumdaengrit, B.
Sun, C.
Sun, H.
Sun, P.
Sun, X.
Sun, Y.
Sun, Z.
Sundar, S.
Sundborg, M.
Sung, C.O.
Sung, Han, K.
Sung, M.-S.
Sunvisson, H.
Suprasert, P.
Suryanarayan, U.
Susumu, N.
Sutherland, R.
Suwannarurk, K.
Suzuki, A.
Suzuki, M.
Suzuki, N.
Suzuki, R.
Suzuki, Y.
Svecova, I.
Svoboda, B.
Svobodova, S.
Swan, R.
Swart, A.M.
Swee, Peng, Y.
Sweep, F.
Swenerton, K.
Swierzko, A.
Swing, D.
Swisher, E.
Syamala, V.
Sykes, P.
Sykes, P.H.
Sykorova, J.
Symiakaki, I.
Syversen, U.
Szabo, B.
Szafron, L.
Szala, A.
Szarewski, A.
Szatkowski, W.
Szczylik, C.
Szemraj, J.
Szeto, E.
Sznurkowski, J.
Sznurkowski, J.J.
Szymanski, J.
114
162
155
79
92, 121
67, 119, 158, 161
190
87, 96, 133
7, 29, 47, 118, 125, 141
136
136
132
129
176
131
98
4
155
89
133, 144
175
134
47, 131, 144, 165
23
97, 103, 117, 126, 147
157
48, 128, 129, 190
148
138
187
181
20, 159, 177
91, 130
151
22
178
163
156
77
28
47, 132
75
100
177
79, 96
165
178
16, 20, 46, 112
180
44, 178
178
97
28, 57
66
178
T
Tabassum, U.
Tabata, T.
Tablante-Reyes, D.J.
Taehwa, L.
Taffas, P.
Tahseen, M.
Tai, S.M.
Taib, N.A.
Tailor, A.
Tajalli, T.
Takada, S.
Takaesu, Y.
Takagi, K.
Takahashi-Shiga, N.
Takai, N.
Takai, Y.
Takaishi, K.
Takakura, S.
Takal, M.K.
Takanashi, M.
Takano, M.
Takano, T.
Takatsu, A.
Takayanagi, A.
Takeda, M.
Takeda, S.
Takehara, K.
Takekuma, M.
Takemura, M.
Takemura, N.
Takeshima, N.
Takeshita, T.
Takeuchi, S.
Takeya, M.
Takhayev, Z.
Takizawa, K.
Taleska, B.
Tam, K.F.
Tam, K.-F.
Tamalet, C.
Tamim, H.
Tammi, M.
Tammi, R.
Tammineedi, S.R.
Tampakoudis, G.
Tamura, K.
Tan, K.H.
Tan, A.L.
Tan, B.K.
Tan, L.
Tan, X.J.
Tanabe, H.
Tanaka, K.
235
74
93, 176
67
90
100
74
62
76
64, 65, 78, 79, 80
146
132
164, 167
163
88
157
168
180
174
187
164
23, 160, 175, 180
141, 162
47, 95, 131, 165
62
104, 130
26, 81, 168
141
93
47, 140
108
30, 128
90, 167, 175, 187
93, 176
180
140
30, 128
112
82, 97, 165
28
112
86
133
133
61, 103
66, 77
168
125
139
31
173
32, 108
174
175, 182
Tanaka, T.
45, 101, 164, 174
Tanapat, Y.
82
Tanase, F.
65
Tanase, Y.
182
Taneepanichskul, S.
108
Tang, A.
32
Tang, J.
165
Tangjitgamol, S.
135, 136
Tangtrakul, S.
151
Tanimanidis, P.
77
Tanner, P.
3, 121
Tanovic, A.
23, 159
Tantanasis, T.
115, 182
Tantbirojn, P.
175
Tanvanich, S.
136
Tao, T.
179, 180
Tao, X.
158
Tapısız, Ö.L.
128
Taranger-Charpin, C.
91
Tarcea, M.
84
Taşdemir, N.
161
Tase, T.
141, 162
Tashiro, H.
145, 180, 187
Taskin, S.
76, 78, 87, 118, 127, 137, 171
Taskiran, C.
88, 113, 114
Tassi, R.
106, 156, 178
Tassi, R.A.
184
Tatar, S.
137
Tateo, S.
172, 180
Tateyama, N.
167
Tauriala, H.
172
Tavares, F.
173
Tavassoli, F.
71
Taylor, A.
26
Taylor, J.
67
Tchórzewska, H.
83
Tchoulkova, E.
136, 146
Tchoulkova, O.
136
Tebeu, P.M.
102, 106
Tedjarati, S.S.
189
Teimoori, N.
151
Teixeira, A.M.S.
71
Teixeira, J.
20, 46, 112
Teixeira, M.
76
Tejada-Berjes, T.
14
Tekelioglu, T.
187
Tempfer, C.
104
Tenestedt, B.-M.
4
Teng, N.
181
Tenjin, Y.
45, 101
Teo, S.H.
76
Teoh, D.
23
Teoh, Y.-L.
95
ter Brugge, H.G.
51, 130
ter Harmsel, W.
31
ter Harmsel, W.A.
ter Kuile, M.
Terakawa, N.
Terao, Y.
Terathongkum, S.
Terauchi, F.
Termrungruanglert, W.
Terzakis, E.
Terzea, D.C.
Terzic, M.
Testa, A.
Testa, A.C.
Tetedeg, V.
Tevdoradze, T.
Tewari, K.
Thacker, P.
Thanapprapasr, D.
Thavaramara, T.
Thaweekul, Y.
Theletsane, M.
Theodora, M.
Therasakvichaya, S.
Thigpen, J.T.
Thille, A.
Thirapakawong, C.
Thomakos, N.
Thomas, C.
Thomas, G.
Thomas, J.
Thomeer, M.G.J.
Thompson, T.D.
Thong, M.
Thulkar, S.
Tian, M.
Tichy, M.
Tidy, J.
Tikovsky, K.
Timmerman, D.
Tingulstad, S.
Tinker, L.
Tîrnovanu, M.
Tischkowitz, M.
Tisi, G.
Titova, V.
Tjalma, W.
Tjan-Heijnen, V.C.G.
Tjin Asjoe, F.
Tjulandin, S.
Todeschini, P.
Todo, Y.
Tognon, G.
Toita, T.
Toki, N.
Toksöz, L.
236
46, 99
116
167
26, 81
181
164, 167
108
107, 130
58
171
23
63
172
75
25
161
83
135, 136
134
113
135
112
25
104, 110
112
26, 67, 100, 129
131, 139 183
151
10, 37, 38, 119
29
109
166
76
33, 179
140
90
54, 120
138
63
27, 177
108
141, 176
22
163, 184
116, 142
43, 46, 107, 175
169
43, 175
23
156, 184
48, 128, 129, 190
106, 178, 184
85, 91, 95
133
67
Tokunaga, H.
Tolhurst, J.
Toma, A.
Tomao, F.
Tomobe, J.
Tong, P.
Tong, S.-Y.
Tong, X.W.
Tongaonkar, H.B.
Tonk, V.
Tootill, D.
Topolcan, O.
Topuk, S.
Topuz, S.
Toral, J.A.
Torensma, R.
Torii, Y.
Törnberg, S.
Torne, A.
Torp, S.H.
Torres, D.
Torres, P.
Torsello, A.
Tortorella, L.
Tońner, J.
Tosun, N.
Touboul, C.
Tousseyn, T.
Townsend, J.S.
Townsley, C.
Toyoda, M.
Toyoda, S.
Toyoshima, M.
Tozawa, A.
Traen, K.
Traiman, P.
Trajkovska, E.
Traut, A.
Tredan, O.
Trietsch, M.D.
Trihia, E.
Trillet-Lenoir, V.
Trimble, C.
Trimble, E.
Trimbos, B.
Trinh, X.B.
Tripodi, E.
Triratanachat, S.
Tropé, C.G.
Trovik, J.
Troyano, Luque, J.M.
Trujillo, J.L.
Truntzer, C.
Tsai, C.Y.
Tsai, Y.C.
162
69, 70
79, 96
83, 188
132
131
57, 59
58
51, 191
190
188
187
116
145, 146, 147, 173
109
177, 178
160
45, 100
54, 120
177
74
88
187
174
185, 188
77
85
138
52, 181
108
126
176
88
97, 103, 117, 147
80, 142
61, 62, 71, 185
94, 132
49
181
69
69
161
41
37, 53, 55, 119
116
43, 175
64, 141, 169
60
33
27, 55, 136, 143
189
113
162
26
60
Tsapanos, V.
188
Tselepi, V.
148
Tserkezoglou, A.
107, 130
Tsiaousi, I.
107
Tsimberidou, A.
29
Tsipis, A.
76
Tsipouras, P.
100
Tsivian, M.J.
64, 68, 170, 171
Tsoncheva, V.
96
Tsonev, A.
67, 78, 88
Tsubamoto, H.
93, 140, 176
Tsuda, H.
23, 86, 90, 92, 144
Tsuda, N.
60
Tsujii, H.
108
Tsujioka, H.
57, 127
Tsukazaki, K.
144
Tsunoda, A.T. 30, 64, 69, 74, 77, 140, 185
Tsuruta, T.
144
Tu, X.
126, 143
Tufinashvili, T.
143
Tuipae, S.
114
Tülek, F.
137
Tulunay, G.
55, 106, 134, 138
Tummers, P.
111
Tuncbilek, E.
55
Tuncer, M.
117, 120
Tuncer, Z.S.
99, 132
Tuppurainen, L.
164
Turan, A.T.
55
Turan, T.
106, 134, 138
Turkyilmaz, E.
88
Turnbull, L.
99
Tuteja, S.
71
Tuunanen, P.
164
Tuzlalı, S.
146
Tyko, Hill, K.
145
Tzafettas, M.
68, 145, 151, 182
U
Ubellacker, J.
Uccella, S.
Uchida, T.
Udagawa, Y.
Ueda, S.
Ueda, T.
Ueda, Y.
Uegaki, K.
Ueki, A.
Ueland, F.
Ugaki, H.
Uharcek, P.
Uharţek, P.
Uitterhoeve, A.
Ulrich, U.
237
43, 156
143, 144
141
23, 117, 160
47, 131, 163
57, 127
47, 140
167
133, 144
43, 156, 172
47, 140
78
101
24
172
Ulrych, V.
Umayahara, K.
Umezawa, A.
Umezu, T.
Unal, A.S.
Unal, O.
Unkila-Kallio, L.
Unlukaptan, M.
Unsal, M.
Urban, R.
Urbanski, K.
Urbauer, D.
Urrejola, L.
Urrejola, R.
Ürünsak, I.F.
Urzal, C.
Ushakova, G.
Ushijima, K.
Usmani, A.
Ustun, H.
Ustuner, I.
Utsugi, K.
Utsunomiya, H.
Uzan, C.
Uzir, B.
Uzun, M.
111
30, 128
126
183
121
63
172
114
131, 136
43, 81, 159, 162, 174
174, 180
161, 172
88
88
30, 67
89
116
60, 88, 90, 168
79
88
114
30, 128
162
85, 154
23, 61
63
van den Akker, P.
170
Van den Broecke, R.
105
van den Einden, L.C.G.
28, 69
van den Hende, M.
24
Van der Auwera, I.
43, 175
van der Avoort, I.A.M.
69
van der Burg, M.
22
van der Burg, M.E.L.
49
van der Burg, S.H.
24, 101
van der Sijde, R.
51, 130
van der Steeg, J.W.
24
van der Steen-Banasik, E.
24
van der Velden, J.
24, 43, 49, 167
van der Wilt, C.
24
van der Zee, A.G.
66
van der Zee, A.G.J.
8, 28, 51, 130
van der Zee, J.
24
van Diest, P.
60
van Dijck, J.A.A.M.
169
van Dongen, R.A.J.M.
45, 92
van Doorn, H.
111
van Doorn, H.C.
109
van Doorn, L.
66
van Dyk, S.
45, 84
Van Gool, S.W.
127
Van Gorp, T.
49, 100
van Groningen, K.
45, 92
van Ham, M.
130, 171
Van Holsbeke, C.
63
Van Huffel, S.
63
van Kemenade, F.
31
van Kemenade, F.J.
45, 92
van Kempen, L.C.
66, 145
van Krimpen, K.
45, 92
Van Laere, S.
43, 175
van Lonkhuijzen, L.
119, 170
van Nagell, J.
43, 156
van Nagell, Jr., J.
172
Van Nes, M.C.
63
Van Rensburg, E.
113
Van Schalkwyk, G.
171
Van Tendeloo, V.
127
van Tinteren, H.
24
Van Wijk, L.
142
Vaňásek, J.
90, 111
Vandecasteele, K.
105
Vandenput, I.
27, 138, 142, 143
Vandromme, J.
81
Vanecek, T.
101
Vanichtantikul, A.
129
Vardar, M.A.
30, 67, 109, 151, 160
Vasanthan, S.
159
Vashakmadze, S.
142
Vasilev, S.
146
Vasilikou, T.
107
V
Vadiveloo, V.
Vafaiezadeh, F.
Vago, P.
Vaidya, A.
Vainio, O.
Vaknin, Z.
Vakselj, A.
Valadares, F.
Valentin, L.
Valentino, V.
Valeri, B.
Valery, P.C.
Valizadeh, N.
Valmadre, S.
van der Zee, A.G.J.
van Altena, A.M.
van Baal, M.
van Beurden, M.
van Bree, R.
Van Calster, B.
Van Calsteren, K.
van Dam, P.
van de Nieuwenhof, H.P.
van de Poll-Franse, L.
van de Rijn, M.
Van de Vijver, K.
136
125
43, 172
95
44, 184
81
187
72, 117
63
162
79, 178
140
71
123
49
157, 169
65, 99
43, 167
31, 60
63
31, 41
43, 80, 142, 175
28, 66
10
27
49, 59, 100
238
Vasiljeva, J.
64, 137, 148
Vasovic, S.
164
Vassallo, J.
76
Vassilakos, P.
106
Vazquez, V.
68
Vecchio, S.
145
Velcheva, D.
96
Vélez, J.I.
119
Vellone, V.
104
Vencken, P.M.
22
Venizelos, I.
145
Ventura, L.H.A.
185
Venturini, E.
122
Venturoli, S.
64, 68, 69, 170, 171
Vera, C.
166
Verardi, R.
178
Verbeek, A.L.M.
169
Verbesselt, R.
31
Verbist, G.
142, 143
Vergara Ibañez, R.A.
146
Vergote, I.
17, 23, 43, 49, 60, 80
100, 127, 138, 142, 143, 161, 167
Verheijen, R.
31, 43, 49, 60, 65, 99, 167
Verheijen, R.H.M.
46, 99, 151
Verleye, L.
49
Vermeulen, K.M.
51, 130
Vermeulen, P.
43, 175
Vermorken, J.B.
159
Vernerova, Z.
138
Verriele, V.
74
Verschraegen, C.
180
Verweij, E.
170
Veshapidze, N.
75, 143
Vet, J.N.I.
101
Veyalkin, I.
75
Viana, C.
68
Victor, A.
182
Vidal-Sicart, S.
65
Vieira de Castro, P.
173
Vieira, M.A.
64, 140
Vieira, R.A.C.
74
Viganò, R.
145, 180
Vigliotta, M.
174
Vijayananthan, A.
136
Villa, A.
63, 102
Villa, G.
122
Villanueva, R.
75
Vincent, L.
181
Vincenzoni, C.
83
Vine, S.J.
191
Vinod, S.
84
Viriyapak, B.
108, 112
Visnovsky, J.
185
Visser, O.
43, 167
Vistad, I.
88
Vitorovic, S.
Vizza, E.
Vizzielli, G.
Vlachos, G.
Vloon, A.
Vojnika, A.
Volgger, B.
Volkov, A.
Volkov, V.G.
Vollebergh, J.
Volpi, E.
Voogd, A.C.
Voorhoof, L.
Vorapongsathorn, T.
Vorasittha, A.
Vorgias, G.
Voss, M.
Voulgaris, Z.
Vouza, E.
Vowler, S.
Voysey, M.
Vrabie, C.
Vranova, V.
Vrekoussis, T.
Vrzalova, J.
Vuckovic, Z.
Vuduyaraju, H.
Vuento, M.
Vukajlovic, S.
Vukcevic, G.
Vukmirovic, L.
Vuleta, D.
Vyas, R.
110
83
81, 139, 174
26, 67, 129, 131, 139
101
119
47, 131
112
183
170
64
49, 100
80, 142
92
129
69, 129
132, 145
149
66
189
55
58
107
149
187
176
103
64
70, 93
145
93
85
55, 89, 92
W
Wada, Y.
167
Wafelman, A.R.
101
Wagener, A.
171
Wagner, U.
55
Wake, K.
167
Wake, N.
26
Walker, G.
80, 147
Walker, J.
20, 41
Wallwiener, D.
14
Walsh, T.
28
Wan, T.
52, 191
Wan, X.
150, 152, 164
Wang, C.-C.
103, 111
Wang, D.Q.
153
Wang, H. 86, 112, 126, 130, 134, 136, 140
143, 147
Wang, H.-W.
26
Wang, H.Y.
165
Wang, H.-Y.
58, 59, 94, 96, 164
239
Wang, J.
Wang, J.-L.
Wang, J.-P.
Wang, K.L.
Wang, K.-L.
Wang, L.
Wang, M.
Wang, P.-H.
Wang, S.-J.
Wang, T.
Wang, T.Y.
Wang, W.
Wang, W.-T.
Wang, X.
Wang, Y.
Wang, Y.C.
Wanke, N.
Ware, R.
Waring, K.
Warnnissorn, N.
Warren, A.
Warton, K.
Watanabe, A.
Watanabe, C.
Watanabe, N.
Watanabe, Y.
Watari, H.
Watts, S.
Waziri, G.
Weare, K.
Weathers, T.
Weber, F.
Weber, S.
Wegdam, W.
Wegscheider, K.
Wei, L.
Wei, L.-H.
Weitner, B.B.
Welch, S.
Welters, M.J.P.
Wen, H.
Wen, Y.
Wenham, R.
Wenzel, L.
Werner, H.
Wertel, I.
West, L.
Westermann, A.
Wethington, S.
Wętka, M.
Wetzels, K.
Wheeler, C.
Wheler, J.
White, K.
Whitworth, J.
85, 125, 146, 176
181
110
168
111, 162
50, 55, 108, 152
61
60, 181
181
150
26, 111, 168
51, 175, 181
64, 69, 81
97, 166, 167
163, 164, 186
43, 74, 174
101
43, 156, 172
145
134
159
175
160, 175
143
132
162
88, 104, 130, 157
3
125
3
159
83
48, 148
43, 167
33
86, 90, 125, 146
98, 105, 108, 181
93
50
101
70, 160, 178
87
23
11, 35, 186
53, 59, 60, 133
155, 169, 182
71
24
59
101, 102
167
20, 46, 112
29
3, 122
169
Wicherek, L.
61, 106
Wiebe, E.
138
Wijma, J.
51, 130
Wik, E.
27, 55, 136
Wike, J.M.
52, 166, 181
Wilailak, S.
92, 93, 151, 181
Wilczok, J.
101, 102
Wilkin, D.
101
Wilkinson, S.
23
Williams, H.
83
Wilson, C.
76
Wilson, D.
190
Wimberger, P.
26, 33, 55, 172
Winship, A.
116
Winter, K.
53, 120, 152
Winter, Roach, B.
122
Winter-Roach, B.
123
Witteveen, P.
31
Witteveen, P.O.
151, 170
Woelber, L.
24, 70
Wölfl, M.
127
Wollschlaeger, K.
55
Wollschläger, K.
33
Wolterbeek, R.
31
Wolters, R.
101
Wong, C.-S.
162
Wong, H.
188
Wong, S.M.
140
Wongvatunyu, S.
121
Wongyu, K.
90
Woo, Y.L.
24, 76
Wootton, J.
25
Woronoff-Lemsi, M.-C.
168
Wozniak, G.
156
Wrede, D.
28
Wright, J.
7, 22, 29, 47, 118, 141
Wu, C.
83
Wu, K.-Y.
83
Wu, L.
98
Wu, M.
32, 108, 179
Wu, P.-J.
148
Wu, R.
84
Wu, R.-F.
98
Wu, T.
103
Wu, T.-I.
111
Wu, W.-C.
62
Wu, X.
53, 59, 98, 112, 113
Wu, X.H.
165
Wurz, K.
156
Wust, P.
158
Wydra, D.
28, 122, 134, 172, 178
Wynne-Simmons, R.
134
Wysocka, T.
168
Wysocka-Bobryk, T.
83
240
Yang, Y.
Yang, Y.C.
Yano, K.
Yao, T.
Yao, Y.Y.
Yap, S.P.
Yarandi, F.
Yarandi, N.
Yaremko, B.
Yari, M.
Yashar, C.
Yasmaras, B.
Yasugi, T.
Yates, M.
Yavan, T.
Yavuz, E.
Ye, T.
Ye, X.
Ye, Y.Z.
Yen, C.-F.
Yenen, M.
Yenen, M.C.
Yeo, M.C.R.
Yeo, R.
Yesilyurt, B.
Yetimalar, H.
Yezhova, I.
Yi, X.
Yiannou, P.
Yigit, R.
Yildirim, C.
Yildirim, Y.
Yıldız, A.
Yildiz Eren, C.
Yıldız, R.
Yim, G.W.
Yin, D.
Yin, Nin, C.
Yin, R.
Yin, R.T.
Yip, C.H.
Yla-Herttuala, S.
Ylikorkala, O.
Yo, Y.T.
Yokota, N.
Yokoyama, M.
Yokoyama, Y.
Yoney, A.
Yoneyama, K.
Yong, C.-M.
Yong, Kuei, L.
Yonghua, C.
Yoo, C.-W.
Yoo, H.-J.
Yoon, B.S.
X
Xercavins, J.
Xiang, L.
Xiang, Y.
XiaoHua, W.
Xiaoping, L.
Xie, C.
Xie, X.
Xing, C.
Xing, Y.
Xirou, P.
Xue, H.-D.
76, 113
53, 59
150
97, 116, 169
143
153, 155
97, 98, 167
110
33
66
63
Y
Yaegashi, N.
Yağcı, G.
Yaguchi, H.
Yahagi, N.
Yahata, T.
Yahya, H.
Yalçın, H.R.
Yam, K.L.
Yam, P.
Yamada, A.
Yamada, H.
Yamada, K.
Yamada, Y.
Yamagami, W.
Yamaguchi, K.
Yamaguchi, S.
Yamakado, M.
Yamamoto, A.
Yamamoto, E.
Yamamoto, F.
Yamamoto, H.
Yamamoto, T.
Yamamura, S.
Yamanaka, S.
Yaman-Tunc, S.
Yan, L.
Yan, X.
Yanaihara, N.
Yanaranop, M.
Yang, E.J.
Yang, G.
Yang, H.
Yang, H.C.
Yang, J.
Yang, J.X.
Yang, L.
Yang, L.W.
Yang, P.Y.
Yang, W.
9, 23, 88, 141, 162
76
57
103, 117, 147
175, 182
136
128
141
123, 125
60
107, 108, 141, 144
174
182
144
22, 165
24
128
187
183
186
128
132
165
58
113
176
51, 175, 181
164, 174
114
123
126
53, 59, 140, 143
134
179, 180
63
156
60
57
143
241
164
111, 162, 168
128
84, 90
163
123, 141
86, 89
89
152
68, 84, 127
106, 141
101
95
172, 179
77, 121
145
177
163
57
64
114
85, 105, 154, 167, 178
98
125, 141
167
98, 114, 137
109
190
149
177, 178
131, 136
60, 114, 143
98, 137
125, 139
76
129
125
68, 91, 130, 160
162
153
76
162, 164
131
43, 74, 174
157
168
141
131, 136
175, 187
95
68, 91, 130, 160
143
186
82, 87
125
Yoon, J.
Yoon, M.S.
Yoon, S.Y.
Yoonessi, M.
Yosefe, Z.
Yoshida, A.
Yoshida, K.
Yoshida, S.
Yoshihara, K.
Yoshikawa, H.
Yoshinaga, K.
Yoshino, K.
Yoshioka, N.
Yoshioka, Y.
Yoshizato, T.
Yotsumoto, F.
You, K.
Young R.
Young, F.
Young, T.
Yousefe, A.
Yousefi, Z.
Youssef, A.
Yu, H.
Yu, M.
Yu, M.H.
Yu, X.
Yu, Y.
Yu, Y.H.
Yu, Y.S.
Yuan, S.S.
Yuce, K.
Yue, W.
Yuksel, H.
Yuksel, O.
Yuksel, S.
Yun, B.
Yuqi, Z.
70
158
76
167
150
97
89
107, 108, 144, 182
182
95
162
47, 86, 140
117
57
57, 127
57
69
15
174
54, 120
150
73, 157
30
189
63, 95
43, 174
43, 81, 159, 162, 174
47, 136, 185
145
78
72, 74
55, 114
143
114
115, 116
187
141
97, 116
Zanaboni, F.
80, 171, 178
Zanagnolo, V.
49, 83, 152, 163
Zanfagnin, V.
64, 141, 169
Zang, R.
33, 112
Zang, R.Y.
165
Zannoni, G.F.
81, 104
Zanotti, L.
106, 178, 184
Zapardiel, I.
76, 83, 163
Żawrocki, A.
28, 57, 66
Zayyan, M.S.
119
Zeillinger, R.
5
Zeimet, A.
47, 131
Zeimet, A.G.
171
Zeng, L.
84
Zerbini, M.
69
Zerdoud, S.
108
Zergeroglu, S.
157
Zerlin, M.
22
Zezulkova, D.
107
Zhang, B.
60, 169
Zhang, G.
98, 108, 147
Zhang, J.
69, 155, 164
Zhang, L.
166
Zhang, T.
166
Zhang, W.
84
Zhang, Y.
59
Zhang, Y.-G.
64, 69, 81
Zhang, Z.
172
Zhao, C.
86, 90, 98, 108
Zhao, J.
156
Zhao, L.
146
Zhao, X.
146, 153
Zhao, Y.
86, 98, 108, 181
Zheng, H.
51, 118, 175, 181
Zheng, L.M.
96
Zheng, M.
59, 94, 96, 164
Zhou, C.
167
Zhou, L.
153
Zhou, Q.M.
94, 164
Zhou, X.
20, 47, 53, 59, 116, 136, 140
Zhou, Y.
112, 113
Zhu, G.
73
Zhukovsky, D.
161
Zibzibadze, M.
75, 143
Zieger, W.
161
Zikan, M.
43, 65, 119, 185
Zikán, M.
87
Ņikiš, D.
65, 86, 183
Zima, T.
87
Zimmerman, Y.
44, 184
Zimmermann, A.
44, 178
Zintl, P.
23, 161
Zito, R.
188
Ņivaljeviš, M.
65, 183
Zizioli, V.
178
Z
Zaal, A.
Zaatary, G.
Zabel, N.
Zaganelli, F.
Zahaf, T.
Zaharuddin, R.
Zahedi, F.
Zaiac, M.
Zakashansky, K.
Zalameda-Castro, C.
Zaloudek, C.
Zamagni, C.
Zamecnik, J.
Zampogiannis, A.
31, 46, 99, 191
86
139
89, 107
20, 46, 112
96, 114
90
16
165
83
176, 186
171
113
77
242
Zlatkov, V.
Zmira, N.
Znaor, A.
Zola, P.
Zolciak-Siwinska, A.
Zolciak-Siwińska, A.
Zou, C.-F.
Zou, L.
Zouaoui, B.
Zu, Z.
96
163
88
23, 64, 68, 141, 169
89, 158
84, 153
64, 69, 81
155
186
147
Zubor, P.
Zuborova, D.
Zugravu, C.
zur, Hausen, A.
Zusterzeel, P.
Zusterzeel, P.L.M.
Zvaigznite, M.
Zweemer, R.
Zygouris, D.
243
65, 111, 148, 185
65
84
58
32, 170
177, 178
78
60, 65
130

Congresses/IGCS2010/Documents/Secretariat

Transcription

Similar documents

Stakeholder mapping - Service Design Toolkit

Universal Health Care and Interdisciplinar y Research in Asia

TUMORI UTERINI MESENCHIMALI

donor report - American-Italian Cancer Foundation

TUMOR LAMBUNG

Prostate Biopsy - Facoltà di Medicina e Chirurgia

biobanking for cancer research: rules and roles

Tumori del polmone. Dati epidemiologici, prevenzione e diagnostica

DeFlora - Tumori_professionali

Donor Report - American-Italian Cancer Foundation